id,adj.P.Val.xBirA.Cre.over.NoBirA,AveExpr.xBirA.Cre.over.NoBirA,Log.P.Value.xBirA.Cre.over.NoBirA,logFC.xBirA.Cre.over.NoBirA,P.Value.xBirA.Cre.over.NoBirA,t.xBirA.Cre.over.NoBirA,PlexesSearchedTogether_correct..126.126.127.128.129.130.131..NoBirA_6Combo.multimedian,PlexesSearchedTogether_correct..128.126.127.128.129.130.131..NoBirA_4Combo.multimedian,PlexesSearchedTogether_correct..129.126.127.128.129.130.131..NoBirA_5Combo.multimedian,PlexesSearchedTogether_correct..127.126.127.128.129.130.131..BirA.Cre_3Combo.multimedian,PlexesSearchedTogether_correct..130.126.127.128.129.130.131..BirA.Cre_2Combo.multimedian,PlexesSearchedTogether_correct..131.126.127.128.129.130.131..BirA.Cre_1Combo.multimedian,id.query,id.mapped,id.concat,id.1,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,PlexesSearchedTogether_correct.unique_peptides,PlexesSearchedTogether_correct.numSpectra,PlexesSearchedTogether_correct.totalIntensity,PlexesSearchedTogether_correct.pct_cov
E9Q414,0.531980433,-0.062,5.161324023,0.313333333,0.304696593,1.121341665,-0.526,-0.302,0.172,0.212,-0.136,0.208,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,2206,277,277,E9Q414,MOUSE,510791.9,55.2,1,1.1,4364.47,4364.47,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,277,2206,2.74E+12,55.2%
P01027,0.372901545,-0.105333333,7.918560407,0.529333333,0.161489377,1.595536418,-0.858,-0.324,0.072,0.118,-0.125,0.485,P01027,C3,P01027_C3,P01027,C3,1,2121,185,162,P01027|P01027-2|Q2UVX4|G3X7A5,MOUSE,188021,90.3,2,2.1,3125.9,2801.99,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,186,2121,6.9E+12,90.3%
A0A0F6QNP7,0.432253305,-0.04525,6.758067261,0.678333333,0.210956676,1.487131797,,-0.554,,-0.004,-0.153,0.53,A0A0F6QNP7,NotFound,A0A0F6QNP7_NotFound,A0A0F6QNP7,C3,1,2,26,1,A0A0F6QNP7,BOVIN,188719.1,10,2,2.2,348.51,7.96,,1661,Complement component 3,,,,1,2,17800000,0.6%
Q61838,0.595170996,-0.0925,4.166197729,0.314333333,0.383160055,0.940454316,-0.842,-0.182,0.275,-0.008,0.118,0.084,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,4113,148,143,Q61838,MOUSE,167218.8,75.7,3,3.1,2782.24,2702.38,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,148,4113,1.91E+14,75.7%
F1MI18,0.565439223,0.902666667,4.711134244,-1.098,0.337976556,-1.041679903,1.141,2.538,0.676,2.615,-0.881,-0.673,F1MI18,NotFound,F1MI18_NotFound,F1MI18,,1,8,9,4,F1MI18|F1MJK3,BOVIN,167182.2,6.9,3,3.2,108.18,28.32,,1478,Uncharacterized protein,,,,4,8,248000000,3.9%
A0A087WSN6,0.83268412,0.827666667,1.555776165,-0.319333333,0.698911817,-0.406015995,2.428,0.509,0.025,0.85,1.549,-0.395,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,1003,120,120,A0A087WSN6|B9EHT6|A0A087WR50|Q3UHL6|P11276|B7ZNJ1|A0A087WS56|Q4KL80,MOUSE,256658.4,60.7,4,4.1,1990.99,1990.99,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,120,1003,9.56E+11,60.7%
P06684,0.267456564,-0.200333333,11.10540555,0.536,0.077528154,2.123779787,-0.77,-0.203,-0.432,0.227,-0.048,0.024,P06684,Hc,P06684_Hc,P06684,C5,1,1072,131,131,P06684|A0A0J9YUU3,MOUSE,190586.2,61,5,5.1,1982.7,1982.7,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,131,1072,1.8E+12,61.0%
P28665,0.572853107,-0.083166667,4.566186037,0.331666667,0.349447064,1.01423557,-0.842,-0.048,0.143,0.259,-0.048,0.037,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,1351,108,52,P28665,MOUSE,166721,62.1,6,6.1,1825.68,971.3,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,108,1351,3.13E+12,62.1%
P28666,0.564806326,-0.0865,4.752704163,0.289,0.334756936,1.047904916,-0.115,-0.586,0.008,-0.141,-0.015,0.33,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,30,63,15,P28666,MOUSE,163805.4,39.2,6,6.2,912.37,179.67,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,15,30,1470000000,11.5%
A0A0N4SVU1,0.402360978,-0.148833333,7.305868021,0.481666667,0.185957285,1.492518344,-0.964,-0.235,0.03,0.253,-0.02,0.043,A0A0N4SVU1,NotFound,A0A0N4SVU1_NotFound,A0A0N4SVU1,Gm7298,1,6,40,2,A0A0N4SVU1,MOUSE,166767.7,24.3,6,6.3,566.2,14.9,,1476,Predicted gene 7298,,,,2,6,99800000,1.2%
P01029,0.926318894,0.043166667,0.75695184,0.076333333,0.840049381,0.21074085,-0.421,-0.27,0.706,0.143,-0.124,0.225,P01029,C4b,P01029_C4b,P01029,C4b,1,1089,116,116,P01029|E1BH06|F1MVK1|P01030,MOUSE,194566.4,62.3,7,7.1,1704.26,1704.26,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,116,1089,1.63E+12,62.3%
Q921I1,0.296820483,-0.113166667,10.20193367,0.644333333,0.095456748,1.975146124,-1.005,-0.012,-0.289,0.313,0.315,-0.001,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,1784,90,87,Q921I1|E9Q035|Q29443|E9Q939,MOUSE,78890.5,82.2,8,8.1,1669.13,1617.66,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,90,1784,2.9E+13,82.2%
Q2HJF0,0.484449308,-0.4,5.83163833,1.421333333,0.261117613,1.241355576,0.604,-0.135,-3.801,0.632,0.34,-0.04,Q2HJF0,NotFound,Q2HJF0_NotFound,Q2HJF0,LOC525947,1,23,8,5,Q2HJF0,BOVIN,70893.5,4.8,8,8.2,85.18,33.71,,622,Serotransferrin-like,,,,5,23,18900000000,1.4%
E9Q8I0,0.438943049,-0.129333333,6.52098499,0.444,0.222792979,1.359042745,-0.712,-0.439,0.097,-0.141,-0.085,0.504,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,939,95,77,E9Q8I0|P06909|D6RGQ0|E9Q8H9|A0A0A6YVP8,MOUSE,145947.1,76.1,9,9.1,1615.22,1330.82,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,95,939,3.14E+12,76.1%
E9Q8B5,0.374847149,-0.1335,7.837976014,0.637,0.164513824,1.582500431,-0.093,-0.048,-1.215,0.235,-0.168,0.488,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,23,50,4,E9Q8B5|E9Q8B6,MOUSE,102688.5,63.9,9,9.2,834.24,71.86,,879,Predicted gene 4788,,,,4,23,20200000000,6.8%
E9PUM5,0.774476598,0.1024,2.176815089,0.1815,0.605784966,0.549991102,0.173,-0.186,,0.2,-0.169,0.494,E9PUM5,NotFound,E9PUM5_NotFound,E9PUM5,Gm4788,1,2,46,1,E9PUM5,MOUSE,94467.4,63.9,9,9.3,770.89,16.87,,808,Predicted gene 4788,,,,1,2,34300000,2.5%
Q4LDF6,0.385738721,-0.0802,7.622391977,0.458,0.172886389,1.586827511,-0.555,-0.155,,0.283,0.041,-0.015,Q4LDF6,Cfhr2,Q4LDF6_Cfhr2,Q4LDF6,Cfhr2,1,19,18,6,Q4LDF6|Q61405,MOUSE,39129.7,69.5,9,9.4,325.37,99.08,,332,Complement factor H-related 2,,,,6,19,1330000000,25.9%
P20918,0.42797268,0.054666667,6.834837868,0.649333333,0.207260343,1.413020032,-0.753,0.478,-0.535,1.041,0.14,-0.043,P20918,Plg,P20918_Plg,P20918,Plg,1,1250,87,87,P20918,MOUSE,93544.9,86.3,10,10.1,1482.37,1482.37,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,87,1250,8.92E+12,86.3%
E9PZD8,0.789399258,0.065,2.057253832,0.217333333,0.622693908,0.518400713,-0.842,0.031,0.68,0.251,0.279,-0.009,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,1067,79,1,E9PZD8|Q61147,MOUSE,125007.5,59.3,11,11.1,1447.9,17.49,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,79,1067,3.69E+12,59.3%
G3X8Q5,0.902789601,0.2372,0.925798102,-0.071333333,0.808016426,-0.256060284,0.301,0.259,,0.24,0.409,-0.023,G3X8Q5,Cp,G3X8Q5_Cp,G3X8Q5,Cp,1,9,79,1,G3X8Q5|G3X9T8,MOUSE,124936.5,59.3,11,11.2,1443.77,13.36,,1085,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,1,9,1650000000,1.0%
B8JJN0,0.644376089,-0.002166667,3.503367817,0.253,0.446337337,0.81433107,-0.557,-0.088,0.259,0.45,-0.096,0.019,B8JJN0,NotFound,B8JJN0_NotFound,B8JJN0,Gm20547,1,769,90,64,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00|Q9WTX6,MOUSE,144605,52.5,12,12.1,1423.12,1012.9,,1276,Predicted gene 20547,,proteolysis|,serine-type endopeptidase activity|,90,769,1.39E+12,52.5%
P21180,0.987463289,0.119666667,0.144974554,0.011333333,0.967169393,0.042891715,0.042,-0.019,0.319,0.455,-0.164,0.085,P21180,C2,P21180_C2,P21180,C2,1,54,37,11,P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,85995.1,47.3,12,12.2,553.32,143.1,,760,Complement C2,extracellular exosome|,"proteolysis|complement activation|complement activation, classical pathway|response to nutrient|innate immune response|positive regulation of apoptotic cell clearance|",serine-type endopeptidase activity|metal ion binding|,11,54,42600000000,16.7%
P07724,0.785113221,-0.067333333,2.097571004,0.18,0.616939958,0.527184476,-0.68,-0.264,0.472,0.007,-0.003,0.064,P07724,Alb,P07724_Alb,P07724,Alb,1,1273,73,70,P07724,MOUSE,70745.2,92.5,13,13.1,1292.24,1238.24,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,73,1273,1.6E+13,92.5%
P02769,0.145366797,0.445333333,17.16064738,-2.492666667,0.019228051,-3.181436425,0.67,3.533,0.872,-0.758,-0.919,-0.726,P02769,NotFound,P02769_NotFound,P02769,ALB,1,31,12,9,P02769,BOVIN,71289,20.4,13,13.2,149.87,95.87,,607,Serum albumin,,,,9,31,5930000000,14.9%
O88783,0.693022361,0.084666667,2.990777243,0.182666667,0.502252695,0.713299784,-0.298,0.07,0.208,0.382,0.173,-0.027,O88783,F5,O88783_F5,O88783,F5,1,434,83,83,O88783,MOUSE,248366.9,36,14,14.1,1234.51,1234.51,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,83,434,1.24E+11,36.0%
Q5SWU9,0.177068997,1.045833333,15.36631524,-1.659666667,0.029064876,-2.859114323,1.425,1.92,2.282,1.407,-0.658,-0.101,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,269,83,71,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,35,15,15.1,1069.38,899.93,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,83,269,34200000000,35.0%
E9Q4Z2,0.296922676,1.053333333,10.15745595,-1.244,0.096439379,-1.97190482,1.004,2.003,2.019,1.66,-0.542,0.176,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,14,21,9,E9Q4Z2,MOUSE,278141.4,9.8,15,15.2,256.63,87.18,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,9,14,171000000,4.2%
Q80YQ1,0.705287932,0.275333333,2.836281815,-0.659333333,0.520441379,-0.682707079,2.816,-0.206,-0.795,0.313,0.128,-0.604,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,508,68,68,Q80YQ1|P35441|Q03350,MOUSE,133681.8,57.6,16,16.1,1068.46,1068.46,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,69,508,5.41E+11,57.6%
A6X935,0.573072924,-0.024333333,4.556239704,0.237333333,0.350248295,1.012145541,-0.225,-0.159,-0.045,0.353,-0.096,0.026,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,539,63,1,A6X935|A6X935-2|E9Q5L2,MOUSE,104828.7,70.5,17,17.1,1027.99,24.1,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,63,539,1.05E+12,70.5%
E9PVD2,0.774476598,0.0676,2.18530529,0.155166667,0.604601849,0.551849574,0.164,-0.215,,0.227,0.177,-0.015,E9PVD2,Itih4,E9PVD2_Itih4,E9PVD2,Itih4,1,19,63,1,E9PVD2|A0A0R4J1N1,MOUSE,104757.7,70.5,17,17.2,1027.99,24.1,,941,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|calcium ion binding|hyaluronic acid binding|,1,19,11900000000,2.2%
Q9DBD0,0.678082416,0.063,3.2048764,0.242,0.478092972,0.756101998,-0.55,-0.054,0.43,0.367,0.204,-0.019,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,602,60,60,Q9DBD0|D3YY36,MOUSE,78761.2,67.5,18,18.1,982.11,982.11,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,60,602,1.38E+12,67.5%
P06728,0.198868004,-0.224166667,14.04661699,0.643666667,0.039385676,2.6185329,-0.829,-0.31,-0.499,0.02,0.252,0.021,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,1119,51,51,P06728,MOUSE,45028.2,85.8,19,19.1,900.53,900.53,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,51,1119,2.24E+13,85.8%
Q91ZX7,0.678082416,0.070166667,3.195219902,-0.220333333,0.479157191,-0.754034563,-0.015,-0.132,0.688,-0.102,-0.03,0.012,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,191,73,73,A0A0R4J0I9|Q91ZX7|Q3U5J2|Q9JI18|A2API5|E9Q202|D3Z5M3|Q3TES0|A0A0N4SWH8|D6RHQ8,MOUSE,523675.1,18.1,20,20.1,891.37,891.37,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,73,191,20100000000,18.1%
P21614,0.466509631,-0.0525,6.11046495,0.487,0.244880106,1.288634058,-1.028,0.036,0.104,0.442,0.164,-0.033,P21614,Gc,P21614_Gc,P21614,Gc,1,442,49,49,P21614,MOUSE,55196.9,89.2,21,21.1,887,887,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,49,442,6.54E+11,89.2%
P32261,0.519630802,0.136,5.325565383,0.377333333,0.293388753,1.150886071,-0.564,0.111,0.295,0.503,0.504,-0.033,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,682,57,57,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,72.4,22,22.1,885.21,885.21,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,57,682,2.57E+12,72.4%
Q8K0E8,0.679504976,0.794,3.178561445,-1.006,0.480998648,-0.751457233,3.706,-0.222,0.407,-0.294,2.35,-1.183,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,380,52,52,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,79.6,23,23.1,855.45,855.45,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",52,380,3.72E+11,79.6%
P19221,0.326571299,-0.140166667,9.212538985,0.583666667,0.119879825,1.811085576,-0.756,0.036,-0.576,0.521,-0.13,0.064,P19221,F2,P19221_F2,P19221,F2,1,554,50,50,P19221|H7BX99,MOUSE,71693.8,58.5,24,24.1,841.78,841.78,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,50,554,1.59E+12,58.5%
Q60841,0.826430946,0.020833333,1.642123236,0.155,0.685153178,0.425682972,-0.439,-0.348,0.617,-0.21,0.26,0.245,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,229,61,61,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,19.3,25,25.1,835.78,835.78,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,61,229,20200000000,19.3%
E9PV24,0.594937809,0.712166667,4.218337904,-1.245,0.378587447,-0.950973016,3.877,-0.049,0.176,-0.495,1.919,-1.155,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,429,61,61,E9PV24|E9PV24-2|P02672|A5PJE3,MOUSE,88169.4,60.2,26,26.1,826.72,826.72,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",61,429,7.85E+11,60.2%
P26262,0.665648011,0.066666667,3.318740529,0.381333333,0.465721135,0.778667448,-1.047,-0.114,0.789,0.41,0.373,-0.011,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,478,49,49,P26262|P04187,MOUSE,73492.3,68.1,27,27.1,824.46,824.46,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,49,478,8.88E+11,68.1%
Q61702,0.337209389,-0.065166667,8.889614831,0.547666667,0.129133379,1.756575401,-0.847,0.01,-0.18,0.435,0.208,-0.017,Q61702,Itih1,Q61702_Itih1,Q61702,Itih1,1,420,47,2,Q61702,MOUSE,101521.5,50.8,28,28.1,820.26,31.83,,907,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,47,420,5.74E+11,50.8%
F8WJ05,0.925271487,0.287,0.767443878,-0.098666667,0.838022371,-0.218014178,,0.361,,0.613,0.265,-0.091,F8WJ05,Itih1,F8WJ05_Itih1,F8WJ05,Itih1,1,6,46,2,F8WJ05,MOUSE,102089.1,50.9,28,28.2,802.65,20.28,,911,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,2,6,1480000000,3.4%
E9PUU8,0.421402913,-0.261333333,6.950460226,0.599333333,0.201815249,1.432697118,-0.068,-0.165,-1.45,-0.03,0.153,-0.008,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,155,59,59,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,16.6,29,29.1,763.01,763.01,,4249,Fibrocystin-L,cilium|,,protein binding|,59,155,12200000000,16.6%
P42703,0.174473057,-0.028666667,15.49249992,1.138,0.028232544,2.873350405,-0.552,-0.351,-0.89,-0.22,0.796,1.045,P42703,Lifr,P42703_Lifr,P42703,Lifr,1,431,49,3,P42703,MOUSE,123883.7,40.1,30,30.1,755.34,45.04,,1092,Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,49,431,9.03E+11,40.1%
P42703-2,0.432253305,0.759666667,6.731868024,-0.573333333,0.212233139,-1.395458935,0.675,1.476,0.988,-0.226,0.604,1.041,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,26,47,2,P42703-2,MOUSE,82255.7,58.4,30,30.2,723.76,28,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,2,26,25200000000,3.7%
A0A0R4J0I1,0.589033005,-0.097666667,4.314597738,0.26,0.370288501,0.96771664,-0.599,-0.188,0.104,-0.097,0.151,0.043,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,1670,37,25,A0A0R4J0I1|P07759,MOUSE,46900.1,68.1,31,31.1,748.6,504.18,,418,MCG1051009,,,,37,1670,1.96E+13,68.1%
G3X8T9,0.595170996,-0.114166667,4.169833463,0.374333333,0.382839424,0.941238951,-0.223,0.352,-1.033,0.318,-0.048,-0.051,G3X8T9,Serpina3n,G3X8T9_Serpina3n,G3X8T9,Serpina3n,1,29,31,2,G3X8T9|Q6P4P1|D3Z451,MOUSE,46936.4,55.5,31,31.2,508.69,43.82,,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,29,31900000000,6.6%
Q91WP6,0.326571299,0.1692,9.299753637,-0.548,0.117496421,-1.885617813,0.263,0.733,,-0.078,0.077,-0.149,Q91WP6,NotFound,Q91WP6_NotFound,Q91WP6,Serpina3n,1,2,31,1,Q91WP6|Q5I2A0|F2Z405,MOUSE,46888.3,55.9,31,31.3,493.68,13.01,,418,Serine protease inhibitor A3N,extracellular region|extracellular space|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,1,2,21000000,4.3%
Q03734,0.623538023,0.424,3.734616673,-0.306666667,0.423192861,-0.859121986,0.455,0.095,1.182,0.52,0.339,-0.047,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,102,29,16,Q03734,MOUSE,47234.5,58.8,31,31.4,507.95,239.1,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,16,102,71600000000,39.2%
P29621,0.314778944,-0.2374,9.730394494,0.514333333,0.106404636,1.96265289,-0.619,-0.473,,-0.077,-0.127,0.109,P29621,Serpina3c,P29621_Serpina3c,P29621,Serpina3c,1,24,16,10,P29621|Q80X76,MOUSE,46936.4,41,31,31.5,237.16,131.54,,417,Serine protease inhibitor A3C,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,10,24,1830000000,29.7%
D3Z450,0.229655912,0.29,12.61103794,-0.641666667,0.054814595,-2.488614082,0.766,0.584,,-0.055,0.073,0.082,D3Z450,Serpina3i,D3Z450_Serpina3i,D3Z450,Serpina3i,1,7,6,3,D3Z450,MOUSE,45964.2,12,31,31.6,54.5,19.93,,408,"Serine (or cysteine) peptidase inhibitor, clade A, member 3I",extracellular space|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,3,7,2250000000,8.3%
A0A0R4J038,0.232324458,-0.118666667,12.17637344,0.604,0.060584657,2.302281866,-0.742,-0.125,-0.395,0.35,0.192,0.008,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,536,42,8,A0A0R4J038|D3YTY9|O08677|O08677-3|B99909|P01044|P01045,MOUSE,74183.9,51.5,32,32.1,742.38,151.88,,661,Kininogen-1,,,,42,536,3.97E+12,51.5%
O08677-2,0.4346842,0.1615,6.603355627,-0.465,0.218607188,-1.373488224,0.008,1.022,0.152,0.077,-0.269,-0.021,O08677,Kng1,O08677-2_Kng1,O08677-2,Kng1,1,39,33,3,O08677-2,MOUSE,48981.4,64.3,32,32.2,591.75,35.5,,661,Isoform LMW of Kininogen-1,extracellular space|cytosol|extracellular exosome|blood microparticle|,inflammatory response|blood coagulation|negative regulation of endopeptidase activity|vasodilation|,cysteine-type endopeptidase inhibitor activity|receptor binding|,3,39,50100000000,6.2%
Q6S9I3,0.702114845,0.0385,2.87354723,0.229666667,0.515994743,0.689792018,-0.645,0.21,0.206,0.465,0.015,-0.02,Q6S9I3,Kng2,Q6S9I3_Kng2,Q6S9I3,Kng2,1,163,32,25,Q6S9I3|Q6S9I2|E0CYI5,MOUSE,72355.1,37.1,32,32.3,505.69,421.91,,644,HMW kininogen-II,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,25,163,98600000000,35.2%
Q61129,0.51337052,-0.060166667,5.432267242,0.327666667,0.286268311,1.169410002,-0.631,-0.215,0.174,0.102,0.187,0.022,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,416,42,42,Q61129,MOUSE,69541.5,59.8,33,33.1,732.18,732.18,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,42,416,7.73E+11,59.8%
Q00623,0.343967985,-0.1435,8.636023596,0.622333333,0.136898169,1.715847738,-1.171,-0.132,-0.061,0.324,0.158,0.021,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,1753,44,44,Q00623,MOUSE,30615,81.4,34,34.1,730.74,730.74,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,44,1753,3.05E+14,81.4%
P20029,0.284070507,-0.181,10.57267561,0.560666667,0.087646068,2.035402588,-0.661,-0.042,-0.681,0.275,0.054,-0.031,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,339,46,43,P20029,MOUSE,72534.8,57.7,35,35.1,726.45,687.53,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,46,339,2.57E+11,57.7%
P63017,0.466509631,0.209333333,6.109560077,-0.467333333,0.244931133,-1.288476025,0.036,0.14,1.153,0.13,-0.204,0.001,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,53,24,21,P63017|Q504P4|P17156|P16627|P17879|Q61696,MOUSE,71098,34,35,35.2,291.49,252.57,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",21,53,1300000000,31.2%
Q8K182,0.970099283,0.087166667,0.337151069,0.050333333,0.925304966,0.097756065,-0.506,-0.486,1.178,0.042,-0.123,0.418,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,371,45,45,Q8K182|A2A997|A2A998,MOUSE,67733.7,65.4,36,36.1,697.14,697.14,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,45,371,4.77E+11,65.4%
P06683,0.442036594,-0.122833333,6.460704201,0.411666667,0.225906944,1.348212809,-0.773,-0.374,0.161,0.006,0.229,0.014,P06683,C9,P06683_C9,P06683,C9,1,338,43,43,A0A0R4J032|P06683,MOUSE,63256.4,66.2,37,37.1,696.87,696.87,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,43,338,6.09E+11,66.2%
E9Q6D8,0.588159354,0.036666667,4.329093905,0.390666667,0.369054589,0.97081349,-0.593,-0.456,0.573,0.019,0.664,0.013,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,226,41,41,E9Q6D8|Q91X70,MOUSE,108049.4,49.5,38,38.1,682.27,682.27,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,41,226,66600000000,49.5%
P01872,0.394001833,0.0745,7.441023712,0.547,0.180259279,1.515740868,-0.203,-0.233,-0.161,-0.051,1.079,0.016,P01872,NotFound,P01872_NotFound,P01872,Ighm,1,455,38,37,P01872|P01872-2|P04221,MOUSE,50655.7,62.7,39,39.1,655.86,636.11,,454,Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,38,455,1.79E+12,62.7%
P03988,0.850670217,0.026,1.361755739,0.156,0.730843563,0.368689384,,-0.091,,-0.268,0.195,0.268,P03988,NotFound,P03988_NotFound,P03988,,1,1,2,1,P03988,RABIT,50581.1,6.9,39,39.2,30.97,11.22,,458,Ig mu chain C region secreted form,,,,1,1,6630000,4.8%
P08113,0.296820483,-0.256333333,10.19019527,0.521333333,0.095715103,1.972044248,-0.868,-0.488,-0.195,-0.125,0.127,0.011,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,198,48,46,P08113|E9PX27,MOUSE,92759.4,48.7,40,40.1,654.48,615.54,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,48,198,47600000000,48.7%
P11499,0.438943049,0.4156,6.524902267,-0.9915,0.222592114,-1.393943525,0.001,2.02,,-0.617,0.395,0.279,P11499,Hsp90ab1,P11499_Hsp90ab1,P11499,Hsp90ab1,1,2,7,2,P11499,MOUSE,83622,9.2,40,40.2,81.03,18.8,,724,Heat shock protein HSP 90-beta,intracellular|cytoplasm|mitochondrion|cytosol|cell surface|membrane|inclusion body|basolateral plasma membrane|apical plasma membrane|brush border membrane|melanosome|extracellular exosome|COP9 signalosome|,"placenta development|protein folding|response to salt stress|virion attachment to host cell|positive regulation of protein binding|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein import into nucleus, translocation|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of cell size|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|cellular response to interleukin-4|cellular response to organic cyclic compound|positive regulation of protein serine/threonine kinase activity|fibril organization|",UTP binding|CTP binding|double-stranded RNA binding|protein binding|ATP binding|GTP binding|sulfonylurea receptor binding|kinase binding|protein kinase binding|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|dATP binding|ion channel binding|poly(A) RNA binding|unfolded protein binding|,2,2,23700000,3.0%
P07901,0.039479358,0.71575,26.30577268,-5.936333333,0.002341115,-6.951241796,,5.168,,-0.054,-1.847,-0.404,P07901,Hsp90aa1,P07901_Hsp90aa1,P07901,Hsp90aa1,1,1,4,1,P07901,MOUSE,85185.7,5.4,40,40.3,27.7,4.41,,733,Heat shock protein HSP 90-alpha,intracellular|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|membrane|ruffle membrane|melanosome|myelin sheath|extracellular exosome|,nitric oxide biosynthetic process|response to unfolded protein|response to cold|protein refolding|protein import into mitochondrial outer membrane|positive regulation of nitric oxide biosynthetic process|positive regulation of cytotoxic T cell differentiation|regulation of catalytic activity|chaperone-mediated protein complex assembly|,protein binding|ATP binding|ATPase activity|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|GTPase binding|unfolded protein binding|,1,1,725000,1.2%
Q07968,0.680102626,-0.002666667,3.135903633,0.243333333,0.485746452,0.742432386,-0.537,-0.295,0.459,0.037,0.319,0.001,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,382,41,41,Q07968,MOUSE,78476.1,54.8,41,41.1,650.8,650.8,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,41,382,3.41E+11,54.8%
P09103,0.193614767,-0.3535,14.33091985,1.003,0.036889946,2.67116531,-0.722,-0.274,-1.569,0.23,0.226,-0.012,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,202,46,46,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,66.6,42,42.1,641.23,641.23,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,46,202,70700000000,66.6%
Q91WP0,0.373963386,-0.130833333,7.894552481,0.401666667,0.162384567,1.59080737,-0.629,-0.366,0,0.11,0.081,0.019,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,366,44,44,Q91WP0|Q91WP0-2,MOUSE,76998.6,63.5,43,43.1,640.87,640.87,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,45,366,4.49E+11,63.5%
D3YXF5,0.151945202,-0.361333333,16.65946343,0.845333333,0.02158011,3.075395997,-1.046,-0.379,-0.927,-0.08,0.25,0.014,D3YXF5,C7,D3YXF5_C7,D3YXF5,C7,1,210,39,39,D3YXF5,MOUSE,96587.9,43.6,44,44.1,622.19,622.19,,845,Complement component 7,membrane attack complex|extracellular exosome|,immune response|,,39,210,50500000000,43.6%
G3X977,0.403070996,-0.025833333,7.272964467,0.463,0.187371509,1.486352617,-0.723,0.117,-0.166,0.493,0.153,-0.029,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,413,38,38,G3X977|Q61703,MOUSE,106758.8,40.5,45,45.1,617.02,617.02,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,38,413,1.24E+12,40.5%
P98064,0.388922599,-0.189833333,7.575426804,0.377666667,0.17476615,1.537291653,-0.628,-0.412,-0.096,-0.141,0.053,0.085,P98064,Masp1,P98064_Masp1,P98064,Masp1,1,245,40,19,P98064,MOUSE,81621.4,55.8,46,46.1,605.46,269.73,,704,Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,40,245,86200000000,55.8%
P98064-2,0.343967985,-0.276333333,8.628137707,0.604,0.137146974,1.714534303,-1.116,-0.674,0.055,-0.141,0.18,0.038,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,39,29,8,P98064-2,MOUSE,83984.9,41,46,46.2,457.29,121.56,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,8,39,7570000000,10.2%
Q8BH35,0.206885477,-0.249166667,13.5999509,0.651666667,0.043652077,2.542338558,-0.546,-0.322,-0.857,0.077,-0.12,0.273,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,270,37,37,Q8BH35|Q8BH35-2,MOUSE,68053.9,58,47,47.1,601.62,601.62,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,37,270,1.61E+11,58.0%
Q00897,0.485757101,-0.013333333,5.801210532,0.368666667,0.262953495,1.234163872,-0.684,-0.072,0.163,0.329,0.179,0.005,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,465,33,10,Q00897,MOUSE,46168.7,66.8,48,48.1,596.99,189.57,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,33,465,3.74E+12,66.8%
P22599,0.68605069,-0.072666667,3.066484832,0.405333333,0.493573139,0.72913945,-1.487,0.057,0.604,0.295,0.121,-0.026,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,80,31,9,P22599,MOUSE,46145,65.8,48,48.2,570.79,166.93,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,9,80,2.56E+11,21.7%
A0A0A0MQA3,0.570415662,0.0604,4.600079023,-0.2735,0.346730541,-1.03729168,0.284,0.165,,0.063,-0.207,-0.003,A0A0A0MQA3,Serpina1a,A0A0A0MQA3_Serpina1a,A0A0A0MQA3,Serpina1a,1,2,31,2,A0A0A0MQA3|P07758,MOUSE,49023.3,62.6,48,48.3,529.01,22.52,,436,Alpha-1-antitrypsin 1-1,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,protein N-linked glycosylation|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,2,2,23400000,11.9%
A0A0R4J0X5,0.346454144,0.475833333,8.552713045,-0.733,0.139549632,-1.701970849,0.158,0.663,1.706,0.291,-0.048,0.085,A0A0R4J0X5,Serpina1c,A0A0R4J0X5_Serpina1c,A0A0R4J0X5,Serpina1c,1,62,29,1,A0A0R4J0X5,MOUSE,46024.7,64.6,48,48.4,535.74,26.75,,413,Alpha-1-antitrypsin 1-3,,,,1,62,5070000000,7.2%
Q00898,0.993586203,0.455166667,0.053297408,0.007,0.987802815,0.015933675,-0.062,0.748,0.669,-0.347,0.865,0.858,Q00898,Serpina1e,Q00898_Serpina1e,Q00898,Serpina1e,1,21,23,3,Q00898,MOUSE,46118.8,34.6,48,48.5,360.92,47.56,,413,Alpha-1-antitrypsin 1-5,extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,3,21,2240000000,8.7%
J3QQ16,0.838945551,-0.004166667,1.499913878,-0.093666667,0.707959823,-0.392776473,-0.063,-0.089,0.28,-0.213,-0.063,0.123,J3QQ16,Col6a3,J3QQ16_Col6a3,J3QQ16,Col6a3,1,122,48,48,J3QQ16|E9PWQ3|A0A087WS16,MOUSE,290173.5,19.3,49,49.1,587.73,587.73,,2677,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,48,122,6630000000,19.3%
Q91X72,0.955428034,0.2645,0.479240144,0.057,0.895521435,0.136975279,0.838,-0.314,0.184,0.074,0.879,-0.074,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,314,36,36,Q91X72,MOUSE,52058.5,53,50,50.1,583.84,583.84,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,36,314,3.12E+11,53.0%
E9QPD7,0.126655669,1.1585,18.18983522,-1.777,0.015171079,-3.361178935,2.118,1.862,2.161,1.383,-0.634,0.061,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,159,42,42,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,37.7,51,51.1,577.87,577.87,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,42,159,24400000000,37.7%
O08601-2,0.813811541,0.069666667,1.842255948,0.122,0.654296211,0.470791446,-0.287,0.165,0.148,0.39,0.037,-0.035,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,131,38,38,O08601-2|O08601,MOUSE,101433.7,36.6,52,52.1,572.28,572.28,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,38,131,17300000000,36.6%
Q8CG16,0.895801409,-0.003333333,1.009678303,0.1,0.792560036,0.274946335,-0.553,-0.249,0.642,0.224,-0.098,0.014,Q8CG16,C1ra,Q8CG16_C1ra,Q8CG16,C1ra,1,183,35,32,Q8CG16|Q8CFG9,MOUSE,81555.2,59.2,53,53.1,556.65,517.34,,707,Complement C1r-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|,35,183,65500000000,59.2%
Q3UZ09,0.189842544,0.330666667,14.68891948,-0.643333333,0.033970978,-2.728973626,0.806,0.383,0.768,0.111,-0.09,0.006,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,48,19,16,Q3UZ09,MOUSE,54233.1,36.7,53,53.2,221.9,182.59,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,16,48,3370000000,32.3%
E9Q6C2,0.970099283,0.045666667,0.339251844,0.044,0.924857485,0.098341318,-0.759,-0.074,0.904,0.226,-0.048,0.025,E9Q6C2,C1s1,E9Q6C2_C1s1,E9Q6C2,C1s1,1,215,33,2,E9Q6C2,MOUSE,79039.3,51.4,54,54.1,554,17.67,,694,"Complement component 1, s subcomponent 1",extracellular exosome|blood microparticle|,proteolysis|complement activation|,serine-type endopeptidase activity|calcium ion binding|identical protein binding|,33,215,68500000000,51.4%
Q8CG14,0.492904439,-0.246,5.654520928,0.716,0.27198685,1.210295353,-0.461,0.491,-1.842,0.179,0.151,0.006,Q8CG14,C1s1,Q8CG14_C1s1,Q8CG14,C1sa,1,17,32,2,Q8CG14,MOUSE,78396.6,51.7,54,54.2,543.88,27.94,,688,Complement C1s-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|identical protein binding|,2,17,2820000000,3.9%
Q06890,0.596444418,0.337333333,4.125679902,-0.282666667,0.386751503,-0.932610461,0.822,0.18,0.434,0.594,0.075,-0.081,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,361,34,34,Q06890,MOUSE,52282.3,48.4,55,55.1,551.91,551.91,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,34,361,1.07E+12,48.4%
Q01339,0.816464714,0.110333333,1.812807266,0.184,0.658747945,0.464327986,-0.69,0.054,0.691,0.412,0.213,-0.018,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,386,34,34,Q01339,MOUSE,39930.4,70.7,56,56.1,542.84,542.84,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,34,386,1.99E+12,70.7%
O89020,0.230974077,-0.165666667,12.45031529,0.517333333,0.056881164,2.348190222,-0.571,-0.266,-0.436,0.192,0.091,-0.004,O89020,Afm,O89020_Afm,O89020,Afm,1,260,38,38,O89020|O89020-3|O89020-2,MOUSE,71317.7,53.7,57,57.1,542,542,,608,Afamin,extracellular space|extracellular exosome|blood microparticle|,vitamin transport|,vitamin E binding|,38,260,1.6E+11,53.7%
B2RPV6,0.813811541,0.309833333,1.83593189,-0.210333333,0.65524967,-0.469505545,1.201,-0.374,0.418,0.207,0.521,-0.114,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,145,40,40,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,33.4,58,58.1,527.42,527.42,,1210,Multimerin-1,extracellular region|,,,40,145,14700000000,33.4%
P13020,0.970099283,0.065833333,0.296714708,-0.027666667,0.933960544,-0.08638319,-0.348,-0.073,0.66,0.027,0.144,-0.015,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,168,37,37,P13020|P13020-2,MOUSE,86339.4,38.9,59,59.1,523.23,523.23,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,37,168,1.36E+11,38.9%
Q61508,0.850670217,0.6255,1.383818733,0.241,0.727140152,0.365816765,1.323,0.271,-0.079,0.387,1.989,-0.138,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,188,34,34,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,67.2,60,60.1,509.54,509.54,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,34,188,95700000000,67.2%
Q8VCU2,0.987463289,0.081833333,0.107451975,-0.022333333,0.975561836,-0.031941622,-0.89,-0.538,1.707,0.233,-0.038,0.017,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,206,33,33,Q8VCU2|O70362,MOUSE,94192.4,45.9,61,61.1,501.16,501.16,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,33,206,98900000000,45.9%
Q19LI2,0.821775379,0.713333333,1.716433553,0.381333333,0.673529535,0.442808194,0.113,0.103,1.352,-0.141,2.768,0.085,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,353,30,30,Q19LI2,MOUSE,57237.7,66,62,62.1,495.2,495.2,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,30,353,1.52E+12,66.0%
Q5XQN5,0.189842544,0.293833333,14.70281124,-1.960333333,0.033862489,-2.7426771,2.171,2.026,-0.375,-0.899,-0.738,-0.422,Q5XQN5,NotFound,Q5XQN5_NotFound,Q5XQN5,KRT5,1,199,40,26,Q5XQN5|Q922U2|P07744|P11679|Q99M73|Q9DCV7|P19246,BOVIN,63107,42.4,63,63.1,478.52,298.2,,601,"Keratin, type II cytoskeletal 5",,,,42,199,1.06E+11,42.4%
P50446,0.259510246,0.520333333,11.38492717,-2.578,0.072695459,-2.176878069,3.623,2.681,-0.876,-1.169,-1.149,0.012,P50446,Krt6a,P50446_Krt6a,P50446,Krt6a,1,16,24,7,P50446|Q9Z331|Q3UV11|Q6IFZ8,MOUSE,59676.4,32.9,63,63.2,288.53,75.09,,553,"Keratin, type II cytoskeletal 6A",keratin filament|extracellular exosome|,morphogenesis of an epithelium|Wnt signaling pathway|keratinization|wound healing|intermediate filament organization|,structural molecule activity|,7,16,5580000000,11.0%
Q3TTY5,0.232324458,0.255,12.19547647,-1.32,0.060318753,-2.313114726,1.741,1.352,-0.348,-0.589,-0.441,-0.185,Q3TTY5,Krt2,Q3TTY5_Krt2,Q3TTY5,Krt2,1,74,15,9,Q3TTY5,MOUSE,71377.9,12.3,63,63.3,180.69,106.76,,707,"Keratin, type II cytoskeletal 2 epidermal",extracellular space|nucleus|Golgi apparatus|membrane|keratin filament|extracellular exosome|,keratinization|keratinocyte activation|keratinocyte proliferation|keratinocyte migration|,structural molecule activity|,9,74,52600000000,9.0%
Q3UV17,0.189842544,0.360666667,14.68078897,-2.304,0.034034635,-2.738835225,2.858,2.085,-0.405,-0.99,-0.906,-0.478,Q3UV17,Krt76,Q3UV17_Krt76,Q3UV17,Krt76,1,12,12,1,Q3UV17,MOUSE,63357,13.8,63,63.4,157.73,17.6,,594,"Keratin, type II cytoskeletal 2 oral",nucleus|keratin filament|extracellular exosome|,epidermis development|sebaceous gland development|,structural molecule activity|,1,12,49300000000,1.5%
Q8VED5,0.189842544,0.2595,14.84494362,-2.367,0.032772203,-2.767506978,3.128,1.556,-0.355,-0.998,-1.094,-0.68,Q8VED5,Krt79,Q8VED5_Krt79,Q8VED5,Krt79,1,11,10,1,Q8VED5,MOUSE,57836.6,10.3,63,63.5,122.11,19.85,,531,"Keratin, type II cytoskeletal 79",keratin filament|extracellular exosome|,,structural molecule activity|enzyme binding|,1,11,4710000000,2.2%
Q6IFZ6,0.232324458,0.2875,12.20181293,-2.001666667,0.06023081,-2.314183631,3.281,0.623,-0.039,-0.575,-0.534,-1.031,Q6IFZ6,Krt77,Q6IFZ6_Krt77,Q6IFZ6,Krt77,1,8,10,5,Q6IFZ6|Q6IFZ9,MOUSE,61414.7,12,63,63.6,120.32,45.95,,572,"Keratin, type II cytoskeletal 1b",cytoskeleton|keratin filament|extracellular exosome|,,structural molecule activity|,5,8,1010000000,5.7%
P04104,0.56840997,-0.011666667,4.641641189,-1.355333333,0.343428143,-1.029012249,3,1.361,-2.363,-0.814,-0.715,-0.539,P04104,Krt1,P04104_Krt1,P04104,Krt1,1,29,9,5,P04104,MOUSE,66118.3,7.2,63,63.7,116.77,67.2,,637,"Keratin, type II cytoskeletal 1",extracellular space|nucleus|plasma membrane|membrane|extracellular matrix|keratin filament|extracellular exosome|blood microparticle|,"complement activation, lectin pathway|retina homeostasis|negative regulation of inflammatory response|establishment of skin barrier|",structural molecule activity|carbohydrate binding|,5,29,88900000000,3.9%
Q6NXH9,0.339304798,0.4425,8.744486146,-1.651666667,0.133521556,-1.736423119,2.461,2.273,-0.929,-0.86,-0.396,0.106,Q6NXH9,Krt73,Q6NXH9_Krt73,Q6NXH9,Krt73,1,9,9,3,Q6NXH9,MOUSE,59538,11.1,63,63.8,101.29,24.01,,539,"Keratin, type II cytoskeletal 73",nucleus|keratin filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|,3,9,17100000000,4.0%
Q9R0H5,0.846059867,0.83225,1.456554486,0.419,0.715063403,0.392275949,,0.518,,2.21,-0.246,0.847,Q9R0H5,Krt71,Q9R0H5_Krt71,Q9R0H5,Krt71,1,1,7,1,Q9R0H5,MOUSE,57895,10.1,63,63.9,88.05,8.21,,524,"Keratin, type II cytoskeletal 71",cytoplasm|keratin filament|extracellular exosome|,hair follicle morphogenesis|intermediate filament organization|,structural molecule activity|,1,1,1520000,2.2%
Q6IME9,0.774476598,-0.258,2.169698001,-0.861333333,0.606778522,-0.543083023,3.012,0.988,-3.482,-0.778,-0.533,-0.755,Q6IME9,Krt72,Q6IME9_Krt72,Q6IME9,Krt72,1,3,5,1,Q6IME9,MOUSE,57262.8,7.3,63,63.1,62.07,15.75,,520,"Keratin, type II cytoskeletal 72",keratin filament|extracellular exosome|,,structural molecule activity|,1,3,892000000,2.3%
Q8BPB5,0.995469936,0.113666667,0.029841935,0.002666667,0.993152194,0.008943294,-0.025,-0.244,0.606,0.04,0.283,0.022,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,190,27,27,Q8BPB5,MOUSE,57234.1,59.2,64,64.1,473.28,473.28,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,27,190,1.32E+11,59.2%
Q9ESB3,0.390409452,-0.011,7.525232385,0.690666667,0.176797761,1.529934198,-0.563,0.299,-0.805,1.063,-0.03,-0.03,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,282,26,26,A0A0R4J039|Q9ESB3,MOUSE,60131.6,42.8,65,65.1,429.95,429.95,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,26,282,7.47E+11,42.8%
Q01279,0.732787357,0.079166667,2.547676002,0.235666667,0.556201813,0.62293111,-0.395,-0.335,0.614,-0.213,0.524,0.28,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,159,30,30,Q01279|Q9WVF5,MOUSE,138274.2,23.2,66,66.1,411.11,411.11,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,30,159,60000000000,23.2%
A2A7A7,0.946089108,0.011166667,0.566304211,-0.039,0.877747455,-0.160458247,-0.128,-0.093,0.313,-0.025,-0.143,0.143,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,130,28,28,A2A7A7|Q8CFX1,MOUSE,90478.8,36.2,67,67.1,409.25,409.25,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,28,130,35700000000,36.2%
P97290,0.866332813,0.048666667,1.259044947,0.135333333,0.748334048,0.335931714,-0.656,-0.167,0.766,0.297,0.063,-0.011,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,234,27,27,P97290|A2ATR8,MOUSE,55868.8,39.2,68,68.1,405.64,405.64,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,27,234,2.22E+11,39.2%
Q8R121,0.558282094,0.014166667,4.847089285,0.287,0.327560158,1.064976113,-0.407,-0.228,0.247,0.167,0.32,-0.014,Q8R121,Serpina10,Q8R121_Serpina10,Q8R121,Serpina10,1,155,27,27,Q8R121|Q8R121-2,MOUSE,51910.6,53.7,69,69.1,404.14,404.14,,448,Protein Z-dependent protease inhibitor,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,27,155,71700000000,53.7%
Q9JKR6,0.311230275,-0.239666667,9.860664678,0.427333333,0.103260336,1.917484413,-0.553,-0.259,-0.548,-0.139,0.044,0.017,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,127,29,29,Q9JKR6|E0CYZ2,MOUSE,111407.3,31.8,70,70.1,403.28,403.28,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,29,127,14700000000,31.8%
Q61247,0.206885477,-0.129166667,13.58191771,0.769,0.04383371,2.539272115,-0.679,-0.044,-0.818,0.366,0.422,-0.022,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,272,25,25,Q61247,MOUSE,55199.1,41.1,71,71.1,402.22,402.22,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,25,272,9.06E+11,41.1%
Q3UER8,0.692195309,0.9655,3.006729121,-0.874333333,0.500411277,-0.717164926,3.336,0.02,0.852,-0.181,2.646,-0.88,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,212,28,28,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,59.1,72,72.1,401.01,401.01,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",28,212,2.37E+11,59.1%
F8VQ07,0.443636341,-0.056833333,6.415437797,0.351,0.22827388,1.340445574,-0.542,-0.182,0.027,0.351,0.024,-0.019,F8VQ07,5830473C10Rik,F8VQ07_5830473C10Rik,F8VQ07,5830473C10Rik,1,120,30,30,F8VQ07|A0A0J9YV75,MOUSE,72340.4,41.7,73,73.1,396.62,396.62,,620,RIKEN cDNA 5830473C10 gene,extracellular space|,transport|,,30,120,15900000000,41.7%
Q8BH61,0.977884168,1.108166667,0.241047249,-0.063,0.946009015,-0.070622772,1.96,1.009,0.45,0.534,2.952,-0.256,Q8BH61,F13a1,Q8BH61_F13a1,Q8BH61,F13a1,1,148,26,26,Q8BH61,MOUSE,83719.2,32.9,74,74.1,392.34,392.34,,732,Coagulation factor XIII A chain,cytoplasm|blood microparticle|,blood coagulation|peptide cross-linking|,protein-glutamine gamma-glutamyltransferase activity|metal ion binding|,26,148,30000000000,32.9%
Q9QWK4,0.970099283,0.230666667,0.31186864,0.032666667,0.930707334,0.090659876,0.303,-0.123,0.463,-0.138,0.885,-0.006,Q9QWK4,Cd5l,Q9QWK4_Cd5l,Q9QWK4,Cd5l,1,209,26,26,Q9QWK4,MOUSE,40345.4,60.7,75,75.1,390.37,390.37,,352,CD5 antigen-like,membrane|extracellular exosome|blood microparticle|,receptor-mediated endocytosis|apoptotic process|,scavenger receptor activity|,26,209,4.57E+11,60.7%
Q8BHN3-2,0.717632589,-0.053666667,2.689248914,0.14,0.538362881,0.652035498,-0.282,-0.087,-0.002,0.021,0.05,-0.022,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,112,33,33,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,33.6,76,76.1,387.82,387.82,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",33,112,15800000000,33.6%
P49182,0.200709248,-0.212333333,13.90876532,0.793333333,0.04065589,2.594966936,-0.378,-0.367,-1.082,0.486,0.058,0.009,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,210,26,26,P49182,MOUSE,54781,49.3,77,77.1,384.86,384.86,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,26,210,2.02E+11,49.3%
P26928,0.311388971,-0.337,9.80036443,0.759333333,0.104704068,1.909287451,-0.45,-0.167,-1.533,0.152,-0.032,0.008,P26928,Mst1,P26928_Mst1,P26928,Mst1,1,138,29,29,P26928|E0CXN0,MOUSE,83185.1,40,78,78.1,378.2,378.2,,716,Hepatocyte growth factor-like protein,extracellular exosome|,proteolysis|spermatogenesis|embryo implantation|sperm motility|,serine-type endopeptidase activity|,29,138,31300000000,40.0%
A2AS37,0.29282357,-0.051666667,10.39252339,0.536666667,0.091358227,2.005553506,-0.579,-0.089,-0.292,0.521,0.151,-0.022,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,158,23,23,A2AS37,MOUSE,40887.3,52.2,79,79.1,374.1,374.1,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,23,158,1.61E+11,52.2%
P14211,0.34084781,-0.2905,8.699537391,0.609666667,0.134910658,1.726423866,-1.241,-0.524,-0.021,0.064,-0.033,0.012,P14211,Calr,P14211_Calr,P14211,Calr,1,141,26,26,P14211,MOUSE,48164.8,54.3,80,80.1,368.72,368.72,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,26,141,79700000000,54.3%
Q8BK48,0.561700919,-0.032,4.796402228,0.262666667,0.33140555,1.055816947,-0.452,-0.161,0.123,0.121,0.191,-0.014,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,140,23,18,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,44.5,81,81.1,358.53,287.37,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,23,140,32400000000,44.5%
Q91WG0,0.826430946,-0.023333333,1.669576557,0.137333333,0.680835738,0.431905686,-0.626,0.027,0.323,0.26,-0.098,-0.026,Q91WG0,Ces2c,Q91WG0_Ces2c,Q91WG0,Ces2c,1,32,16,9,Q91WG0,MOUSE,62753.8,31.3,81,81.2,239.59,134.84,,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,9,32,1270000000,16.2%
Q8QZR3,0.201482994,-0.288,13.84242099,0.564,0.041281731,2.583641628,-0.703,-0.408,-0.599,0.069,-0.092,0.005,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,23,10,5,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,17.7,81,81.3,143.29,73.57,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,5,23,1120000000,10.2%
E9PV38,0.985530267,-0.114666667,0.165612362,0.019333333,0.962584277,0.048897967,-0.196,0.616,-0.793,0.049,-0.236,-0.128,E9PV38,Ces2g,E9PV38_Ces2g,E9PV38,Ces2g,1,3,9,3,E9PV38,MOUSE,63005,19.6,81,81.4,113.08,24.29,,560,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,3,3,334000000,7.1%
P00920,0.890797218,0.2195,1.091530483,-0.128333333,0.777762414,-0.295208275,-0.288,-0.029,1.168,0.329,-0.137,0.274,P00920,Car2,P00920_Car2,P00920,Ca2,1,108,19,19,P00920|A0A0A6YX78|P00921,MOUSE,29146.1,66.5,82,82.1,349.71,349.71,,260,Carbonic anhydrase 2,extracellular space|cytoplasm|cytosol|plasma membrane|microvillus|basolateral plasma membrane|axon|myelin sheath|apical part of cell|extracellular exosome|,"kidney development|morphogenesis of an epithelium|one-carbon metabolic process|regulation of pH|response to pH|response to zinc ion|carbon dioxide transport|positive regulation of synaptic transmission, GABAergic|positive regulation of cellular pH reduction|angiotensin-activated signaling pathway|odontogenesis of dentin-containing tooth|response to estrogen|regulation of anion transport|positive regulation of osteoclast differentiation|positive regulation of bone resorption|secretion|regulation of intracellular pH|cellular response to fluid shear stress|positive regulation of dipeptide transmembrane transport|regulation of chloride transport|",arylesterase activity|carbonate dehydratase activity|zinc ion binding|,19,108,26100000000,66.5%
P35917,0.443636341,-0.119833333,6.433125231,0.306333333,0.227346083,1.343481526,-0.091,-0.364,-0.364,-0.096,0.204,-0.008,P35917,Flt4,P35917_Flt4,P35917,Flt4,1,70,26,26,P35917,MOUSE,155124.7,19,83,83.1,349.12,349.12,,1363,Vascular endothelial growth factor receptor 3,nucleus|cytoplasm|plasma membrane|integral component of plasma membrane|receptor complex|,positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|vasculature development|lymph vessel development|lymphangiogenesis|sprouting angiogenesis|positive regulation of cell proliferation|positive regulation of vascular endothelial growth factor production|positive regulation of endothelial cell migration|peptidyl-tyrosine phosphorylation|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor signaling pathway|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of JNK cascade|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|blood vessel morphogenesis|regulation of blood vessel remodeling|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein kinase C signaling|,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|protein binding|ATP binding|growth factor binding|protein phosphatase binding|,26,70,7120000000,19.0%
E9Q557,0.278786168,0.305833333,10.73748593,-2.041,0.084382309,-2.068622061,2.758,2.215,-0.994,-0.982,-0.653,-0.509,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,71,37,37,E9Q557|E9PZW0,MOUSE,335359.7,11.5,84,84.1,348.98,348.98,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",37,71,2010000000,11.5%
P39039,0.37230644,-0.141833333,7.968919455,0.437,0.159627626,1.603248657,-0.796,-0.07,-0.215,0.13,0.054,0.046,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,222,22,22,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,66.9,85,85.1,344.34,344.34,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,22,222,1.33E+12,66.9%
Q3U3V1,0.17113477,-0.296166667,15.63934342,0.834333333,0.027293904,2.894517859,-0.742,-0.304,-1.094,0.329,0.04,-0.006,Q3U3V1,F10,Q3U3V1_F10,Q3U3V1,F10,1,144,23,23,Q3U3V1|O88947|D3Z215|D3Z521,MOUSE,56680.8,42.7,86,86.1,337.76,337.76,,493,Coagulation factor X,extracellular region|membrane|intracellular membrane-bounded organelle|,proteolysis|blood coagulation|positive regulation of protein kinase B signaling|,serine-type endopeptidase activity|calcium ion binding|phospholipid binding|,23,144,1.43E+11,42.7%
A11111,0.319502447,-0.277666667,9.582272645,0.560666667,0.110096303,1.871389733,-1.08,-0.189,-0.405,0.069,-0.054,-0.007,A11111,NotFound,A11111_NotFound,A11111,,1,100,21,21,A11111|P06709,MOUSE,39099.5,69.3,87,87.1,336.4,336.4,,,BirAG3ER,,,,21,100,4.14E+11,69.3%
P63260,0.946089108,-0.115666667,0.574333881,0.108,0.876126087,0.162709307,0.206,0.922,-1.637,0.024,-0.307,0.098,P63260,Actg1,P63260_Actg1,P63260,Actg1,1,114,23,1,P63260|G3UYG0|B1ATY1|V9GXQ2,MOUSE,42134.4,58.9,88,88.1,331.02,23.1,,375,"Actin, cytoplasmic 2",extracellular space|nucleus|cytosol|plasma membrane|focal adhesion|actin cytoskeleton|membrane|myofibril|filamentous actin|costamere|myelin sheath|extracellular exosome|blood microparticle|dense body|,retina homeostasis|sarcomere organization|response to calcium ion|platelet aggregation|,structural constituent of cytoskeleton|protein binding|ATP binding|ubiquitin protein ligase binding|identical protein binding|,23,114,41600000000,58.9%
P60710,0.343967985,-0.0352,8.621810215,0.5305,0.137346937,1.764745786,-0.359,-0.348,,0.422,-0.149,0.258,P60710,Actb,P60710_Actb,P60710,Actb,1,6,23,1,P60710|E9Q1F2,MOUSE,42078.3,58.9,88,88.2,328.95,21.03,,375,"Actin, cytoplasmic 1",nuclear chromatin|extracellular space|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|cortical cytoskeleton|NuA4 histone acetyltransferase complex|cytoplasmic ribonucleoprotein granule|myelin sheath|protein complex|extracellular exosome|MLL5-L complex|blood microparticle|dense body|,retina homeostasis|substantia nigra development|ATP-dependent chromatin remodeling|platelet aggregation|,protein binding|ATP binding|kinesin binding|Tat protein binding|identical protein binding|nitric-oxide synthase binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,1,6,410000000,4.5%
P68134,0.487434197,0.3394,5.776912527,-0.625166667,0.264428796,-1.256122938,1.415,0.014,,0.355,-0.175,0.088,P68134,Acta1,P68134_Acta1,P68134,Acta1,1,6,18,3,P68134|P68033|P62737|P63268,MOUSE,42392.6,42.7,88,88.3,237.92,28.71,,377,"Actin, alpha skeletal muscle",stress fiber|extracellular space|cytoplasm|striated muscle thin filament|actin filament|actin cytoskeleton|sarcomere|lamellipodium|filopodium|protein complex|cell body|extracellular exosome|blood microparticle|,response to mechanical stimulus|response to extracellular stimulus|response to lithium ion|positive regulation of gene expression|cell growth|skeletal muscle thin filament assembly|skeletal muscle fiber adaptation|response to steroid hormone|skeletal muscle fiber development|mesenchyme migration|,protein binding|ATP binding|,3,6,1590000000,12.9%
Q8BFZ3,0.602024006,0.096,4.069675464,0.448333333,0.391771152,0.936776433,-0.778,0.432,,0.283,0.644,-0.101,Q8BFZ3,Actbl2,Q8BFZ3_Actbl2,Q8BFZ3,Actbl2,1,1,10,1,Q8BFZ3,MOUSE,42345.8,20.7,88,88.4,108.08,4.65,,376,Beta-actin-like protein 2,extracellular space|cytoplasm|cytoskeleton|extracellular exosome|,,ATP binding|,1,1,11900000,3.7%
Q02819,0.326571299,-0.259166667,9.148651716,0.544333333,0.121656363,1.799546014,-0.477,-0.126,-0.991,-0.209,0.163,0.085,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,79,25,25,Q02819|A0A1C7CYU3,MOUSE,53407.7,54.4,89,89.1,327.11,327.11,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,25,79,8150000000,54.4%
Q61704,0.594937809,-0.039,4.207410353,0.268,0.379541234,0.947840011,0.161,-0.09,-0.59,0.292,0.007,-0.014,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,131,24,24,Q61704,MOUSE,99698.3,27.3,90,90.1,326.79,326.79,,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,24,131,54300000000,27.3%
O70570,0.819375851,-0.083333333,1.760997364,0.098,0.666653654,0.452557415,-0.114,-0.02,-0.263,0.035,-0.152,0.014,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,77,21,21,O70570,MOUSE,86309.5,30,91,91.1,322.65,322.65,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,21,77,12800000000,30.0%
P97298,0.201036971,-0.281,13.87679183,0.778,0.04095631,2.589507589,-0.738,-0.184,-1.088,0.236,0.09,-0.002,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,122,19,19,P97298|E9PWS2,MOUSE,46290.3,52.9,92,92.1,319.45,319.45,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,19,122,30700000000,52.9%
P08226,0.434226419,-0.090166667,6.617996504,0.349666667,0.217871463,1.375140434,-0.475,-0.249,-0.071,-0.209,0.212,0.251,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,149,24,24,P08226,MOUSE,35923,58.8,93,93.1,318.79,318.79,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,24,149,85800000000,58.8%
Q03311,0.337209389,-0.132333333,8.887394839,0.496,0.129199406,1.756206905,-0.803,-0.338,0,0.204,0.15,-0.007,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,103,20,20,Q03311,MOUSE,68974.5,30,94,94.1,317.53,317.53,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,20,103,41000000000,30.0%
P23953,0.232976837,-0.280666667,12.1257198,0.704,0.061295419,2.29380587,-0.745,-0.126,-1.027,0.261,-0.048,0.001,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,115,21,13,P23953|Q8VCT4|E9PYP1,MOUSE,61339.9,35.3,95,95.1,317.22,199.45,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",21,115,41900000000,35.3%
D3Z5G7,0.807879833,0.139833333,1.892544503,-0.133,0.64676357,-0.481992773,0.034,-0.031,0.616,0.276,-0.048,-0.008,D3Z5G7,Ces1b,D3Z5G7_Ces1b,D3Z5G7,Ces1b,1,28,17,8,D3Z5G7,MOUSE,62538.2,33.1,95,95.2,256.39,122,,567,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,8,28,2100000000,19.4%
Q8VCC2,0.193614767,-0.04825,14.32238634,1.203666667,0.036962502,3.063736475,,-0.951,,0.297,0.444,0.017,Q8VCC2,Ces1g,Q8VCC2_Ces1g,Q8VCC2,Ces1,1,1,4,1,Q8VCC2,MOUSE,63078.1,7.4,95,95.3,56.33,10.07,,565,Liver carboxylesterase 1,endoplasmic reticulum lumen|,metabolic process|,carboxylic ester hydrolase activity|,1,1,10700000,2.1%
Q07456,0.189842544,-0.254333333,14.71024684,0.817333333,0.033804562,2.732659646,-0.541,-0.298,-1.15,0.324,0.135,0.004,Q07456,Ambp,Q07456_Ambp,Q07456,Ambp,1,126,19,19,Q07456,MOUSE,39941.4,50.1,96,96.1,312.84,312.84,,349,Protein AMBP,extracellular space|plasma membrane|cell surface|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|protein-chromophore linkage|protein catabolic process|protein maturation|,serine-type endopeptidase inhibitor activity|IgA binding|heme binding|small molecule binding|protein homodimerization activity|,19,126,1.39E+11,50.1%
Q06194,0.338116008,-0.313333333,8.79127356,0.638,0.132090822,1.741694834,-0.249,-0.279,-1.369,-0.1,0.132,-0.015,Q06194,F8,Q06194_F8,Q06194,F8,1,68,25,25,Q06194|B2RRC9,MOUSE,267560.2,9.4,97,97.1,311.53,311.53,,2319,Coagulation factor VIII,extracellular space|,acute-phase response|platelet activation|oxidation-reduction process|,copper ion binding|oxidoreductase activity|,25,68,4600000000,9.4%
Q8CG19,0.456739783,0.423166667,6.240167995,-0.500333333,0.237674835,-1.311061932,0.862,-0.012,1.17,0.063,0.524,-0.068,Q8CG19,Ltbp1,Q8CG19_Ltbp1,Q8CG19,Ltbp1,1,54,20,20,Q8CG19|Q8CG19-2|Q8CG19-3|Q61810|F8VQ06|Q61810-2,MOUSE,195158.2,14.4,98,98.1,309.5,309.5,,1712,Latent-transforming growth factor beta-binding protein 1,microfibril|proteinaceous extracellular matrix|extracellular matrix|protein complex|extracellular matrix|,transforming growth factor beta receptor signaling pathway|,calcium ion binding|transforming growth factor beta binding|microfibril binding|,20,54,3140000000,14.4%
Q64726,0.38012959,0.015333333,7.731365108,0.474,0.168602298,1.563468712,-0.248,0.168,-0.585,0.552,0.244,-0.039,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,125,21,21,Q64726,MOUSE,35559.5,53.7,99,99.1,309.44,309.44,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,21,125,63500000000,53.7%
P70389,0.232324458,0.213333333,12.25953337,-0.539333333,0.059435602,-2.316205654,0.403,0.324,0.722,-0.18,-0.048,0.059,P70389,Igfals,P70389_Igfals,P70389,Igfals,1,88,22,22,A0A0R4J0S2|P70389,MOUSE,67757.5,40.1,100,100.1,304.56,304.56,,603,Insulin-like growth factor-binding protein complex acid labile subunit,nucleoplasm|insulin-like growth factor ternary complex|extracellular exosome|,cell adhesion|,,22,88,10600000000,40.1%
Q9DBB9,0.219519399,-0.191333333,13.16058455,0.530666667,0.048299379,2.467828664,-0.615,-0.42,-0.335,0.117,0.076,0.029,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,145,19,19,Q9DBB9,MOUSE,61333.9,45.5,101,101.1,303.11,303.11,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,19,145,1.04E+11,45.5%
P16294,0.145366797,-0.262,17.26063362,0.946666667,0.018790427,3.409163366,-1.006,-0.654,,0.253,0.086,0.011,P16294,F9,P16294_F9,P16294,F9,1,113,18,18,P16294,MOUSE,54289.1,43.7,102,102.1,299.74,299.74,,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,18,113,83100000000,43.7%
A0A0A6YXW6,0.275554082,-0.284,10.85546349,1.236,0.082120891,2.088320145,-0.32,-0.454,-1.932,-0.142,-0.073,1.217,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,126,15,4,A0A0A6YXW6,MOUSE,42869.8,48.8,103,103.1,294.53,68.76,,389,Immunoglobulin heavy constant alpha (Fragment),,,,15,126,1.91E+11,48.8%
P01878,0.232324458,-0.221,12.38380503,1.148333333,0.057758978,2.450652198,-1.445,-0.375,,0.024,-0.049,0.74,P01878,NotFound,P01878_NotFound,P01878,,1,4,12,1,P01878,MOUSE,37616.9,46.8,103,103.2,232.45,6.68,,344,Ig alpha chain C region,,,antigen binding|immunoglobulin receptor binding|,1,4,59200000,6.3%
P41317,0.170855912,-0.564666667,15.67824245,1.34,0.027050529,2.906059515,-1.311,-0.324,-2.069,0.202,0.103,0.011,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,168,17,17,P41317,MOUSE,26356,60.2,104,104.1,292.13,292.13,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,17,168,4.01E+11,60.2%
Q6GQT1,0.126655669,-0.3185,18.18531304,0.816333333,0.015186885,3.353029693,-0.561,-0.635,-0.984,-0.112,0.18,0.201,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,148,25,21,Q6GQT1|K4JBR5|K4JF13|K4JB97,MOUSE,165776,18.5,105,105.1,290.94,244.16,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,27,148,1.41E+13,18.5%
Q7SIH1,0.702114845,0.1232,2.887028641,0.196166667,0.514395471,0.700842811,-0.047,0.058,,0.418,-0.017,0.204,Q7SIH1,NotFound,Q7SIH1_NotFound,Q7SIH1,A2M,1,2,8,2,Q7SIH1|K4JR81|K4JDS3|K4JDR8|K4JBA2|R9QSM8,BOVIN,169056.4,5.8,105,105.2,77.94,9.58,,1510,Alpha-2-macroglobulin,,,,2,2,107000000,2.6%
Q9R1E6-2,0.595170996,0.021166667,4.150584215,0.340333333,0.38454005,0.937647375,-0.221,0.349,-0.575,0.698,-0.074,-0.05,Q9R1E6,Enpp2,Q9R1E6-2_Enpp2,Q9R1E6-2,Enpp2,1,61,21,21,Q9R1E6-2|G3UXY9|Q9R1E6-3|Q9R1E6,MOUSE,106969.5,26.9,106,106.1,286.37,286.37,,862,Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,21,61,7050000000,26.9%
P29699,0.326571299,-0.198333333,9.187211344,0.548666667,0.120580996,1.805938483,-1.015,-0.186,-0.217,0.193,0.035,0,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,167,18,18,P29699,MOUSE,38123.7,63.1,107,107.1,284.6,284.6,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,18,167,4.85E+11,63.1%
O70165,0.495652184,-0.151666667,5.621225299,0.528,0.274080079,1.203311573,-1.298,-0.252,0.303,0.065,0.283,-0.011,O70165,Fcna,O70165_Fcna,O70165,Fcn1,1,132,18,18,O70165,MOUSE,36868.4,38.9,108,108.1,283.49,283.49,,334,Ficolin-1,collagen trimer|extrinsic component of external side of plasma membrane|blood microparticle|,cell surface pattern recognition receptor signaling pathway|G-protein coupled receptor signaling pathway|recognition of apoptotic cell|negative regulation of viral entry into host cell|defense response to virus|negative regulation of RNA biosynthetic process|positive regulation of interleukin-8 secretion|,antigen binding|protein binding|signaling pattern recognition receptor activity|carbohydrate binding|metal ion binding|carbohydrate derivative binding|,18,132,1.33E+11,38.9%
P70375,0.877114071,-0.002166667,1.193641503,0.144333333,0.75968902,0.320146974,-0.738,-0.374,0.889,0.066,0.13,0.014,P70375,F7,P70375_F7,P70375,F7,1,138,20,20,P70375,MOUSE,51701.8,40.3,109,109.1,283.43,283.43,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,20,138,73500000000,40.3%
Q9Z0Z4,0.394001833,-0.507833333,7.451105778,1.021,0.179841295,1.519303965,-0.245,-0.226,-2.584,0.018,-0.008,-0.002,Q9Z0Z4,Heph,Q9Z0Z4_Heph,Q9Z0Z4,Heph,1,63,22,22,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,22.3,110,110.1,280.49,280.49,,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,22,63,5720000000,22.3%
Q08761,0.993586203,0.074666667,0.053794009,0.008,0.987689869,0.016081652,-0.696,-0.236,1.144,0.216,0.032,-0.012,Q08761,Pros1,Q08761_Pros1,Q08761,Pros1,1,89,23,23,Q08761,MOUSE,76987.1,31.1,111,111.1,278.78,278.78,,675,Vitamin K-dependent protein S,extracellular space|protein complex|extracellular exosome|blood microparticle|,blood coagulation|response to lipopolysaccharide|fibrinolysis|positive regulation of phagocytosis|,calcium ion binding|protein complex binding|,23,89,23700000000,31.1%
Q61730-2,0.794134698,0.004666667,2.009518802,0.165333333,0.629575936,0.507895916,-0.491,-0.201,0.458,0.342,-0.132,0.052,Q61730,Il1rap,Q61730-2_Il1rap,Q61730-2,Il1rap,1,79,20,20,Q61730-2|Q61730-3|E9Q6I2|Q61730|G3UY13,MOUSE,42194.2,44.1,112,112.1,276.48,276.48,,570,Isoform 2 of Interleukin-1 receptor accessory protein,extracellular region|plasma membrane|membrane|integral component of membrane|,inflammatory response|cytokine-mediated signaling pathway|interleukin-2 biosynthetic process|innate immune response|,signal transducer activity|interleukin-1 receptor activity|protein binding|,20,79,13900000000,44.1%
P00761,0.007983705,0.812833333,40.27075831,-2.621,9.39559E-05,-9.112729961,2.558,1.718,2.094,-0.583,-0.529,-0.381,P00761,NotFound,P00761_NotFound,P00761,,1,571,15,14,P00761,PIG,25093.7,64,113,113.1,276.47,260.27,,231,Trypsin,,,,15,571,8.48E+13,64.0%
B99907,0.035407766,0.6285,27.29497698,-1.681,0.001864242,-5.266500089,2.071,1.17,1.166,-0.152,-0.217,-0.267,B99907,NotFound,B99907_NotFound,B99907,,1,101,5,4,B99907,PromTArt7,5560.1,98,113,113.2,104.96,88.76,,50,"Promega trypsin artifact 2 K to R mods +28 (2239.1, 2914)(1987, 2003) [Sus scrofa]",,,,4,101,91000000000,98.0%
B99908,0.230911153,1.161333333,12.50401968,-1.740666667,0.056182108,-2.365243229,2.433,1.689,1.973,-0.647,-0.44,1.96,B99908,NotFound,B99908_NotFound,B99908,,1,1,2,1,B99908,PromTArt8,3352.7,96.7,113,113.3,24.94,8.74,,31,Promega trypsin artifact LIK -> GNPK +42 [Sus scrofa],,,,1,1,17500000,64.5%
Q9JHH6,0.284070507,0.038166667,10.59709519,0.511,0.087154634,2.039449776,-0.149,-0.139,-0.364,0.393,0.516,-0.028,Q9JHH6,Cpb2,Q9JHH6_Cpb2,Q9JHH6,Cpb2,1,117,18,18,Q9JHH6,MOUSE,49269,36.7,114,114.1,274.75,274.75,,422,Carboxypeptidase B2,extracellular space|cell|extracellular exosome|,positive regulation of extracellular matrix constituent secretion|proteolysis|blood coagulation|response to heat|negative regulation of plasminogen activation|response to drug|fibrinolysis|negative regulation of fibrinolysis|cellular response to glucose stimulus|liver regeneration|negative regulation of hepatocyte proliferation|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,18,117,59500000000,36.7%
P27773,0.277480131,-0.1985,10.77461508,0.435666667,0.083663974,2.068881002,-0.473,-0.301,-0.475,-0.021,0.092,-0.013,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,53,20,20,P27773|A5D7E8|P38657,MOUSE,57133.7,40,115,115.1,273.3,273.3,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,20,53,4430000000,40.0%
P82198,0.468546069,-0.1235,6.06185012,0.326333333,0.247636689,1.279476224,-0.356,-0.296,-0.208,-0.145,-0.145,0.409,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,66,20,20,P82198|Q3UXJ2,MOUSE,75223.3,26.6,116,116.1,273.23,273.23,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,20,66,3370000000,26.6%
P08607,0.432253305,-0.153833333,6.763872107,0.354333333,0.210674897,1.40003167,-0.537,-0.423,-0.033,-0.023,-0.132,0.225,P08607,C4bp,P08607_C4bp,P08607,C4bpa,1,126,16,16,P08607|E9PUZ8,MOUSE,53006.2,33.9,117,117.1,271.53,271.53,,469,C4b-binding protein,extracellular region|,"complement activation, classical pathway|innate immune response|",protein binding|,16,126,68600000000,33.9%
Q5I012-3,0.685439514,-0.1695,3.084433148,0.259,0.491537533,0.732286731,-0.119,0.205,-0.983,-0.01,-0.102,-0.008,Q5I012,Slc38a10,Q5I012-3_Slc38a10,Q5I012-3,Slc38a10,1,48,18,18,Q5I012-3|Q5I012-4|Q5I012|J3QNE8|Q5I012-2,MOUSE,116909.1,26.2,118,118.1,266.08,266.08,,1090,Isoform 3 of Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,18,48,21700000000,26.2%
Q9CQF9,0.472601761,-0.106666667,5.985037605,0.267333333,0.252055535,1.266156899,-0.125,-0.237,-0.359,0.036,0.058,-0.013,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,70,17,17,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,40.3,119,119.1,265.71,265.71,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,17,70,6920000000,40.3%
Q9EQH2,0.269872202,-0.276,11.03160082,0.596666667,0.07885694,2.111523659,-0.346,-0.344,-1.033,0.153,-0.109,0.023,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,53,23,23,Q9EQH2,MOUSE,107167.8,25.3,120,120.1,263.58,263.58,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,23,53,3270000000,25.3%
A0A0A6YVP0,0.62503481,-0.1315,3.704719133,0.447,0.42611624,0.853444751,0.56,-0.172,-1.453,0.077,0.219,-0.02,A0A0A6YVP0,NotFound,A0A0A6YVP0_NotFound,A0A0A6YVP0,Ighg2b,1,82,18,16,A0A0A6YVP0|P01867|P01867-2|P01865|P01863,MOUSE,45094.4,47.1,121,121.1,256.71,214.61,,405,Immunoglobulin heavy constant gamma 2B (Fragment),"extracellular space|immunoglobulin complex, circulating|","positive regulation of type IIa hypersensitivity|positive regulation of type I hypersensitivity|humoral immune response mediated by circulating immunoglobulin|phagocytosis, recognition|phagocytosis, engulfment|complement activation, classical pathway|immunoglobulin mediated immune response|positive regulation of phagocytosis|positive regulation of immune response|",antigen binding|,18,82,17600000000,47.1%
F6TQW2,0.428691221,-1.0305,6.817125189,2.181666667,0.20810738,1.411584077,-0.346,-0.159,-5.859,0.045,0.153,-0.017,F6TQW2,NotFound,F6TQW2_NotFound,F6TQW2,Ighg2c,1,56,13,11,F6TQW2|P01864,MOUSE,44892.5,32.9,121,121.2,230.3,188.2,,404,Immunoglobulin heavy constant gamma 2C (Fragment),"extracellular space|immunoglobulin complex, circulating|",humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antibacterial humoral response|defense response to bacterium|,antigen binding|,11,56,14000000000,28.2%
Q9QWL7,0.155174868,0.467166667,16.19320137,-2.455,0.024025911,-3.006217986,3.132,2.063,-0.111,-0.994,-0.813,-0.474,Q9QWL7,Krt17,Q9QWL7_Krt17,Q9QWL7,Krt17,1,116,21,6,Q9QWL7|Q9D312|Q8CCX5|Q8CCX5-2|Q99PS0,MOUSE,48446.3,33.9,122,122.1,256.44,73.93,,433,"Keratin, type I cytoskeletal 17",cytoplasm|intermediate filament|extracellular exosome|cell periphery|,morphogenesis of an epithelium|signal transduction|positive regulation of cell growth|hair follicle morphogenesis|keratinization|intermediate filament organization|positive regulation of translation|positive regulation of hair follicle development|,structural molecule activity|protein binding|MHC class II receptor activity|MHC class II protein binding|,22,116,5.2E+11,33.9%
Q61781,0.028187415,0.477166667,29.27635413,-1.508333333,0.001181312,-5.74233944,1.506,1.26,0.928,-0.34,-0.442,-0.049,Q61781,Krt14,Q61781_Krt14,Q61781,Krt14,1,3,21,3,Q61781|Q9Z320|Q8VCW2,MOUSE,53208.4,35.7,122,122.2,254.8,29.07,,484,"Keratin, type I cytoskeletal 14",intracellular|nucleus|cytoplasm|intermediate filament|keratin filament|extracellular exosome|cell periphery|,aging|response to zinc ion|response to ionizing radiation|epithelial cell differentiation|hair cycle|intermediate filament bundle assembly|,structural molecule activity|protein binding|keratin filament binding|,3,3,13800000,7.2%
Q6IFX2,0.774178712,-0.196166667,2.20375476,-0.997,0.602038859,-0.550426811,3.235,1.635,-3.963,-1.186,-0.568,-0.33,Q6IFX2,Krt42,Q6IFX2_Krt42,Q6IFX2,Krt42,1,12,21,6,Q6IFX2,MOUSE,50474.5,30.5,122,122.3,229.96,61.98,,452,"Keratin, type I cytoskeletal 42",cytoplasm|intermediate filament|,,structural molecule activity|,6,12,1460000000,8.8%
P08730,0.947301503,0.601166667,0.55502046,0.162333333,0.880030966,0.157529685,1.234,1.196,-0.87,-0.408,-0.264,2.719,P08730,Krt13,P08730_Krt13,P08730,Krt13,1,4,16,3,P08730|P08730-2|A6BLY7,MOUSE,48095.6,21.9,122,122.4,163.4,25.83,,437,"Keratin, type I cytoskeletal 13",nucleus|keratin filament|intermediate filament cytoskeleton|extracellular exosome|,cytoskeleton organization|response to radiation|tongue morphogenesis|cellular response to retinoic acid|,structural molecule activity|protein binding|,3,4,462000000,5.9%
Q9Z2K1,0.226931035,0.409333333,12.748963,-2.312666667,0.053101122,-2.406749645,3.337,1.858,-0.498,-1.171,-0.801,-0.269,Q9Z2K1,Krt16,Q9Z2K1_Krt16,Q9Z2K1,Krt16,1,12,15,6,Q9Z2K1,MOUSE,52004.9,23.6,122,122.5,183.42,82.81,,469,"Keratin, type I cytoskeletal 16",nucleus|cytoskeleton|intermediate filament|extracellular exosome|,morphogenesis of an epithelium|inflammatory response|aging|keratinocyte differentiation|negative regulation of cell migration|keratinization|hair cycle|innate immune response|intermediate filament cytoskeleton organization|keratinocyte migration|establishment of skin barrier|,structural constituent of cytoskeleton|protein binding|,6,12,2910000000,11.5%
O77727,0.452865805,0.307833333,6.297133065,-0.983,0.234577684,-1.32226201,2.265,0.885,-0.752,-0.264,-0.21,-0.077,O77727,NotFound,O77727_NotFound,O77727,KRT15,1,22,13,4,O77727,SHEEP,48769.2,18.7,122,122.6,159.52,49.74,,453,"Keratin, type I cytoskeletal 15",,,,4,22,11900000000,5.7%
P02535,0.206972229,0.265,13.55629998,-1.602666667,0.044093036,-2.544430751,2.064,1.479,-0.344,-0.662,-0.407,-0.54,P02535,Krt10,P02535_Krt10,P02535,Krt10,1,57,12,7,P02535|P02535-2|A2A513|P02535-3,MOUSE,57940,17,122,122.7,175.58,109.55,,570,"Keratin, type I cytoskeletal 10",keratin filament|,epithelial cell differentiation|cellular response to calcium ion|,structural molecule activity|protein binding|,7,57,1.44E+11,11.7%
B1AQ77,0.155174868,0.697,16.4436125,-3.883333333,0.022679775,-3.261892124,1.02,5.034,,-0.813,-0.793,-0.963,B1AQ77,Krt15,B1AQ77_Krt15,B1AQ77,Krt15,1,4,11,1,B1AQ77|Q61414,MOUSE,49664.3,13.5,122,122.8,134.34,17.36,,456,"Keratin 15, isoform CRA_a",nucleus|intermediate filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|scaffold protein binding|,1,4,1370000000,3.9%
P19001,0.121109301,0.409666667,18.55180471,-2.143333333,0.013957882,-3.439971229,2.832,1.199,0.413,-0.854,-0.638,-0.494,P19001,Krt19,P19001_Krt19,P19001,Krt19,1,3,6,1,P19001,MOUSE,44541,11.4,122,122.9,77.2,9.39,,403,"Keratin, type I cytoskeletal 19",intermediate filament|plasma membrane|dystrophin-associated glycoprotein complex|Z disc|sarcolemma|costamere|extracellular exosome|cell periphery|terminal web|,Notch signaling pathway|response to estrogen|sarcomere organization|cell differentiation involved in embryonic placenta development|,protein binding|structural constituent of muscle|protein complex binding|,1,3,56700000,2.9%
Q9BGM5,0.232324458,0.234333333,12.19099114,-1.824666667,0.060381081,-2.312358129,2.771,1.117,-0.448,-0.684,-0.566,-0.784,Q9BGM5,NotFound,Q9BGM5_NotFound,Q9BGM5,KRT25,1,11,2,1,Q9BGM5,SHEEP,49883,4,122,122.1,33.78,17.51,,450,"Keratin, type I cytoskeletal 25",,,,1,11,27600000000,2.0%
P29788,0.719487463,0.236333333,2.653949274,-0.250666667,0.542756549,-0.644967167,0.289,-0.264,1.06,0.38,-0.048,0.001,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,184,16,16,P29788,MOUSE,55646.8,34.5,123,123.1,255.79,255.79,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,16,184,4.32E+11,34.5%
P29533,0.399769484,-0.181333333,7.344883386,0.321333333,0.184294197,1.498485958,-0.422,-0.358,-0.246,-0.147,0.081,0.004,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,58,19,19,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,27.8,124,124.1,253.07,253.07,,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,19,58,8400000000,27.8%
Q3U9N4,0.709461512,-0.0645,2.798458956,0.219666667,0.524993715,0.67452763,0.045,0.212,-0.78,-0.01,0.171,-0.025,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,71,18,18,Q3U9N4|P28798,MOUSE,70037.8,29.9,125,125.1,252.36,252.36,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,18,71,4540000000,29.9%
Q9R098,0.668458111,-0.050166667,3.286016544,0.222333333,0.469243587,0.771933387,0.099,0.067,-0.65,0.051,0.164,-0.032,Q9R098,Hgfac,Q9R098_Hgfac,Q9R098,Hgfac,1,62,17,17,Q9R098,MOUSE,72905.8,26.6,126,126.1,248.86,248.86,,653,Hepatocyte growth factor activator,extracellular space|cytoplasm|rough endoplasmic reticulum|,proteolysis|,serine-type endopeptidase activity|,17,62,13200000000,26.6%
P70663,0.705287932,0.075666667,2.835374533,-0.161333333,0.520550115,-0.681910283,0.417,0.143,-0.091,-0.04,0.046,-0.021,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,64,19,19,P70663,MOUSE,73141.8,33,127,127.1,245.26,245.26,,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,19,64,9130000000,33.0%
P28653,0.049306582,0.5995,24.70236254,-1.745,0.003386599,-4.677085539,2.195,0.914,1.307,-0.398,-0.175,-0.246,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,50,17,17,P28653,MOUSE,42094.9,53.6,128,128.1,244.49,244.49,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,17,50,13100000000,53.6%
Q06770,0.326571299,-0.120833333,9.185654036,0.517666667,0.120624242,1.805680328,-0.803,-0.111,-0.225,0.388,0.045,-0.019,Q06770,Serpina6,Q06770_Serpina6,Q06770,Serpina6,1,99,15,15,Q06770,MOUSE,44939.5,35,129,129.1,242.09,242.09,,397,Corticosteroid-binding globulin,extracellular space|extracellular exosome|,transport|glucocorticoid metabolic process|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|steroid binding|,15,99,1.17E+11,35.0%
Q9R0E2,0.857365992,0.037333333,1.321824725,-0.096,0.737594259,-0.350862672,-0.245,-0.01,0.511,-0.065,0.037,-0.004,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,66,21,20,Q9R0E2|A8Y5E6,MOUSE,84164,31,130,130.1,240.07,227.56,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,21,66,2840000000,31.0%
Q9R0E1,0.612514063,-0.159666667,3.899305818,0.45,0.407445399,0.890473552,-0.974,-0.918,0.738,-0.067,0.221,0.042,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,20,8,7,Q9R0E1,MOUSE,85491.3,12.8,130,130.2,73.53,61.02,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,7,20,2020000000,11.4%
P01898,0.934912217,0.203833333,0.705712948,-0.117666667,0.850019141,-0.197477747,-0.604,-0.208,1.6,0.315,0.131,-0.011,P01898,H2-Q10,P01898_H2-Q10,P01898,H2-Q10,1,122,15,8,P01898|G3UXE9|E9Q0G4|A7VMS6|V9GXR0|V9GXI4|Q05A75|G3UZL7|A0A0B4J1G3,MOUSE,37478.5,40.6,131,131.1,240.04,134.39,,325,"H-2 class I histocompatibility antigen, Q10 alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,15,122,43800000000,40.6%
Q8HWB2,0.294065232,-0.407666667,10.2621679,0.918,0.094141954,1.985918853,-0.501,-0.228,-1.871,0.114,0.058,-0.018,Q8HWB2,H2-Q4,Q8HWB2_H2-Q4,Q8HWB2,H2-Q4,1,20,15,6,Q8HWB2|P01899|O19441|E9PX63|P01900|P14427|P01895-2,MOUSE,39902.4,37,131,131.2,205.53,80.74,,354,"Histocompatibility 2, Q region locus 4",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,6,20,774000000,16.1%
P79568,0.351857538,-0.0976,8.472968294,0.614833333,0.142135699,1.739472735,-0.844,-0.089,,0.391,0.096,-0.042,P79568,H2-Q6,P79568_H2-Q6,P79568,H2-Q6,1,4,6,4,P79568|P01901|Q3TH01|P14429|E9QJR9|E9PWT4|P14431|L7N260|P06339|P03991,MOUSE,37691.1,16.5,131,131.3,78.71,30.24,,326,Class Ib MHC antigen Qa-2,endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,4,4,47300000,3.6%
P33587,0.323689613,-0.159666667,9.511079507,0.630666667,0.111915966,1.861281341,-0.224,-0.126,-1.075,0.439,0.046,-0.018,P33587,Proc,P33587_Proc,P33587,Proc,1,59,15,15,P33587,MOUSE,53186.4,38,132,132.1,239.95,239.95,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,15,59,7720000000,38.0%
Q61207,0.145366797,-0.457166667,16.8973649,1.105666667,0.020429772,3.123636689,-0.9,-0.512,-1.618,-0.141,0.369,0.059,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,78,16,16,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,36.2,133,133.1,237.18,237.18,,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,16,78,23600000000,36.2%
Q9R097,0.946089108,0.1245,0.624356927,0.073666667,0.866092559,0.175971951,-0.425,-0.271,0.959,0.324,0.185,-0.025,Q9R097,Spint1,Q9R097_Spint1,Q9R097,Spint1,1,50,18,18,Q9R097,MOUSE,58358.6,37.8,134,134.1,237.12,237.12,,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,18,50,3050000000,37.8%
P46412,0.090242298,-0.524333333,20.70097998,1.151333333,0.00850946,3.832545401,-1.055,-0.663,-1.582,0.146,-0.048,0.056,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,180,17,17,P46412|P21765,MOUSE,25581.2,48.2,135,135.1,236.26,236.26,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,17,180,3.45E+11,48.2%
P55065,0.91303325,0.109,0.853270764,0.091333333,0.821623635,0.235516798,-0.273,-0.384,0.847,0.125,0.342,-0.003,P55065,Pltp,P55065_Pltp,P55065,Pltp,1,74,16,16,P55065|A2A5K2,MOUSE,54680.3,41.7,136,136.1,235.85,235.85,,493,Phospholipid transfer protein,extracellular space|,lipid metabolic process|lipid transport|vitamin E biosynthetic process|positive regulation of cholesterol efflux|sperm motility|high-density lipoprotein particle remodeling|,lipid binding|,16,74,14100000000,41.7%
E0CZ58,0.974026738,-0.010833333,0.273919481,0.045666667,0.938875599,0.07997551,1.136,-0.148,-1.089,0.213,-0.09,-0.087,E0CZ58,Prg4,E0CZ58_Prg4,E0CZ58,Prg4,1,55,17,17,E0CZ58|Q9JM99|Q9JM99-2|E9QQ17|Q9JM99-3|E9QQ18|Q9JM99-4|A0A0R4J207|Q9JM99-5,MOUSE,135831.6,15.3,137,137.1,229.33,229.33,,1221,Proteoglycan 4,extracellular space|cytoplasm|,receptor-mediated endocytosis|immune response|peptide cross-linking|regulation of cell proliferation|negative regulation of interleukin-6 biosynthetic process|hematopoietic stem cell proliferation|,scavenger receptor activity|polysaccharide binding|,17,55,10000000000,15.3%
Q9JJN5,0.595170996,0.517333333,4.164936731,-0.806666667,0.383271324,-0.941013409,-0.209,0.024,2.947,0.207,0.136,-0.001,Q9JJN5,Cpn1,Q9JJN5_Cpn1,Q9JJN5,Cpn1,1,83,15,15,Q9JJN5|Q2KJ83,MOUSE,52129.7,37.4,138,138.1,227.96,227.96,,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,15,83,17500000000,37.4%
G3X8T3,0.337209389,-0.278166667,8.836492723,0.759666667,0.130722615,1.749218141,-0.517,0.071,-1.528,0.142,0.187,-0.024,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,85,16,16,G3X8T3|P16675,MOUSE,56352.8,30.2,139,139.1,224.44,224.44,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,16,85,4.36E+11,30.2%
P68368,0.819375851,0.2215,1.758054964,-0.187,0.667105473,-0.45201475,0.604,0.797,-0.456,0.321,-0.292,0.355,P68368,Tuba4a,P68368_Tuba4a,P68368,Tuba4a,1,35,18,4,P68368|Q9JJZ2|Q3UX10,MOUSE,50665.2,42.1,140,140.1,222.89,45.52,,448,Tubulin alpha-4A chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,18,35,3300000000,42.1%
P05213,0.948474645,-0.213333333,0.53877451,0.191333333,0.883329123,0.15315868,0.304,1.897,-3.128,0.154,-0.633,0.126,P05213,Tuba1b,P05213_Tuba1b,P05213,Tuba1b,1,7,17,3,P05213|P68369|P68373|P05214,MOUSE,50835.4,39.6,140,140.2,219.15,41.78,,451,Tubulin alpha-1B chain,cytosol|microtubule|cytoplasmic microtubule|myelin sheath|extracellular exosome|,microtubule cytoskeleton organization|protein folding|protein polymerization|cellular response to interleukin-4|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|ubiquitin protein ligase binding|,3,7,120000000,9.7%
A8DUK4,0.969210124,0.172333333,0.353531652,-0.054666667,0.921821504,-0.102333169,-0.847,0.325,1.121,0.408,-0.252,0.279,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,148,12,4,A8DUK4|P02081|P02104|D4QBB3|P02070|P06642|P06643,MOUSE,15804.8,89.7,141,141.1,222.66,67.24,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,13,148,2.31E+11,89.7%
P02088,0.338116008,0.4275,8.785258991,-0.505,0.132273882,-1.739248516,0.831,0.689,0.52,0.626,-0.186,0.085,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,36,12,3,P02088,MOUSE,15954,89.7,141,141.2,218.6,54.62,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,36,38800000000,27.8%
P02089,0.96539578,0.949,0.402669134,0.1275,0.911450498,0.117002202,0.106,1.639,,0.542,2.844,-0.386,P02089,Hbb-b2,P02089_Hbb-b2,P02089,Hbb-b2,1,28,12,5,P02089,MOUSE,15992.1,78.9,141,141.3,197.11,89.42,,147,Hemoglobin subunit beta-2,hemoglobin complex|,oxygen transport|positive regulation of myeloid cell differentiation|regulation of erythrocyte differentiation|erythrocyte development|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,5,28,3110000000,35.3%
O09164,0.612514063,0.134166667,3.902282599,-0.196333333,0.40716622,-0.890640503,0.049,0.31,0.338,0.138,-0.019,-0.011,O09164,Sod3,O09164_Sod3,O09164,Sod3,1,59,14,14,O09164,MOUSE,27733.7,51.3,142,142.1,222.2,222.2,,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,14,59,23900000000,51.3%
O35930,0.487771635,-0.050666667,5.764597419,0.268,0.26517969,1.227771207,-0.121,-0.084,-0.349,0.117,0.153,-0.02,O35930,Gp1ba,O35930_Gp1ba,O35930,Gp1ba,1,61,14,14,O35930,MOUSE,80567.4,20.2,143,143.1,221.97,221.97,,734,Platelet glycoprotein Ib alpha chain,plasma membrane|integral component of plasma membrane|cell surface|membrane|extracellular exosome|anchored component of external side of plasma membrane|,cell morphogenesis|cell adhesion|blood coagulation|hemostasis|fibrinolysis|,,14,61,8590000000,20.2%
P45700,0.537100743,-0.081666667,5.093322119,0.272666667,0.309505085,1.109202491,-0.481,-0.244,0.071,0.012,0.17,-0.018,P45700,Man1a,P45700_Man1a,P45700,Man1a1,1,53,20,20,P45700|A0A1W2P6N0,MOUSE,73502.6,30.6,144,144.1,220.83,220.83,,655,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",Golgi membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",20,53,3000000000,30.6%
P07309,0.277480131,-0.7035,10.7859965,1.896333333,0.083445006,2.076720303,-0.961,-0.227,-3.767,0.455,0.29,-0.011,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,112,15,15,P07309,MOUSE,15889.7,77.5,145,145.1,220.74,220.74,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,15,112,1.39E+11,77.5%
P00687,0.535239042,-0.052333333,5.117184298,0.278666667,0.307809182,1.113465744,-0.425,0.141,-0.291,0.169,0.112,-0.02,P00687,Amy1,P00687_Amy1,P00687,Amy1,1,57,16,16,P00687|P00688|E9PV85|Q3MHH8,MOUSE,58327.3,34.4,146,146.1,220.56,220.56,,511,Alpha-amylase 1,extracellular space|extracellular exosome|,carbohydrate catabolic process|,alpha-amylase activity|calcium ion binding|amylase activity|chloride ion binding|,16,57,11900000000,34.4%
G5E8J0,0.403070996,-0.1825,7.265516236,0.336333333,0.18769313,1.485095241,-0.5,-0.437,-0.115,-0.072,-0.003,0.032,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,47,17,17,G5E8J0|O35516|O35516-2,MOUSE,279492.6,8.4,147,147.1,219.73,219.73,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,17,47,1370000000,8.4%
P02534,0.364618865,0.6695,8.140122957,-1.571666667,0.153457354,-1.635297938,0.606,3.234,0.526,1.328,-0.934,-0.743,P02534,NotFound,P02534_NotFound,P02534,,1,62,16,8,P02534|Q61765|Q61897|B0LKP1|Q9D646,SHEEP,48099.9,27.4,148,148.1,213.62,116.04,,412,"Keratin, type I microfibrillar 48 kDa, component 8C-1",,,,17,62,1.21E+11,27.4%
P25690,0.226931035,0.784,12.73974833,-2.209166667,0.053213909,-2.525764634,1.358,2.861,,1.291,-1.08,-0.51,P25690,NotFound,P25690_NotFound,P25690,,1,9,13,5,P25690|B1AQ75,SHEEP,47374.2,25.4,148,148.2,140.36,47.11,,404,"Keratin, type I microfibrillar, 47.6 kDa",,,,5,9,2010000000,8.6%
Q9QXC1,0.848045337,0.234,1.41063012,-0.265333333,0.722664944,-0.372143123,-0.706,-0.18,1.986,0.359,-0.109,0.054,Q9QXC1,Fetub,Q9QXC1_Fetub,Q9QXC1,Fetub,1,92,14,14,Q9QXC1|Q6YJU1,MOUSE,43567.8,28.6,149,149.1,213.1,213.1,,388,Fetuin-B,extracellular region|extracellular space|extracellular exosome|,single fertilization|binding of sperm to zona pellucida|negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|metalloendopeptidase inhibitor activity|,14,92,59300000000,28.6%
P25691,0.421402913,0.613666667,6.943984145,-1.434666667,0.202116415,-1.433232147,0.738,3.115,0.14,1.441,-1.055,-0.697,P25691,NotFound,P25691_NotFound,P25691,,1,36,17,7,P25691|Q9Z2T6|Q6IMF0|Q9CPR6,SHEEP,56452.4,28.6,150,150.1,209.26,98.02,,502,"Keratin, type II microfibrillar, component 5",,,,17,36,14600000000,28.6%
P15241,0.970099283,-0.269333333,0.323699875,0.168,0.928175312,0.09402045,0.105,2.954,-4.119,1.179,-1.029,-0.706,P15241,NotFound,P15241_NotFound,P15241,,1,13,16,4,P15241,SHEEP,55506.6,23.4,150,150.2,205.54,56.9,,491,"Keratin, type II microfibrillar, component 7C",,,,4,13,4520000000,9.1%
P02539,0.738097288,0.1744,2.506438258,-0.792666667,0.561508292,-0.621865946,-1.173,2.473,,1.181,-0.932,-0.677,P02539,NotFound,P02539_NotFound,P02539,,1,2,4,2,P02539,SHEEP,12911.1,35.7,150,150.3,51.8,14.4,,109,"Keratin, type II microfibrillar (Fragment)",,,,2,2,549000000,24.7%
Q99M74,0.009081837,1.296833333,37.66248126,-4.428333333,0.000171298,-8.239257554,3.346,4.62,2.567,-1.082,-0.681,-0.989,Q99M74,Krt82,Q99M74_Krt82,Q99M74,Krt82,1,2,4,2,Q99M74,MOUSE,58736.9,9.3,150,150.4,29.34,9.45,,516,"Keratin, type II cuticular Hb2",keratin filament|,,structural molecule activity|,2,2,1240000000,5.6%
Q3UTR7,0.898438274,0.188333333,0.975528059,-0.084666667,0.798816808,-0.266393528,-0.224,0.329,0.587,0.509,-0.062,-0.009,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,83,13,13,Q3UTR7|P11859,MOUSE,52954.5,34,151,151.1,207.63,207.63,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,13,83,35500000000,34.0%
Q8VDD5,0.206287245,0.526333333,13.64248283,-2.434666667,0.043226664,-2.559215063,3.643,-0.208,1.796,-0.74,-1.058,-0.275,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,24,20,18,Q8VDD5|Q6URW6-3|Q6URW6|K3W4R2|Q6URW6-2|Q3UH59|Q5SV64|Q61879|F2Z494,MOUSE,227566.2,12.1,152,152.1,205.65,178.31,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,20,24,421000000,12.1%
O08638,0.391130802,0.1538,7.494943885,-0.528666667,0.178035091,-1.564111128,0.784,0.158,,-0.2,-0.2,0.227,O08638,NotFound,O08638_NotFound,O08638,Myh11,1,2,4,2,O08638|E9QPE7|O08638-2,MOUSE,227879.9,2.1,152,152.2,38.85,11.51,,1972,Myosin-11,stress fiber|muscle myosin complex|brush border|myosin complex|myofibril|smooth muscle contractile fiber|myosin filament|melanosome|extracellular exosome|,smooth muscle contraction|metabolic process|skeletal muscle myosin thick filament assembly|elastic fiber assembly|cardiac muscle fiber development|activation of mitophagy in response to mitochondrial depolarization|,motor activity|actin binding|calmodulin binding|ATP binding|structural constituent of muscle|,2,2,15500000,0.8%
O54782,0.996786,0.109833333,0.019039465,0.001666667,0.995625597,0.005712956,-0.274,0.066,0.535,-0.012,0.322,0.022,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,54,16,16,O54782,MOUSE,115835.7,18.3,153,153.1,205.38,205.38,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,16,54,11000000000,18.3%
P28654,0.035407766,0.659166667,27.41101904,-2.473666667,0.00181509,-5.301236607,2.833,1.079,1.776,-0.693,-0.431,-0.609,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,72,16,16,P28654,MOUSE,40150.6,35.8,154,154.1,204.64,204.64,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,16,72,19300000000,35.8%
P16858,0.970099283,0.237,0.297256671,-0.05,0.933844,-0.086577376,0.613,1.071,-0.898,0.644,-0.335,0.327,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,51,14,14,A0A0A0MQF6|P16858|A0A1D5RLD8|S4R1W1|P10096|Q64467|S4R2G5|A0A0R4J0X7|V9GX06|V9GXA7,MOUSE,36094.6,44.7,155,155.1,202.93,202.93,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,14,51,3300000000,44.7%
P11680,0.214183843,-0.084833333,13.31364851,0.723,0.04662675,2.493739178,-0.381,-0.14,-0.818,0.277,0.552,0.001,P11680,Cfp,P11680_Cfp,P11680,Cfp,1,120,14,14,P11680,MOUSE,52836.7,34.6,156,156.1,202.34,202.34,,464,Properdin,extracellular region|extracellular matrix|,"complement activation, alternative pathway|",,14,120,2.05E+11,34.6%
Q8VCG4,0.225652809,-0.349,12.87753236,0.842,0.051552148,2.423132298,-0.525,-0.363,-1.422,0.08,-0.119,0.255,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,113,12,12,Q8VCG4|Q9DAC2,MOUSE,22678.7,63.3,157,157.1,200.2,200.2,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,12,113,63700000000,63.3%
P18242,0.467366282,-0.086166667,6.091973519,0.271,0.245924982,1.284692053,-0.193,-0.168,-0.304,-0.047,0.147,0.048,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,45,14,14,P18242|F8WIR1,MOUSE,45409.4,32.6,158,158.1,199.28,199.28,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,14,45,9550000000,32.6%
O55111,0.252930251,-0.493333333,11.58080386,0.967333333,0.069489568,2.20534104,-0.586,-0.42,-1.925,0.019,-0.069,0.021,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,35,14,14,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,15.2,159,159.1,198.95,198.95,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,14,35,718000000,15.2%
Q02257,0.214183843,0.350166667,13.31806093,-2.141666667,0.046579402,-2.503652789,2.599,2.247,-0.583,-0.954,-0.685,-0.523,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,43,18,18,Q02257|Q02248|E9Q6A9,MOUSE,82541,29.1,160,160.1,197.88,197.88,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,18,43,1540000000,29.1%
Q9D154,0.193614767,-0.588166667,14.34885276,1.219666667,0.036737933,2.67425768,-0.815,-0.613,-2.166,-0.188,0.216,0.037,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,42,18,18,Q9D154|Q8VHP7|Q5SV42|Q9JK88|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,39.5,161,161.1,197.68,197.68,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,18,42,1690000000,39.5%
P03987,0.702114845,0.036833333,2.881297413,0.246333333,0.515074748,0.69145307,0.511,-0.391,-0.379,-0.04,0.561,-0.041,P03987,NotFound,P03987_NotFound,P03987,,1,103,13,13,A0A1Y7VJN6|P03987|P03987-2,MOUSE,44498.8,29.8,162,162.1,197.62,197.62,,398,Ig gamma-3 chain C region,extracellular region|plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,13,103,35400000000,29.8%
Q63880,0.984291239,-0.029166667,0.202245429,-0.021,0.954498955,-0.059477759,-0.547,-0.138,0.629,-0.155,-0.09,0.126,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,81,14,7,Q63880|Q63880-2,MOUSE,63715.9,26.7,163,163.1,197.5,105.86,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,14,81,18000000000,26.7%
Q8VCU1,0.540728216,-0.1274,5.029135863,0.307666667,0.314113364,1.117584816,-0.127,-0.497,,-0.095,-0.003,0.085,Q8VCU1,Ces3b,Q8VCU1_Ces3b,Q8VCU1,Ces3b,1,9,10,3,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,16.2,163,163.2,129.31,37.67,,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,3,9,657000000,5.7%
Q8CIF4,0.970099283,0.109833333,0.321071813,0.047666667,0.928737152,0.09324867,-0.695,-0.246,1.199,0.23,0.172,-0.001,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,91,12,12,A0A0R4J131|Q8CIF4,MOUSE,58952,26.1,164,164.1,196.87,196.87,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,12,91,24800000000,26.1%
Q61805,0.488526068,-0.155833333,5.748595683,0.538333333,0.266158556,1.225642542,0.038,0.006,-1.319,0.441,-0.126,0.025,Q61805,Lbp,Q61805_Lbp,Q61805,Lbp,1,55,15,15,Q61805|A2AC65,MOUSE,53282.7,29.3,165,165.1,196.62,196.62,,481,Lipopolysaccharide-binding protein,extracellular space|cell surface|extracellular exosome|,"liver development|leukocyte chemotaxis involved in inflammatory response|macrophage activation involved in immune response|acute-phase response|opsonization|lipopolysaccharide transport|lipopolysaccharide-mediated signaling pathway|detection of molecule of bacterial origin|response to lipopolysaccharide|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of toll-like receptor 4 signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of growth of symbiont in host|innate immune response|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|positive regulation of phagocytosis, engulfment|positive regulation of respiratory burst involved in inflammatory response|cellular response to lipopolysaccharide|cellular response to lipoteichoic acid|positive regulation of neutrophil chemotaxis|regulation of membrane permeability|",lipopolysaccharide binding|receptor binding|lipoteichoic acid binding|,15,55,5010000000,29.3%
E9QN70,0.200392311,-0.381333333,13.94066006,1.102666667,0.040358405,2.604075395,-0.778,-0.33,-1.69,-0.216,0.183,0.543,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,34,18,18,E9QN70|P02469,MOUSE,209741,10.8,166,166.1,196.09,196.09,,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,18,34,967000000,10.8%
Q91Y47,0.269971759,-0.128833333,10.98482317,0.818333333,0.079710895,2.105998136,-0.293,-0.199,-1.122,-0.23,0.744,0.327,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,59,15,15,Q91Y47,MOUSE,71784.4,24.1,167,167.1,195.25,195.25,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,15,59,13600000000,24.1%
Q8K0D2,0.586078514,-0.049166667,4.352550883,0.343,0.367066636,0.97514885,-0.865,-0.042,0.245,0.358,0.019,-0.01,Q8K0D2,Habp2,Q8K0D2_Habp2,Q8K0D2,Habp2,1,58,17,17,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,26.7,168,168.1,194.56,194.56,,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,17,58,5620000000,26.7%
Q3UEL9,0.723660471,0.2365,2.60877325,0.297666667,0.548431858,0.635624534,0.84,-0.063,-0.514,0.922,-0.22,0.454,Q3UEL9,Serpina7,Q3UEL9_Serpina7,Q3UEL9,Serpina7,1,62,15,15,Q3UEL9|P61939|Q8BII9,MOUSE,48364.8,34.7,169,169.1,194.55,194.55,,426,Thyroxine-binding globulin,extracellular space|extracellular exosome|,aging|post-embryonic development|negative regulation of endopeptidase activity|response to vitamin A|response to prostaglandin E|response to drug|response to peptide hormone|response to corticosterone|thyroid hormone transport|,serine-type endopeptidase inhibitor activity|hormone binding|,15,62,13400000000,34.7%
Q60590,0.612514063,-0.023166667,3.927688579,0.197,0.404791274,0.895439732,-0.066,-0.211,-0.088,-0.057,0.256,0.027,Q60590,Orm1,Q60590_Orm1,Q60590,Orm1,1,65,13,7,Q60590|J3JRU4|Q63805,MOUSE,24008.9,34.7,170,170.1,193.29,111.95,,207,Alpha-1-acid glycoprotein 1,extracellular space|,regulation of immune system process|transport|acute-phase response|,,13,65,47000000000,34.7%
P07361,0.987463289,-0.283166667,0.140065125,-0.050333333,0.968263336,-0.0414867,2.584,-2.046,-1.312,-0.715,-0.39,0.18,P07361,Orm2,P07361_Orm2,P07361,Orm2,1,17,10,4,P07361,MOUSE,23957.1,29.4,170,170.2,129.67,48.33,,207,Alpha-1-acid glycoprotein 2,extracellular space|,regulation of immune system process|transport|acute-phase response|,,4,17,2380000000,12.5%
P16301,0.223777099,-0.300333333,13.04936388,1.018,0.049552277,2.452217533,-0.93,-0.025,-1.473,0.46,0.186,-0.02,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,105,12,12,P16301,MOUSE,50088.2,31,171,171.1,191.56,191.56,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,12,105,1.65E+11,31.0%
Q8BND5,0.265117224,-0.108833333,11.17858266,0.497666667,0.076232776,2.135936317,-0.153,-0.44,-0.48,0.107,0.319,-0.006,Q8BND5,Qsox1,Q8BND5_Qsox1,Q8BND5,Qsox1,1,43,17,2,Q8BND5|Q8BND5-2,MOUSE,83582.5,22.5,172,172.1,191.17,30.5,,748,Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,17,43,2630000000,22.5%
Q8BND5-3,0.145366797,0.551166667,16.97079421,-1.127,0.020087254,-3.136912352,1.812,0.696,0.836,0.107,-0.205,0.061,Q8BND5,Qsox1,Q8BND5-3_Qsox1,Q8BND5-3,Qsox1,1,5,17,3,Q8BND5-3,MOUSE,64076.9,26.9,172,172.2,175.86,26.29,,748,Isoform 3 of Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,3,5,96000000,3.8%
Q922D8,0.561700919,0.026166667,4.788442753,-0.221666667,0.332013486,-1.05437689,0.066,0.096,0.249,-0.115,-0.124,-0.015,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,30,18,18,Q922D8|A0A1W2P733,MOUSE,101882.4,19.8,173,173.1,190.86,190.86,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,18,30,1270000000,19.8%
Q3TQC7,0.830947352,0.008166667,1.58348449,0.122333333,0.6944669,0.412118378,-0.459,-0.037,0.337,0.321,-0.136,0.023,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,46,13,13,Q3TQC7|Q9WUZ9,MOUSE,50293.2,35.3,174,174.1,186.36,186.36,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,13,46,5180000000,35.3%
Q62009,0.997757813,-0.052,0.009748629,0.000666667,0.997757813,0.002928276,-0.055,-0.209,0.107,-0.225,0.015,0.055,Q62009,Postn,Q62009_Postn,Q62009,Postn,1,34,15,15,Q62009|Q62009-2|Q62009-3|Q62009-5|Q62009-4,MOUSE,93826.5,21.4,175,175.1,183.11,183.11,,838,Periostin,proteinaceous extracellular matrix|extracellular space|trans-Golgi network|extracellular matrix|,cell adhesion|regulation of Notch signaling pathway|tissue development|extracellular matrix organization|,heparin binding|cell adhesion molecule binding|,15,34,1470000000,21.4%
P47879,0.744835591,0.154833333,2.443673736,0.153666667,0.569682169,0.600983296,0.038,0.312,-0.116,0.447,0.29,-0.042,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,82,13,13,P47879|H3BLB7,MOUSE,28947.5,48.8,176,176.1,181.41,181.41,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,13,82,36500000000,48.8%
P00760,0.007983705,0.8135,40.25774674,-2.779,9.42378E-05,-9.107929285,2.723,1.802,2.084,-0.685,-0.58,-0.463,P00760,NotFound,P00760_NotFound,P00760,,1,61,11,11,P00760,BOVIN,26469.4,51.6,177,177.1,181.14,181.14,,246,Cationic trypsin,,,,11,61,30700000000,51.6%
Q91WU0,0.594937809,-0.273,4.237947931,0.456,0.376881836,0.95396454,-0.411,0.37,-1.462,-0.023,-0.033,-0.079,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,46,14,14,Q91WU0,MOUSE,62010.5,33.1,178,178.1,180.59,180.59,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,14,46,2.75E+11,33.1%
P01837,0.531399018,0.040666667,5.174909238,0.391333333,0.303744957,1.124320169,-0.124,-0.58,0.239,-0.212,0.668,0.253,P01837,NotFound,P01837_NotFound,P01837,,1,104,11,11,P01837|A0A075B5P2,MOUSE,11948.8,94.3,179,179.1,180.18,180.18,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,11,104,3.36E+11,94.3%
P52480,0.145366797,0.319166667,17.02898666,-0.851,0.019819894,-3.141814173,0.899,0.993,0.342,0.003,-0.274,-0.048,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,41,16,16,P52480|P52480-2|P53657|G3X925|E9Q509,MOUSE,58414.4,38.4,180,180.1,179.44,179.44,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,19,41,5010000000,38.4%
P98086,0.619108766,0.476166667,3.779930792,0.457,0.418800239,0.867807206,0.84,0.193,-0.29,0.588,1.62,-0.094,P98086,C1qa,P98086_C1qa,P98086,C1qa,1,100,12,12,P98086,MOUSE,26202.1,41.6,181,181.1,179.23,179.23,,245,Complement C1q subcomponent subunit A,collagen trimer|extracellular exosome|,"complement activation, classical pathway|innate immune response|",protein binding|,12,100,1.79E+11,41.6%
P16882-2,0.132162271,-0.287666667,17.79461914,0.838,0.016616444,3.281071065,-0.8,-0.392,-0.928,0.069,0.328,-0.003,P16882,Ghr,P16882-2_Ghr,P16882-2,Ghr,1,80,10,10,P16882-2|P16882|Q3UP14,MOUSE,34617.4,36.7,182,182.1,179.13,179.13,,650,Isoform 2 of Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,11,80,74700000000,36.7%
O08795-2,0.332209056,-0.078333333,9.020366866,0.411333333,0.125303532,1.778271673,-0.499,-0.177,-0.176,0.176,0.241,-0.035,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,54,14,14,O08795-2|O08795,MOUSE,60528.5,18.3,183,183.1,178.97,178.97,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,14,54,7270000000,18.3%
Q80YC5,0.5676994,-0.010833333,4.655449692,0.383666667,0.342337938,1.030710767,-0.762,-0.317,0.471,0.434,0.108,0.001,Q80YC5,F12,Q80YC5_F12,Q80YC5,F12,1,64,12,12,Q80YC5|E9Q698,MOUSE,67982.3,23.2,184,184.1,177.24,177.24,,597,Coagulation factor XII,extracellular space|extracellular exosome|,plasma kallikrein-kinin cascade|Factor XII activation|blood coagulation|positive regulation of plasminogen activation|protein processing|protein autoprocessing|regulation of blood coagulation|positive regulation of blood coagulation|zymogen activation|fibrinolysis|response to misfolded protein|positive regulation of fibrinolysis|,serine-type endopeptidase activity|peptidase activity|serine-type aminopeptidase activity|,12,64,17100000000,23.2%
G5E8Q8,0.326571299,-0.516666667,9.232525612,1.050666667,0.119329395,1.817831674,-0.402,-0.362,-2.362,-0.068,0.091,0.003,G5E8Q8,Adgrf5,G5E8Q8_Adgrf5,G5E8Q8,Adgrf5,1,41,14,14,G5E8Q8,MOUSE,151723.4,11.5,185,185.1,176.79,176.79,,1348,Adhesion G protein-coupled receptor F5,,,,14,41,4440000000,11.5%
Q02566,0.193614767,0.454333333,14.32021352,-2.636666667,0.036981,-2.676128635,0.612,4.117,0.589,-0.733,-1.082,-0.777,Q02566,Myh6,Q02566_Myh6,Q02566,Myh6,1,25,17,4,Q02566|Q5SX39|Q5SX40|G3UW82|P13542|B1AR69,MOUSE,224360.2,9.4,186,186.1,176.78,43.64,,1938,Myosin-6,stress fiber|nucleoplasm|cytoplasm|mitochondrion|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,in utero embryonic development|regulation of the force of heart contraction|regulation of heart rate|muscle contraction|striated muscle contraction|adult heart development|visceral muscle development|regulation of heart contraction|regulation of blood pressure|response to heat|actin filament-based movement|muscle filament sliding|myofibril assembly|BMP signaling pathway|regulation of ATPase activity|sarcomere organization|ATP metabolic process|cardiac muscle fiber development|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|canonical Wnt signaling pathway|regulation of heart growth|,microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein kinase binding|actin-dependent ATPase activity|calcium-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,18,25,9980000000,9.4%
Q91Z83,0.155174868,0.8594,16.2741511,-4.417666667,0.023582231,-3.226539889,1.244,5.776,,-0.653,-1.497,-0.573,Q91Z83,Myh7,Q91Z83_Myh7,Q91Z83,Myh7,1,1,15,1,Q91Z83,MOUSE,223673.7,8.2,186,186.2,151,12.52,,1935,Myosin-7,stress fiber|nucleoplasm|cytoplasm|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,response to reactive oxygen species|regulation of the force of heart contraction|regulation of heart rate|skeletal muscle contraction|muscle contraction|striated muscle contraction|adult heart development|regulation of the force of skeletal muscle contraction|transition between fast and slow fiber|muscle filament sliding|regulation of slow-twitch skeletal muscle fiber contraction|ATP metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,microfilament motor activity|actin binding|calmodulin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,1,1,7730000,0.8%
P13541,0.946089108,-0.289,0.574036378,-0.204166667,0.876186106,-0.164028885,,1.919,-2.252,-0.269,-0.69,-0.153,P13541,Myh3,P13541_Myh3,P13541,Myh3,1,2,5,1,P13541,MOUSE,224870.7,2.9,186,186.3,42.07,5.96,,1940,Myosin-3,myosin complex|myofibril|myosin filament|contractile fiber|extracellular exosome|,skeletal muscle contraction|ATP metabolic process|,"microfilament motor activity|calmodulin binding|ATP binding|ATPase activity, coupled|actin filament binding|",1,2,104000000,1.0%
A0A075B5T3,0.229655912,-0.153666667,12.59048313,0.678,0.055074642,2.3717277,-0.55,-0.172,-0.756,0.024,0.542,-0.01,A0A075B5T3,NotFound,A0A075B5T3_NotFound,A0A075B5T3,Ighv6-6,1,88,12,7,A0A075B5T3,MOUSE,13464,81.5,187,187.1,175.85,110.12,,119,Immunoglobulin heavy variable 6-6 (Fragment),,,,12,88,1.27E+11,81.5%
A0A075B5T2,0.223777099,-0.4485,12.98620216,1.354333333,0.050278207,2.447062703,-0.9,-0.221,-2.256,-0.141,0.53,0.297,A0A075B5T2,NotFound,A0A075B5T2_NotFound,A0A075B5T2,Ighv6-3,1,38,10,5,A0A075B5T2,MOUSE,13430,56.7,187,187.2,151.63,82.48,,118,Immunoglobulin heavy variable 6-3 (Fragment),,,,5,38,29200000000,26.2%
P01801,,1.191,,,,,,,,-0.141,1.964,1.75,P01801,NotFound,P01801_NotFound,P01801,,1,1,9,1,P01801|P01796|P01799|P01797|P01802|P01800|P01803,MOUSE,12924.2,58.2,187,187.3,120.32,4.2,,115,Ig heavy chain V-III region J606,,,antigen binding|,1,1,24000000,13.0%
P01798,0.985191588,0.406,0.181437035,-0.025833333,0.959083229,-0.053917941,0.04,0.803,,0.314,1.033,-0.16,P01798,NotFound,P01798_NotFound,P01798,,1,4,6,2,P01798,MOUSE,12761.1,46,187,187.4,86.34,26.78,,113,Ig heavy chain V-III region E109,,,antigen binding|,2,4,381000000,17.6%
A0A0A6YWU3,0.375626103,0.205,7.817455999,1.111666667,0.165292976,1.626408145,-0.753,-0.171,,0.267,-0.167,1.849,A0A0A6YWU3,NotFound,A0A0A6YWU3_NotFound,A0A0A6YWU3,Ighv6-7,1,3,4,1,A0A0A6YWU3,MOUSE,13943.6,24.3,187,187.5,55.51,15.11,,119,Immunoglobulin heavy variable V6-7 (Fragment),,,,1,3,51100000,7.5%
Q07113,0.946089108,-0.0235,0.588672685,-0.039666667,0.873238212,-0.166439465,0.044,0.229,-0.284,-0.104,0,-0.026,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,35,16,16,Q07113,MOUSE,280828.2,6.8,188,188.1,174.5,174.5,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,16,35,3000000000,6.8%
P52430,0.889483844,0.153166667,1.103732817,0.106333333,0.775580209,0.298207759,-0.525,0.198,0.627,0.386,0.278,-0.045,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,60,12,12,P52430|H3BLB8,MOUSE,39735.6,32.3,189,189.1,174.42,174.42,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,12,60,13200000000,32.3%
P12399,0.338116008,-0.706,8.772975297,1.351333333,0.132648539,1.741180156,-0.435,-0.5,-3.21,-0.086,-0.044,0.039,P12399,Ctla2a,P12399_Ctla2a,P12399,Ctla2a,1,92,11,11,P12399|A0A286YDF0|A0A286YD17|P12400|A0A0R4J245,MOUSE,16053.8,59.8,190,190.1,172.89,172.89,,137,Protein CTLA-2-alpha,extracellular space|lysosome|dendrite|,negative regulation of protein processing|regulation of regulatory T cell differentiation|negative regulation of inflammatory response|proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|,11,92,1.11E+11,59.8%
P03953,0.433615197,-0.252,6.694333585,0.569333333,0.21407534,1.389048504,-0.565,0.217,-1.262,-0.141,0.061,0.178,P03953,Cfd,P03953_Cfd,P03953,Cfd,1,79,9,9,P03953|P03953-2,MOUSE,28569.8,45.9,191,191.1,171.59,171.59,,259,Complement factor D,extracellular space|extracellular exosome|,"proteolysis|complement activation, alternative pathway|",serine-type endopeptidase activity|,9,79,73300000000,45.9%
Q9CQW3,0.334148694,-0.063166667,8.968357955,0.450333333,0.126813125,1.769643261,-0.626,-0.089,-0.15,0.178,0.295,0.013,Q9CQW3,Proz,Q9CQW3_Proz,Q9CQW3,Proz,1,84,9,9,Q9CQW3|Q8CI01,MOUSE,45615.9,33.8,192,192.1,167.8,167.8,,399,Vitamin K-dependent protein Z,extracellular region|extracellular exosome|,proteolysis|blood coagulation|,serine-type endopeptidase activity|calcium ion binding|,9,84,41500000000,33.8%
P98063,0.174790542,-0.3385,15.45347199,0.593666667,0.028487399,2.861929007,-0.667,-0.635,-0.604,-0.068,-0.109,0.052,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,33,15,15,P98063|Q9WVM6|E9Q5B9|G3X9F5|Q62381|Q62381-2,MOUSE,113889.4,17.9,193,193.1,167.46,167.46,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,15,33,2550000000,17.9%
Q3SXB8-2,0.225652809,-0.195,12.86176407,0.753333333,0.051739663,2.417380514,-0.25,-0.42,-1.045,0.044,0.503,-0.002,Q3SXB8,Colec11,Q3SXB8-2_Colec11,Q3SXB8-2,Colec11,1,40,11,11,Q3SXB8-2|A0A1Y7VKG6|Q3SXB8|A0A0R4J0M6,MOUSE,29981.5,33,194,194.1,163.08,163.08,,272,Isoform 2 of Collectin-11,extracellular region|collagen trimer|,multicellular organismal development|developmental process|,mannose binding|,11,40,2960000000,33.0%
Q8CIT9,0.709461512,-0.0975,2.782436447,0.167666667,0.526934162,0.671128665,-0.065,-0.012,-0.467,-0.225,0.114,0.07,Q8CIT9,Sbsn,Q8CIT9_Sbsn,Q8CIT9,Sbsn,1,39,12,12,Q8CIT9|E9QPB2|S4R2I1|Q8CIT9-3|A0A0R4J2A5,MOUSE,72446.7,23.4,195,195.1,161.85,161.85,,700,Suprabasin,cytoplasm|extracellular exosome|,,,12,39,1910000000,23.4%
P04202,0.903377586,0.1456,0.91069475,0.070166667,0.810831337,0.252209003,0.155,0.052,,0.167,0.388,-0.034,P04202,Tgfb1,P04202_Tgfb1,P04202,Tgfb1,1,35,13,13,P04202,MOUSE,44993.8,31.5,196,196.1,159.61,159.61,,390,Transforming growth factor beta-1,proteinaceous extracellular matrix|extracellular space|nucleus|cytoplasm|cell surface|secretory granule|axon|neuronal cell body|blood microparticle|microvillus|,"protein import into nucleus, translocation|negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|skeletal system development|ureteric bud development|response to hypoxia|cell activation|epithelial to mesenchymal transition|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|regulation of sodium ion transport|chondrocyte differentiation|hematopoietic progenitor cell differentiation|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|tolerance induction to self antigen|protein phosphorylation|protein export from nucleus|ATP biosynthetic process|phosphate-containing compound metabolic process|cellular calcium ion homeostasis|defense response|inflammatory response|cell cycle arrest|mitotic cell cycle checkpoint|epidermal growth factor receptor signaling pathway|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein complex assembly|SMAD protein import into nucleus|Notch signaling pathway|negative regulation of neuroblast proliferation|salivary gland morphogenesis|endoderm development|skeletal muscle tissue development|female pregnancy|aging|negative regulation of DNA replication|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|germ cell migration|response to radiation|response to wounding|response to glucose|defense response to fungus, incompatible interaction|organ morphogenesis|regulation of gene expression|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|positive regulation of fibroblast migration|positive regulation of peptidyl-threonine phosphorylation|positive regulation of pathway-restricted SMAD protein phosphorylation|negative regulation of macrophage cytokine production|oligodendrocyte development|cell growth|regulation of striated muscle tissue development|regulation of transforming growth factor beta receptor signaling pathway|evasion or tolerance of host defenses by virus|negative regulation of cell-cell adhesion|hyaluronan catabolic process|T cell differentiation|negative regulation of ossification|negative regulation of cell growth|positive regulation of cell migration|positive regulation of bone mineralization|mammary gland development|positive regulation of histone deacetylation|organ regeneration|positive regulation of protein complex assembly|positive regulation of exit from mitosis|lipopolysaccharide-mediated signaling pathway|positive regulation of cellular protein metabolic process|response to estradiol|response to progesterone|regulation of interleukin-23 production|negative regulation of interleukin-17 production|positive regulation of interleukin-17 production|receptor catabolic process|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|positive regulation of superoxide anion generation|mononuclear cell proliferation|positive regulation of collagen biosynthetic process|positive regulation of peptidyl-serine phosphorylation|response to vitamin D|response to laminar fluid shear stress|positive regulation of histone acetylation|positive regulation of protein dephosphorylation|wound healing|T cell activation|regulation of cell proliferation|negative regulation of T cell proliferation|regulation of protein import into nucleus|positive regulation of protein import into nucleus|positive regulation of odontogenesis|response to drug|myelination|regulation of apoptotic process|myeloid dendritic cell differentiation|T cell homeostasis|positive regulation of apoptotic process|positive regulation of MAP kinase activity|regulation of MAPK cascade|protein kinase B signaling|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|ossification involved in bone remodeling|regulatory T cell differentiation|cell-cell junction organization|negative regulation of fat cell differentiation|negative regulation of myoblast differentiation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of fibroblast proliferation|positive regulation of isotype switching to IgA isotypes|cell development|lymph node development|digestive tract development|negative regulation of skeletal muscle tissue development|inner ear development|positive regulation of epithelial cell proliferation|negative regulation of epithelial cell proliferation|positive regulation of protein secretion|negative regulation of phagocytosis|negative regulation of T cell activation|positive regulation of chemotaxis|positive regulation of NF-kappaB transcription factor activity|regulation of binding|regulation of DNA binding|positive regulation of smooth muscle cell differentiation|negative regulation of release of sequestered calcium ion into cytosol|positive regulation of protein kinase B signaling|face morphogenesis|frontal suture morphogenesis|pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|SMAD protein signal transduction|mammary gland branching involved in thelarche|branch elongation involved in mammary gland duct branching|regulation of branching involved in mammary gland duct morphogenesis|negative regulation of gene silencing by miRNA|regulation of cartilage development|lens fiber cell differentiation|response to cholesterol|positive regulation of cell cycle arrest|cellular response to growth factor stimulus|cellular response to organic cyclic compound|cellular response to dexamethasone stimulus|cellular response to transforming growth factor beta stimulus|T-helper 17 cell lineage commitment|extracellular matrix assembly|positive regulation of branching involved in ureteric bud morphogenesis|extrinsic apoptotic signaling pathway|negative regulation of hyaluronan biosynthetic process|positive regulation of protein localization to nucleus|positive regulation of NAD+ ADP-ribosyltransferase activity|regulation of actin cytoskeleton reorganization|positive regulation of transcription regulatory region DNA binding|",glycoprotein binding|antigen binding|type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|enzyme binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|protein homodimerization activity|protein heterodimerization activity|protein N-terminus binding|,13,35,1850000000,31.5%
P47877,0.193614767,-0.179166667,14.36180876,0.697,0.036628499,2.672593693,-0.691,-0.257,-0.635,0.463,0.052,-0.007,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,46,11,11,P47877|D3YU40,MOUSE,33930.2,38.6,197,197.1,158.81,158.81,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,11,46,6840000000,38.6%
P12246,0.813811541,0.2176,1.83363225,0.226833333,0.655596724,0.473742115,0.24,-0.077,,-0.135,1.107,-0.047,P12246,Apcs,P12246_Apcs,P12246,Apcs,1,59,11,11,P12246,MOUSE,26417.6,33.9,198,198.1,158.55,158.55,,224,Serum amyloid P-component,extracellular space|nucleus|protein complex|extracellular exosome|blood microparticle|extracellular matrix|,protein complex assembly|negative regulation by host of viral exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|innate immune response|negative regulation of monocyte differentiation|negative regulation of viral entry into host cell|negative regulation of viral process|negative regulation of exo-alpha-sialidase activity|negative regulation of glycoprotein metabolic process|,complement component C1q binding|calcium ion binding|carbohydrate binding|virion binding|,11,59,22700000000,33.9%
P11627,0.846730908,-0.024166667,1.441163715,0.082333333,0.71760198,0.379056628,0.069,-0.235,-0.03,-0.005,0.077,-0.021,P11627,NotFound,P11627_NotFound,P11627,L1cam,1,31,14,14,P11627|Q6PGJ3|A2AFG8|A2AFG7,MOUSE,141935.8,10.5,199,199.1,157.34,157.34,,1260,Neural cell adhesion molecule L1,plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integral component of membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,14,31,860000000,10.5%
P31532,0.326571299,0.027666667,9.202978044,0.48,0.12014403,1.808552047,-0.44,0.041,-0.238,0.399,0.449,-0.045,P31532,Saa4,P31532_Saa4,P31532,Saa4,1,52,10,10,P31532,MOUSE,15144.6,68.4,200,200.1,155,155,,130,Serum amyloid A-4 protein,extracellular space|high-density lipoprotein particle|,acute-phase response|positive chemotaxis|cell chemotaxis|,chemoattractant activity|,10,52,17100000000,68.4%
Q7TSK7,0.363571016,-0.0356,8.18309461,0.468166667,0.151946443,1.686657358,-0.225,-0.408,,0.083,0.371,0.001,Q7TSK7,Adamtsl2,Q7TSK7_Adamtsl2,Q7TSK7,Adamtsl2,1,34,14,14,Q7TSK7,MOUSE,109068.3,16.7,201,201.1,154.9,154.9,,957,ADAMTS-like protein 2,extracellular region|proteinaceous extracellular matrix|,proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|,metalloendopeptidase activity|zinc ion binding|,14,34,2560000000,16.7%
Q60994,0.082065589,-0.356666667,21.50600352,1.069333333,0.007069678,3.992502127,-0.91,-0.765,-0.999,-0.184,0.52,0.198,Q60994,Adipoq,Q60994_Adipoq,Q60994,Adipoq,1,108,9,9,Q60994,MOUSE,26922.6,30.3,202,202.1,154.74,154.74,,247,Adiponectin,collagen trimer|extracellular space|endoplasmic reticulum|cell surface|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,"response to hypoxia|positive regulation of protein phosphorylation|glucose metabolic process|fatty acid beta-oxidation|response to nutrient|circadian rhythm|response to sucrose|response to glucose|positive regulation of signal transduction|negative regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of protein kinase A signaling|negative regulation of macrophage derived foam cell differentiation|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol efflux|regulation of glucose metabolic process|response to activity|negative regulation of smooth muscle cell migration|fatty acid oxidation|negative regulation of cell migration|negative regulation of granulocyte differentiation|negative regulation of protein autophosphorylation|positive regulation of cellular protein metabolic process|negative regulation of tumor necrosis factor production|positive regulation of interleukin-8 production|cellular response to insulin stimulus|positive regulation of myeloid cell apoptotic process|adiponectin-activated signaling pathway|negative regulation of heterotypic cell-cell adhesion|low-density lipoprotein particle clearance|response to tumor necrosis factor|cellular response to drug|glucose homeostasis|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAP kinase activity|response to ethanol|negative regulation of fat cell differentiation|negative regulation of macrophage differentiation|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of gluconeogenesis|negative regulation of blood pressure|positive regulation of blood pressure|negative regulation of transcription, DNA-templated|positive regulation of fatty acid metabolic process|positive regulation of glucose import|negative regulation of hormone secretion|negative regulation of smooth muscle cell proliferation|negative regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|negative regulation of phagocytosis|negative regulation of synaptic transmission|brown fat cell differentiation|protein homooligomerization|response to glucocorticoid|membrane depolarization|membrane hyperpolarization|protein heterotrimerization|negative regulation of ERK1 and ERK2 cascade|response to linoleic acid|detection of oxidative stress|cellular response to cAMP|positive regulation of monocyte chemotactic protein-1 production|cellular response to epinephrine stimulus|protein localization to plasma membrane|negative regulation of intracellular protein transport|negative regulation of receptor binding|negative regulation of DNA biosynthetic process|positive regulation of glycogen (starch) synthase activity|positive regulation of metanephric glomerular visceral epithelial cell development|positive regulation of cAMP-dependent protein kinase activity|positive regulation of renal albumin absorption|negative regulation of platelet-derived growth factor receptor-alpha signaling pathway|negative regulation of metanephric mesenchymal cell migration|",receptor binding|hormone activity|protein binding|sialic acid binding|identical protein binding|protein homodimerization activity|,9,108,2.9E+11,30.3%
Q8C196,0.424840634,0.061,6.898170642,-1.924666667,0.204259816,-1.425420113,0.55,4.049,-1.529,-0.798,-1.064,-0.842,Q8C196,Cps1,Q8C196_Cps1,Q8C196,Cps1,1,17,14,14,Q8C196,MOUSE,165813.2,10.9,203,203.1,153.36,153.36,,1500,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|protein complex|,urea cycle|glycogen catabolic process|'de novo' pyrimidine nucleobase biosynthetic process|proteolysis|arginine biosynthetic process|glutamine metabolic process|midgut development|response to toxic substance|response to zinc ion|response to amine|triglyceride catabolic process|response to food|response to lipopolysaccharide|response to drug|response to starvation|response to amino acid|cellular response to fibroblast growth factor stimulus|positive regulation of vasodilation|nitric oxide metabolic process|homocysteine metabolic process|anion homeostasis|response to growth hormone|hepatocyte differentiation|carbamoyl phosphate biosynthetic process|cellular response to cAMP|cellular response to glucagon stimulus|cellular response to oleic acid|response to dexamethasone|,carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|endopeptidase activity|calcium ion binding|protein binding|ATP binding|phospholipid binding|glutamate binding|protein complex binding|modified amino acid binding|,14,17,802000000,10.9%
Q07235,0.564806326,0.008833333,4.739449541,0.273666667,0.335780171,1.045502089,-0.101,-0.125,-0.158,0.547,-0.099,-0.011,Q07235,Serpine2,Q07235_Serpine2,Q07235,Serpine2,1,33,12,12,Q07235|A2RSF9,MOUSE,44263.6,33.5,204,204.1,150.25,150.25,,397,Glia-derived nexin,extracellular region|extracellular space|cytosol|extracellular matrix|platelet alpha granule|extrinsic component of external side of plasma membrane|neuromuscular junction|neuronal cell body|extracellular vesicle|,"embryo implantation|blood coagulation|negative regulation of cell proliferation|response to radiation|response to wounding|negative regulation of peptidase activity|negative regulation of platelet activation|negative regulation of plasminogen activation|negative regulation of sodium ion transport|negative regulation of endopeptidase activity|negative regulation of protein processing|positive regulation of neuron projection development|negative regulation of phosphatidylinositol 3-kinase signaling|cerebellar granular layer morphogenesis|negative regulation of blood coagulation|negative regulation of cell growth|secretion by cell|secretory granule organization|negative regulation of protein catabolic process|mating plug formation|negative regulation of proteolysis|negative regulation of smoothened signaling pathway|regulation of timing of cell differentiation|positive regulation of astrocyte differentiation|detection of mechanical stimulus involved in sensory perception|regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|innervation|seminal vesicle epithelium development|dense core granule biogenesis|negative regulation of platelet aggregation|",serine-type endopeptidase inhibitor activity|receptor binding|glycosaminoglycan binding|heparin binding|,12,33,1010000000,33.5%
P11589,0.191531368,-0.371833333,14.53096167,1.231,0.035229285,2.705709697,-0.613,-0.513,-1.836,-0.041,0.768,0.004,P11589,NotFound,P11589_NotFound,P11589,Mup2,1,39,10,10,P11589|Q4FZE8|A2BIN1|P04938|A2CEK7|P02762|P11588|A2CEL1|A2AKN8|Q58EV3|B5X0G2|A9C496|E9PVW0|A2CEL0|E9QA79|A9C497|A2AKN9|A9R9W0|A2CEK6|L7N222|A2BIN0|A2AV72|P11591|P04939|Q3KQQ2|Q80YX8|A2ANT6,MOUSE,20948.4,58.8,205,205.1,148.97,148.97,,180,Major urinary protein 2,extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,10,39,3850000000,58.8%
Q9CWF2,0.717632589,0.314166667,2.685312967,-0.276333333,0.538851013,-0.65143223,0.692,0.96,-0.295,0.433,-0.328,0.423,Q9CWF2,Tubb2b,Q9CWF2_Tubb2b,Q9CWF2,Tubb2b,1,26,11,1,Q9CWF2|Q7TMM9|A0A1D5RM76,MOUSE,50408.6,28,206,206.1,148.86,16.49,,445,Tubulin beta-2B chain,nucleus|cytoplasm|microtubule|,neuron migration|microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,11,26,1050000000,28.0%
P99024,0.326571299,0.292,9.170399512,-0.671333333,0.121048677,-1.80472131,-0.009,1.041,0.851,0.186,-0.454,0.137,P99024,Tubb5,P99024_Tubb5,P99024,Tubb5,1,2,11,1,P99024,MOUSE,50126.4,28.1,206,206.2,146.75,14.38,,444,Tubulin beta-5 chain,nucleus|nuclear envelope lumen|cytosol|microtubule|cytoplasmic ribonucleoprotein granule|cell body|tubulin complex|extracellular exosome|,protein folding|microtubule-based process|cellular process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|protein domain specific binding|ubiquitin protein ligase binding|protein complex binding|GTPase activating protein binding|MHC class I protein binding|,1,2,18200000,3.3%
P68372,0.946089108,0.30975,0.566027996,-0.085666667,0.877803282,-0.163804853,,0.374,,0.375,-0.226,0.716,P68372,Tubb4b,P68372_Tubb4b,P68372,Tubb4b,1,1,10,1,P68372|Q9D6F9|Q922F4,MOUSE,50286.6,24.7,206,206.3,127.36,5.11,,445,Tubulin beta-4B chain,nucleus|cytoplasm|microtubule|myelin sheath|tubulin complex|extracellular exosome|extracellular vesicle|,microtubule-based process|metabolic process|protein polymerization|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|GTP binding|,1,1,57000000,3.3%
A2AQ07,0.878801684,0.4715,1.17363456,-0.177666667,0.763196806,-0.315423639,1.181,1.003,-0.503,0.66,-0.326,0.814,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,5,6,3,A2AQ07,MOUSE,51124.7,12.6,206,206.4,74.73,38.44,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,5,163000000,8.4%
B2RXS4,0.653640456,-0.058,3.412274173,0.272,0.455798176,0.796925898,0.33,-0.112,-0.8,0.032,0.225,-0.023,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,32,12,12,B2RXS4,MOUSE,209079.3,7.7,207,207.1,146.74,146.74,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,12,32,1980000000,7.7%
O88968,0.442036594,-0.415166667,6.463313914,0.666333333,0.225771235,1.349577006,-0.339,-0.07,-1.836,-0.191,-0.053,-0.002,O88968,Tcn2,O88968_Tcn2,O88968,Tcn2,1,44,11,11,O88968,MOUSE,48041.3,24.1,208,208.1,143.9,143.9,,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,11,44,6940000000,24.1%
Q8CJH3,0.952197507,0.041833333,0.516336076,0.036333333,0.887904777,0.1470092,-0.109,-0.173,0.353,0.022,0.159,-0.001,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,38,11,11,Q8CJH3,MOUSE,234738.4,5.9,209,209.1,141.26,141.26,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,11,38,1540000000,5.9%
Q5MJS3,0.569326761,0.109333333,4.618983651,-0.271333333,0.34522452,-1.023599895,0.413,0.486,-0.164,0.029,-0.103,-0.005,Q5MJS3,Fam20c,Q5MJS3_Fam20c,Q5MJS3,Fam20c,1,27,11,11,Q5MJS3|Q8CID3,MOUSE,66392.3,17.4,210,210.1,141.04,141.04,,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,11,27,1570000000,17.4%
P70428,0.326571299,0.1715,9.400625991,-0.384333333,0.114798814,-1.841303876,0.424,0.361,0.306,0.049,-0.113,0.002,P70428,Ext2,P70428_Ext2,P70428,Ext2,1,28,11,11,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,20.1,211,211.1,141.04,141.04,,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",11,28,298000000,20.1%
P11152,0.069588246,-0.487,22.53653587,1.210833333,0.005576304,4.625956976,-1.305,-1.122,,-0.125,0.032,0.085,P11152,Lpl,P11152_Lpl,P11152,Lpl,1,38,10,10,P11152,MOUSE,53679,25.5,212,212.1,139.9,139.9,,474,Lipoprotein lipase,extracellular space|plasma membrane|cell surface|extracellular matrix|anchored component of membrane|very-low-density lipoprotein particle|chylomicron|extracellular exosome|,fatty acid biosynthetic process|response to cold|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|positive regulation of sequestering of triglyceride|triglyceride biosynthetic process|triglyceride catabolic process|very-low-density lipoprotein particle remodeling|response to drug|triglyceride homeostasis|,lipoprotein lipase activity|triglyceride lipase activity|receptor binding|protein binding|heparin binding|triglyceride binding|apolipoprotein binding|,10,38,5300000000,25.5%
P51885,0.830947352,-0.029333333,1.570871591,-0.092666667,0.696486721,-0.409212038,0.153,-0.22,0.118,-0.138,-0.052,-0.037,P51885,Lum,P51885_Lum,P51885,Lum,1,29,10,10,P51885,MOUSE,38663.6,34.9,213,213.1,136.44,136.44,,338,Lumican,proteinaceous extracellular matrix|fibrillar collagen trimer|extracellular space|extracellular exosome|extracellular matrix|,visual perception|response to organic cyclic compound|collagen fibril organization|positive regulation of transforming growth factor beta1 production|positive regulation of transcription from RNA polymerase II promoter|cartilage development|response to growth factor|,collagen binding|,10,29,4620000000,34.9%
A0A075B5R5,0.891021159,0.319833333,1.065206353,-0.213666667,0.782491025,-0.288839916,-0.82,0.024,2.076,0.339,0.339,-0.039,A0A075B5R5,NotFound,A0A075B5R5_NotFound,A0A075B5R5,Ighv4-1,1,40,8,8,A0A075B5R5|P01807|P01808|P01812|P01806|P01809|P01810|A0A075B5Q2|A0A075B5P7|A0A0A6YWG4,MOUSE,13044.9,69.8,214,214.1,135.49,130.34,,116,Immunoglobulin heavy variable 4-1 (Fragment),,,,10,40,4350000000,69.8%
P18524,0.789930378,0.606833333,2.038954356,-0.408333333,0.625323233,-0.514654846,0.467,-0.483,2.449,-0.308,0.888,0.628,P18524,NotFound,P18524_NotFound,P18524,,1,3,3,1,P18524,MOUSE,13036.9,23.9,214,214.2,32.57,14.59,,117,Ig heavy chain V region RF,,,antigen binding|,1,3,17500000,9.4%
Q61406,0.229834514,-0.200833333,12.54514581,0.661666667,0.055652595,2.364110831,-0.493,-0.219,-0.883,0.314,-0.139,0.215,Q61406,Cfhr1,Q61406_Cfhr1,Q61406,Cfhr1,1,40,10,10,Q61406,MOUSE,39640.4,34.6,215,215.1,135.19,135.19,,343,Complement factor H-related 1,extracellular exosome|blood microparticle|,,,10,40,5610000000,34.6%
Q04857,0.612514063,-0.076166667,3.903044257,0.204333333,0.407094818,0.890784482,-0.321,-0.111,-0.103,-0.191,0.164,0.105,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,21,11,11,Q04857,MOUSE,109628.6,12.4,216,216.1,134.47,134.47,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,11,21,1090000000,12.4%
P01592,0.537892177,-0.087666667,5.06941547,0.250666667,0.311213518,1.104927388,-0.187,-0.252,-0.2,-0.207,0.173,0.147,P01592,Jchain,P01592_Jchain,P01592,Jchain,1,70,10,10,P01592,MOUSE,18469.7,71.6,217,217.1,132.48,132.48,,159,Immunoglobulin J chain,extracellular space|extracellular exosome|monomeric IgA immunoglobulin complex|dimeric IgA immunoglobulin complex|secretory IgA immunoglobulin complex|secretory dimeric IgA immunoglobulin complex|pentameric IgM immunoglobulin complex|blood microparticle|,adaptive immune response|glomerular filtration|humoral immune response|antibacterial humoral response|positive regulation of protein oligomerization|innate immune response|positive regulation of respiratory burst|,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding|,10,70,87300000000,71.6%
O08689,0.689877178,-0.029333333,3.02829696,0.186,0.497932306,0.720821973,0.232,-0.222,-0.377,0.011,0.202,-0.022,O08689,Mstn,O08689_Mstn,O08689,Mstn,1,31,11,11,O08689|A0A087WQL8|Q9Z1W4,MOUSE,43662.3,33.2,218,218.1,131.41,131.41,,376,Growth/differentiation factor 8,extracellular space|cytoplasm|,"positive regulation of defense response to virus by host|transforming growth factor beta receptor signaling pathway|response to heat|response to gravity|positive regulation of pathway-restricted SMAD protein phosphorylation|skeletal muscle atrophy|negative regulation of muscle hypertrophy|response to muscle activity|ovulation cycle process|response to testosterone|negative regulation of kinase activity|regulation of apoptotic process|skeletal muscle tissue regeneration|regulation of MAPK cascade|response to estrogen|response to ethanol|negative regulation of myoblast differentiation|positive regulation of transcription, DNA-templated|negative regulation of insulin receptor signaling pathway|muscle cell cellular homeostasis|cell development|negative regulation of skeletal muscle tissue growth|response to electrical stimulus|negative regulation of protein kinase B signaling|SMAD protein signal transduction|cellular response to dexamethasone stimulus|activation of mitophagy in response to mitochondrial depolarization|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of satellite cell differentiation|negative regulation of myoblast proliferation|",receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|heparin binding|identical protein binding|,11,31,1090000000,33.2%
P55284,0.145366797,-0.232666667,17.2560941,0.671333333,0.018810078,3.182885815,-0.552,-0.55,-0.603,0.085,0.228,-0.004,P55284,Cdh5,P55284_Cdh5,P55284,Cdh5,1,24,11,11,P55284,MOUSE,88186.6,13.3,219,219.1,131.32,131.32,,784,Cadherin-5,plasma membrane|cell-cell junction|adherens junction|bicellular tight junction|integral component of membrane|cell junction|cell periphery|,blood vessel maturation|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of cell proliferation|single organismal cell-cell adhesion|regulation of establishment of cell polarity|,receptor binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|ion channel binding|,11,24,13400000000,13.3%
P06330,0.232324458,-0.296,12.32462292,0.864,0.058551457,2.329941932,-0.556,-0.294,-1.334,-0.235,0.522,0.121,P06330,NotFound,P06330_NotFound,P06330,,1,40,9,2,P06330|P01757|P01756|A0A075B5U6,MOUSE,13048.2,72.8,220,220.1,131.3,28.53,,118,Ig heavy chain V region AC38 205.12,,,antigen binding|,10,40,12800000000,72.8%
A0A075B5U4,0.617758953,0.1572,3.797461219,0.288666667,0.417113146,0.883410395,-0.188,0.156,,0.584,0.301,-0.067,A0A075B5U4,NotFound,A0A075B5U4_NotFound,A0A075B5U4,Ighv1-18,1,12,7,2,A0A075B5U4,MOUSE,11351.7,58.8,220,220.2,95.01,40.47,,102,Immunoglobulin heavy variable V1-18,,,,2,12,637000000,34.3%
A0A075B5U7,0.472601761,0.204,5.97666261,0.711666667,0.252542072,1.292641663,-0.2,-0.246,,-0.087,1.468,0.085,A0A075B5U7,NotFound,A0A075B5U7_NotFound,A0A075B5U7,Ighv1-22,1,11,6,3,A0A075B5U7|P01758,MOUSE,13135.6,61.5,220,220.3,90.72,52.84,,117,Immunoglobulin heavy variable 1-22 (Fragment),,,,3,11,192000000,35.8%
A0A075B5V6,0.684234079,-0.326666667,3.099133471,0.947333333,0.489876553,0.735659568,-3.3,-1.103,2.002,-0.163,0.55,0.054,A0A075B5V6,NotFound,A0A075B5V6_NotFound,A0A075B5V6,Ighv1-42,1,8,6,2,A0A075B5V6|A0A075B5V7,MOUSE,10890,55.1,220,220.4,81.61,18.65,,98,Immunoglobulin heavy variable V1-42,,,,2,8,10500000000,15.3%
A0A075B5U5,0.131134782,-0.320833333,17.86891488,1.202333333,0.0163346,3.300978718,-1.419,-0.436,-0.911,-0.188,0.604,0.425,A0A075B5U5,NotFound,A0A075B5U5_NotFound,A0A075B5U5,Ighv1-19,1,6,4,2,A0A075B5U5,MOUSE,12970.5,41.3,220,220.5,45.47,26.16,,116,Immunoglobulin heavy variable V1-19,,,,2,6,154000000,30.1%
P22629,0.009195729,0.765,37.15134506,-2.144,0.000192693,-8.022996729,2.252,1.596,1.663,-0.28,-0.397,-0.244,P22629,NotFound,P22629_NotFound,P22629,,1,372,7,1,P22629,STRAV,18833.4,43.1,221,221.1,129.37,23.98,,183,Streptavidin,,,,7,372,1.41E+13,43.1%
Q53532,0.015300471,0.792,33.3476372,-2.470666667,0.000462633,-6.874525408,2.751,1.636,1.695,-0.451,-0.371,-0.508,Q53532,NotFound,Q53532_NotFound,Q53532,,1,53,7,2,Q53532|Q53533,STRVL,18863.4,43.1,221,221.2,117.65,31.24,,183,Streptavidin-V1,,,,2,53,5.61E+11,20.2%
E9QPK1,0.807506073,-0.0435,1.90523251,0.173666667,0.644876794,0.484941841,0.523,-0.255,-0.659,-0.138,0.227,0.041,E9QPK1,Cgref1,E9QPK1_Cgref1,E9QPK1,Cgref1,1,37,9,9,E9QPK1|Q8R1U2,MOUSE,35428.9,36.9,222,222.1,129.25,129.25,,325,Cell growth regulator with EF hand domain protein 1,,negative regulation of cell growth|,calcium ion binding|,9,37,30000000000,36.9%
P14106,0.846730908,0.6926,1.442562836,0.230166667,0.717370835,0.38331794,0.959,0.15,,0.76,1.651,-0.057,P14106,C1qb,P14106_C1qb,P14106,C1qb,1,75,8,8,P14106,MOUSE,26945.1,38.7,223,223.1,127.2,127.2,,253,Complement C1q subcomponent subunit B,collagen trimer|extracellular exosome|blood microparticle|,"complement activation, classical pathway|innate immune response|inner ear development|",protein homodimerization activity|,8,75,2.03E+11,38.7%
Q71KU9,0.263987871,0.259833333,11.24843851,-0.517,0.075016388,-2.147545635,0.582,0.348,0.625,-0.246,0.212,0.038,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,36,10,10,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,26.7,224,224.1,126.83,126.83,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,10,36,1310000000,26.7%
P70274,0.36327596,-0.220666667,8.214418877,0.716666667,0.150854445,1.645522228,-0.174,-0.055,-1.508,0.277,0.145,-0.009,P70274,Selenop,P70274_Selenop,P70274,Selenop,1,54,9,9,P70274,MOUSE,43595.1,20.7,225,225.1,126.38,126.38,,380,Selenoprotein P,extracellular region|extracellular space|extracellular exosome|,selenium compound metabolic process|brain development|locomotory behavior|post-embryonic development|sexual reproduction|growth|,selenium binding|,9,54,15100000000,20.7%
A0A075B5Y4,0.955428034,0.309666667,0.487368933,-0.059333333,0.893846835,-0.139187188,0.146,-0.086,0.958,-0.1,0.946,-0.006,A0A075B5Y4,NotFound,A0A075B5Y4_NotFound,A0A075B5Y4,Ighv1-81,1,38,9,4,A0A075B5Y4|A0A0A6YVW3|P06327|A0A075B5X2|A0A075B5W5,MOUSE,13102.5,65.8,226,226.1,126.02,74.75,,117,Immunoglobulin heavy variable 1-81 (Fragment),,,,9,38,6510000000,65.8%
A0A0B4J1J7,0.819212335,0.321833333,1.786118761,-0.177,0.662808583,-0.458335624,0.635,-0.153,0.749,-0.256,0.738,0.218,A0A0B4J1J7,NotFound,A0A0B4J1J7_NotFound,A0A0B4J1J7,Ighv1-82,1,8,8,4,A0A0B4J1J7,MOUSE,10763.9,68.3,226,226.2,71.94,38.54,,98,Immunoglobulin heavy variable 1-82,,,,4,8,348000000,54.0%
A0A0B4J1M0,0.435497999,0.3504,6.585191038,0.749833333,0.219523438,1.402757885,0.044,-0.243,,0.289,1.577,0.085,A0A0B4J1M0,NotFound,A0A0B4J1M0_NotFound,A0A0B4J1M0,Ighv1-77,1,7,5,2,A0A0B4J1M0,MOUSE,10775.9,42.8,226,226.3,58.12,32.11,,98,Immunoglobulin heavy variable 1-77,,,,2,7,132000000,27.5%
A0A075B674,0.833158071,0.1102,1.541274608,-0.153833333,0.701249459,-0.40635123,-0.07,0.475,,-0.341,0.486,0.001,A0A075B674,NotFound,A0A075B674_NotFound,A0A075B674,Ighv1-78,1,4,5,1,A0A075B674,MOUSE,11161.3,40.8,226,226.4,48.28,17.92,,98,Immunoglobulin heavy variable 1-78,,,,1,4,121000000,16.3%
A0A075B5Y3,0.362133072,-0.514166667,8.275402462,1.243,0.148750952,1.657973983,0.112,-0.762,-2.757,-0.248,0.559,0.011,A0A075B5Y3,NotFound,A0A075B5Y3_NotFound,A0A075B5Y3,Ighv1-80,1,3,4,1,A0A075B5Y3,MOUSE,12877.4,29.9,226,226.5,48.76,22.75,,117,Immunoglobulin heavy variable 1-80 (Fragment),,,,1,3,101000000,17.0%
A0A0A6YWI9,0.978593628,-0.0582,0.232674542,0.018,0.947834573,0.068744103,0.028,-0.166,,-0.172,0.017,0.002,A0A0A6YWI9,NotFound,A0A0A6YWI9_NotFound,A0A0A6YWI9,Ighv1-11,1,9,4,3,A0A0A6YWI9,MOUSE,13035.6,40.1,226,226.6,46.18,38.79,,117,Immunoglobulin heavy variable V1-11 (Fragment),,,,3,9,13800000000,29.9%
A0A075B5Y6,0.891021159,0.60025,1.061581949,-0.222333333,0.783144325,-0.294546137,,,0.767,0.402,-0.191,1.423,A0A075B5Y6,NotFound,A0A075B5Y6_NotFound,A0A075B5Y6,Ighv1-85,1,1,3,1,A0A075B5Y6,MOUSE,13125.6,26.4,226,226.7,15.39,4.6,,117,Immunoglobulin heavy variable 1-85 (Fragment),,,,1,1,2540000,13.6%
A0A0A6YXA5,,0.328666667,,,,,,,,0.618,0.283,0.085,A0A0A6YXA5,NotFound,A0A0A6YXA5_NotFound,A0A0A6YXA5,Ighv1-15,1,1,2,1,A0A0A6YXA5,MOUSE,13066.5,29.9,226,226.8,24.6,12.63,,117,Immunoglobulin heavy variable 1-15 (Fragment),,,,1,1,5640000,21.3%
P01746,0.789399258,-0.011166667,2.054667559,-0.237666667,0.62306484,-0.517835982,0.231,0.914,-0.822,-0.155,-0.141,-0.094,P01746,NotFound,P01746_NotFound,P01746,,1,8,2,1,P01746|P01747,MOUSE,15628.2,17.1,226,226.9,21.77,8.48,,140,Ig heavy chain V region 93G7,,,antigen binding|,1,8,350000000,7.1%
Q9WUB3,0.848045337,-0.205,1.413424093,0.225333333,0.722200177,0.372801109,0.537,0.202,-1.692,-0.089,-0.187,-0.001,Q9WUB3,Pygm,Q9WUB3_Pygm,Q9WUB3,Pygm,1,23,13,13,Q9WUB3|E9PUM3|Q8CI94|Q9ET01|Q3UEJ6,MOUSE,97741,17.4,227,227.1,125.14,125.14,,842,"Glycogen phosphorylase, muscle form",cytoplasm|sarcoplasmic reticulum|Z disc|extracellular exosome|,response to hypoxia|glycogen catabolic process|cellular calcium ion homeostasis|response to cAMP|,drug binding|glycogen phosphorylase activity|AMP binding|pyridoxal phosphate binding|carbohydrate binding|,13,23,473000000,17.4%
A0A075B5R6,0.652295807,0.296166667,3.428473931,0.356333333,0.454101155,0.800082875,-0.625,0.351,0.628,0.476,1,-0.053,A0A075B5R6,NotFound,A0A075B5R6_NotFound,A0A075B5R6,Ighv11-1,1,26,9,9,A0A075B5R6|A0A075B5R8,MOUSE,13378.9,51.2,228,228.1,123.54,123.54,,117,Immunoglobulin heavy variable 11-1 (Fragment),,,,9,26,1180000000,51.2%
O09159,0.820031235,0.1342,1.732396345,0.1345,0.671058475,0.45048458,-0.123,0.23,,0.198,0.41,-0.044,O09159,Man2b1,O09159_Man2b1,O09159,Man2b1,1,21,13,13,O09159,MOUSE,115216.7,16,229,229.1,122.05,122.05,,1013,Lysosomal alpha-mannosidase,lysosome|extracellular exosome|,mannose metabolic process|cellular protein modification process|learning or memory|,alpha-mannosidase activity|mannose binding|zinc ion binding|,13,21,546000000,16.0%
P10493,0.145366797,0.243833333,16.95403888,-0.771666667,0.020164902,-3.128302528,0.48,0.957,0.452,-0.229,-0.149,-0.048,P10493,Nid1,P10493_Nid1,P10493,Nid1,1,25,12,12,P10493,MOUSE,139387.9,10.6,230,230.1,121.04,121.04,,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,12,25,407000000,10.6%
P39876,0.612514063,0.171833333,3.899717537,-0.267,0.407406774,-0.890155575,0.055,0.031,0.83,0.176,-0.034,-0.027,P39876,Timp3,P39876_Timp3,P39876,Timp3,1,32,10,10,P39876,MOUSE,24923.3,42.1,231,231.1,119.98,119.98,,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,10,32,1410000000,42.1%
Q91VB8,0.993516919,0.071666667,0.069665655,-0.010666667,0.984086864,-0.020789232,-0.997,0.346,0.882,0.313,-0.199,0.085,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,76,7,7,Q91VB8|P01942|P01966,MOUSE,15169,63.3,232,232.1,119.71,119.71,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,7,76,2.59E+11,63.3%
P27656,0.319502447,-0.167333333,9.595147825,0.474,0.109770393,1.873521844,-0.357,-0.118,-0.738,0.073,0.141,-0.005,P27656,Lipc,P27656_Lipc,P27656,Lipc,1,34,8,8,P27656|Q3TYU0,MOUSE,58072.5,17.8,233,233.1,119.69,119.69,,510,Hepatic triacylglycerol lipase,extracellular space|high-density lipoprotein particle|,fatty acid biosynthetic process|cholesterol metabolic process|triglyceride catabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol homeostasis|triglyceride homeostasis|,triglyceride lipase activity|protein binding|heparin binding|lipase activity|,8,34,2510000000,17.8%
Q99K41,0.680102626,0.547166667,3.132503408,-0.608333333,0.486126906,-0.742307661,2.348,0.939,-0.733,0.696,0.554,-0.521,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,16,10,10,Q99K41,MOUSE,108895,12.6,234,234.1,118.03,118.03,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,10,16,158000000,12.6%
P43025,0.472601761,-0.359166667,5.964307865,0.673,0.253261523,1.26335311,-0.177,-0.02,-1.89,-0.182,0.071,0.043,P43025,NotFound,P43025_NotFound,P43025,Clec3b,1,25,8,8,P43025|Q8CFZ6,MOUSE,22656.5,38.6,235,235.1,117.36,117.36,,202,Tetranectin,granular component|proteinaceous extracellular matrix|extracellular space|cytoplasm|extracellular exosome|,skeletal system development|ossification|positive regulation of plasminogen activation|bone mineralization|,calcium ion binding|protein binding|heparin binding|carbohydrate binding|kringle domain binding|,8,25,786000000,38.6%
P00698,0.016132211,0.7005,32.71112916,-2.425666667,0.000535657,-6.690550063,2.561,1.299,1.88,-0.606,-0.521,-0.41,P00698,NotFound,P00698_NotFound,P00698,LYZ,1,17,9,9,P00698,CHICK,16751.9,65.3,236,236.1,116.5,116.5,,147,Lysozyme C,,,,9,17,3020000000,65.3%
Q02105,0.641492083,0.484833333,3.530154183,0.362333333,0.443592895,0.819818736,0.531,-0.106,0.486,0.579,1.461,-0.042,Q02105,C1qc,Q02105_C1qc,Q02105,C1qc,1,69,8,8,Q02105,MOUSE,26390.5,35.3,237,237.1,115.04,115.04,,246,Complement C1q subcomponent subunit C,collagen trimer|extracellular space|membrane|extracellular exosome|blood microparticle|,"complement activation, classical pathway|negative regulation of granulocyte differentiation|innate immune response|negative regulation of macrophage differentiation|",tumor necrosis factor receptor binding|,8,69,1.58E+11,35.3%
F8VQJ3,0.388941504,-0.426166667,7.563979093,0.822333333,0.17522743,1.536587338,-0.189,-0.281,-2.042,0.004,-0.152,0.103,F8VQJ3,Lamc1,F8VQJ3_Lamc1,F8VQJ3,Lamc1,1,14,10,10,F8VQJ3|P02468,MOUSE,182889.8,8.2,238,238.1,113.75,113.75,,1607,Laminin subunit gamma-1,basement membrane|basal lamina|laminin-1 complex|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,10,14,326000000,8.2%
Q62356,0.565439223,0.275333333,4.703642927,-0.596666667,0.338560048,-1.04031617,-0.278,0.14,1.859,-0.126,0.023,0.034,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,17,8,8,Q62356,MOUSE,35694.4,31.3,239,239.1,112.44,112.44,,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,8,17,476000000,31.3%
P02662,0.189992891,0.434,14.59356161,-1.079333333,0.034725127,-2.716542225,0.598,0.524,1.799,0.023,-0.226,-0.114,P02662,NotFound,P02662_NotFound,P02662,CSN1S1,1,22,7,7,P02662,BOVIN,24585.5,36.9,240,240.1,111.77,111.77,,214,"Alpha-S1-casein, Michrom mix 6",,,,7,22,1680000000,36.9%
Q8VCS0,0.987463289,0.145833333,0.119103794,-0.009,0.97294798,-0.035338197,-0.136,0.262,0.325,0.363,0.118,-0.057,Q8VCS0,Pglyrp2,Q8VCS0_Pglyrp2,Q8VCS0,Pglyrp2,1,29,7,7,Q8VCS0|Q8VCS0-2|Q8VCS0-3,MOUSE,58219.2,18.3,241,241.1,111.3,111.3,,530,N-acetylmuramoyl-L-alanine amidase,membrane|extracellular exosome|,pattern recognition receptor signaling pathway|peptidoglycan catabolic process|detection of bacterium|negative regulation of interferon-gamma production|negative regulation of natural killer cell differentiation involved in immune response|growth of symbiont in host|regulation of inflammatory response|defense response to Gram-positive bacterium|,zinc ion binding|N-acetylmuramoyl-L-alanine amidase activity|peptidoglycan receptor activity|peptidoglycan binding|,7,29,1410000000,18.3%
Q91ZA3,0.039479358,0.723666667,26.30052903,-2.252666667,0.002343943,-5.039044404,2.685,1.385,1.48,0.016,-0.858,-0.366,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,19,11,11,Q91ZA3,MOUSE,80547.9,17.8,242,242.1,110.69,110.69,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,11,19,160000000,17.8%
Q8QZR4,0.390427989,-0.732833333,7.513876134,1.736333333,0.17726067,1.529911644,-0.635,0.106,-4.274,0.462,-0.026,-0.03,Q8QZR4,Oaf,Q8QZR4_Oaf,Q8QZR4,Oaf,1,16,8,8,Q8QZR4,MOUSE,32151.3,26.2,243,243.1,110.22,110.22,,282,Out at first protein homolog,extracellular exosome|,,,8,16,1510000000,26.2%
O88200,0.595170996,0.040833333,4.187966062,-0.211666667,0.38124433,-0.944222652,0.07,0.02,0.35,-0.173,-0.03,0.008,O88200,Clec11a,O88200_Clec11a,O88200,Clec11a,1,22,11,11,O88200,MOUSE,36793.1,38.4,244,244.1,110.07,110.07,,328,C-type lectin domain family 11 member A,extracellular region|extracellular space|cytoplasm|,positive regulation of cell proliferation|,growth factor activity|carbohydrate binding|,11,22,1330000000,38.4%
Q91XL1,0.672760406,0.068,3.250958014,-0.266,0.473046898,-0.765305175,-0.111,-0.159,0.873,-0.171,-0.126,0.102,Q91XL1,Lrg1,Q91XL1_Lrg1,Q91XL1,Lrg1,1,55,8,8,Q91XL1,MOUSE,37829.6,23.9,245,245.1,109.05,109.05,,342,Leucine-rich HEV glycoprotein,extracellular space|extracellular exosome|,positive regulation of endothelial cell proliferation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of angiogenesis|brown fat cell differentiation|,transforming growth factor beta receptor binding|,8,55,14900000000,23.9%
Q99P87,0.38012959,-0.319833333,7.731786299,0.596333333,0.168585947,1.56467531,-0.182,-0.272,-1.4,-0.044,-0.11,0.089,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,28,7,7,Q99P87,MOUSE,13119,62.2,246,246.1,108.2,108.2,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,7,28,8710000000,62.2%
A0A0B4J1H7,0.296922676,-0.236,10.15896728,1.516,0.096405824,1.972156625,-0.189,-0.159,-2.634,-0.242,0.827,0.981,A0A0B4J1H7,NotFound,A0A0B4J1H7_NotFound,A0A0B4J1H7,Igkv1-135,1,39,9,9,A0A0B4J1H7,MOUSE,13419.1,45.8,247,247.1,107.88,107.88,,120,Immunoglobulin kappa variable 1-135 (Fragment),,,,9,39,10100000000,45.8%
A0A0B4J1H9,0.326571299,0.695333333,9.254386666,-0.97,0.118730237,-1.818859356,1.965,0.7,0.876,-0.164,-0.326,1.121,A0A0B4J1H9,NotFound,A0A0B4J1H9_NotFound,A0A0B4J1H9,Igkv1-132,1,7,3,3,A0A0B4J1H9,MOUSE,13548.3,33.3,247,247.2,29.39,29.39,,120,Immunoglobulin kappa variable 1-132 (Fragment),,,,3,7,71600000,33.3%
Q80VA0-2,0.232324458,-0.304833333,12.15715714,0.801666667,0.060853321,2.301813193,-0.466,-0.269,-1.382,0.194,0.101,-0.007,Q80VA0,Galnt7,Q80VA0-2_Galnt7,Q80VA0-2,Galnt7,1,25,11,11,Q80VA0-2|Q80VA0|Q80VA0-3,MOUSE,76183.4,14.3,248,248.1,106.19,106.19,,657,Isoform 2 of N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,11,25,798000000,14.3%
Q8BI84,0.850670217,0.127,1.369380047,-0.184,0.729561647,-0.362252397,-0.365,-0.317,1.339,-0.102,-0.05,0.257,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,26,11,11,Q8BI84|Q8BI84-2|J3KMH5|Q8BI84-3,MOUSE,214298.7,7,249,249.1,105.88,105.88,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,11,26,8850000000,7.0%
Q02788,0.955428034,-0.082,0.48679001,0.030666667,0.893965995,0.138998563,-0.133,-0.013,-0.146,-0.2,-0.122,0.122,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,24,10,10,Q02788|D3Z7D5,MOUSE,111473.4,8.6,250,250.1,105.85,105.85,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,10,24,872000000,8.6%
Q8C7G5,0.977024585,-0.0465,0.250095796,0.017666667,0.944040053,0.073159012,-0.055,0.201,-0.312,0.079,-0.132,-0.06,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,20,8,8,Q8C7G5|A0A1L1SQP3|A0A1L1SV61,MOUSE,41318.5,25,251,251.1,104.54,104.54,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,8,20,457000000,25.0%
Q9Z0M6,0.721717211,0.009666667,2.633814052,0.189333333,0.545278777,0.640606459,-0.503,-0.034,0.282,-0.024,0.37,-0.033,Q9Z0M6,Adgre5,Q9Z0M6_Adgre5,Q9Z0M6,Cd97,1,27,7,7,E9QJS7|Q9Z0M6|Q9Z0M6-3|E9QMJ5|Q9Z0M6-2|A0A0D9SEG8|Q9DC42,MOUSE,92922.2,10,252,252.1,103.98,103.98,,818,CD97 antigen,plasma membrane|focal adhesion|membrane|integral component of membrane|extracellular exosome|,cell adhesion|G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,transmembrane signaling receptor activity|G-protein coupled receptor activity|calcium ion binding|,7,27,443000000,10.0%
P47878,0.697122426,-0.126,2.948040924,0.23,0.50721946,0.704846107,0.133,-0.024,-0.832,-0.197,0.125,0.039,P47878,Igfbp3,P47878_Igfbp3,P47878,Igfbp3,1,33,8,8,P47878,MOUSE,32713.3,29.1,253,253.1,103.17,103.17,,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,8,33,14800000000,29.1%
Q01705,0.223777099,0.279666667,13.00015896,-0.602,0.050116889,-2.440723182,0.84,0.587,0.315,-0.166,0.115,-0.013,Q01705,Notch1,Q01705_Notch1,Q01705,Notch1,1,19,9,9,Q01705|Q01705-3|Q01705-4|Q01705-2,MOUSE,284808.6,4.3,254,254.1,101.34,101.34,,2531,Neurogenic locus notch homolog protein 1,Golgi membrane|acrosomal vesicle|ruffle|MAML1-RBP-Jkappa- ICN1 complex|extracellular region|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|plasma membrane|integral component of plasma membrane|cell surface|lamellipodium|cytoplasmic vesicle|receptor complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|cell fate specification|epithelial to mesenchymal transition|liver development|heart looping|sprouting angiogenesis|osteoblast fate commitment|positive regulation of neuroblast proliferation|inflammatory response to antigenic stimulus|endocardium development|endocardium morphogenesis|atrioventricular node development|coronary vein morphogenesis|aortic valve morphogenesis|atrioventricular valve morphogenesis|pulmonary valve morphogenesis|mitral valve formation|epithelial to mesenchymal transition involved in endocardial cushion formation|endocardial cushion morphogenesis|cardiac chamber formation|cardiac ventricle morphogenesis|cardiac atrium morphogenesis|cardiac right atrium morphogenesis|cardiac left ventricle morphogenesis|cardiac right ventricle formation|ventricular trabecula myocardium morphogenesis|growth involved in heart morphogenesis|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation|cell migration involved in endocardial cushion formation|pericardium morphogenesis|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|humoral immune response|Notch signaling pathway|positive regulation of transcription of Notch receptor target|spermatogenesis|determination of left/right symmetry|compartment pattern specification|axonogenesis|foregut morphogenesis|endoderm development|heart development|positive regulation of cell proliferation|negative regulation of cell proliferation|epidermis development|regulation of Notch signaling pathway|auditory receptor cell fate commitment|glial cell differentiation|regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|negative regulation of myotube differentiation|mesenchymal cell development|regulation of somitogenesis|cell differentiation in spinal cord|neural tube development|cell differentiation|neuron differentiation|keratinocyte differentiation|negative regulation of ossification|lung development|embryonic limb morphogenesis|regulation of cell migration|positive regulation of cell migration|positive regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|forebrain development|hair follicle morphogenesis|organ regeneration|response to corticosteroid|response to muramyl dipeptide|response to lipopolysaccharide|embryonic hindlimb morphogenesis|tube formation|skeletal muscle cell differentiation|cellular response to vascular endothelial growth factor stimulus|regulation of cell proliferation|tissue regeneration|positive regulation of apoptotic process|negative regulation of catalytic activity|cell fate commitment|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of auditory receptor cell differentiation|negative regulation of auditory receptor cell differentiation|positive regulation of keratinocyte differentiation|negative regulation of myoblast differentiation|negative regulation of neuron differentiation|negative regulation of osteoblast differentiation|positive regulation of Notch signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of calcium ion-dependent exocytosis|positive regulation of JAK-STAT cascade|negative regulation of photoreceptor cell differentiation|somatic stem cell division|neuron fate commitment|astrocyte differentiation|oligodendrocyte differentiation|positive regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|branching morphogenesis of an epithelial tube|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of neurogenesis|negative regulation of neurogenesis|cardiac muscle tissue morphogenesis|cardiac muscle cell proliferation|positive regulation of cardiac muscle cell proliferation|negative regulation of glial cell proliferation|cilium morphogenesis|cardiac epithelial to mesenchymal transition|cardiac septum morphogenesis|ventricular septum morphogenesis|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|negative regulation of cell death|prostate gland epithelium morphogenesis|regulation of epithelial cell proliferation involved in prostate gland development|arterial endothelial cell differentiation|venous endothelial cell differentiation|cardiac vascular smooth muscle cell development|endocardial cell differentiation|vasculogenesis involved in coronary vascular morphogenesis|coronary artery morphogenesis|Notch signaling involved in heart development|regulation of cell adhesion involved in heart morphogenesis|heart trabecula morphogenesis|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia|left/right axis specification|cellular response to follicle-stimulating hormone stimulus|distal tubule development|collecting duct development|glomerular mesangial cell development|interleukin-4 secretion|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of canonical Wnt signaling pathway|neuronal stem cell maintenance|positive regulation of ephrin receptor signaling pathway|regulation of extracellular matrix assembly|apoptotic process involved in embryonic digit morphogenesis|negative regulation of stem cell differentiation|negative regulation of anoikis|negative regulation of pro-B cell differentiation|negative regulation of endothelial cell chemotaxis|",core promoter binding|RNA polymerase II transcription factor binding transcription activator activity|chromatin binding|sequence-specific DNA binding transcription factor activity|enzyme inhibitor activity|receptor activity|Notch binding|calcium ion binding|protein binding|enzyme binding|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|,9,19,467000000,4.3%
Q8VC49,0.581644855,-0.025333333,4.409814911,0.211333333,0.362258437,0.985284889,-0.016,-0.237,-0.14,0.158,0.11,-0.027,Q8VC49,Ifi27l2b,Q8VC49_Ifi27l2b,Q8VC49,Ifi27l2b,1,19,6,6,Q8VC49,MOUSE,27886.1,26.1,255,255.1,98.33,98.33,,283,Interferon alpha-inducible protein 27-like protein 2B,integral component of membrane|,,,6,19,12700000000,26.1%
O35664-3,0.276633933,-0.491,10.82154589,1.180666667,0.082764751,2.082655986,-0.784,-0.154,-2.306,0.306,0.024,-0.032,O35664,Ifnar2,O35664-3_Ifnar2,O35664-3,Ifnar2,1,48,7,7,O35664-3|O35664|O35664-2|F6XX07,MOUSE,28268.1,19.3,256,256.1,98.25,98.25,,513,Isoform 3 of Interferon alpha/beta receptor 2,extracellular space|plasma membrane|integral component of plasma membrane|integral component of membrane|,regulation of transcription from RNA polymerase II promoter|cell proliferation|cytokine-mediated signaling pathway|response to interferon-alpha|type I interferon signaling pathway|,type I interferon receptor activity|protein kinase binding|type I interferon binding|,7,48,15800000000,19.3%
Q9ET66,0.519119874,-0.311666667,5.338801465,0.506,0.292495948,1.153468527,-0.354,0.134,-1.474,-0.012,-0.131,-0.033,Q9ET66,Pi16,Q9ET66_Pi16,Q9ET66,Pi16,1,29,6,6,E9QNE5|Q9ET66|D3Z6T6|Q9ET66-2,MOUSE,53234.3,15.1,257,257.1,97.65,97.65,,489,Peptidase inhibitor 16,extracellular space|integral component of membrane|extracellular exosome|,negative regulation of peptidase activity|negative regulation of cell growth involved in cardiac muscle cell development|,peptidase inhibitor activity|,6,29,1820000000,15.1%
P02663,0.546260245,0.452,4.976235647,-0.980666667,0.31796289,-1.08966606,0.143,-0.374,3.058,0.102,-0.143,-0.074,P02663,NotFound,P02663_NotFound,P02663,CSN1S2,1,24,8,8,P02663,BOVIN,26189.4,30.6,258,258.1,97.03,97.03,,222,Alpha-S2-casein,,,,8,24,2010000000,30.6%
Q8R357,0.434226419,-2.814666667,6.662080619,5.649333333,0.215671092,1.385054205,-0.749,-0.587,-15.582,0.072,-0.053,0.011,Q8R357,Olfm1,Q8R357_Olfm1,Q8R357,Olfm1,1,16,7,7,Q8R357|O88998|G3X9Q7|O88998-3|A3KGE4|O88998-2|O88998-4,MOUSE,55769.1,15.8,259,259.1,96.97,96.97,,485,Noelin,extracellular space|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|synaptic membrane|,atrioventricular valve formation|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|protein oligomerization|cardiac epithelial to mesenchymal transition|regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|negative regulation of neuron migration|,beta-amyloid binding|protein binding|,7,16,593000000,15.8%
Q3U367,0.311388971,0.0796,9.83814072,-0.504833333,0.103797269,-1.981969391,0.409,0.356,,-0.109,-0.221,-0.037,Q3U367,Aldh9a1,Q3U367_Aldh9a1,Q3U367,Aldh9a1,1,12,8,8,Q3U367|Q9JLJ2,MOUSE,56856.5,14.8,260,260.1,96.82,96.82,,518,4-trimethylaminobutyraldehyde dehydrogenase,mitochondrion|cytosol|extracellular exosome|,cellular aldehyde metabolic process|carnitine metabolic process|neurotransmitter biosynthetic process|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity|",8,12,1010000000,14.8%
Q91YW3,0.516028538,-0.1706,5.400782067,0.3265,0.28835122,1.186272877,-0.45,-0.283,,-0.254,0.037,0.097,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,17,9,9,Q91YW3,MOUSE,57919.4,15.8,261,261.1,95.52,95.52,,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,9,17,481000000,15.8%
Q8R0Z6,0.37702299,0.533333333,7.78986121,-0.788,0.166346581,-1.574562778,0.608,0.194,1.98,-0.025,0.447,-0.004,Q8R0Z6,Angptl6,Q8R0Z6_Angptl6,Q8R0Z6,Angptl6,1,18,8,8,Q8R0Z6,MOUSE,51493.9,20.5,262,262.1,94.92,94.92,,457,Angiopoietin-related protein 6,secretory granule|extracellular exosome|,angiogenesis|cell differentiation|,,8,18,628000000,20.5%
A0A075B5S2,0.294065232,-0.385333333,10.29871434,1.146,0.093353062,1.995443637,-0.608,-0.114,-2.153,-0.103,0.649,0.017,A0A075B5S2,NotFound,A0A075B5S2_NotFound,A0A075B5S2,Ighv7-1,1,33,7,7,A0A075B5S2|P01791|P01794|P01788|P01787|P01790|P01793|P01792|P01789,MOUSE,13815.5,56.1,263,263.1,93.92,93.92,,121,Immunoglobulin heavy variable 7-1 (Fragment),,,,8,33,4340000000,56.1%
P14847,0.499232111,-0.0242,5.580836995,0.369666667,0.276640844,1.219306268,-0.423,-0.069,,0.406,-0.011,-0.024,P14847,Crp,P14847_Crp,P14847,Crp,1,18,7,7,P14847,MOUSE,25530.6,35.1,264,264.1,93.8,93.8,,225,C-reactive protein,extracellular space|extracellular exosome|,acute-phase response|positive regulation of gene expression|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|positive regulation of superoxide anion generation|negative regulation of vasodilation|regulation of interleukin-8 secretion|,complement component C1q binding|calcium ion binding|low-density lipoprotein particle binding|low-density lipoprotein particle receptor binding|,7,18,592000000,35.1%
P01843,0.326571299,-1.2325,9.304937394,2.639,0.11735626,1.829898855,-0.93,-0.702,-6.024,-0.19,0.27,0.181,P01843,NotFound,P01843_NotFound,P01843,,1,35,5,5,A0A0G2JE99|P01843,MOUSE,11745.8,69.5,265,265.1,93.01,93.01,,105,Ig lambda-1 chain C region,plasma membrane|,,antigen binding|,5,35,16400000000,69.5%
P62827,0.319209151,0.44,9.615705003,-0.858,0.109252026,-1.878647186,0.177,0.653,1.777,0.301,-0.27,0.002,P62827,Ran,P62827_Ran,P62827,Ran,1,11,8,8,P62827|Q14AA6|Q61820,MOUSE,24593.8,33.3,266,266.1,91.77,91.77,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,8,11,4650000000,33.3%
Q9CZT5,0.225652809,0.443333333,12.89887045,-0.902,0.051299479,-2.426745697,0.65,0.423,1.61,0.173,-0.23,0.034,Q9CZT5,Vasn,Q9CZT5_Vasn,Q9CZT5,Vasn,1,15,7,7,Q9CZT5,MOUSE,73401,12.3,267,267.1,90.74,90.74,,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,7,15,304000000,12.3%
Q61646,0.984803069,-0.624833333,0.189572949,-0.092333333,0.957288199,-0.05584877,3.181,-1.29,-3.627,-0.392,-0.719,-0.902,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,13,7,7,Q61646,MOUSE,39265.1,21.6,268,268.1,90.15,90.15,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,7,13,419000000,21.6%
E9QPU1,0.975859467,0.0955,0.260513538,0.045666667,0.941778228,0.076168895,0.929,0.507,-1.218,-0.299,0.277,0.377,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,22,8,8,E9QPU1|Q8CIZ8|Q3TPE1|Q3TD35|Q8CIZ8-2,MOUSE,322558.9,2.8,269,269.1,90.12,90.12,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,9,22,1300000000,2.8%
Q9QUM0,0.612514063,-0.000833333,3.930481483,0.453,0.404531041,0.896367601,0.481,0.099,-1.262,0.476,-0.184,0.385,Q9QUM0,Itga2b,Q9QUM0_Itga2b,Q9QUM0,Itga2b,1,14,8,8,Q9QUM0,MOUSE,113760,10.1,270,270.1,90.02,90.02,,1033,Integrin alpha-IIb,focal adhesion|integrin complex|external side of plasma membrane|cell surface|extracellular exosome|blood microparticle|,positive regulation of leukocyte migration|cell-matrix adhesion|integrin-mediated signaling pathway|platelet aggregation|,identical protein binding|metal ion binding|extracellular matrix binding|fibrinogen binding|,8,14,293000000,10.1%
P01845,0.994093377,0.046,0.044134546,-0.005333333,0.989889107,-0.013208062,-0.634,0.043,0.737,-0.178,-0.057,0.365,P01845,NotFound,P01845_NotFound,P01845,Iglc3,1,25,5,2,P01845,MOUSE,11541.6,65.3,271,271.1,89.73,41.91,,104,Ig lambda-3 chain C region,plasma membrane|,,antigen binding|,5,25,10700000000,65.3%
P01844,0.201489859,-0.243666667,13.81766704,0.702666667,0.041517701,2.579418688,-0.644,-0.332,-0.809,-0.24,0.287,0.276,P01844,NotFound,P01844_NotFound,P01844,Iglc2,1,17,5,3,P01844,MOUSE,11425.5,65.3,271,271.2,89.36,45.84,,104,Ig lambda-2 chain C region,plasma membrane|,,,3,17,3540000000,57.6%
A0A140T8M2,0.36327596,0.1032,8.210882885,0.837833333,0.15097732,1.693527342,-0.912,0.113,,1.015,0.35,-0.05,A0A140T8M2,NotFound,A0A140T8M2_NotFound,A0A140T8M2,Igkv12-44,1,41,5,3,A0A140T8M2,MOUSE,12728.1,43.4,272,272.1,88.78,46.77,,115,Immunoglobulin kappa variable 12-44 (Fragment),,,,5,41,16800000000,43.4%
P01636,0.61589699,0.046,3.837972518,0.6025,0.413240376,0.892717443,-1.272,0.641,,0.856,0.137,-0.132,P01636,NotFound,P01636_NotFound,P01636,,1,1,3,1,P01636,MOUSE,12144.3,35.1,272,272.2,49.47,7.46,,108,Ig kappa chain V-V region MOPC 149,,,antigen binding|,1,1,7820000,9.2%
Q9JHI0,0.832711521,0.181333333,1.549613929,-0.145333333,0.699904212,-0.404407567,0.08,-0.252,0.934,0.28,0.067,-0.021,Q9JHI0,Mmp19,Q9JHI0_Mmp19,Q9JHI0,Mmp19,1,9,7,7,Q9JHI0|Q3UW97,MOUSE,59349.2,18.4,273,273.1,88.72,88.72,,527,Matrix metalloproteinase-19,extracellular region|proteinaceous extracellular matrix|plasma membrane|anchored component of membrane|,angiogenesis|ovarian follicle development|ovulation from ovarian follicle|luteolysis|proteolysis|response to hormone|cell differentiation|collagen catabolic process|response to cAMP|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,7,9,66000000,18.4%
E9QKW2,0.370653676,0.424833333,8.003587877,-0.925,0.158358439,-1.612382846,0.082,0.396,2.184,0.041,-0.111,-0.043,E9QKW2,Smoc1,E9QKW2_Smoc1,E9QKW2,Smoc1,1,23,7,7,A0A0R4J1E4|E9QKW2|D3Z3A3|Q8BLY1|Q8BLY1-2,MOUSE,51031.9,18.1,274,274.1,87.71,87.71,,452,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,7,23,5600000000,18.1%
Q9R100,0.966296393,0.028,0.38296663,0.028666667,0.915594841,0.110493472,0.239,-0.063,-0.135,-0.144,-0.094,0.365,Q9R100,Cdh17,Q9R100_Cdh17,Q9R100,Cdh17,1,12,7,7,Q9R100|A2AKS7,MOUSE,92100.1,10.6,275,275.1,86.59,86.59,,827,Cadherin-17,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,oligopeptide transport|homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|oligopeptide transmembrane transport|,proton-dependent oligopeptide secondary active transmembrane transporter activity|calcium ion binding|protein binding|,7,12,313000000,10.6%
Q8BYB9,0.702114845,0.198333333,2.868679302,-0.499333333,0.516573436,-0.689291916,-0.714,-0.013,2.071,-0.246,-0.151,0.243,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,15,8,8,Q8BYB9,MOUSE,46892.1,21.4,276,276.1,86.26,86.26,,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,8,15,1130000000,21.4%
O08538,0.564806326,0.158166667,4.736727117,-0.475,0.335990725,-1.045490402,1.308,0.253,-0.374,0.016,0.005,-0.259,O08538,Angpt1,O08538_Angpt1,O08538,Angpt1,1,12,8,8,O08538,MOUSE,58088.5,16,277,277.1,85.68,85.68,,498,Angiopoietin-1,extracellular space|plasma membrane|microvillus|membrane raft|extracellular exosome|,angiogenesis|patterning of blood vessels|vasculogenesis|in utero embryonic development|negative regulation of protein phosphorylation|sprouting angiogenesis|positive regulation of receptor internalization|negative regulation of cytokine secretion involved in immune response|endocardium morphogenesis|negative regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|activation of transmembrane receptor protein tyrosine kinase activity|endoderm development|positive regulation of endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of satellite cell proliferation|hemopoiesis|heparin biosynthetic process|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of protein ubiquitination|cell-substrate adhesion|regulation of tumor necrosis factor production|positive regulation of peptidyl-serine phosphorylation|protein localization to cell surface|negative regulation of protein import into nucleus|negative regulation of apoptotic process|negative regulation of vascular permeability|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of protein binding|negative regulation of neuron apoptotic process|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|Tie signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of protein kinase B signaling|cardiac muscle tissue morphogenesis|vasculogenesis involved in coronary vascular morphogenesis|positive regulation of ERK1 and ERK2 cascade|glomerulus vasculature development|negative regulation of endothelial cell apoptotic process|regulation of macrophage migration inhibitory factor signaling pathway|,receptor binding|vascular endothelial growth factor receptor binding|receptor tyrosine kinase binding|,8,12,393000000,16.0%
P01869,0.895801409,0.139833333,1.023536858,0.095666667,0.790034968,0.27839437,0.142,-0.041,0.175,-0.236,-0.048,0.847,P01869,NotFound,P01869_NotFound,P01869,Ighg1,1,25,5,5,P01869|P01868,MOUSE,44070.3,20.8,278,278.1,85.48,85.48,,393,"Ig gamma-1 chain C region, membrane-bound form",plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,5,25,2050000000,20.8%
A0A075B5R2,0.751273786,0.177,2.39309514,-0.264666667,0.576355559,-0.590505745,1.006,-0.584,0.506,0.037,-0.198,0.295,A0A075B5R2,NotFound,A0A075B5R2_NotFound,A0A075B5R2,Ighv7-3,1,33,5,5,A0A075B5R2|A0A075B5R3|P01786,MOUSE,13628.3,41.6,279,279.1,84.67,84.67,,120,Immunoglobulin heavy variable 7-3 (Fragment),,,,5,33,1970000000,41.6%
P05366,0.17956197,0.396833333,15.18410801,-2.486333333,0.030310228,-2.827003513,3.294,-0.289,1.915,-0.966,-0.777,-0.796,P05366,Saa1,P05366_Saa1,P05366,Saa1,1,30,6,5,P05366|P04918,MOUSE,13884.1,50,280,280.1,84.37,71.92,,122,Serum amyloid A-1 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|cholesterol metabolic process|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|heparin binding|chemoattractant activity|,6,30,3330000000,50.0%
P05367,0.058262161,0.951,23.81749965,-3.744666667,0.00415193,-4.505624251,4.672,2.476,1.322,-0.932,-1.021,-0.811,P05367,Saa2,P05367_Saa2,P05367,Saa2,1,14,6,5,P05367|A0A1B0GQV5,MOUSE,13736,46.7,280,280.2,60.4,47.95,,122,Serum amyloid A-2 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|response to stilbenoid|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|chemoattractant activity|,5,14,574000000,38.5%
P26618,0.830947352,0.095166667,1.586128215,-0.112333333,0.694044279,-0.41272699,0.57,-0.186,0.07,0.07,0.038,0.009,P26618,Pdgfra,P26618_Pdgfra,P26618,Pdgfra,1,13,8,8,P26618|P26618-2|A0A0J9YV87,MOUSE,123651.1,8.1,281,281.1,83.58,83.58,,1089,Platelet-derived growth factor receptor alpha,nucleus|cytoplasm|cytosol|integral component of plasma membrane|microvillus|external side of plasma membrane|cell surface|membrane|intrinsic component of plasma membrane|protein complex|,luteinization|in utero embryonic development|hematopoietic progenitor cell differentiation|positive regulation of cytosolic calcium ion concentration|estrogen metabolic process|positive regulation of cell proliferation|female gonad development|anatomical structure morphogenesis|organ morphogenesis|response to inorganic substance|negative regulation of platelet activation|positive regulation of phospholipase C activity|cell migration|peptidyl-tyrosine phosphorylation|signal transduction involved in regulation of gene expression|extracellular matrix organization|lung development|adrenal gland development|positive regulation of cell migration|male genitalia development|response to estradiol|Leydig cell differentiation|response to cytokine|cellular response to reactive oxygen species|platelet-derived growth factor receptor-alpha signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|wound healing|gliogenesis|odontogenesis of dentin-containing tooth|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|embryonic digestive tract morphogenesis|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|inner ear development|regulation of chemotaxis|cardiac myofibril assembly|response to hyperoxia|palate development|face morphogenesis|cell chemotaxis|retina vasculature development in camera-type eye|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to amino acid stimulus|metanephric glomerular capillary formation|regulation of mesenchymal stem cell differentiation|,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|platelet-derived growth factor receptor binding|ATP binding|protein complex binding|vascular endothelial growth factor binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|platelet-derived growth factor binding|,8,13,219000000,8.1%
A0A075B5N4,0.666521733,0.1898,3.30582358,0.342166667,0.467108362,0.786496349,0.002,-0.033,,-0.035,1.043,-0.028,A0A075B5N4,NotFound,A0A075B5N4_NotFound,A0A075B5N4,Igkv8-27,1,32,6,2,A0A075B5N4,MOUSE,11090.2,60,282,282.1,82.67,28.56,,100,Immunoglobulin kappa chain variable 8-27,,,,6,32,7230000000,60.0%
A0A140T8P5,0.987463289,0.353166667,0.114300086,-0.014333333,0.974024748,-0.03393844,0.466,0.09,0.525,-0.145,1.211,-0.028,A0A140T8P5,NotFound,A0A140T8P5_NotFound,A0A140T8P5,Igkv8-24,1,13,5,2,A0A140T8P5,MOUSE,13434.9,35.5,282,282.2,70.08,32.79,,121,Immunoglobulin kappa chain variable 8-24 (Fragment),,,,2,13,1890000000,17.3%
A0A140T8M3,0.92359906,0.1758,0.780886627,0.092166667,0.835432444,0.21880274,0.355,-0.114,,-0.169,0.834,-0.027,A0A140T8M3,NotFound,A0A140T8M3_NotFound,A0A140T8M3,Igkv8-30,1,4,5,1,A0A140T8M3,MOUSE,13506,35.5,282,282.3,66.18,12.07,,121,Immunoglobulin kappa chain variable 8-30 (Fragment),,,,1,4,186000000,9.9%
A0A140T8P7,0.537892177,0.3254,5.074640884,-0.939333333,0.310839292,-1.128246948,2.237,-0.459,,0.103,0.092,-0.346,A0A140T8P7,NotFound,A0A140T8P7_NotFound,A0A140T8P7,Igkv8-21,1,1,5,1,A0A140T8P7,MOUSE,13298.8,33.3,282,282.4,63.2,9.09,,120,Immunoglobulin kappa variable 8-21 (Fragment),,,,1,1,13000000,7.5%
A0A140T8M4,0.41556629,-0.080333333,7.089714877,0.977333333,0.195446777,1.45803948,-0.302,0.412,-1.817,-0.259,0.296,1.188,A0A140T8M4,NotFound,A0A140T8M4_NotFound,A0A140T8M4,Igkv8-19,1,13,4,2,A0A140T8M4,MOUSE,11230.2,42.5,282,282.5,64.89,36.51,,101,Immunoglobulin kappa variable 8-19,,,,2,13,1580000000,26.7%
A0A140T8N5,0.354527881,-0.069,8.402747248,0.554166667,0.144452571,1.725749062,-0.368,-0.435,,-0.214,0.488,0.184,A0A140T8N5,NotFound,A0A140T8N5_NotFound,A0A140T8N5,Igkv6-23,1,18,4,3,A0A140T8N5,MOUSE,12901.2,26.9,282,282.6,42.51,37.53,,115,Immunoglobulin kappa variable 6-23 (Fragment),,,,3,18,3810000000,21.7%
P08003,0.625702986,-0.004833333,3.689868351,-0.280333333,0.427575847,-0.850432283,0.631,0.221,-0.446,-0.208,-0.199,-0.028,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,12,8,8,A0A0R4J0Z1|P08003,MOUSE,72323.4,11.7,283,283.1,80.8,80.8,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,8,12,458000000,11.7%
Q61982,0.189842544,0.44,14.74123911,-1.006,0.033564184,-2.742140171,1.23,1.394,0.205,-0.053,-0.155,0.019,Q61982,Notch3,Q61982_Notch3,Q61982,Notch3,1,18,7,7,Q61982,MOUSE,257423.3,3.3,284,284.1,79.46,79.46,,2318,Neurogenic locus notch homolog protein 3,nucleoplasm|cytoplasm|plasma membrane|integral component of plasma membrane|actin cytoskeleton|receptor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|Notch signaling pathway|forebrain development|negative regulation of cell differentiation|negative regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|neuron fate commitment|artery morphogenesis|glomerular capillary formation|",calcium ion binding|protein binding|enzyme binding|,7,18,248000000,3.3%
P01645,0.865516972,0.2715,1.268993677,-0.303666667,0.746621741,-0.338466381,-0.962,-0.23,2.462,-0.215,0.574,0,P01645,NotFound,P01645_NotFound,P01645,,1,35,7,6,P01645|P01644|P01646|P01647|A0A140T8M1|P01648|P01643|P01649|A0A075B5L0,MOUSE,12068.2,65.7,285,285.1,79.25,67.02,,108,Ig kappa chain V-V region HP 93G7,,,antigen binding|,8,35,6570000000,65.7%
P01670,0.592453065,0.224666667,4.267218933,-0.354666667,0.374350232,-0.95935156,0.9,0.627,-0.321,0.059,0.188,-0.105,P01670,NotFound,P01670_NotFound,P01670,,1,8,3,1,P01670,MOUSE,12153.4,25.2,285,285.2,35.7,19.59,,111,Ig kappa chain V-III region PC 6684,,,antigen binding|,1,8,413000000,15.3%
P97873,0.629316069,0.323166667,3.650090481,-0.453,0.431510087,-0.842971992,1.475,0.695,-0.521,0.042,0.446,-0.198,P97873,Loxl1,P97873_Loxl1,P97873,Loxl1,1,11,7,7,P97873|A0A0R4J0Q4,MOUSE,67189.7,12.8,286,286.1,79.09,79.09,,607,Lysyl oxidase homolog 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,oxidation-reduction process|,"copper ion binding|protein binding|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|",7,11,811000000,12.8%
A0A075B5N3,0.581245909,0.016833333,4.420919977,0.701,0.361333312,0.988515521,0.462,0.354,-1.817,-0.278,0.37,1.01,A0A075B5N3,NotFound,A0A075B5N3_NotFound,A0A075B5N3,Igkv8-28,1,22,5,5,A0A075B5N3,MOUSE,11017,59.4,287,287.1,78.96,78.96,,101,Immunoglobulin kappa variable 8-28,,,,5,22,4330000000,59.4%
P16056,0.715522672,-0.0785,2.718347366,0.185,0.534767818,0.658013357,-0.144,0.223,-0.592,0.09,-0.005,-0.043,P16056,NotFound,P16056_NotFound,P16056,Met,1,12,7,7,P16056|F8VQL0,MOUSE,155885.1,6.9,288,288.1,78.71,78.71,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,7,12,207000000,6.9%
P01631,0.189992891,-0.204,14.61026053,0.991333333,0.034591863,2.719426614,-1.07,-0.551,-0.478,-0.157,0.916,0.116,P01631,NotFound,P01631_NotFound,P01631,,1,48,5,5,P01631|A0A140T8M0|A0A0B4J1I0|A0A075B5K8|A0A140T8N1|A0A140T8M9|A0A075B5N0,MOUSE,12386.7,40.7,289,289.1,78.22,78.22,,113,Ig kappa chain V-II region 26-10,,,antigen binding|,7,48,71300000000,40.7%
P97464,0.678082416,-0.107,3.198045668,0.178666667,0.478845525,0.754593342,0.061,-0.24,-0.41,0.072,-0.127,0.002,P97464,Ext1,P97464_Ext1,P97464,Ext1,1,16,7,7,P97464,MOUSE,87047.9,9.5,290,290.1,77.63,77.63,,746,Exostosin-1,Golgi membrane|endoplasmic reticulum|Golgi apparatus|integral component of endoplasmic reticulum membrane|,"ossification|glycosaminoglycan biosynthetic process|protein glycosylation|gastrulation|axon guidance|brain development|endoderm development|mesoderm development|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|olfactory bulb development|cellular polysaccharide biosynthetic process|embryonic skeletal joint development|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|",7,16,544000000,9.5%
Q8VI78,0.443636341,0.538166667,6.418930875,-1.173,0.22809035,-1.343275516,0.024,0.156,3.194,0.056,-0.163,-0.038,Q8VI78,Pla1a,Q8VI78_Pla1a,Q8VI78,Pla1a,1,14,7,7,Q8VI78,MOUSE,50838.6,19.9,291,291.1,76.97,76.97,,456,Phospholipase A1 member A,acrosomal membrane|extracellular exosome|,lipid catabolic process|,phosphatidylcholine 1-acylhydrolase activity|,7,14,1480000000,19.9%
Q61171,0.891021159,0.292166667,1.083080083,0.121,0.779277239,0.293127827,-0.029,0.844,-0.12,0.599,-0.276,0.735,Q61171,Prdx2,Q61171_Prdx2,Q61171,Prdx2,1,9,7,7,Q61171,MOUSE,21949.4,39.3,292,292.1,76.73,76.73,,198,Peroxiredoxin-2,mitochondrion|myelin sheath|extracellular exosome|,activation of MAPK activity|respiratory burst involved in inflammatory response|response to oxidative stress|regulation of hydrogen peroxide metabolic process|removal of superoxide radicals|positive regulation of blood coagulation|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|response to lipopolysaccharide|cellular response to oxidative stress|T cell proliferation|hydrogen peroxide metabolic process|hydrogen peroxide catabolic process|regulation of apoptotic process|negative regulation of T cell differentiation|thymus development|homeostasis of number of cells|oxidation-reduction process|negative regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,peroxidase activity|protein binding|thioredoxin peroxidase activity|selenium binding|antioxidant activity|,7,9,725000000,39.3%
Q769J6,0.232324458,0.552833333,12.16384179,-1.224333333,0.060759728,-2.303265514,0.557,0.581,2.357,-0.228,0.076,-0.026,Q769J6,Adamts13,Q769J6_Adamts13,Q769J6,Adamts13,1,16,7,7,Q769J6|A2ALB3,MOUSE,160032.5,7,293,293.1,76.43,76.43,,1426,A disintegrin and metalloproteinase with thrombospondin motifs 13,proteinaceous extracellular matrix|extracellular space|,proteolysis|blood coagulation|response to toxic substance|response to interferon-gamma|response to tumor necrosis factor|peptide catabolic process|response to interleukin-4|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,7,16,165000000,7.0%
G3UX19,0.594937809,-0.413166667,4.218765031,0.871,0.378550215,0.951052568,0.406,0.065,-3.017,0.092,-0.11,0.085,G3UX19,NotFound,G3UX19_NotFound,G3UX19,Atf6b,1,16,6,6,G3UX19|A0A0A0MQ69|O35451,MOUSE,77389.6,12.1,294,294.1,75.17,75.17,,709,Cyclic AMP-dependent transcription factor ATF-6 beta,intracellular|nucleus|endoplasmic reticulum membrane|protein-DNA complex|,endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,sequence-specific DNA binding transcription factor activity|cAMP response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|,6,16,370000000,12.1%
A0A075B5S9,0.612514063,0.103,3.927779244,0.392,0.404782824,0.895814836,0.33,-0.116,-0.493,-0.192,1.118,-0.029,A0A075B5S9,NotFound,A0A075B5S9_NotFound,A0A075B5S9,Ighv9-4,1,16,6,5,A0A075B5S9|A0A0B4J1J4|A0A075B5S1,MOUSE,11048.3,60.2,295,295.1,74.36,54.63,,98,Immunoglobulin heavy variable 9-4,,,,7,16,820000000,60.2%
A0A0B4J1J5,0.744835591,0.134833333,2.445388476,-0.284333333,0.569457284,-0.601547368,0.956,0.565,-0.69,-0.256,0.31,-0.076,A0A0B4J1J5,NotFound,A0A0B4J1J5_NotFound,A0A0B4J1J5,Ighv9-3,1,2,3,1,A0A0B4J1J5,MOUSE,13109.7,26.4,295,295.2,35.48,9.76,,117,Immunoglobulin heavy variable V9-3 (Fragment),,,,1,2,13300000,12.8%
Q8CBR6,0.519119874,0.160166667,5.346613037,-0.595666667,0.291970314,-1.154923202,0.885,1.181,-0.692,-0.108,-0.126,-0.179,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,12,4,4,Q8CBR6,MOUSE,38760.8,16.6,296,296.1,74.15,74.15,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,4,12,207000000,16.6%
O88325,0.830947352,-0.211666667,1.578182173,0.251333333,0.695315295,0.411190188,0.25,0.474,-1.736,-0.197,-0.066,0.005,O88325,Naglu,O88325_Naglu,O88325,Naglu,1,11,6,6,O88325,MOUSE,83165.4,11.5,297,297.1,74.03,74.03,,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,,6,11,93900000,11.5%
E9QP56,0.768822314,0.163166667,2.273091947,0.264333333,0.592503343,0.565012175,0.307,0.677,-0.891,0.615,0.369,-0.098,E9QP56,Apoc3,E9QP56_Apoc3,E9QP56,Apoc3,1,46,4,4,E9QP56|P33622|A0A0R4J1N3,MOUSE,15162.8,36.4,298,298.1,72.24,72.24,,137,Apolipoprotein C-III,extracellular region|,triglyceride metabolic process|triglyceride mobilization|lipid transport|cholesterol metabolic process|triglyceride catabolic process|lipoprotein metabolic process|,lipid binding|,4,46,37200000000,36.4%
Q9Z1T2,0.434226419,-0.766833333,6.652495718,1.811,0.216147605,1.383411401,0.233,-0.473,-4.777,-0.162,0.526,0.052,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,7,5,4,Q9Z1T2,MOUSE,109046.1,7.5,299,299.1,71.9,53.91,,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,5,7,1010000000,7.5%
Q9R0G6,0.438943049,-0.1018,6.530287284,0.347833333,0.222316282,1.391464476,-0.281,-0.34,,0.039,0.071,0.002,Q9R0G6,Comp,Q9R0G6_Comp,Q9R0G6,Comp,1,4,4,3,Q9R0G6,MOUSE,84965.2,6.3,299,299.2,56.64,38.65,,755,Cartilage oligomeric matrix protein,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,growth plate cartilage development|apoptotic process|cell adhesion|extracellular matrix organization|negative regulation of apoptotic process|limb development|,protease binding|extracellular matrix structural constituent|calcium ion binding|protein binding|collagen binding|heparin binding|heparan sulfate proteoglycan binding|,3,4,30000000,5.0%
E9QPX1,0.795925562,0.07,1.981289128,-0.138,0.633681586,-0.501609829,0.556,0.083,-0.222,0.036,0.022,-0.055,E9QPX1,Col18a1,E9QPX1_Col18a1,E9QPX1,Col18a1,1,20,5,5,E9QPX1|P39061|P39061-1|P39061-2,MOUSE,183320.5,3.4,300,300.1,71.8,71.8,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,5,20,2920000000,3.4%
Q9Z0L8,0.635196944,0.0052,3.587630569,0.223666667,0.437760874,0.84220238,-0.251,-0.007,,0.176,0.135,-0.027,Q9Z0L8,Ggh,Q9Z0L8_Ggh,Q9Z0L8,Ggh,1,13,5,5,Q9Z0L8|Q9Z0L8-2,MOUSE,35697.1,17.9,301,301.1,70.58,70.58,,317,Gamma-glutamyl hydrolase,extracellular space|nucleus|lysosome|cytosol|melanosome|extracellular exosome|,proteolysis|glutamine metabolic process|response to zinc ion|response to insulin|response to drug|response to ethanol|,gamma-glutamyl-peptidase activity|,5,13,878000000,17.9%
A0A075B5N7,0.484207703,-0.022166667,5.843194941,0.319666667,0.260423701,1.2414858,-0.276,-0.291,0.021,-0.177,0.204,0.386,A0A075B5N7,NotFound,A0A075B5N7_NotFound,A0A075B5N7,Igkv6-13,1,32,6,3,A0A075B5N7|A0A140T8P1,MOUSE,10554.5,56.8,302,302.1,69.71,39.67,,95,Immunoglobulin kappa variable 6-13,,,,7,32,10200000000,56.8%
A0A140T8M5,0.230974077,-0.0746,12.44094062,1.019,0.05700408,2.461340209,-0.741,-0.631,,-0.219,0.925,0.293,A0A140T8M5,NotFound,A0A140T8M5_NotFound,A0A140T8M5,Igkv6-15,1,19,5,3,A0A140T8M5,MOUSE,12871.1,40,302,302.2,69.29,50.45,,115,Immunoglobulin kappa variable 6-15 (Fragment),,,,3,19,5690000000,32.1%
A0A140T8Q3,0.878801684,0.0902,1.174922163,0.156166667,0.762970566,0.318467055,-0.399,0.392,,-0.21,-0.199,0.867,A0A140T8Q3,NotFound,A0A140T8Q3_NotFound,A0A140T8Q3,Igkv6-17,1,4,5,1,A0A140T8Q3|P01633,MOUSE,12874.2,40,302,302.3,66.84,13.82,,115,Immunoglobulin kappa variable 6-17 (Fragment),,,,1,4,429000000,7.8%
A0A140T8N7,0.556212681,0.1938,4.889145522,0.397166667,0.324403438,1.091964713,0.154,-0.243,,0.287,0.799,-0.028,A0A140T8N7,NotFound,A0A140T8N7_NotFound,A0A140T8N7,Igkv6-25,1,6,5,1,A0A140T8N7,MOUSE,12853.2,40,302,302.4,65.49,16.82,,115,Immunoglobulin kappa chain variable 6-25 (Fragment),,,,1,6,473000000,7.8%
Q9EPS3,0.955428034,0.038166667,0.477606408,-0.033,0.895858377,-0.136499698,0.147,-0.224,0.241,0.122,-0.128,0.071,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,12,7,7,Q9EPS3,MOUSE,70429.9,12.7,303,303.1,69.55,69.55,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",7,12,78700000,12.7%
Q9R182,0.946089108,-0.044833333,0.60777231,0.089,0.869406272,0.171571217,-0.493,-0.824,1.049,-0.173,0.172,0,Q9R182,Angptl3,Q9R182_Angptl3,Q9R182,Angptl3,1,15,6,6,Q9R182,MOUSE,52770.3,15.3,304,304.1,69.55,69.55,,455,Angiopoietin-related protein 3,extracellular region|extracellular space|early endosome|Golgi apparatus|cell surface|,glycerol metabolic process|fatty acid metabolic process|triglyceride metabolic process|phospholipid metabolic process|cell-matrix adhesion|signal transduction|cholesterol metabolic process|phospholipid catabolic process|response to hormone|negative regulation of phospholipase activity|lipid storage|positive regulation of cell migration|cholesterol homeostasis|positive regulation of angiogenesis|positive regulation of lipid metabolic process|artery morphogenesis|positive regulation of lipid catabolic process|negative regulation of lipoprotein lipase activity|lipid homeostasis|acylglycerol homeostasis|phospholipid homeostasis|triglyceride homeostasis|,enzyme inhibitor activity|phospholipase inhibitor activity|integrin binding|growth factor activity|,6,15,815000000,15.3%
P09813,0.57889404,0.034,4.486598525,0.602666667,0.355909965,1.00060875,0.508,0.265,-1.575,0.645,0.45,-0.089,P09813,Apoa2,P09813_Apoa2,P09813,Apoa2,1,33,4,4,P09813,MOUSE,11366,43.1,305,305.1,68.65,68.65,,102,Apolipoprotein A-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|,acute inflammatory response|negative regulation of cytokine secretion involved in immune response|protein folding|fatty acid metabolic process|phosphatidylcholine biosynthetic process|lipid transport|cholesterol metabolic process|phospholipid catabolic process|response to glucose|positive regulation of cholesterol esterification|negative regulation of very-low-density lipoprotein particle remodeling|beta-glucoside transport|protein oxidation|peptidyl-methionine modification|regulation of intestinal cholesterol absorption|organ regeneration|regulation of protein stability|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|lipoprotein metabolic process|response to drug|cholesterol homeostasis|positive regulation of catalytic activity|response to estrogen|reverse cholesterol transport|positive regulation of interleukin-8 biosynthetic process|diacylglycerol catabolic process|negative regulation of lipid catabolic process|positive regulation of lipid catabolic process|response to glucocorticoid|negative regulation of lipase activity|negative regulation of cholesterol import|negative regulation of cholesterol transporter activity|,lipid transporter activity|phospholipid binding|high-density lipoprotein particle binding|lipid binding|cholesterol binding|phosphatidylcholine binding|apolipoprotein receptor binding|protein homodimerization activity|protein heterodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|cholesterol transporter activity|,4,33,75100000000,43.1%
A0A075B5M7,0.816464714,0.702,1.806962732,0.4075,0.659635054,0.468003623,0.604,0.311,,0.111,2.518,-0.034,A0A075B5M7,NotFound,A0A075B5M7_NotFound,A0A075B5M7,Igkv5-39,1,34,4,4,A0A075B5M7|A0A0B4J1J1|A0A0B4J1J2,MOUSE,10459.3,52.6,306,306.1,68.36,68.36,,95,Immunoglobulin kappa variable 5-39,,,,4,34,11900000000,52.6%
Q9WUU7,0.259510246,-0.086,11.37720802,0.562,0.072824783,2.168958138,-0.311,-0.12,-0.67,0.31,0.309,-0.034,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,22,6,6,Q9WUU7,MOUSE,34680.3,18.9,307,307.1,68.03,68.03,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,6,22,1790000000,18.9%
P34928,0.263987871,0.1066,11.21474083,0.836833333,0.075600717,2.234421473,-0.645,-0.146,,0.791,0.556,-0.023,P34928,Apoc1,P34928_Apoc1,P34928,Apoc1,1,36,5,5,P34928,MOUSE,9696.2,32.9,308,308.1,67.88,67.88,,88,Apolipoprotein C-I,endoplasmic reticulum|very-low-density lipoprotein particle|high-density lipoprotein particle|extracellular exosome|,triglyceride metabolic process|cholesterol metabolic process|negative regulation of phosphatidylcholine catabolic process|negative regulation of very-low-density lipoprotein particle clearance|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|plasma lipoprotein particle remodeling|chylomicron remnant clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|negative regulation of fatty acid biosynthetic process|negative regulation of receptor-mediated endocytosis|negative regulation of lipoprotein lipase activity|,phospholipase inhibitor activity|fatty acid binding|,5,36,28300000000,32.9%
O35887,0.259510246,-0.3026,11.36023289,0.754,0.073109988,2.257399518,-1.114,-0.396,,-0.141,0.153,-0.015,O35887,Calu,O35887_Calu,O35887,Calu,1,9,5,5,O35887|G3UWR0|Q6XLQ8|G3V004|G3UWV3,MOUSE,37177.2,17.4,309,309.1,67.59,67.59,,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,5,9,1070000000,17.4%
Q04592,0.125817542,0.397,18.29930595,-1.06,0.014793448,-3.375943093,0.901,0.444,1.436,-0.083,-0.266,-0.05,Q04592,Pcsk5,Q04592_Pcsk5,Q04592,Pcsk5,1,15,8,8,Q04592|Q04592-2,MOUSE,220321.6,4.8,310,310.1,67.23,67.23,,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,8,15,768000000,4.8%
A0A0B4J1N0,0.823849335,0.4604,1.693406671,0.239,0.677110164,0.441716732,0.134,0.5,,0.289,1.47,-0.091,A0A0B4J1N0,NotFound,A0A0B4J1N0_NotFound,A0A0B4J1N0,Ighv1-76,1,19,6,6,A0A0B4J1N0|A0A075B5Y2|A0A075B5Y5,MOUSE,10993.2,62.2,311,311.1,66.88,66.88,,98,Immunoglobulin heavy variable 1-76,,,,7,19,5840000000,62.2%
O08742,0.29913981,0.172166667,10.0941263,-0.560333333,0.09785598,-1.956137003,0.241,0.916,0.2,-0.113,-0.258,0.047,O08742,NotFound,O08742_NotFound,O08742,Gp5,1,11,7,7,O08742,MOUSE,63980.2,10.5,312,312.1,66.65,66.65,,567,Platelet glycoprotein V,integral component of membrane|,cell adhesion|blood coagulation|,,7,11,9600000000,10.5%
Q09200,0.232324458,0.386166667,12.29621993,-0.977,0.05893564,-2.325168811,0.409,0.439,1.776,-0.096,-0.156,-0.055,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,18,7,7,Q09200|A0A1W2P6F0,MOUSE,59610.2,12,313,313.1,66.51,66.51,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,7,18,269000000,12.0%
A0A075B5K2,0.807879833,0.2545,1.890579585,0.249,0.647056257,0.481703586,0.931,0.061,-0.602,0.057,1.133,-0.053,A0A075B5K2,NotFound,A0A075B5K2_NotFound,A0A075B5K2,Igkv9-124,1,15,5,5,A0A075B5K2,MOUSE,10533.4,63.1,314,314.1,66.15,66.15,,95,Immunoglobulin kappa chain variable 9-124,,,,5,15,544000000,63.1%
Q6S5C2-2,0.121109301,0.445333333,18.56751054,-0.984666667,0.013907496,-3.424038601,0.6,0.811,1.402,0.068,-0.176,-0.033,Q6S5C2,Gnptg,Q6S5C2-2_Gnptg,Q6S5C2-2,Gnptg,1,9,5,5,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,16.5,315,315.1,66.15,66.15,,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,5,9,560000000,16.5%
Q08879-2,0.612787035,0.1335,3.885289739,-0.427666667,0.408762481,-0.887820296,1.165,0.531,-0.654,-0.052,-0.189,0,Q08879,Fbln1,Q08879-2_Fbln1,Q08879-2,Fbln1,1,18,7,7,Q08879-2|Q08879,MOUSE,79390.4,10.8,316,316.1,65.28,65.28,,705,Isoform C of Fibulin-1,proteinaceous extracellular matrix|basement membrane|extracellular space|extracellular exosome|elastic fiber|fibrinogen complex|extracellular matrix|,"negative regulation of protein phosphorylation|negative regulation of cell adhesion|embryo implantation|positive regulation of gene expression|positive regulation of peptidase activity|extracellular matrix organization|positive regulation of fibroblast proliferation|negative regulation of ERK1 and ERK2 cascade|blood coagulation, fibrin clot formation|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of cell motility|negative regulation of stem cell proliferation|negative regulation of transforming growth factor-beta secretion|",fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|protein C-terminus binding|peptidase activator activity|protein complex binding|identical protein binding|fibrinogen binding|,7,18,460000000,10.8%
Q8CG85,0.941122499,0.062666667,0.662451064,-0.05,0.85852885,-0.185999933,0.389,0.111,-0.237,-0.141,-0.008,0.262,Q8CG85,Mamdc2,Q8CG85_Mamdc2,Q8CG85,Mamdc2,1,7,6,6,A0A0R4J0J7|Q8CG85,MOUSE,78406.9,9.3,317,317.1,64.38,64.38,,686,MAM domain-containing protein 2,proteinaceous extracellular matrix|interstitial matrix|endoplasmic reticulum|membrane|,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|,6,7,40700000,9.3%
P62983,0.09808131,0.3775,20.15912438,-2.312333333,0.009640234,-3.749562011,1.504,2.758,0.339,-0.627,-1.053,-0.656,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,16,7,7,P62983|P0CG50|P0CG49|P62984|A0A0A6YW67|E9QNP0|D3YYZ2,MOUSE,18292.9,44.8,318,318.1,64.13,64.13,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,7,16,219000000,44.8%
O09043,0.226931035,-0.295333333,12.79097546,0.842666667,0.052589913,2.408505851,-1.295,-0.691,-0.164,-0.001,0.378,0.001,O09043,Napsa,O09043_Napsa,O09043,Napsa,1,15,4,4,O09043,MOUSE,45942.9,13.6,319,319.1,63.09,63.09,,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,4,15,854000000,13.6%
Q02596,0.33297859,-0.223166667,8.996934926,0.460333333,0.125981422,1.774384514,-0.578,-0.101,-0.681,0.15,-0.148,0.019,Q02596,Glycam1,Q02596_Glycam1,Q02596,Glycam1,1,7,4,4,Q02596,MOUSE,16208.6,29.1,320,320.1,62.95,62.95,,151,Glycosylation-dependent cell adhesion molecule 1,extracellular region|plasma membrane|,cell adhesion|,sulfate binding|cell adhesion molecule binding|,4,7,576000000,29.1%
P01639,0.511095948,0.1926,5.46972347,0.5485,0.283809973,1.199850466,-0.201,-0.072,,0.091,1.175,-0.03,P01639,NotFound,P01639_NotFound,P01639,Gm5571,1,12,4,4,P01639|A0A140T8N0,MOUSE,14482,33,321,321.1,61.5,61.5,,130,Ig kappa chain V-V region MOPC 41,,,antigen binding|,4,12,730000000,33.0%
Q62351,0.970099283,-0.094333333,0.299517349,0.029333333,0.933358023,0.087181352,-0.028,0.408,-0.707,-0.198,-0.034,-0.007,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,10,7,7,Q62351|Q8C872,MOUSE,86129.2,9.3,322,322.1,61.04,61.04,,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,7,10,310000000,9.3%
A0A075B5K0,0.984803069,0.41,0.193560977,-0.022666667,0.956409546,-0.056977084,0.096,0.29,0.878,0.126,1.09,-0.02,A0A075B5K0,NotFound,A0A075B5K0_NotFound,A0A075B5K0,Igkv14-126,1,37,4,2,A0A075B5K0|P01637,MOUSE,13228.7,41.8,323,323.1,60.63,37.43,,117,Immunoglobulin kappa variable 14-126 (Fragment),,,,5,37,15000000000,41.8%
A0A140T8P9,0.468450627,0.2212,6.072311374,0.8195,0.247040901,1.311822922,-0.453,-0.088,,-0.141,1.663,0.125,A0A140T8P9,NotFound,A0A140T8P9_NotFound,A0A140T8P9,Igkv14-111,1,7,4,1,A0A140T8P9,MOUSE,13403.1,40.1,323,323.2,56.08,23.18,,117,Immunoglobulin kappa variable 14-111 (Fragment),,,,1,7,385000000,15.3%
P01887,0.09837553,-0.3522,19.91716073,1.258833333,0.010192575,3.994320214,-1.419,-0.796,,0.166,0.272,0.016,P01887,B2m,P01887_B2m,P01887,B2m,1,45,4,4,P01887,MOUSE,13892.8,22.6,324,324.1,60.5,60.5,,119,Beta-2-microglobulin,extracellular space|cytoplasm|Golgi apparatus|plasma membrane|focal adhesion|external side of plasma membrane|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular defense response|T cell differentiation in thymus|protein refolding|response to drug|response to cadmium ion|iron ion homeostasis|negative regulation of receptor binding|",glycoprotein binding|protein binding|identical protein binding|,4,45,63400000000,22.6%
O54819,0.131134782,-0.339,17.90537013,1.181666667,0.016198059,3.546593539,-1.254,-0.842,,-0.132,0.498,0.035,O54819,Tfpi,O54819_Tfpi,O54819,Tfpi,1,10,4,4,O54819|A2ARA0|O54819-2|A2ARA3|Q8BSB7,MOUSE,36070.2,16.3,325,325.1,59.28,59.28,,306,Tissue factor pathway inhibitor,extracellular space|cell surface|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,4,10,463000000,16.3%
Q6P542,0.015720174,0.733,33.06172054,-2.594,0.000494115,-6.791440654,1.752,1.621,2.717,-0.833,-0.677,-0.182,Q6P542,Abcf1,Q6P542_Abcf1,Q6P542,Abcf1,1,8,6,6,Q6P542,MOUSE,95400.1,6.2,326,326.1,59.23,59.23,,837,ATP-binding cassette sub-family F member 1,nuclear envelope|nucleoplasm|cytoplasm|membrane|polysomal ribosome|,translational initiation|positive regulation of translation|ribosome biogenesis|,ATP binding|translation activator activity|ATPase activity|ribosome binding|poly(A) RNA binding|,6,8,180000000,6.2%
Q9Z2L6,0.326571299,-0.292833333,9.180784685,0.744333333,0.120759563,1.806446365,-0.075,-0.429,-1.491,0.303,-0.064,-0.001,Q9Z2L6,Minpp1,Q9Z2L6_Minpp1,Q9Z2L6,Minpp1,1,10,5,5,Q9Z2L6,MOUSE,55164,11.6,327,327.1,58.66,58.66,,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,5,10,79400000,11.6%
D3Z4E2,0.229834514,-0.0448,12.54670085,0.7645,0.055632671,2.476588923,-0.686,-0.321,,0.49,0.316,-0.023,D3Z4E2,NotFound,D3Z4E2_NotFound,D3Z4E2,Nrn1,1,20,4,4,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,20.8,328,328.1,58.51,58.51,,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,,4,20,4640000000,20.8%
Q3UFC6,0.826430946,0.057166667,1.646638291,0.211666667,0.684441242,0.426728658,0.404,0.406,-0.956,-0.082,-0.227,0.798,Q3UFC6,Dsg3,Q3UFC6_Dsg3,Q3UFC6,Dsg3,1,11,6,6,Q3UFC6|O35902|O35902-2,MOUSE,109212.9,8.3,329,329.1,58.28,58.28,,993,Desmoglein-3,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,6,11,368000000,8.3%
Q8VCC9,0.326571299,-0.1556,9.162620553,0.759833333,0.121265691,1.863522093,-0.141,-1.082,,-0.189,0.413,0.221,Q8VCC9,Spon1,Q8VCC9_Spon1,Q8VCC9,Spon1,1,5,4,4,Q8VCC9|Q3UYD7,MOUSE,93444.1,6.1,330,330.1,57.89,57.89,,807,Spondin-1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,cell adhesion|,,4,5,45600000,6.1%
A0A140T8P6,0.530912738,-0.416,5.187739388,0.758666667,0.302848942,1.127591902,-0.536,0.414,-2.264,-0.042,-0.048,-0.02,A0A140T8P6,NotFound,A0A140T8P6_NotFound,A0A140T8P6,Igkv12-46,1,27,3,3,A0A140T8P6,MOUSE,12733.1,40.8,331,331.1,57.85,57.85,,115,Immunoglobulin kappa variable 12-46 (Fragment),,,,3,27,1850000000,40.8%
Q6T5E4,0.472601761,-0.372166667,5.978794702,1.031,0.252418121,1.267040968,0.272,-0.15,-2.785,0.348,0.1,-0.018,Q6T5E4,Gcnt2,Q6T5E4_Gcnt2,Q6T5E4,Gcnt2,1,7,5,5,Q6T5E4,MOUSE,46854.9,13.2,332,332.1,57.09,57.09,,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",5,7,95600000,13.2%
A0A0A6YYE7,0.946089108,0.1255,0.568166062,0.133666667,0.877371239,0.161057133,0.511,1.452,-1.787,-0.163,0.536,0.204,A0A0A6YYE7,NotFound,A0A0A6YYE7_NotFound,A0A0A6YYE7,Igkv4-57,1,13,3,3,A0A0A6YYE7|A0A075B5M4|A0A0B4J1I4|A0A0B4J1I3|A0A0A6YYE5|A0A075B5L8,MOUSE,12803.3,39.3,333,333.1,57.01,42.86,,117,Immunoglobulin kappa variable 4-57 (Fragment),,,,4,13,2260000000,39.3%
A0A0B4J1I9,0.895801409,0.3102,1.019588479,-0.143833333,0.790753553,-0.279886764,0.771,0.022,,-0.283,1.025,0.016,A0A0B4J1I9,NotFound,A0A0B4J1I9_NotFound,A0A0B4J1I9,Igkv4-55,1,8,2,1,A0A0B4J1I9|P04945,MOUSE,12850.3,27.3,333,333.2,37.9,17.02,,117,Immunoglobulin kappa variable 4-55 (Fragment),,,,1,8,431000000,13.6%
P09803,0.617758953,-0.1152,3.798263983,0.386333333,0.417036053,0.884067625,0.26,-0.954,,0.056,-0.116,0.178,P09803,Cdh1,P09803_Cdh1,P09803,Cdh1,1,7,5,5,A0A0R4IZW5|P09803,MOUSE,98767.5,6.3,334,334.1,56.55,56.55,,884,Cadherin-1,cytoplasm|endosome|trans-Golgi network|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|focal adhesion|cytoplasmic side of plasma membrane|cell surface|actin cytoskeleton|integral component of membrane|aggresome|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|lamellipodium|cell junction|axon|node of Ranvier|lateral loop|Schmidt-Lanterman incisure|apical junction complex|axon terminus|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|cell periphery|catenin complex|cortical actin cytoskeleton|,"in utero embryonic development|trophectodermal cell differentiation|epithelial cell morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|embryo implantation|sensory perception of sound|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|protein metabolic process|negative regulation of cell-cell adhesion|regulation of protein localization|regulation of water loss via skin|adherens junction organization|uterine epithelium development|positive regulation of transcription factor import into nucleus|regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|decidualization|negative regulation of epithelial cell proliferation|protein homooligomerization|intestinal epithelial cell development|salivary gland cavitation|regulation of branching involved in salivary gland morphogenesis|bicellular tight junction assembly|cellular response to amino acid stimulus|cellular response to lithium ion|cellular response to indole-3-methanol|protein localization to plasma membrane|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|cochlea development|regulation of protein localization to cell surface|regulation of neuron migration|",glycoprotein binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|protein domain specific binding|ankyrin binding|GTPase activating protein binding|gamma-catenin binding|cell adhesion molecule binding|,5,7,88500000,6.3%
Q8BM72,0.592453065,0.311,4.265393837,-0.328,0.374507584,-0.959012223,0.09,0.204,1.131,0.26,0.179,0.002,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,12,5,5,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,10.8,335,335.1,56.35,56.35,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,5,12,198000000,10.8%
Q62178,0.466324425,0.166833333,6.140269869,0.326333333,0.243205288,1.293045776,-0.032,-0.025,0.068,0.416,0.592,-0.018,Q62178,Sema4a,Q62178_Sema4a,Q62178,Sema4a,1,9,5,5,Q62178|D3YWV5,MOUSE,84389.1,7.1,336,336.1,55.99,55.99,,760,Semaphorin-4A,plasma membrane|integral component of membrane|,angiogenesis|T cell differentiation involved in immune response|axonogenesis|regulation of cell shape|regulation of endothelial cell migration|negative regulation of angiogenesis|T-helper 1 cell differentiation|semaphorin-plexin signaling pathway|,,5,9,108000000,7.1%
A0A1Y7VJX7,0.91303325,0.381166667,0.85709401,-0.108333333,0.820900649,-0.23649225,1.187,0.179,-0.06,0.303,-0.23,0.908,A0A1Y7VJX7,NotFound,A0A1Y7VJX7_NotFound,A0A1Y7VJX7,Ighe,1,9,5,5,A0A1Y7VJX7|P06336,MOUSE,55752.3,13.7,337,337.1,55.96,55.96,,486,Immunoglobulin heavy constant epsilon (Fragment),,,,5,9,334000000,13.7%
Q9D1Q6,0.489116217,-0.811,5.728786867,1.554666667,0.267375318,1.223338995,-0.182,0.065,-4.648,-0.011,-0.033,-0.057,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,10,5,5,Q9D1Q6,MOUSE,47251.5,11,338,338.1,55.78,55.78,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,5,10,223000000,11.0%
A0A075B680,0.665420656,0.466,3.327456353,-0.499333333,0.46478742,-0.780833252,-0.132,0.216,2.063,-0.219,0.772,0.096,A0A075B680,NotFound,A0A075B680_NotFound,A0A075B680,Ighv1-62-2,1,12,5,3,A0A075B680|A0A0G2JFL3,MOUSE,11338.5,53,339,339.1,54.86,38.72,,100,Immunoglobulin heavy variable 1-62-2,,,,5,12,3010000000,53.0%
A0A075B5V8,0.795925562,0.15,1.980646092,0.32,0.633775419,0.507183275,0.874,-0.958,,0.727,0.175,-0.068,A0A075B5V8,NotFound,A0A075B5V8_NotFound,A0A075B5V8,Ighv1-47,1,1,3,1,A0A075B5V8,MOUSE,11197.4,31.6,339,339.2,24.26,8.12,,98,Immunoglobulin heavy variable 1-47,,,,1,1,316000000,13.2%
Q922Q9,0.337209389,0.396166667,8.837976867,-0.863666667,0.13067795,-1.749637845,1.748,0.832,-0.096,0.095,-0.328,0.126,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,9,6,6,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,12.2,340,340.1,54.69,54.69,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,6,9,539000000,12.2%
Q9EQ21,0.679504976,0.044166667,3.171832301,0.310333333,0.481744505,0.749665881,0.257,0.351,-0.941,0.477,0.17,-0.049,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,22,3,2,Q9EQ21,MOUSE,9865.4,45.7,341,341.1,54.27,42.54,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,3,22,774000000,45.7%
Q80T19,0.62503481,0.2302,3.701913425,0.305333333,0.426391617,0.864991207,0.037,0.057,,0.812,0.301,-0.056,Q80T19,Hamp2,Q80T19_Hamp2,Q80T19,Hamp2,1,7,3,2,Q5M9M1|Q80T19,MOUSE,9923.4,46.9,341,341.2,42.23,30.5,,83,Hepcidin-2,extracellular region|cell|,cellular iron ion homeostasis|killing of cells of other organism|defense response to bacterium|defense response to fungus|,hormone activity|,2,7,162000000,30.1%
P01723,0.579921534,0.007,4.450855058,0.383333333,0.358851275,1.009719533,0.156,-0.602,,-0.214,0.373,0.322,P01723,NotFound,P01723_NotFound,P01723,,1,28,3,2,P01727|A0A075B663|P01723|P01726|P01729,MOUSE,12335.6,41.8,342,342.1,53.88,38.06,,117,Ig lambda-1 chain V region,plasma membrane|,,antigen binding|,4,28,37800000000,41.8%
P01728,0.372901545,0.04875,7.919442091,0.985,0.161456596,1.713936455,,-0.69,,-0.129,0.929,0.085,P01728,NotFound,P01728_NotFound,P01728,,1,4,3,1,P01728|A0A075B664,MOUSE,12392.7,41.8,342,342.2,50.96,26.26,,117,Ig lambda-2 chain V region,,,antigen binding|,1,4,111000000,28.2%
Q9Z1R3,0.803819308,0.064,1.931441586,0.128333333,0.64099677,0.495613298,-0.093,0.067,,0.169,0.174,0.003,Q9Z1R3,Apom,Q9Z1R3_Apom,Q9Z1R3,Apom,1,18,4,4,Q9Z1R3,MOUSE,21615.3,16.3,343,343.1,53.55,53.55,,190,Apolipoprotein M,extracellular region|very-low-density lipoprotein particle|low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|extracellular exosome|,response to glucose|cholesterol efflux|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|negative regulation of plasma lipoprotein particle oxidation|lipoprotein metabolic process|reverse cholesterol transport|,lipid transporter activity|phospholipid binding|antioxidant activity|,4,18,735000000,16.3%
E9Q0F0,0.352162391,0.115166667,8.456709459,-1.753,0.142668815,-1.688325888,2.363,2.095,-1.483,-0.861,-0.851,-0.572,E9Q0F0,Krt78,E9Q0F0_Krt78,E9Q0F0,Krt78,1,34,3,3,E9Q0F0,MOUSE,114088.5,1.9,344,344.1,53.5,53.5,,1068,Keratin 78,extracellular space|keratin filament|extracellular exosome|,,structural molecule activity|,3,34,40100000000,1.9%
A0A140T8N3,0.193614767,-0.2405,14.29570743,0.684333333,0.037190264,2.661235135,-0.736,-0.621,-0.391,-0.227,0.295,0.237,A0A140T8N3,NotFound,A0A140T8N3_NotFound,A0A140T8N3,Igkv13-84,1,14,4,4,A0A140T8N3|A0A075B666,MOUSE,12788.3,37.3,345,345.1,53.07,53.07,,115,Immunoglobulin kappa chain variable 13-84 (Fragment),,,,4,14,2490000000,37.3%
Q8CAR0,0.609809027,-0.313333333,3.990629993,0.529333333,0.398967023,0.908310107,0.378,-0.249,-1.863,-0.09,-0.048,-0.008,Q8CAR0,Igf1,Q8CAR0_Igf1,Q8CAR0,Igf1,1,15,4,4,Q8CAR0|Q4VJB9|P05017-2|P05017|E9PU89|E9Q138,MOUSE,18872.4,25.4,346,346.1,52.96,52.96,,165,Insulin-like growth factor I,extracellular space|intracellular|insulin-like growth factor ternary complex|,"cell activation|regulation of protein phosphorylation|blood vessel remodeling|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|response to heat|glial cell differentiation|regulation of gene expression|positive regulation of glycoprotein biosynthetic process|positive regulation of cardiac muscle hypertrophy|phosphatidylinositol 3-kinase signaling|positive regulation of phosphatidylinositol 3-kinase signaling|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration|muscle hypertrophy|myotube cell development|positive regulation of smooth muscle cell migration|positive regulation of cerebellar granule cell precursor proliferation|water homeostasis|proteoglycan biosynthetic process|lung development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|regulation of establishment or maintenance of cell polarity|positive regulation of protein import into nucleus, translocation|negative regulation of smooth muscle cell apoptotic process|multicellular organism growth|bone mineralization involved in bone maturation|regulation of multicellular organism growth|positive regulation of activated T cell proliferation|positive regulation of tyrosine phosphorylation of Stat5 protein|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation of MAPK cascade|protein kinase B signaling|positive regulation of insulin-like growth factor receptor signaling pathway|myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of Ras protein signal transduction|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|lung alveolus development|cell development|positive regulation of smooth muscle cell proliferation|branching morphogenesis of an epithelial tube|inner ear development|chondroitin sulfate proteoglycan biosynthetic process|positive regulation of epithelial cell proliferation|positive regulation of protein secretion|positive regulation of peptidyl-tyrosine phosphorylation|protein stabilization|regulation of protein metabolic process|myoblast proliferation|positive regulation of protein kinase B signaling|negative regulation of oocyte development|lung vasculature development|lung lobe morphogenesis|Type I pneumocyte differentiation|Type II pneumocyte differentiation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate gland growth|prostate gland epithelium morphogenesis|prostate gland stromal morphogenesis|negative regulation of androgen receptor signaling pathway|ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of trophectodermal cell proliferation|positive regulation of myoblast proliferation|negative regulation of extrinsic apoptotic signaling pathway|",insulin receptor binding|insulin-like growth factor receptor binding|integrin binding|hormone activity|protein binding|growth factor activity|,4,15,1120000000,25.4%
Q6P069,0.37230644,-0.1384,7.960436585,0.507666667,0.159939724,1.647028312,-0.446,-0.44,,-0.098,-0.138,0.43,Q6P069,Sri,Q6P069_Sri,Q6P069,Sri,1,6,5,5,Q6P069|Q6P069-2,MOUSE,21912.2,28.7,347,347.1,52.92,52.92,,198,Sorcin,intracellular|nucleoplasm|cytoplasm|mitochondrion|endoplasmic reticulum membrane|smooth endoplasmic reticulum|cytosol|plasma membrane|membrane|Z disc|T-tubule|vesicle|sarcoplasmic reticulum membrane|axon terminus|dendritic spine neck|extracellular exosome|chromaffin granule membrane|,proteolysis|calcium ion transport|heart development|negative regulation of heart rate|positive regulation of insulin secretion involved in cellular response to glucose stimulus|cytoplasmic sequestering of transcription factor|positive regulation of release of sequestered calcium ion into cytosol|regulation of calcium ion transport|negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of cardiac muscle cell contraction|regulation of relaxation of muscle|regulation of high voltage-gated calcium channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction|negative regulation of transcription regulatory region DNA binding|,protease binding|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|protein heterodimerization activity|repressing transcription factor binding|,5,6,409000000,28.7%
A0A087WPN7,0.914305201,0.285666667,0.836002712,-0.118666667,0.824897009,-0.23110993,-0.09,-0.265,1.39,-0.22,0.618,0.281,A0A087WPN7,NotFound,A0A087WPN7_NotFound,A0A087WPN7,Ighv13-2,1,16,4,4,A0A087WPN7,MOUSE,11456.7,44,348,348.1,52.57,52.57,,100,Immunoglobulin heavy variable 13-2,,,,4,16,779000000,44.0%
O35622,0.326571299,-0.260833333,9.189641448,0.455666667,0.120513543,1.806341318,-0.827,-0.213,-0.426,0.031,-0.099,-0.031,O35622,Fgf15,O35622_Fgf15,O35622,Fgf15,1,10,5,5,O35622,MOUSE,25520.6,26.6,349,349.1,52.37,52.37,,218,Fibroblast growth factor 15,extracellular region|,neural crest cell migration|positive regulation of protein phosphorylation|heart development|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|negative regulation of gene expression|positive regulation of glucose import|positive regulation of JNK cascade|positive regulation of ERK1 and ERK2 cascade|negative regulation of bile acid biosynthetic process|,fibroblast growth factor receptor binding|growth factor activity|,5,10,219000000,26.6%
A0A075B5R9,0.427513465,0.217166667,6.849952692,-0.563666667,0.206540265,-1.415594805,-0.163,0.395,1.265,-0.066,-0.178,0.05,A0A075B5R9,NotFound,A0A075B5R9_NotFound,A0A075B5R9,Ighv14-3,1,12,4,2,A0A075B5R9|A0A075B5R4|A0A075B5S3,MOUSE,13088.7,31.6,350,350.1,52.3,27.75,,117,Immunoglobulin heavy variable V14-3 (Fragment),,,,4,12,1030000000,31.6%
A0A075B5R7,0.795925562,0.3858,1.98521663,-0.211166667,0.633108781,-0.507847569,0.736,0.289,,0.133,0.9,-0.129,A0A075B5R7,NotFound,A0A075B5R7_NotFound,A0A075B5R7,Ighv14-2,1,3,4,2,A0A075B5R7,MOUSE,13172.7,30.7,350,350.2,40.53,15.98,,117,Immunoglobulin heavy variable 14-2 (Fragment),,,,2,3,147000000,16.2%
P01675,0.579921534,0.156,4.446621403,0.399333333,0.359201267,0.992489387,-0.502,-0.191,0.562,-0.208,0.729,0.546,P01675,NotFound,P01675_NotFound,P01675,,1,16,4,4,P01675|P01676|P01677|P01678|P01679|A0A075B5L5,MOUSE,11741,36.4,351,351.1,51.39,51.39,,107,Ig kappa chain V-VI region XRPC 44,,,antigen binding|,4,16,3990000000,36.4%
Q60805,0.576352888,-0.328333333,4.52318946,0.770666667,0.352923887,1.007330151,0.239,0.13,-2.51,0.017,0.186,-0.032,Q60805,Mertk,Q60805_Mertk,Q60805,Mertk,1,12,6,6,Q60805,MOUSE,111239.5,4.6,352,352.1,51.09,51.09,,994,Tyrosine-protein kinase Mer,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,6,12,243000000,4.6%
P35700,0.069249242,0.197,22.67503338,-2.676666667,0.00540128,-4.681282104,0.948,2.658,,-0.71,-1.174,-0.737,P35700,Prdx1,P35700_Prdx1,P35700,Prdx1,1,5,4,2,P35700,MOUSE,22404.3,16.5,353,353.1,50.7,28.09,,199,Peroxiredoxin-1,extracellular space|nucleus|cytoplasm|mitochondrion|melanosome|myelin sheath|extracellular exosome|,response to reactive oxygen species|retina homeostasis|response to oxidative stress|cell proliferation|removal of superoxide radicals|regulation of stress-activated MAPK cascade|erythrocyte homeostasis|natural killer cell mediated cytotoxicity|regulation of NF-kappaB import into nucleus|hydrogen peroxide catabolic process|oxidation-reduction process|,peroxidase activity|protein binding|thioredoxin peroxidase activity|identical protein binding|poly(A) RNA binding|,4,5,46700000,16.5%
O08807,0.239722797,-0.678,11.90160712,1.472,0.064541535,2.263612098,-1.53,-0.061,-2.651,0,-0.057,0.231,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,4,4,2,O08807,MOUSE,31280.1,16,353,353.2,44.57,21.96,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,2,4,18300000000,9.1%
P01751,0.583422591,0.052,4.380356363,0.324166667,0.364724018,0.995689361,-0.226,-0.059,,-0.204,0.498,0.251,P01751,NotFound,P01751_NotFound,P01751,Ighv1-72,1,13,5,5,P01751|P01754|P01753,MOUSE,15590.3,23.7,354,354.1,50.62,50.62,,139,Ig heavy chain V region B1-8/186-2,,,,5,13,5570000000,23.7%
A0A075B5M3,0.359352124,-0.598833333,8.331658314,1.774333333,0.146836549,1.667396148,-0.462,-0.085,-3.911,-0.191,1.04,0.016,A0A075B5M3,NotFound,A0A075B5M3_NotFound,A0A075B5M3,Igkv4-58,1,17,4,3,A0A075B5M3|P01680|A0A075B5L2,MOUSE,10407.3,40.2,355,355.1,49.99,33.19,,97,Immunoglobulin kappa variable 4-58,,,,4,17,3950000000,40.2%
A0A075B5M2,0.898958083,0.2524,0.960249527,-0.080166667,0.801632004,-0.264812057,0.224,0.377,,0.099,0.552,0.01,A0A075B5M2,NotFound,A0A075B5M2_NotFound,A0A075B5M2,Igkv4-61,1,6,2,1,A0A075B5M2|J3QNZ9|L7N239,MOUSE,10267.2,29.7,355,355.2,38.77,21.97,,94,Immunoglobulin kappa chain variable 4-61,,,,1,6,142000000,18.0%
A0A075B6D5,0.902789601,0.8802,0.922683639,-0.1805,0.808596088,-0.255503657,0.87,1.107,,-0.414,1.833,1.005,A0A075B6D5,NotFound,A0A075B6D5_NotFound,A0A075B6D5,Igkv19-93,1,11,5,5,A0A075B6D5,MOUSE,12905.5,42.1,356,356.1,49.96,49.96,,114,Immunoglobulin kappa chain variable 19-93,,,,5,11,809000000,42.1%
A0A0A6YXQ0,0.466509631,-0.141833333,6.127257137,0.289,0.243935095,1.290796038,-0.468,-0.231,-0.16,-0.115,0,0.123,A0A0A6YXQ0,NotFound,A0A0A6YXQ0_NotFound,A0A0A6YXQ0,Ighv8-8,1,21,4,4,A0A0A6YXQ0,MOUSE,13299,26,357,357.1,49.33,49.33,,119,Immunoglobulin heavy variable 8-8 (Fragment),,,,4,21,3540000000,26.0%
G5E8D6,0.040323912,0.544833333,26.12427157,-1.197666667,0.002441028,-4.982837093,0.882,1.15,1.399,-0.008,-0.157,0.003,G5E8D6,Efemp2,G5E8D6_Efemp2,G5E8D6,Efemp2,1,15,4,4,G5E8D6|Q9WVJ9|E9Q3N9,MOUSE,53745,8.6,358,358.1,49.21,49.21,,462,EGF-containing fibulin-like extracellular matrix protein 2,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|,,calcium ion binding|,4,15,1920000000,8.6%
F8VQD7,0.604472528,0.1558,4.04428569,-0.278666667,0.394068237,-0.931322323,0.042,0.604,,0.105,0.061,-0.033,F8VQD7,Ptprg,F8VQD7_Ptprg,F8VQD7,Ptprg,1,11,6,6,F8VQD7|Q05909|D6RD11,MOUSE,162430.7,5.1,359,359.1,48.37,48.37,,1442,Receptor-type tyrosine-protein phosphatase gamma,extracellular exosome|,negative regulation of epithelial cell migration|peptidyl-tyrosine dephosphorylation|toxin transport|,protein tyrosine phosphatase activity|identical protein binding|,6,11,344000000,5.1%
P35454,0.594937809,0.214166667,4.213009244,-0.342333333,0.379052247,-0.949279581,1.07,-0.178,0.264,0.094,0.016,0.019,P35454,Oxt,P35454_Oxt,P35454,Oxt,1,8,3,3,P35454|P35455,MOUSE,13934.7,36.8,360,360.1,48.18,48.18,,125,Oxytocin-neurophysin 1,extracellular region|extracellular space|cytoplasm|cytosol|secretory granule|terminal bouton|,response to amphetamine|regulation of heart rate|maternal aggressive behavior|positive regulation of cytosolic calcium ion concentration|heart development|female pregnancy|memory|grooming behavior|response to mechanical stimulus|response to sucrose|positive regulation of norepinephrine secretion|response to activity|sleep|response to food|positive regulation of prostaglandin secretion|response to estradiol|response to retinoic acid|response to progesterone|response to prostaglandin E|social behavior|negative regulation of urine volume|positive regulation of renal sodium excretion|response to cocaine|hyperosmotic salinity response|maternal behavior|sperm ejaculation|eating behavior|drinking behavior|response to external biotic stimulus|response to peptide hormone|response to ether|negative regulation of blood pressure|positive regulation of blood pressure|positive regulation of ossification|positive regulation of female receptivity|positive regulation of synaptic transmission|response to glucocorticoid|response to cAMP|response to electrical stimulus|regulation of sensory perception of pain|positive regulation of synapse assembly|male mating behavior|positive regulation of penile erection|positive regulation of hindgut contraction|negative regulation of gastric acid secretion|positive regulation of uterine smooth muscle contraction|,neurohypophyseal hormone activity|oxytocin receptor binding|,3,8,32000000,36.8%
A0A075B5R1,0.344837187,0.012833333,8.598206277,0.584333333,0.138095451,1.70954845,-0.159,0.039,-0.718,0.074,0.806,0.035,A0A075B5R1,NotFound,A0A075B5R1_NotFound,A0A075B5R1,Ighv5-17,1,10,3,2,A0A075B5R1|P18529|P18527,MOUSE,13075.8,35,361,361.1,48.09,33.47,,117,Immunoglobulin heavy variable 5-17 (Fragment),,,,4,10,670000000,35.0%
P18528,0.898438274,0.3024,0.982599818,0.1315,0.797517127,0.270557151,0.587,-0.14,,0.027,1.079,-0.041,P18528,NotFound,P18528_NotFound,P18528,,1,5,3,1,P18528,MOUSE,11121.3,35.7,361,361.2,43.71,22.25,,98,Ig heavy chain V region 6.96,,,antigen binding|,1,5,460000000,18.3%
A0A075B5P9,0.565439223,0.0252,4.689143273,0.451166667,0.339692277,1.054758851,-0.583,0.092,,-0.108,0.785,-0.06,A0A075B5P9,NotFound,A0A075B5P9_NotFound,A0A075B5P9,Ighv5-4,1,5,3,1,A0A075B5P9,MOUSE,13135.8,23.9,361,361.3,38.33,16.87,,117,Immunoglobulin heavy variable 5-4 (Fragment),,,,1,5,55400000,9.4%
P18526,0.789930378,0.606833333,2.038954356,-0.408333333,0.625323233,-0.514654846,0.467,-0.483,2.449,-0.308,0.888,0.628,P18526,NotFound,P18526_NotFound,P18526,,1,6,3,2,P18526|A0A075B5Q0,MOUSE,13072.8,23.9,361,361.4,36.05,19.08,,117,Ig heavy chain V region 345,,,antigen binding|,2,6,246000000,9.4%
A0A075B5Q4,0.985191588,0.15825,0.1722845,-0.022333333,0.961106579,-0.051851269,,0.175,,0.329,-0.202,0.331,A0A075B5Q4,NotFound,A0A075B5Q4_NotFound,A0A075B5Q4,Ighv5-12,1,1,3,1,A0A075B5Q4|P18525|A0A075B5Q9,MOUSE,13246,28.2,361,361.5,29.04,7.58,,117,Immunoglobulin heavy variable 5-12 (Fragment),,,,1,1,6370000,13.6%
P10126,0.198868004,0.1902,14.02432138,-1.318,0.039588392,-2.762817016,0.294,1.668,,-0.226,-0.531,-0.254,P10126,Eef1a1,P10126_Eef1a1,P10126,Eef1a1,1,11,4,4,P10126|P62631,MOUSE,50455.3,8.4,362,362.1,47.83,47.83,,462,Elongation factor 1-alpha 1,extracellular space|nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|membrane|cortical actin cytoskeleton|ruffle membrane|myelin sheath|extracellular exosome|,translational elongation|cellular response to epidermal growth factor stimulus|,tRNA binding|translation elongation factor activity|GTPase activity|protein binding|GTP binding|protein kinase binding|poly(A) RNA binding|,4,11,519000000,8.4%
P15116,0.364618865,-0.395,8.139473017,0.860666667,0.153480321,1.633142192,-0.43,-0.048,-1.998,0.047,0.026,0.033,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,10,4,4,P15116|D3YYT0,MOUSE,100251,6.4,363,363.1,47.34,47.34,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,4,10,187000000,6.4%
A0A0B4J1J6,0.434226419,-0.0968,6.640356096,0.427,0.216752637,1.41125031,-0.24,-0.466,,-0.219,0.334,0.107,A0A0B4J1J6,NotFound,A0A0B4J1J6_NotFound,A0A0B4J1J6,Ighv10-1,1,15,4,4,A0A0B4J1J6,MOUSE,13720.5,35.2,364,364.1,47.31,47.31,,119,Immunoglobulin heavy variable 10-1 (Fragment),,,,4,15,1080000000,35.2%
P12382,0.743445116,-0.141,2.46502951,0.165,0.56688772,0.612286361,-0.084,-0.396,,-0.139,-0.116,0.03,P12382,Pfkl,P12382_Pfkl,P12382,Pfkl,1,10,5,3,P12382|Q9WUA3-2,MOUSE,86157.1,9.3,365,365.1,46.98,29.73,,780,"ATP-dependent 6-phosphofructokinase, liver type",cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,"fructose 6-phosphate metabolic process|glycolytic process|response to glucose|fructose 1,6-bisphosphate metabolic process|negative regulation of insulin secretion|carbohydrate phosphorylation|protein oligomerization|protein homotetramerization|",6-phosphofructokinase activity|ATP binding|kinase binding|identical protein binding|metal ion binding|fructose binding|fructose-6-phosphate binding|6-phosphofructokinase activity|,5,10,295000000,9.3%
P47857-3,0.519886187,-0.031,5.30178433,-0.762666667,0.294999695,-1.147919556,-0.142,1.828,-0.635,-0.186,-0.763,-0.288,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,4,3,2,P47857-3|P47857-2|P47857,MOUSE,103523.5,3.6,365,365.2,26.51,14.91,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,2,4,9120000,2.6%
Q8C605,0.415969236,-0.1515,7.070879767,0.552666667,0.196296259,1.545625186,,-0.566,,0.065,-0.1,-0.005,Q8C605,Pfkp,Q8C605_Pfkp,Q8C605,Pfkp,1,1,3,1,Q8C605|Q9WUA3,MOUSE,86686.7,5.1,365,365.3,23.86,6.61,,784,ATP-dependent 6-phosphofructokinase,nucleus|cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,fructose 6-phosphate metabolic process|glycolytic process|carbohydrate phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,6-phosphofructokinase activity|ATP binding|protein complex binding|metal ion binding|,1,1,2660000,1.5%
Q91W90,0.023763838,-0.6652,30.26597669,1.788833333,0.000940594,6.905575132,-1.85,-1.627,,-0.01,0.11,0.051,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,8,3,3,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,10,366,366.1,46.83,46.83,,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,3,8,1920000000,10.0%
Q8CF98,0.914305201,0.113666667,0.840330913,-0.104666667,0.824075322,-0.232210905,-0.196,-0.44,1.134,-0.015,0.2,-0.001,Q8CF98,Colec10,Q8CF98_Colec10,Q8CF98,Colec10,1,16,4,4,Q8CF98,MOUSE,30922.6,15.1,367,367.1,46.6,46.6,,277,Collectin-10,extracellular region|collagen trimer|nucleus|cytoplasm|cytosol|,defense response|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|embryo development|,mannose binding|,4,16,476000000,15.1%
Q9EPL0,0.518220351,0.149166667,5.364632391,-0.409,0.290761406,-1.158045935,0.122,1.012,-0.073,-0.006,-0.285,0.125,Q9EPL0,Xylt2,Q9EPL0_Xylt2,Q9EPL0,Xylt2,1,5,5,5,Q9EPL0|F2Z436,MOUSE,97608.3,7.2,368,368.1,46.03,46.03,,865,Xylosyltransferase 2,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|heparin biosynthetic process|,acetylglucosaminyltransferase activity|protein xylosyltransferase activity|,5,5,27200000,7.2%
P01655,0.717931807,0.281666667,2.676650179,-0.240666667,0.539926921,-0.649648264,0.9,0.627,-0.321,0.059,0.34,0.085,P01655,NotFound,P01655_NotFound,P01655,,1,15,3,1,P01655|P01654|P01656|A0A075B5P0|P01659|P01667|P01672|P01669|P01671|P01673,MOUSE,12168.4,51.7,369,369.1,45.96,12.77,,112,Ig kappa chain V-III region PC 7132,,,antigen binding|,4,15,712000000,51.7%
P01660,0.96539578,0.341,0.40748508,-0.051666667,0.910440339,-0.118278091,0.529,0.215,,-0.301,0.906,0.356,P01660,NotFound,P01660_NotFound,P01660,,1,6,3,1,P01660|A0A140T8M6,MOUSE,12213.3,31.5,369,369.2,43.8,17.68,,111,Ig kappa chain V-III region PC 3741/TEPC 111,,,antigen binding|,1,6,1020000000,9.9%
P03977,0.769532427,0.64025,2.252551214,0.560333333,0.595312331,0.576770927,0.22,,,-0.236,1.957,0.62,P03977,NotFound,P03977_NotFound,P03977,,1,1,3,1,P03977,MOUSE,12156.3,39.6,369,369.3,39.55,6.36,,111,Ig kappa chain V-III region 50S10.1,,,antigen binding|,1,1,1760000000,9.9%
A0A075B5N9,0.396390804,-0.145,7.392724975,0.415833333,0.182275166,1.5458808,-0.46,-0.329,,0.205,-0.119,-0.022,A0A075B5N9,NotFound,A0A075B5N9_NotFound,A0A075B5N9,Igkv3-7,1,3,2,1,A0A075B5N9|P01674,MOUSE,10969.9,29.2,369,369.4,35.71,16.12,,99,Immunoglobulin kappa variable 3-7,,,,1,3,172000000,12.1%
P01657,0.25387955,-0.2404,11.54617097,0.949333333,0.070045929,2.29527929,-1.252,-0.368,,-0.201,0.529,0.09,P01657,NotFound,P01657_NotFound,P01657,,1,2,2,1,P01657,MOUSE,12063.3,23.4,369,369.5,32.66,13.07,,111,Ig kappa chain V-III region PC 2413,,,antigen binding|,1,2,111000000,8.1%
P01665,0.171155781,0.260833333,15.60722504,-0.985,0.027496505,-2.893532161,0.414,1.337,0.509,-0.474,-0.302,0.081,P01665,NotFound,P01665_NotFound,P01665,,1,3,2,1,P01665|P01664|P01666|P01668|A0A140T8Q0|A0A140T8Q4,MOUSE,12116.1,29.7,369,369.6,29.88,10.29,,111,Ig kappa chain V-III region PC 7043,,,antigen binding|,1,3,139000000,14.4%
A0A075B5M1,0.893440333,0.253666667,1.044058141,-0.094,0.786310701,-0.283459919,-0.179,0.315,0.766,0.534,0.132,-0.046,A0A075B5M1,NotFound,A0A075B5M1_NotFound,A0A075B5M1,Igkv4-63,1,13,4,4,A0A075B5M1,MOUSE,10271.2,41,370,370.1,45.88,45.88,,95,Immunoglobulin kappa variable 4-63,,,,4,13,1130000000,41.0%
Q8K2I4,0.993516919,-0.074333333,0.068883363,0.008666667,0.984264142,0.020557058,0.727,-0.122,-0.841,-0.105,-0.074,-0.031,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,6,4,4,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,5.6,371,371.1,44.29,44.29,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,4,6,59900000,5.6%
Q05144,0.898958083,-0.077,0.963211919,0.095,0.801085384,0.265616275,0.311,-0.579,,-0.083,-0.048,0.014,Q05144,Rac2,Q05144_Rac2,Q05144,Rac2,1,7,4,4,Q05144|Q3TLP8|P63001|P60764,MOUSE,21839.8,23.9,372,372.1,44.21,44.21,,192,Ras-related C3 botulinum toxin substrate 2,nuclear envelope|cytoplasm|cytosol|focal adhesion|membrane|lamellipodium|extracellular exosome|actin filament|,chemotaxis|actin filament organization|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|positive regulation of cell proliferation|positive regulation of lamellipodium assembly|regulation of cell-substrate adhesion|cell projection assembly|actin cytoskeleton organization|regulation of T cell proliferation|regulation of mast cell degranulation|bone resorption|regulation of protein kinase activity|regulation of respiratory burst|regulation of mast cell chemotaxis|lymphocyte aggregation|positive regulation of neutrophil chemotaxis|regulation of neutrophil migration|positive regulation of protein targeting to mitochondrion|,GTPase activity|GTP binding|protein kinase regulator activity|,4,7,2230000000,23.9%
Q9EQI5,0.819375851,0.2478,1.753759077,0.179666667,0.667765676,0.45554929,0.219,0.061,,0.856,-0.197,0.3,Q9EQI5,Ppbp,Q9EQI5_Ppbp,Q9EQI5,Ppbp,1,17,3,3,Q9EQI5,MOUSE,12593.7,20.3,373,373.1,44.12,44.12,,113,"Chemokine (C-X-C motif) ligand 7, isoform CRA_b",extracellular space|cell|,leukocyte migration involved in inflammatory response|positive regulation of leukocyte chemotaxis|inflammatory response|immune response|G-protein coupled receptor signaling pathway|neutrophil chemotaxis|response to lipopolysaccharide|regulation of cell proliferation|neutrophil degranulation|chemokine-mediated signaling pathway|,chemokine activity|CXCR chemokine receptor binding|,3,17,15000000000,20.3%
P07356,0.307230802,0.1125,9.957215347,-2.093666667,0.100990022,-1.938547714,3.214,1.494,-1.23,-1.025,-0.961,-0.817,P07356,Anxa2,P07356_Anxa2,P07356,Anxa2,1,5,3,3,P07356,MOUSE,38960.8,10.6,374,374.1,44.01,44.01,,339,Annexin A2,ruffle|basement membrane|extracellular space|nucleus|cytoplasm|lysosomal membrane|endosome|early endosome|lipid particle|cytosol|plasma membrane|cell cortex|cell surface|membrane|basolateral plasma membrane|extrinsic component of plasma membrane|midbody|late endosome membrane|vesicle|myelin sheath adaxonal region|sarcolemma|melanosome|Schmidt-Lanterman incisure|macropinosome|perinuclear region of cytoplasm|extracellular exosome|PCSK9-AnxA2 complex|membrane raft|,angiogenesis|membrane raft assembly|positive regulation of protein phosphorylation|negative regulation of receptor internalization|membrane budding|body fluid secretion|collagen fibril organization|positive regulation of vesicle fusion|negative regulation of low-density lipoprotein particle receptor catabolic process|osteoclast development|fibrinolysis|negative regulation of catalytic activity|positive regulation of fibroblast proliferation|positive regulation of binding|protein heterotetramerization|protein targeting to plasma membrane|negative regulation of receptor binding|positive regulation of receptor activity|,"calcium ion binding|protein binding|calcium-dependent phospholipid binding|phosphatidylinositol-4,5-bisphosphate binding|cytoskeletal protein binding|Rab GTPase binding|phospholipase A2 inhibitor activity|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|receptor activator activity|",3,5,156000000,10.6%
P10854,0.031812923,0.913666667,28.27590377,-3.412666667,0.001487338,-5.545107932,1.894,4.034,1.932,-0.748,-0.924,-0.706,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,18,5,5,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|P70696|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0,MOUSE,13935.9,31.7,375,375.1,43.45,43.45,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,18,6320000000,31.7%
Q61592,0.838945551,-0.0738,1.499213819,0.1045,0.708073952,0.396321355,0,-0.273,,0.026,-0.108,-0.014,Q61592,Gas6,Q61592_Gas6,Q61592,Gas6,1,6,5,5,Q61592,MOUSE,76548.1,8.3,376,376.1,43.45,43.45,,674,Growth arrest-specific protein 6,extracellular space|cytoplasm|extracellular exosome|,"neuron migration|positive regulation of protein phosphorylation|positive regulation of cytokine-mediated signaling pathway|positive regulation of glomerular filtration|protein phosphorylation|phagocytosis|signal transduction|enzyme linked receptor protein signaling pathway|blood coagulation|cellular response to starvation|positive regulation of gene expression|negative regulation of tumor necrosis factor-mediated signaling pathway|macrophage cytokine production|peptidyl-serine phosphorylation|fusion of virus membrane with host plasma membrane|viral genome replication|organ regeneration|cell-substrate adhesion|positive regulation of TOR signaling|activation of protein kinase B activity|negative regulation of interferon-gamma production|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|positive regulation of natural killer cell differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein import into nucleus, translocation|cellular response to interferon-alpha|cellular response to drug|B cell chemotaxis|regulation of growth|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|apoptotic cell clearance|negative regulation of sequence-specific DNA binding transcription factor activity|protein kinase B signaling|positive regulation of protein kinase activity|negative regulation of transcription, DNA-templated|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of protein export from nucleus|positive regulation of fibroblast proliferation|negative regulation of interleukin-1 secretion|positive regulation of phagocytosis|positive regulation of protein kinase B signaling|positive regulation of protein tyrosine kinase activity|negative regulation of biomineral tissue development|positive regulation of ERK1 and ERK2 cascade|calcium ion transmembrane transport|cellular response to vitamin K|cellular response to glucose stimulus|cellular response to growth factor stimulus|protein targeting to plasma membrane|extracellular matrix assembly|dendritic cell differentiation|hematopoietic stem cell migration to bone marrow|negative regulation of oligodendrocyte apoptotic process|negative regulation of interleukin-6 secretion|negative regulation of fibroblast apoptotic process|negative regulation of endothelial cell apoptotic process|positive regulation of dendritic cell chemotaxis|negative regulation of renal albumin absorption|negative regulation of dendritic cell apoptotic process|","phosphatidylserine binding|receptor binding|voltage-gated calcium channel activity|calcium ion binding|protein tyrosine kinase activator activity|receptor tyrosine kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor agonist activity|binding, bridging|",5,6,86300000,8.3%
A0A075B5W3,0.337209389,0.0974,8.881200501,0.788166667,0.129383814,1.813194143,-0.418,-0.333,,-0.141,1.08,0.299,A0A075B5W3,NotFound,A0A075B5W3_NotFound,A0A075B5W3,Ighv1-53,1,12,3,3,A0A075B5W3,MOUSE,12962.4,32.4,377,377.1,41.66,41.66,,117,Immunoglobulin heavy variable 1-53 (Fragment),,,,3,12,5480000000,32.4%
H7BWY6,0.938800452,-0.022,0.682131206,0.178,0.85464721,0.191295377,1.159,0.8,-2.292,0.394,-0.194,0.001,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,7,4,4,H7BWY6|Q00724,MOUSE,28746.7,12.6,378,378.1,41.44,41.44,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,4,7,728000000,12.6%
P02666,0.284070507,0.260666667,10.54379109,-1.898,0.088230937,-2.036303611,0.462,-0.225,3.392,-0.606,-0.642,-0.817,P02666,NotFound,P02666_NotFound,P02666,CSN2,1,10,3,3,P02666,BOVIN,25163.9,14.7,379,379.1,40.96,40.96,,224,Beta-casein,,,,3,10,750000000,14.7%
P97333,0.259510246,0.702166667,11.37605312,-1.841666667,0.072844151,-2.175391368,0.281,1.016,3.572,-0.092,-0.447,-0.117,P97333,Nrp1,P97333_Nrp1,P97333,Nrp1,1,11,5,5,P97333,MOUSE,104253.4,6.5,380,380.1,40.68,40.68,,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,5,11,73200000,6.5%
P00974,0.001763822,0.936666667,56.8753841,-5.310666667,2.05334E-06,-17.53770877,4.025,3.199,3.552,-1.917,-1.785,-1.454,P00974,NotFound,P00974_NotFound,P00974,,1,27,3,3,P00974,BOVIN,11359,26,381,381.1,40.62,40.62,,100,Pancreatic trypsin inhibitor,,,,3,27,3.53E+11,26.0%
Q80W65,0.830947352,-0.091833333,1.584586944,-0.310333333,0.694290632,-0.41266662,0.211,1.504,-1.525,-0.144,-0.471,-0.126,Q80W65,Pcsk9,Q80W65_Pcsk9,Q80W65,Pcsk9,1,5,4,4,Q80W65,MOUSE,76419.3,6.9,382,382.1,40.36,40.36,,694,Proprotein convertase subtilisin/kexin type 9,extracellular region|extracellular space|cytoplasm|lysosome|early endosome|late endosome|endoplasmic reticulum|endoplasmic reticulum lumen|rough endoplasmic reticulum|Golgi apparatus|plasma membrane|cell surface|ER to Golgi transport vesicle|perinuclear region of cytoplasm|PCSK9-LDLR complex|PCSK9-AnxA2 complex|,kidney development|liver development|negative regulation of receptor recycling|positive regulation of receptor internalization|triglyceride metabolic process|phospholipid metabolic process|apoptotic process|lysosomal transport|cholesterol metabolic process|cellular response to starvation|regulation of receptor activity|negative regulation of low-density lipoprotein particle clearance|protein autoprocessing|neurogenesis|neuron differentiation|low-density lipoprotein receptor particle metabolic process|low-density lipoprotein particle receptor catabolic process|regulation of low-density lipoprotein particle receptor catabolic process|positive regulation of low-density lipoprotein particle receptor catabolic process|cellular response to insulin stimulus|lipoprotein metabolic process|cholesterol homeostasis|regulation of neuron apoptotic process|positive regulation of neuron apoptotic process|negative regulation of receptor activity|negative regulation of sodium ion transmembrane transporter activity|,serine-type endopeptidase activity|sodium channel inhibitor activity|low-density lipoprotein particle binding|receptor inhibitor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|apolipoprotein receptor binding|protein self-association|poly(A) RNA binding|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,4,5,136000000,6.9%
A2AVA0,0.489116217,-0.1124,5.71560194,0.365166667,0.268188287,1.243937892,-0.343,-0.32,,-0.126,-0.12,0.347,A2AVA0,Svep1,A2AVA0_Svep1,A2AVA0,Svep1,1,6,6,6,A2AVA0,MOUSE,402170.3,1.5,383,383.1,40.2,40.2,,3567,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1",extracellular region|cytoplasm|membrane|,cell adhesion|,chromatin binding|calcium ion binding|,6,6,304000000,1.5%
Q9Z222,0.194225825,-0.2002,14.25578102,0.717166667,0.037533745,2.801791811,-0.698,-0.563,,0.152,0.113,-0.005,Q9Z222,B3gnt2,Q9Z222_B3gnt2,Q9Z222,B3GNT2,1,7,4,4,Q9Z222,MOUSE,46281.5,9.5,384,384.1,40.07,40.07,,397,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2",Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|sensory perception of smell|poly-N-acetyllactosamine biosynthetic process|,"galactosyltransferase activity|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",4,7,265000000,9.5%
A0A0B4J1I8,0.294065232,0.164666667,10.2801739,0.771333333,0.093752447,1.988907649,-0.155,-0.27,-0.238,-0.252,1.04,0.863,A0A0B4J1I8,NotFound,A0A0B4J1I8_NotFound,A0A0B4J1I8,Igkv4-59,1,21,4,4,A0A0B4J1I8|P04944|P04940|P04941|A0A0B4J1I5|P04942|P04943|P70670|Q9JKC6|A0N8I8,MOUSE,12784.1,18.8,385,385.1,39.6,39.6,,117,Immunoglobulin kappa variable 4-59 (Fragment),,,,4,21,13600000000,18.8%
A0A075B5R0,0.891021159,0.0665,1.071112119,-0.085,0.781427675,-0.290107426,0.345,0.336,-0.354,-0.189,0.045,0.216,A0A075B5R0,NotFound,A0A075B5R0_NotFound,A0A075B5R0,Ighv5-16,1,8,3,3,A0A075B5R0,MOUSE,13388.1,32.7,386,386.1,39.39,39.39,,116,Immunoglobulin heavy variable 5-16,,,,3,8,338000000,32.7%
P16014,0.771519896,0.193666667,2.225923389,-0.501333333,0.598973572,-0.555193869,1.339,1.669,-1.675,0.11,-0.358,0.077,P16014,Chgb,P16014_Chgb,P16014,Chgb,1,10,5,5,P16014,MOUSE,78081.7,6.9,387,387.1,39.08,39.08,,677,Secretogranin-1,extracellular region|secretory granule|,,protein binding|,5,10,86900000,6.9%
A2ASS6,0.338116008,-1.125666667,8.807024946,2.222666667,0.131612611,1.746864737,-0.667,-0.747,-5.297,-0.195,0.001,0.151,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,19,7,7,A2ASS6|E9Q8K5|E9Q8N1|A2ASS6-2,MOUSE,3935740.7,0.2,388,388.1,38.81,38.81,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,7,19,1.33E+11,0.2%
P35822,0.230974077,-0.2442,12.46866357,0.622166667,0.056641356,2.462023727,-0.555,-0.68,,-0.042,0.054,0.002,P35822,Ptprk,P35822_Ptprk,P35822,Ptprk,1,8,5,5,A0A1W2P7Y1|P35822|B2RRF0,MOUSE,166179.6,2.7,389,389.1,38.55,38.55,,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,5,8,269000000,2.7%
A0A075B677,0.362133072,-0.0832,8.273502701,0.772166667,0.148816035,1.704700073,-1.165,0.072,,0.338,0.372,-0.033,A0A075B677,NotFound,A0A075B677_NotFound,A0A075B677,Igkv4-53,1,12,2,2,A0A075B677,MOUSE,10480.4,40.2,390,390.1,38.53,38.53,,97,Immunoglobulin kappa variable 4-53,,,,2,12,443000000,40.2%
A0A075B5T7,0.717931807,0.501,2.670056883,-0.429333333,0.54074724,-0.648648615,-0.132,0.216,2.063,-0.177,0.993,0.043,A0A075B5T7,NotFound,A0A075B5T7_NotFound,A0A075B5T7,Ighv1-7,1,8,3,3,A0A075B5T7|A0A075B5T4,MOUSE,13273.8,29,391,391.1,38.29,38.29,,117,Immunoglobulin heavy variable V1-7 (Fragment),,,,3,8,2920000000,29.0%
A0A075B5U0,0.519886187,0.0228,5.296650629,0.374666667,0.295348614,1.167099063,-0.327,-0.077,,-0.19,0.457,0.251,A0A075B5U0,NotFound,A0A075B5U0_NotFound,A0A075B5U0,Ighv1-12,1,8,3,3,A0A075B5U0,MOUSE,10892,34.6,392,392.1,37.64,37.64,,98,Immunoglobulin heavy variable V1-12,,,,3,8,5410000000,34.6%
P01634,0.492546314,-0.038666667,5.666849497,0.471333333,0.27121584,1.211320655,-0.641,-0.203,0.021,-0.243,-0.073,0.907,P01634,NotFound,P01634_NotFound,P01634,,1,12,4,4,P01634|A0A140T8P2|A0A075B5N2|A0A075B5N1|P01632,MOUSE,15072.8,22.7,393,393.1,37.3,37.3,,136,Ig kappa chain V-V region MOPC 21,,,antigen binding|,4,12,3050000000,22.7%
A0A075B5Q6,0.395475391,0.536,7.413774782,-0.984666667,0.181393835,-1.512990912,0.046,0.59,2.449,-0.308,0.401,0.038,A0A075B5Q6,NotFound,A0A075B5Q6_NotFound,A0A075B5Q6,Ighv5-9-1,1,7,3,3,A0A075B5Q6,MOUSE,13238,28.4,394,394.1,37.2,37.2,,116,Immunoglobulin heavy variable 5-9-1,,,,3,7,357000000,28.4%
P70194,0.830947352,0.0166,1.582663037,-0.109833333,0.694598268,-0.415874736,0.002,0.163,,-0.158,0.107,-0.031,P70194,Clec4f,P70194_Clec4f,P70194,Clec4f,1,6,3,3,P70194|A0A0R4IZZ5,MOUSE,61667,6,395,395.1,36.83,36.83,,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,3,6,842000000,6.0%
A0A075B697,0.282199497,-0.0966,10.66796421,0.834,0.085743968,2.134706249,-0.824,-0.37,,-0.141,0.767,0.085,A0A075B697,NotFound,A0A075B697_NotFound,A0A075B697,Ighv2-9-1,1,28,3,1,A0A075B697|P01820|P01819|A0A075B5Q1|P01821|A0A075B6A7|A0A075B696|A0A075B5Q7,MOUSE,12709.4,22.4,396,396.1,36.55,17.88,,116,Immunoglobulin heavy variable 2-9-1 (Fragment),,,,4,28,17100000000,22.4%
A0A075B5P8,0.769532427,-0.300333333,2.262507245,0.515333333,0.593949164,0.563038185,0.954,0.04,-2.668,0.049,-0.187,0.01,A0A075B5P8,NotFound,A0A075B5P8_NotFound,A0A075B5P8,Ighv2-2,1,2,3,1,A0A075B5P8,MOUSE,12806.4,26.7,396,396.2,33.4,13.94,,116,Immunoglobulin heavy variable 2-2 (Fragment),,,,1,2,82900000,13.7%
A0A075B5Q5,0.693022361,-0.0182,2.987578692,-0.315333333,0.502622737,-0.721881672,-0.416,0.758,,-0.378,-0.093,0.038,A0A075B5Q5,NotFound,A0A075B5Q5_NotFound,A0A075B5Q5,Ighv2-9,1,1,3,1,A0A075B5Q5,MOUSE,12705.5,26.7,396,396.3,29.43,10.76,,116,Immunoglobulin heavy variable 2-9 (Fragment),,,,1,1,12200000,13.7%
O35452,0.177690852,0.311833333,15.28841543,-1.065,0.029590919,-2.837537162,0.938,1.462,0.133,-0.283,-0.2,-0.179,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,11,4,4,O35452|E9Q2T3,MOUSE,442488.3,1.1,397,397.1,36.46,36.46,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,4,11,77400000,1.1%
Q91V80,0.898438274,-0.034833333,0.974115602,0.087666667,0.799076649,0.266039902,-0.21,0.512,-0.538,-0.141,0.082,0.086,Q91V80,Apof,Q91V80_Apof,Q91V80,Apof,1,6,2,2,A0A0R4J0M4|Q91V80,MOUSE,34701.1,10.1,398,398.1,36.15,36.15,,315,Apolipoprotein F,low-density lipoprotein particle|high-density lipoprotein particle|,triglyceride metabolic process|cholesterol metabolic process|cholesterol efflux|,,2,6,277000000,10.1%
P63158,0.002698007,0.8775,50.25828832,-3.225,9.42261E-06,-13.55390301,2.726,2.26,2.484,-0.851,-0.749,-0.605,P63158,Hmgb1,P63158_Hmgb1,P63158,Hmgb1,1,10,4,4,P63158|A0A0J9YUD8|P30681,MOUSE,25064.5,12.5,399,399.1,35.82,35.82,,215,High mobility group protein B1,condensed chromosome|extracellular region|extracellular space|nucleus|cytoplasm|cell surface|transcriptional repressor complex|,"inflammatory response to antigenic stimulus|base-excision repair, DNA ligation|inflammatory response|negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|DNA geometric change|V(D)J recombination|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of DNA binding|negative regulation of blood vessel endothelial cell migration|positive regulation of transcription from RNA polymerase II promoter|negative regulation of apoptotic cell clearance|","four-way junction DNA binding|bubble DNA binding|phosphatidylserine binding|sequence-specific DNA binding transcription factor activity|cytokine activity|protein binding|heparin binding|DNA binding, bending|poly(A) RNA binding|repressing transcription factor binding|supercoiled DNA binding|",4,10,537000000,12.5%
Q8K1I3,0.009081837,0.7795,37.87906654,-2.433,0.000162965,-8.266583897,2.238,2.226,1.524,-0.255,-0.645,-0.411,Q8K1I3,Spp2,Q8K1I3_Spp2,Q8K1I3,Spp2,1,10,3,3,Q8K1I3,MOUSE,23421,14.2,400,400.1,35.69,35.69,,203,Secreted phosphoprotein 24,extracellular exosome|,bone remodeling|,,3,10,588000000,14.2%
A0A0B4J1I1,0.237373291,-0.312833333,11.96833477,0.738333333,0.063557459,2.269090607,-0.763,-0.17,-1.113,-0.229,0.129,0.269,A0A0B4J1I1,NotFound,A0A0B4J1I1_NotFound,A0A0B4J1I1,Igkv16-104,1,11,2,2,A0A0B4J1I1,MOUSE,13045.5,23.2,401,401.1,34.94,34.94,,116,Immunoglobulin kappa variable 16-104 (Fragment),,,,2,11,1240000000,23.2%
P10107,0.519886187,0.732666667,5.29812879,-0.784,0.295248106,-1.147269259,1.373,1.755,0.246,0.104,-0.659,1.577,P10107,Anxa1,P10107_Anxa1,P10107,Anxa1,1,4,4,4,P10107,MOUSE,39018.9,12.7,402,402.1,34.86,34.86,,346,Annexin A1,cornified envelope|extracellular space|nucleus|cytoplasm|endosome|cytosol|plasma membrane|focal adhesion|cilium|cell surface|basolateral plasma membrane|mitochondrial membrane|vesicle|sarcolemma|mast cell granule|protein complex|extracellular exosome|,DNA strand renaturation|neutrophil homeostasis|signal transduction|cell surface receptor signaling pathway|response to X-ray|myoblast migration involved in skeletal muscle regeneration|peptide cross-linking|insulin secretion|keratinocyte differentiation|prostate gland development|endocrine pancreas development|positive regulation of vesicle fusion|positive regulation of prostaglandin biosynthetic process|response to estradiol|DNA duplex unwinding|positive regulation of neutrophil apoptotic process|DNA rewinding|gliogenesis|regulation of cell proliferation|response to drug|response to peptide hormone|estrous cycle|alpha-beta T cell differentiation|arachidonic acid secretion|cellular response to hydrogen peroxide|hepatocyte differentiation|prolactin secretion|response to interleukin-1|cellular response to glucocorticoid stimulus|neutrophil clearance|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of phospholipase A2 activity|negative regulation of interleukin-8 secretion|,"single-stranded DNA binding|single-stranded RNA binding|helicase activity|structural molecule activity|calcium ion binding|protein binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding, bridging|double-stranded DNA-dependent ATPase activity|annealing helicase activity|protein homodimerization activity|calcium-dependent protein binding|",4,4,40600000,12.7%
Q9EPK6,0.895801409,0.004,1.012597437,-0.097333333,0.792027491,-0.275673221,0.648,-0.533,0.043,-0.141,-0.146,0.153,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,5,4,4,Q9EPK6,MOUSE,52771.3,10.5,403,403.1,34.76,34.76,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,4,5,51200000,10.5%
A6H6E2,0.512822581,0.291,5.445981274,-0.41,0.285365767,-1.172438193,0.852,0.751,-0.115,0.072,-0.198,0.384,A6H6E2,Mmrn2,A6H6E2_Mmrn2,A6H6E2,Mmrn2,1,5,3,3,A6H6E2|A6H6E2-2,MOUSE,105832,4.2,404,404.1,34.61,34.61,,943,Multimerin-2,basement membrane|extracellular space|extracellular exosome|,negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|,,3,5,26700000,4.2%
P97350,0.044980087,0.9466,25.40610184,-4.2565,0.002879982,-5.459412518,2.386,4.615,,-0.222,-1.439,-0.607,P97350,Pkp1,P97350_Pkp1,P97350,Pkp1,1,6,4,4,P97350|A0A087WS37,MOUSE,82321.1,6.4,405,405.1,34.35,34.35,,728,Plakophilin-1,nucleus|nucleoplasm|plasma membrane|desmosome|intracellular membrane-bounded organelle|extracellular exosome|,single organismal cell-cell adhesion|intermediate filament bundle assembly|,protein binding|lamin binding|,4,6,128000000,6.4%
P09542,0.236055174,0.5406,12.04953783,-3.645666667,0.062380122,-2.395750911,0.14,5.316,,-0.801,-1.002,-0.95,P09542,Myl3,P09542_Myl3,P09542,Myl3,1,4,4,4,P09542|A0A0G2JDM3,MOUSE,22535.3,20,406,406.1,33.67,33.67,,204,Myosin light chain 3,myosin complex|A band|I band|,regulation of the force of heart contraction|regulation of striated muscle contraction|skeletal muscle tissue development|metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,motor activity|actin monomer binding|calcium ion binding|,4,4,418000000,20.0%
Q61495,0.049306582,0.7285,24.75127865,-2.947666667,0.003348668,-4.711665493,2.454,3.305,0.848,-0.795,-0.826,-0.615,Q61495,Dsg1a,Q61495_Dsg1a,Q61495,Dsg1a,1,8,5,5,Q61495|Q7TSF1|Q7TSF0,MOUSE,115622,3.9,407,407.1,33.67,33.67,,1057,Desmoglein-1-alpha,plasma membrane|cytoplasmic side of plasma membrane|integral component of membrane|desmosome|extracellular exosome|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|protein binding|gamma-catenin binding|,5,8,75600000,3.9%
P54818,0.599375367,0.226666667,4.096600747,-0.458666667,0.389349773,-0.927603401,0.133,-0.289,1.524,0.12,-0.147,0.019,P54818,Galc,P54818_Galc,P54818,Galc,1,7,4,4,P54818,MOUSE,77483.2,6.8,408,408.1,33.55,33.55,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,4,7,486000000,6.8%
Q9D0F3,0.595170996,-0.094333333,4.155942816,0.27,0.384065873,0.938257189,-0.117,0.071,-0.642,-0.141,0.296,-0.033,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,7,4,4,Q9D0F3,MOUSE,58073,6.7,409,409.1,33.45,33.45,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,4,7,316000000,6.7%
Q9Z0J1,0.826430946,-0.1125,1.63697063,0.172333333,0.685966547,0.424504439,0.421,0.002,-1.019,-0.115,0.086,-0.05,Q9Z0J1,Reck,Q9Z0J1_Reck,Q9Z0J1,Reck,1,7,4,4,Q9Z0J1,MOUSE,111101,4.1,410,410.1,33.08,33.08,,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,4,7,207000000,4.1%
D3YTY6,0.813232809,0.433,1.855590504,-0.48,0.652290344,-0.474122226,-0.589,-0.464,3.072,0.3,-0.128,0.407,D3YTY6,NotFound,D3YTY6_NotFound,D3YTY6,Gm6096,1,27,3,1,D3YTY6,MOUSE,17281.2,13.9,411,411.1,32.83,10.56,,151,Predicted gene 6096,ribosome|,translation|,structural constituent of ribosome|,3,27,5940000000,13.9%
P62751,0.098250515,0.597166667,20.00061415,-2.801666667,0.009998586,-3.718471497,1.447,1.006,3.541,-1.618,-0.236,-0.557,P62751,Rpl23a,P62751_Rpl23a,P62751,Rpl23a,1,1,3,1,A0A140T8M7|P62751,MOUSE,17694.7,13.4,411,411.2,26.46,4.19,,156,60S ribosomal protein L23a,nucleus|nucleolus|cytosolic large ribosomal subunit|extracellular exosome|TORC2 complex|,translation|cell proliferation|,nucleotide binding|structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,1,1,5390000,7.6%
Q6GSS7,0.039058573,0.783166667,26.58754962,-3.004333333,0.002194043,-5.134341569,2.012,3.469,1.375,-0.442,-1.233,-0.482,Q6GSS7,Hist2h2aa1,Q6GSS7_Hist2h2aa1,Q6GSS7,Hist2h2aa1,1,8,5,3,Q6GSS7|Q64523|Q8R1M2|A0A0N4SV66|P27661|Q8CGP5|Q8CGP7|C0HKE6|Q8BFU2|Q8CGP4|Q8CGP6|Q64522,MOUSE,14095.2,25.3,412,412.1,32.73,17.12,,130,Histone H2A type 2-A,nucleosome|nucleus|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,8,153000000,25.3%
P0C0S6,0.760232177,-0.526333333,2.335029808,0.702666667,0.584113198,0.578507078,0.549,0.614,-3.796,-0.353,-0.104,-0.068,P0C0S6,H2afz,P0C0S6_H2afz,P0C0S6,H2afz,1,1,3,1,P0C0S6|Q3THW5|Q3UA95|G3UWL7,MOUSE,13552.5,17.1,412,412.2,20.55,4.94,,128,Histone H2A.Z,nucleosome|nucleus|nuclear euchromatin|nuclear heterochromatin|extracellular exosome|Barr body|,multicellular organismal development|positive regulation of transcription from RNA polymerase II promoter|cellular response to estradiol stimulus|,RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|chromatin DNA binding|nucleosomal DNA binding|protein heterodimerization activity|,1,1,73100000,11.7%
Q9DC11,0.880399509,0.222833333,1.154117744,-0.247666667,0.766634264,-0.310669304,-0.839,-0.325,2.204,0.184,0.099,0.014,Q9DC11,Plxdc2,Q9DC11_Plxdc2,Q9DC11,Plxdc2,1,11,3,3,Q9DC11|B1AY85,MOUSE,60185.7,4.7,413,413.1,32.7,32.7,,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,,,3,11,231000000,4.7%
Q9CYA0,0.226931035,-0.3852,12.68469102,0.772166667,0.053892819,2.502399609,-1.15,-0.547,,-0.17,-0.09,0.031,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,5,2,2,Q9CYA0,MOUSE,40386.9,9.7,414,414.1,32.65,32.65,,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,2,5,31700000,9.7%
P27046,0.738097288,0.528833333,2.503018058,-0.754333333,0.561950671,-0.613939103,-1.256,0.242,3.732,0.204,0.241,0.01,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,3,2,2,P27046,MOUSE,132370.8,2.2,415,415.1,32.24,32.24,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",2,3,16800000,2.2%
Q8VCN3,0.709461512,-0.0072,2.78969987,0.198,0.526053619,0.680673248,-0.067,-0.185,,0.358,-0.136,-0.006,Q8VCN3,Ugt2b37,Q8VCN3_Ugt2b37,Q8VCN3,Ugt2b37,1,7,3,3,Q8VCN3|Q91WH2|Q8K169|P17717|Q8BJL9|Q8R084|Q3UEP4|K9J7B2|Q64435|E9PXN7|P70691|D3Z748|Q63886|B2RT14|Q62452|Q6ZQM8|D3YZE6,MOUSE,61328.4,6.6,416,416.1,31.42,31.42,,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,3,7,166000000,6.6%
A0A075B5N6,0.218388639,-0.0864,13.20605272,0.9335,0.04779635,2.603641571,-0.709,-0.584,,-0.219,0.62,0.46,A0A075B5N6,NotFound,A0A075B5N6_NotFound,A0A075B5N6,Igkv8-16,1,9,2,2,A0A075B5N6|A0A0G2JGT0,MOUSE,13623.3,15.8,417,417.1,31.23,31.23,,120,Immunoglobulin kappa variable 8-16,,,,2,9,2790000000,15.8%
Q05D44,0.08962435,0.789833333,20.90879104,-2.519,0.008111868,-3.898360009,2.449,0.631,3.068,-0.252,-0.794,-0.363,Q05D44,Eif5b,Q05D44_Eif5b,Q05D44,Eif5b,1,5,3,3,Q05D44,MOUSE,138069.9,3.6,418,418.1,31.12,31.12,,1216,Eukaryotic translation initiation factor 5B,cytoplasm|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,3,5,68300000000,3.6%
Q9CQ45,0.579921534,0.0216,4.448181862,0.297666667,0.359072226,1.008569589,-0.286,-0.028,,0.287,-0.142,0.277,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,5,3,3,Q9CQ45,MOUSE,18904.1,17.5,419,419.1,30.99,30.99,,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,3,5,67600000,17.5%
P10404,0.57889404,-0.1558,4.479384132,0.323666667,0.356501685,1.014483329,-0.042,-0.658,,-0.213,0.06,0.074,P10404,NotFound,P10404_NotFound,P10404,,1,6,2,2,P10404,MOUSE,70752.6,4,420,420.1,30.96,30.96,,641,MLV-related proviral Env polyprotein,plasma membrane|integral component of membrane|viral capsid|viral envelope|virion membrane|,viral life cycle|,metal ion binding|,2,6,120000000,4.0%
A0A075B5V5,0.859745677,0.3554,1.303914432,0.147333333,0.740642376,0.349887921,0.306,0.228,,0.249,1.069,-0.075,A0A075B5V5,NotFound,A0A075B5V5_NotFound,A0A075B5V5,Ighv1-39,1,4,3,3,A0A075B5V5,MOUSE,13044.4,35,421,421.1,30.93,30.93,,117,Immunoglobulin heavy variable 1-39 (Fragment),,,,3,4,1230000000,35.0%
P17742,0.687267675,-0.202333333,3.051765969,-1.5,0.495248767,-0.726194868,1.106,4.577,-4.04,-0.879,-1.277,-0.701,P17742,Ppia,P17742_Ppia,P17742,Ppia,1,4,4,4,P17742|A0A1L1SST0|F8VPN3,MOUSE,18142.2,17.6,422,422.1,30.78,30.78,,164,Peptidyl-prolyl cis-trans isomerase A,extracellular space|nucleus|cytosol|focal adhesion|membrane|myelin sheath|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|neuron differentiation|lipid particle organization|regulation of viral genome replication|positive regulation of viral genome replication|positive regulation of protein secretion|,peptidyl-prolyl cis-trans isomerase activity|peptide binding|poly(A) RNA binding|,4,4,41400000,17.6%
A0A0B4J1H6,0.326571299,-0.282833333,9.26613304,1.277,0.118409541,1.82343251,0.068,-0.432,-2.4,-0.225,0.885,0.407,A0A0B4J1H6,NotFound,A0A0B4J1H6_NotFound,A0A0B4J1H6,Igkv2-137,1,12,2,2,A0A0B4J1H6|P01630,MOUSE,13302,20,423,423.1,30.41,30.41,,120,Immunoglobulin kappa chain variable 2-137 (Fragment),,,,2,12,15800000000,20.0%
Q8BWP8,0.455589346,-0.09,6.260847458,0.415833333,0.236545807,1.342901161,-0.032,-0.647,,0.118,0.141,-0.03,Q8BWP8,B4gat1,Q8BWP8_B4gat1,Q8BWP8,B4gat1,1,5,4,4,Q8BWP8|Q8BWP8-2,MOUSE,47839.9,9.8,424,424.1,30.39,30.39,,415,"Beta-1,4-glucuronyltransferase 1",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|protein O-linked mannosylation|poly-N-acetyllactosamine biosynthetic process|,"glucuronosyltransferase activity|metal ion binding|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",4,5,86000000,9.8%
Q9DAU1,0.702114845,0.0142,2.877048698,0.221166667,0.515578894,0.698781262,0.17,-0.407,,0.031,0.309,-0.032,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,8,3,3,Q9DAU1|Q9DAU1-2,MOUSE,30936.7,10.1,425,425.1,30.38,30.38,,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,3,8,225000000,10.1%
A0A075B5W1,0.565439223,-0.111,4.692197865,0.4825,0.339453439,1.055333642,-1.017,0.216,,0.088,-0.175,0.333,A0A075B5W1,NotFound,A0A075B5W1_NotFound,A0A075B5W1,Ighv1-50,1,3,2,2,A0A075B5W1|A0A075B5X7,MOUSE,13048.5,26.4,426,426.1,30.21,30.21,,117,Immunoglobulin heavy variable 1-50 (Fragment),,,,2,3,624000000,26.4%
P97467,0.963890373,0.092833333,0.425015076,-0.054333333,0.906772817,-0.122133358,-0.683,0.054,0.989,0.063,0.146,-0.012,P97467,Pam,P97467_Pam,P97467,Pam,1,4,3,3,P97467|F8VQA4|E9Q704,MOUSE,109816.4,3.8,427,427.1,29.67,29.67,,979,Peptidyl-glycine alpha-amidating monooxygenase,cytosol|integral component of plasma membrane|membrane|transport vesicle membrane|extracellular exosome|,peptide amidation|peptide metabolic process|oxidation-reduction process|,peptidylglycine monooxygenase activity|peptidylamidoglycolate lyase activity|copper ion binding|zinc ion binding|L-ascorbic acid binding|,3,4,124000000,3.8%
P17182,0.307230802,0.088666667,9.947419736,-1.867333333,0.101218064,-1.936916128,1.678,2.585,-1.196,-0.746,-1.159,-0.63,P17182,Eno1,P17182_Eno1,P17182,Eno1,1,7,4,4,P17182,MOUSE,47482.3,6.9,428,428.1,29.62,29.62,,434,Alpha-enolase,phosphopyruvate hydratase complex|plasma membrane|myelin sheath|,glycolytic process|,magnesium ion binding|phosphopyruvate hydratase activity|,4,7,30900000000,6.9%
Q9QUK9,0.007983705,0.850666667,39.17845318,-2.879333333,0.000120824,-8.744848308,2.818,1.732,2.321,-0.639,-0.649,-0.479,Q9QUK9,Try5,Q9QUK9_Try5,Q9QUK9,Try5,1,7,3,3,Q9QUK9|Q9R0T7|Q9Z1R9|Q792Y9|Q792Z0|Q792Y8,MOUSE,26961,15.4,429,429.1,29.6,29.6,,246,MCG15083,extracellular space|extracellular exosome|,proteolysis|digestion|,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity|,3,7,385000000,15.4%
Q59IW6,0.039058573,0.3555,26.52080715,-1.137,0.002228021,-5.074323825,0.82,1.118,0.834,-0.313,-0.232,-0.094,Q59IW6,Abi3bp,Q59IW6_Abi3bp,Q59IW6,Abi3bp,1,7,3,3,Q59IW6|Q59IW5|Q59IW9|E9Q8E3,MOUSE,130163.5,2,430,430.1,29.4,29.4,,1179,"ABI gene family, member 3 (NESH)-binding protein",proteinaceous extracellular matrix|interstitial matrix|extracellular space|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|glycosaminoglycan binding|heparin binding|,3,7,148000000,2.0%
A6H584,0.145366797,0.358333333,16.8875315,-0.948,0.020476082,-3.116329932,1.033,1.174,0.29,-0.109,-0.202,-0.036,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,6,4,4,A0A140T8W1|A6H584|A0A140T8T7|E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,291566.4,1.8,431,431.1,29.36,29.36,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,4,6,44700000,1.8%
Q02053,0.985191588,-0.0664,0.173306138,0.0185,0.960880514,0.051540482,-0.516,0.361,,0.022,-0.177,-0.022,Q02053,Uba1,Q02053_Uba1,Q02053,Uba1,1,4,4,4,Q02053|P31254,MOUSE,119004.9,4.8,432,432.1,29.28,29.28,,1058,Ubiquitin-like modifier-activating enzyme 1,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|heterochromatin|lysosomal membrane|endosome membrane|desmosome|rough endoplasmic reticulum membrane|,cellular response to DNA damage stimulus|protein ubiquitination|modification-dependent protein catabolic process|,ubiquitin activating enzyme activity|ubiquitin-protein transferase activity|protein binding|ATP binding|poly(A) RNA binding|,4,4,66500000,4.8%
E9QNX4,0.226931035,-0.2888,12.71453837,0.767833333,0.053523704,2.507991961,-1.06,-0.439,,0.008,0.036,0.011,E9QNX4,Alpk1,E9QNX4_Alpk1,E9QNX4,Alpk1,1,16,3,3,E9QNX4|Q9CXB8,MOUSE,137413.2,2.1,433,433.1,29.21,29.21,,1231,Alpha-protein kinase 1,,positive regulation of defense response to virus by host|protein phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,protein serine/threonine kinase activity|ATP binding|,3,16,1170000000,2.1%
P55104,0.570415662,0.414833333,4.593000337,-0.825,0.347296148,-1.020122667,-0.436,0.218,2.7,0.059,-0.087,0.035,P55104,Inhbc,P55104_Inhbc,P55104,Inhbc,1,6,4,4,P55104,MOUSE,40085.3,9.9,434,434.1,29.11,29.11,,352,Inhibin beta C chain,extracellular space|extracellular exosome|,positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of apoptotic process|regulation of MAPK cascade|cell development|SMAD protein signal transduction|,cytokine activity|transforming growth factor beta receptor binding|hormone activity|growth factor activity|,4,6,51200000,9.9%
Q9DBH5,0.987463289,0.073666667,0.105645147,-0.007333333,0.975967791,-0.031391796,0.055,-0.103,0.28,0.244,0.007,-0.041,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,5,3,3,Q9DBH5,MOUSE,40771.4,6.9,435,435.1,29.05,29.05,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,3,5,23200000,6.9%
A0A075B5W6,0.565439223,0.2638,4.718825636,0.493,0.337378526,1.060341648,0.151,-0.215,,-0.141,1.163,0.361,A0A075B5W6,NotFound,A0A075B5W6_NotFound,A0A075B5W6,Ighv1-55,1,3,2,2,A0A075B5W6,MOUSE,12858.3,26.4,436,436.1,29.04,29.04,,117,Immunoglobulin heavy variable 1-55 (Fragment),,,,2,3,562000000,26.4%
A0A1W2P6U8,0.68605069,0.0134,3.069448291,0.204833333,0.493236459,0.738269872,-0.244,0.025,,-0.024,0.286,0.024,A0A1W2P6U8,LOC102635990,A0A1W2P6U8_LOC102635990,A0A1W2P6U8,4932415D10Rik,1,8,5,5,A0A1W2P6U8,MOUSE,557033.8,0.8,437,437.1,29.01,29.01,,4986,RIKEN cDNA 4932415D10 gene,,,,5,8,2760000000,0.8%
P02668,0.769532427,0.2465,2.249445932,-0.301666667,0.595738142,-0.559973552,0.085,-0.445,1.552,0.256,0.202,-0.171,P02668,NotFound,P02668_NotFound,P02668,CSN3,1,5,2,2,P02668,BOVIN,21383.1,14.7,438,438.1,28.9,28.9,,190,Kappa-casein,,,,2,5,80200000,14.7%
E9Q401,0.595170996,-0.211666667,4.172951551,0.458666667,0.382564656,0.941866757,-1.41,-0.298,0.385,-0.181,-0.069,0.303,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,16,4,4,E9Q401|F6U7V1|Q80ZZ5,MOUSE,570001.1,0.9,439,439.1,28.37,28.37,,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,4,16,27900000000,0.9%
P47880,0.294065232,-0.1998,10.27044292,0.743666667,0.093962748,2.061474556,-0.248,-1.044,,0.077,-0.112,0.328,P47880,Igfbp6,P47880_Igfbp6,P47880,Igfbp6,1,5,3,3,P47880,MOUSE,26259,11.7,440,440.1,28.29,28.29,,238,Insulin-like growth factor-binding protein 6,extracellular space|Golgi apparatus|extracellular exosome|,regulation of cell growth|regulation of insulin-like growth factor receptor signaling pathway|,insulin-like growth factor I binding|insulin-like growth factor II binding|,3,5,114000000,11.7%
A0A075B5Y1,0.368631529,-0.0426,8.047157305,0.538166667,0.156777693,1.662464146,-0.51,-0.221,,-0.19,0.457,0.251,A0A075B5Y1,NotFound,A0A075B5Y1_NotFound,A0A075B5Y1,Ighv1-74,1,8,3,3,A0A075B5Y1|P01750,MOUSE,13070.6,21.5,441,441.1,28.04,28.04,,116,Immunoglobulin heavy variable V1-74,,,,3,8,5430000000,21.5%
P24270,0.115012655,0.454,18.9552393,-1.736666667,0.012719677,-3.504746299,1.338,2.241,0.388,-0.207,-0.697,-0.339,P24270,Cat,P24270_Cat,P24270,Cat,1,6,3,3,P24270|A2AL20,MOUSE,60079.5,5.1,442,442.1,28.02,28.02,,527,Catalase,extracellular space|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to reactive oxygen species|osteoblast differentiation|ureteric bud development|response to hypoxia|triglyceride metabolic process|response to oxidative stress|aging|cholesterol metabolic process|aerobic respiration|response to toxic substance|response to light intensity|UV protection|response to ozone|response to lead ion|positive regulation of phosphatidylinositol 3-kinase signaling|response to activity|response to inactivity|hemoglobin metabolic process|negative regulation of NF-kappaB transcription factor activity|response to estradiol|response to insulin|response to vitamin A|response to vitamin E|response to L-ascorbic acid|response to drug|hydrogen peroxide catabolic process|negative regulation of apoptotic process|response to ethanol|response to cadmium ion|positive regulation of NF-kappaB transcription factor activity|protein tetramerization|protein homotetramerization|positive regulation of cell division|response to hyperoxia|response to fatty acid|cellular response to growth factor stimulus|response to phenylpropanoid|,"aminoacylase activity|catalase activity|receptor binding|antioxidant activity|oxidoreductase activity, acting on peroxide as acceptor|enzyme binding|heme binding|protein homodimerization activity|metal ion binding|NADP binding|",3,6,340000000,5.1%
Q0VBK2,0.131134782,0.1605,17.8877733,-1.900333333,0.016263824,-3.315545577,2.032,1.435,-0.135,-0.74,-0.999,-0.63,Q0VBK2,Krt80,Q0VBK2_Krt80,Q0VBK2,Krt80,1,3,2,2,Q0VBK2,MOUSE,51173.1,5,443,443.1,27.93,27.93,,452,"Keratin, type II cytoskeletal 80",cytoplasm|intermediate filament|keratin filament|,,structural molecule activity|,2,3,87000000,5.0%
Q61268,0.226931035,0.0068,12.69953877,0.749666667,0.053708883,2.505181133,-0.339,-0.547,,0.434,0.49,-0.004,Q61268,Apoc4,Q61268_Apoc4,Q61268,Apoc4,1,12,2,2,Q61268,MOUSE,14459.4,16.1,444,444.1,27.88,27.88,,124,Apolipoprotein C-IV,very-low-density lipoprotein particle|high-density lipoprotein particle|,lipid transport|positive regulation of sequestering of triglyceride|triglyceride homeostasis|,,2,12,1840000000,16.1%
Q923X1,0.374847149,0.4005,7.85012412,-0.716333333,0.164054289,-1.584538191,0.394,0.17,1.712,0.226,-0.184,0.085,Q923X1,Adgrl4,Q923X1_Adgrl4,Q923X1,Adgrl4,1,3,2,2,Q923X1,MOUSE,84526.8,4.6,445,445.1,27.52,27.52,,739,Adhesion G protein-coupled receptor L4,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|calcium ion binding|,2,3,23400000,4.6%
Q792Z1,0.007983705,0.908333333,41.03873585,-2.986,7.87275E-05,-9.431569122,2.945,2.066,2.193,-0.742,-0.659,-0.353,Q792Z1,Try10,Q792Z1_Try10,Q792Z1,Try10,1,7,2,2,Q792Z1,MOUSE,26905,7.3,446,446.1,27.46,27.46,,246,MCG140784,extracellular space|extracellular exosome|blood microparticle|,proteolysis|digestion|,serine-type endopeptidase activity|,2,7,485000000,7.3%
Q9Z126,0.709461512,0.1495,2.785647312,-0.241666667,0.526544728,-0.672000579,0.129,-0.252,0.934,0.171,-0.174,0.089,Q9Z126,Pf4,Q9Z126_Pf4,Q9Z126,Pf4,1,9,3,3,Q9Z126|A0A0J9YTR7,MOUSE,11471.5,25.7,447,447.1,27.38,27.38,,105,Platelet factor 4,extracellular space|platelet alpha granule|protein complex|,positive regulation of leukocyte chemotaxis|protein complex assembly|inflammatory response|immune response|G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|negative regulation of angiogenesis|cytokine-mediated signaling pathway|platelet activation|leukocyte chemotaxis|positive regulation of cAMP metabolic process|response to lipopolysaccharide|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of cAMP-mediated signaling|negative regulation of MHC class II biosynthetic process|positive regulation of macrophage differentiation|negative regulation of megakaryocyte differentiation|negative regulation of cytolysis|positive regulation of transcription from RNA polymerase II promoter|chemokine-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,chemokine activity|heparin binding|CXCR chemokine receptor binding|CXCR3 chemokine receptor binding|,3,9,149000000,25.7%
P09581,0.847001203,0.093666667,1.433816086,-0.117333333,0.718817086,-0.377333458,-0.025,-0.229,0.711,0.007,0.128,-0.03,P09581,Csf1r,P09581_Csf1r,P09581,Csf1r,1,3,3,3,P09581,MOUSE,110375.4,2.9,448,448.1,27.36,27.36,,977,Macrophage colony-stimulating factor 1 receptor,intracellular|plasma membrane|cell surface|integral component of membrane|CSF1-CSF1R complex|,positive regulation of protein phosphorylation|inflammatory response|transmembrane receptor protein tyrosine kinase signaling pathway|axon guidance|skeletal muscle tissue development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|olfactory bulb development|forebrain neuron differentiation|hemopoiesis|osteoclast differentiation|positive regulation of cell migration|ruffle organization|cellular response to macrophage colony-stimulating factor stimulus|macrophage colony-stimulating factor signaling pathway|positive regulation of tyrosine phosphorylation of Stat3 protein|negative regulation of apoptotic process|innate immune response|regulation of bone resorption|cell-cell junction maintenance|positive regulation of osteoclast differentiation|phosphatidylinositol metabolic process|protein autophosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein tyrosine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to cytokine stimulus|positive regulation of protein serine/threonine kinase activity|positive regulation of chemokine secretion|positive regulation of cell motility|regulation of actin cytoskeleton reorganization|,macrophage colony-stimulating factor receptor activity|protein binding|ATP binding|protein phosphatase binding|cytokine binding|protein homodimerization activity|,3,3,28700000,2.9%
P01724,0.37230644,-0.0214,7.94890891,0.536,0.160364823,1.644976282,-0.212,-0.474,,-0.196,0.327,0.448,P01724,NotFound,P01724_NotFound,P01724,,1,5,2,2,P01724,MOUSE,13593.1,31,449,449.1,27.26,27.26,,129,Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104,,,antigen binding|,2,5,8800000000,31.0%
O89053,0.36786188,0.0856,8.072069943,-0.429833333,0.155880936,-1.666898135,0.42,0.267,,-0.191,-0.023,-0.045,O89053,Coro1a,O89053_Coro1a,O89053,Coro1a,1,4,3,3,O89053|G3UYK8,MOUSE,51672.9,7.5,450,450.1,26.94,26.94,,461,Coronin-1A,immunological synapse|phagocytic cup|cytoplasm|early endosome|actin filament|plasma membrane|cell-cell junction|membrane|lamellipodium|axon|phagocytic vesicle membrane|cortical actin cytoskeleton|cell leading edge|protein complex|phagocytic vesicle|extracellular exosome|plasma membrane|actin cytoskeleton|cortical actin cytoskeleton|,phagolysosome assembly|calcium ion transport|phagocytosis|actin filament organization|regulation of actin polymerization or depolymerization|regulation of cell shape|cell migration|actin cytoskeleton organization|positive regulation of cell migration|leukocyte chemotaxis|regulation of actin filament polymerization|negative regulation of vesicle fusion|cell-substrate adhesion|uropod organization|regulation of actin cytoskeleton organization|response to cytokine|nerve growth factor signaling pathway|positive regulation of T cell proliferation|T cell homeostasis|natural killer cell degranulation|negative regulation of neuron apoptotic process|homeostasis of number of cells within a tissue|positive regulation of T cell activation|positive chemotaxis|negative regulation of actin nucleation|regulation of release of sequestered calcium ion into cytosol|early endosome to recycling endosome transport|cellular response to interleukin-4|,actin binding|actin monomer binding|protein binding|protein C-terminus binding|cytoskeletal protein binding|myosin heavy chain binding|identical protein binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|poly(A) RNA binding|actin filament binding|,3,4,11600000,7.5%
Q64339,0.848834866,0.0358,1.400659794,-0.108666667,0.72432591,-0.372970711,0.247,-0.045,,-0.101,-0.166,0.244,Q64339,Isg15,Q64339_Isg15,Q64339,Isg15,1,2,2,2,Q64339,MOUSE,18068.5,16.7,451,451.1,26.38,26.38,,161,Ubiquitin-like protein ISG15,extracellular region|cytoplasm|,modification-dependent protein catabolic process|negative regulation of protein ubiquitination|ISG15-protein conjugation|regulation of interferon-gamma production|response to type I interferon|defense response to bacterium|negative regulation of viral genome replication|positive regulation of erythrocyte differentiation|defense response to virus|,protein binding|protein tag|,2,2,2280000,16.7%
F8WID5,0.037248215,0.835666667,26.90789838,-3.430666667,0.002038028,-5.210589953,1.686,3.869,2.098,-0.817,-1.551,-0.271,F8WID5,NotFound,F8WID5_NotFound,F8WID5,Tpm1,1,4,2,2,F8WID5|E9Q454|E9Q450|Q8BP43|E9Q448|P58771-2|Q8BSH3|P58771|B7ZNL3|E9Q452|E9Q455|G5E8R2|E9Q456|G5E8R1|E9Q453|G5E8R0|E9Q5J9|P21107|A0A0R4J1P2|P21107-2|D3Z2H9|D3Z6I8|E9Q7Q3|P58774|S4R2U0,MOUSE,37469.2,5.5,452,452.1,26.26,13.92,,326,Tropomyosin alpha-1 chain,cytoplasm|muscle thin filament tropomyosin|myofibril|filamentous actin|,in utero embryonic development|,structural constituent of cytoskeleton|,3,4,70700000,5.5%
A2AIM4,0.284070507,0.31,10.54055757,-2.469333333,0.088296653,-2.035764296,1.156,4.179,-0.701,-0.666,-1.581,-0.527,A2AIM4,Tpm2,A2AIM4_Tpm2,A2AIM4,Tpm2,1,1,2,1,A2AIM4|P58774-2,MOUSE,33050.3,7.3,452,452.2,22.38,4.7,,284,Tropomyosin beta chain,muscle thin filament tropomyosin|,muscle contraction|,structural constituent of cytoskeleton|protein binding|,1,1,3200000000,3.8%
P47911,0.284070507,0.723833333,10.61722455,-1.055666667,0.08675161,-2.045126201,1.222,0.4,2.133,-0.091,0.791,-0.112,P47911,Rpl6,P47911_Rpl6,P47911,Rpl6,1,3,3,3,P47911,MOUSE,33566.1,9.7,453,453.1,25.85,25.85,,296,60S ribosomal protein L6,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|cytoplasmic ribonucleoprotein granule|,translation|,structural constituent of ribosome|poly(A) RNA binding|,3,3,29900000,9.7%
E9Q1W3,0.933980288,0.306333333,0.715608508,-0.104666667,0.848084546,-0.199989737,-0.132,-0.251,1.459,0.68,0.096,-0.014,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,11,4,4,E9Q1W3|A2AQA9|B2RUJ5|B2RUJ5-3,MOUSE,831956.2,0.6,454,454.1,25.46,25.46,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,4,11,19500000000,0.6%
P01662,0.771519896,-0.259166667,2.225201999,0.391666667,0.599073074,0.555038907,0.704,-0.039,-2.03,-0.311,0.097,0.024,P01662,NotFound,P01662_NotFound,P01662,,1,5,2,2,P01662|P01663,MOUSE,12155.2,21.6,455,455.1,25.28,25.28,,111,Ig kappa chain V-III region ABPC 22/PC 9245,,,antigen binding|,2,5,167000000,21.6%
A0A075B5Q3,0.680102626,0.107333333,3.136014974,0.417333333,0.485733999,0.743006313,-0.762,-0.598,1.056,-0.224,0.562,0.61,A0A075B5Q3,NotFound,A0A075B5Q3_NotFound,A0A075B5Q3,Ighv2-5,1,11,2,2,A0A075B5Q3,MOUSE,12727.5,16.5,456,456.1,25.26,25.26,,115,Immunoglobulin heavy variable 2-5,,,,2,11,5620000000,16.5%
O35490,0.018579829,0.6448,31.87830204,-4.183666667,0.000648888,-7.529197531,2.867,3.443,,-0.12,-1.688,-1.278,O35490,Bhmt,O35490_Bhmt,O35490,Bhmt,1,2,2,2,O35490,MOUSE,45476.1,5.8,457,457.1,24.78,24.78,,407,Betaine--homocysteine S-methyltransferase 1,cytoplasm|,amino-acid betaine catabolic process|methionine biosynthetic process|methylation|,zinc ion binding|S-adenosylmethionine-homocysteine S-methyltransferase activity|betaine-homocysteine S-methyltransferase activity|,2,2,815000000,5.8%
Q00612,0.244430719,0.7005,11.74769517,-1.037,0.066869871,-2.233230987,0.909,0.667,2.081,0.399,-0.352,0.499,Q00612,G6pdx,Q00612_G6pdx,Q00612,G6pdx,1,5,4,4,Q00612|P97324|G3UWD6,MOUSE,59717.9,8.1,458,458.1,24.62,24.62,,515,Glucose-6-phosphate 1-dehydrogenase X,cytoplasm|centrosome|microtubule organizing center|cytosol|cytoplasmic side of plasma membrane|membrane|intracellular membrane-bounded organelle|extracellular exosome|,"cytokine production|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|vasodilation by angiotensin involved in regulation of systemic arterial blood pressure|glucose metabolic process|pentose-phosphate shunt|cholesterol biosynthetic process|NADP metabolic process|NADPH regeneration|NADP biosynthetic process|glutathione metabolic process|response to oxidative stress|pentose-phosphate shunt, oxidative branch|negative regulation of protein glutathionylation|pentose biosynthetic process|interleukin-10 production|interleukin-12 production|cellular response to oxidative stress|regulation of multicellular organism growth|erythrocyte maturation|ribose phosphate biosynthetic process|erythrocyte development|glucose 6-phosphate metabolic process|oxidation-reduction process|",glucose-6-phosphate dehydrogenase activity|glucose binding|identical protein binding|protein homodimerization activity|NADP binding|,4,5,1880000000,8.1%
D3YYQ8,0.117979547,-0.3562,18.79915207,1.158,0.013185141,3.741833747,-1.226,-0.876,,-0.181,0.351,0.151,D3YYQ8,Dnah10,D3YYQ8_Dnah10,D3YYQ8,Dnah10,1,19,4,4,D3YYQ8|F7ABZ6,MOUSE,532755.8,1,459,459.1,24.6,24.6,,4591,"Dynein, axonemal, heavy chain 10",inner dynein arm|,cilium movement|metabolic process|,microtubule motor activity|ATP binding|ATPase activity|,4,19,4670000000,1.0%
Q9CZB2,0.987463289,0.347,0.135524556,0.015833333,0.96927619,0.040475916,0.643,0.032,,0.305,-0.048,0.803,Q9CZB2,Pmel,Q9CZB2_Pmel,Q9CZB2,Pmel,1,3,2,2,Q9CZB2|Q60696,MOUSE,66927.6,4.1,460,460.1,24.59,24.59,,626,Melanocyte protein PMEL,endoplasmic reticulum membrane|Golgi apparatus|multivesicular body membrane|melanosome|,melanosome organization|melanin biosynthetic process|,,2,3,77300000,4.1%
P08032,0.269971759,0.346666667,10.97841111,-2.084,0.079828669,-2.108860207,1.059,-0.436,3.543,-0.369,-1.113,-0.604,P08032,Spta1,P08032_Spta1,P08032,Spta1,1,3,3,3,P08032,MOUSE,281001,1.5,461,461.1,24.51,24.51,,2415,"Spectrin alpha chain, erythrocytic 1",spectrin|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|cuticular plate|,porphyrin-containing compound biosynthetic process|plasma membrane organization|regulation of cell shape|actin cytoskeleton organization|hemopoiesis|positive regulation of protein binding|positive regulation of T cell proliferation|actin filament capping|,actin binding|calcium ion binding|protein heterodimerization activity|,3,3,98300000,1.5%
A0A075B5L4,0.826430946,0.0675,1.648348934,0.222333333,0.684171701,0.427119633,0.492,0.528,-1.151,0.011,-0.048,0.573,A0A075B5L4,NotFound,A0A075B5L4_NotFound,A0A075B5L4,Igkv12-89,1,13,2,2,A0A075B5L4,MOUSE,12138.5,24.3,462,462.1,24.27,24.27,,111,Immunoglobulin kappa chain variable 12-89,,,,2,13,3190000000,24.3%
P01627,0.49155095,0.009,5.684826251,0.588333333,0.270095516,1.239295084,-0.98,0.292,,0.334,0.488,-0.089,P01627,NotFound,P01627_NotFound,P01627,Gm5153,1,4,2,2,P01627|A0A075B5K5|P01628,MOUSE,13451,19.1,463,463.1,24.25,24.25,,120,Ig kappa chain V-II region VKappa167,,,,2,4,72000000,19.1%
A0A075B5T6,0.232324458,-0.2138,12.18654095,0.783666667,0.060442985,2.409551248,-0.487,-0.881,,-0.226,0.384,0.141,A0A075B5T6,NotFound,A0A075B5T6_NotFound,A0A075B5T6,Ighv10-3,1,8,3,3,A0A075B5T6,MOUSE,13715.5,22.6,464,464.1,24.13,24.13,,119,Immunoglobulin heavy variable V10-3 (Fragment),,,,3,8,797000000,22.6%
F6R7E8,0.010747816,0.805333333,36.23919334,-2.636666667,0.000237728,-7.762966726,2.656,1.517,2.198,-0.595,-0.523,-0.421,F6R7E8,Gm2663,F6R7E8_Gm2663,F6R7E8,Gm2663,1,10,3,3,F6R7E8|Q9CPN7,MOUSE,27260.6,16.1,465,465.1,24.07,24.07,,247,Predicted gene 2663,extracellular space|,proteolysis|,serine-type endopeptidase activity|,3,10,1890000000,16.1%
P97927,0.994093377,-0.190666667,0.040922186,0.015333333,0.990621573,0.01225589,1.046,1.54,-3.181,-0.391,0.142,-0.3,P97927,Lama4,P97927_Lama4,P97927,Lama4,1,4,2,2,P97927,MOUSE,204497.2,0.8,466,466.1,23.95,23.95,,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,2,4,17800000,0.8%
P01642,0.993586203,0.1828,0.060765216,0.012166667,0.986105721,0.018309843,1.122,-0.771,,-0.259,0.113,0.709,P01642,NotFound,P01642_NotFound,P01642,Gm10881,1,4,2,2,P01642,MOUSE,12729,15.6,467,467.1,23.92,23.92,,115,Ig kappa chain V-V region L7 (Fragment),,,,2,4,524000000,15.6%
Q9ES89,0.225652809,0.349166667,12.86086193,-0.775666667,0.051750411,-2.41907994,0.151,1.169,0.891,0.014,-0.085,-0.045,Q9ES89,Extl2,Q9ES89_Extl2,Q9ES89,Extl2,1,11,2,2,Q9ES89|Q3TSR0,MOUSE,37618.1,4.2,468,468.1,23.78,23.78,,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",2,11,504000000,4.2%
P60335,0.187564941,0.3585,14.96488644,-0.844333333,0.031879489,-2.77676774,0.63,1.167,0.545,-0.342,-0.17,0.321,P60335,Pcbp1,P60335_Pcbp1,P60335,Pcbp1,1,2,2,2,P60335,MOUSE,38010.7,6.1,469,469.1,23.68,23.68,,356,Poly(rC)-binding protein 1,nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,mRNA processing|positive regulation of translation|,single-stranded DNA binding|RNA binding|protein binding|translation activator activity|poly(A) RNA binding|,2,2,144000000,6.1%
A0A075B5T9,0.722808553,0.1244,2.620565241,0.259833333,0.546944773,0.645559961,0.055,-0.118,,-0.223,0.832,0.076,A0A075B5T9,NotFound,A0A075B5T9_NotFound,A0A075B5T9,Ighv1-9,1,4,2,2,A0A075B5T9,MOUSE,13045.5,26.7,470,470.1,23.64,23.64,,116,Immunoglobulin heavy variable V1-9,,,,2,4,676000000,26.7%
P62242,0.060185867,0.584666667,23.55158091,-2.561333333,0.004414097,-4.447986038,1.283,1.182,3.131,-0.988,-0.736,-0.364,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,3,2,2,P62242,MOUSE,24490,9.6,471,471.1,23.5,23.5,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,2,3,2520000000,9.6%
Q8BKH7,0.61589699,-0.141166667,3.849555526,0.347666667,0.412139697,0.881005172,0.089,0.083,-1.117,0,-0.138,0.236,Q8BKH7,Mapkap1,Q8BKH7_Mapkap1,Q8BKH7,Mapkap1,1,9,3,3,Q8BKH7|Q8BKH7-2|Q8BKH7-3,MOUSE,59521.1,4.7,472,472.1,23.4,23.4,,522,Target of rapamycin complex 2 subunit MAPKAP1,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|cytoplasmic membrane-bounded vesicle|,substantia nigra development|negative regulation of Ras protein signal transduction|,"protein binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|Ras GTPase binding|protein kinase binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3,5-bisphosphate binding|",3,9,13900000000,4.7%
A0A075B5X8,0.284070507,-0.372333333,10.56177784,0.790666667,0.087866275,2.035667495,-0.214,-0.615,-1.474,-0.208,-0.066,0.343,A0A075B5X8,NotFound,A0A075B5X8_NotFound,A0A075B5X8,Ighv8-12,1,11,3,3,A0A075B5X8,MOUSE,11636.9,20,473,473.1,23.36,23.36,,105,Immunoglobulin heavy variable V8-12,,,,3,11,3310000000,20.0%
E9QLL8,0.198868004,0.621666667,14.05917041,-1.476,0.039271995,-2.63095545,0.688,0.776,2.615,-0.229,-0.244,0.124,E9QLL8,Serpina11,E9QLL8_Serpina11,E9QLL8,Serpina11,1,3,3,3,E9QLL8|E9QK54|Q8CIE0,MOUSE,47783.4,7.9,474,474.1,23.07,23.07,,427,Serpin A11,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,3,3,171000000,7.9%
A0A087WRT4,0.717632589,0.244333333,2.686070807,-0.4,0.538756992,-0.651950165,-0.425,-0.067,1.825,0.098,-0.18,0.215,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,5,3,3,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,0.5,475,475.1,22.84,22.84,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,3,5,323000000,0.5%
P13609,0.830947352,0.1008,1.572603591,0.169666667,0.696209012,0.413681738,0.513,-0.515,,0.443,0.066,-0.003,P13609,Srgn,P13609_Srgn,P13609,Srgn,1,3,2,2,P13609,MOUSE,16825.2,19.7,476,476.1,22.81,22.81,,152,Serglycin,Golgi membrane|extracellular space|Golgi apparatus|secretory granule|zymogen granule|mast cell granule|,granzyme-mediated apoptotic signaling pathway|protein processing|negative regulation of bone mineralization|biomineral tissue development|mast cell secretory granule organization|T cell secretory granule organization|maintenance of protease location in mast cell secretory granule|maintenance of granzyme B location in T cell secretory granule|negative regulation of cytokine secretion|,protein binding|collagen binding|,2,3,88100000,19.7%
Q8BYC6,0.155174868,-0.6845,16.41956871,1.431666667,0.022805685,3.038363878,-1.39,-0.51,-2.301,-0.078,0.163,0.009,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,27,3,3,Q8BYC6|Q3V3K3,MOUSE,105790.3,4,477,477.1,22.66,22.66,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,3,27,58600000000,4.0%
D3YZ61,0.145366797,0.451333333,17.02048279,-1.001333333,0.019858741,-3.143655995,1.419,0.94,0.497,0.223,-0.256,-0.115,D3YZ61,C1qtnf3,D3YZ61_C1qtnf3,D3YZ61,C1qtnf3,1,5,2,2,D3YZ61|Q9ES30,MOUSE,35268.9,5.9,478,478.1,22.31,22.31,,319,Complement C1q tumor necrosis factor-related protein 3,extracellular region|collagen trimer|extracellular space|cell|membrane|extracellular exosome|,negative regulation of gene expression|cellular triglyceride homeostasis|negative regulation of NF-kappaB import into nucleus|glucose homeostasis|negative regulation of gluconeogenesis|positive regulation of cytokine secretion|negative regulation of inflammatory response|protein oligomerization|positive regulation of protein kinase B signaling|positive regulation of adiponectin secretion|protein trimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of monocyte chemotactic protein-1 production|negative regulation of interleukin-6 secretion|,identical protein binding|,2,5,83100000,5.9%
A2AQH1,0.031812923,0.893833333,28.18605739,-1.719666667,0.001518428,-5.476115029,1.853,1.578,1.83,0.459,-0.497,0.14,A2AQH1,Cerkl,A2AQH1_Cerkl,A2AQH1,Cerkl,1,6,4,4,A2AQH1,MOUSE,59694.4,7.2,479,479.1,22.26,22.26,,525,Ceramide kinase-like,nucleolus|cytoplasm|endoplasmic reticulum|Golgi apparatus|,phosphorylation|negative regulation of apoptotic process|,kinase activity|,4,6,346000000,7.2%
Q80UM7,0.071727403,0.763333333,22.27049707,-2.371333333,0.005928575,-4.176455151,0.821,2.142,2.884,-0.272,-0.888,-0.107,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,5,3,3,Q80UM7,MOUSE,92000.8,3.1,480,480.1,22.18,22.18,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,3,5,828000000,3.1%
E9Q5D9,0.61589699,-0.0806,3.827889122,0.329833333,0.414200947,0.889854128,0.172,-0.729,,0.024,-0.095,0.225,E9Q5D9,Igfbp7,E9Q5D9_Igfbp7,E9Q5D9,Igfbp7,1,5,3,3,E9Q5D9|F8WH23|Q61581,MOUSE,33887.1,9.2,481,481.1,22.12,22.12,,313,Insulin-like growth factor-binding protein 7,extracellular space|extracellular matrix|extracellular exosome|,regulation of cell growth|cell adhesion|,insulin-like growth factor binding|,3,5,149000000,9.2%
Q7TNC4,0.097976248,0.538166667,20.23794269,-1.881,0.009466855,-3.751373093,1.597,0.462,2.377,-0.238,-0.527,-0.442,Q7TNC4,Luc7l2,Q7TNC4_Luc7l2,Q7TNC4,Luc7l2,1,2,2,2,Q7TNC4|Q7TNC4-4|Q05CX5|Q7TNC4-3|Q7TNC4-2|E9Q715|Q9CYI4|A0A0R4J047|Q9CYI4-2,MOUSE,46981.6,6.3,482,482.1,22.03,22.03,,392,Putative RNA-binding protein Luc7-like 2,U1 snRNP|nuclear speck|,mRNA splice site selection|,mRNA binding|enzyme binding|poly(A) RNA binding|,2,2,40400000,6.3%
Q91Y97,0.294065232,0.2036,10.32980823,-2.783166667,0.092687075,-2.078773265,-0.392,4.139,,-0.766,-1.05,-0.913,Q91Y97,Aldob,Q91Y97_Aldob,Q91Y97,Aldob,1,3,3,3,Q91Y97,MOUSE,39962.7,7.9,483,483.1,21.7,21.7,,364,Fructose-bisphosphate aldolase B,nucleus|lysosome|microtubule organizing center|cytosol|plasma membrane|rough endoplasmic reticulum membrane|smooth endoplasmic reticulum membrane|centriolar satellite|perinuclear region of cytoplasm|extracellular exosome|,"liver development|fructose metabolic process|glycolytic process|NADH oxidation|response to fructose|response to zinc ion|fructose 1,6-bisphosphate metabolic process|cellular response to extracellular stimulus|positive regulation of ATPase activity|cellular response to insulin stimulus|response to drug|response to starvation|response to amino acid|response to copper ion|response to glucocorticoid|response to cAMP|vacuolar proton-transporting V-type ATPase complex assembly|response to interleukin-6|",fructose-bisphosphate aldolase activity|cytoskeletal protein binding|phosphatidylcholine binding|identical protein binding|ATPase binding|fructose-1-phosphate aldolase activity|fructose binding|,3,3,74200000,7.9%
Q9CQV8,0.02433127,0.525,30.03760336,-2.462,0.000991379,-5.959530795,1.326,2.493,1.449,-0.814,-1.059,-0.245,Q9CQV8,Ywhab,Q9CQV8_Ywhab,Q9CQV8,Ywhab,1,3,2,2,Q9CQV8|P68254|P68254-2|Q9CQV8-2|P63101,MOUSE,28200,6.9,484,484.1,21.45,21.45,,246,14-3-3 protein beta/alpha,nucleus|cytoplasm|cytosol|focal adhesion|membrane|transcriptional repressor complex|cytoplasmic vesicle membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"protein targeting|negative regulation of protein dephosphorylation|positive regulation of catalytic activity|negative regulation of transcription, DNA-templated|cytoplasmic sequestering of protein|protein heterooligomerization|",transcription corepressor activity|protein binding|protein C-terminus binding|enzyme binding|protein domain specific binding|protein complex binding|histone deacetylase binding|phosphoserine binding|phosphoprotein binding|,2,3,12400000,6.9%
Q9WTL4,0.007983705,1.017,39.32672347,-4.736,0.000116769,-8.82206961,4.055,3.481,2.619,-1.378,-2.107,-0.568,Q9WTL4,Insrr,Q9WTL4_Insrr,Q9WTL4,Insrr,1,8,2,2,Q9WTL4,MOUSE,147382.5,1.3,485,485.1,21.23,21.23,,1300,Insulin receptor-related protein,integral component of plasma membrane|receptor complex|,transmembrane receptor protein tyrosine kinase signaling pathway|peptidyl-tyrosine phosphorylation|male sex determination|actin cytoskeleton reorganization|protein autophosphorylation|cellular response to alkaline pH|,transmembrane receptor protein tyrosine kinase activity|ATP binding|phosphatidylinositol 3-kinase binding|insulin receptor substrate binding|,2,8,1740000000,1.3%
P13707,0.415969236,0.482833333,7.064059179,-0.900333333,0.196604784,-1.453676736,1.038,1.841,-0.08,0.898,-0.606,-0.194,P13707,Gpd1,P13707_Gpd1,P13707,Gpd1,1,3,2,2,P13707|E0CXN5,MOUSE,38199.6,6,486,486.1,21.13,21.13,,349,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",mitochondrion|cytosol|glycerol-3-phosphate dehydrogenase complex|extracellular exosome|,glycerol-3-phosphate metabolic process|gluconeogenesis|NADH oxidation|glycerophosphate shuttle|positive regulation of glycolytic process|glycerol-3-phosphate catabolic process|glycerolipid metabolic process|cellular response to cAMP|cellular response to tumor necrosis factor|,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase activity|protein homodimerization activity|NAD binding|,2,3,17400000,6.0%
P01626,0.433615197,0.264,6.693900804,-0.478333333,0.214096674,-1.420865484,0.393,0.709,,-0.273,0.449,0.042,P01626,NotFound,P01626_NotFound,P01626,,1,5,3,3,P01626,MOUSE,12462.8,33,487,487.1,21,21,,112,Ig kappa chain V-II region MOPC 167,,,antigen binding|,3,5,142000000,33.0%
Q64700,0.055373256,0.999166667,24.12541854,-2.092333333,0.003867748,-4.550622988,2.734,1.074,2.328,-0.027,-0.199,0.085,Q64700,Rbl2,Q64700_Rbl2,Q64700,Rbl2,1,4,4,4,Q64700|A0A1B0GR06|A0A1B0GRM0,MOUSE,128966.4,2.9,488,488.1,20.96,20.96,,1135,Retinoblastoma-like protein 2,nucleus|transcription factor complex|nucleolus|cytoplasm|extracellular exosome|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|cell cycle|chromatin modification|regulation of lipid kinase activity|regulation of cell cycle|",DNA binding|protein binding|,4,4,3780000000,2.9%
P52431,0.177690852,-0.1998,15.27569967,0.947833333,0.029677686,3.002324259,-0.961,-0.576,,-0.141,0.364,0.315,P52431,Pold1,P52431_Pold1,P52431,Pold1,1,8,2,2,P52431|D6RFB8,MOUSE,125271.5,2.1,489,489.1,20.89,20.89,,1105,DNA polymerase delta catalytic subunit,nucleotide-excision repair complex|nucleus|nucleoplasm|cytoplasm|membrane|aggresome|delta DNA polymerase complex|,"DNA synthesis involved in DNA repair|DNA replication|DNA-dependent DNA replication|base-excision repair, gap-filling|nucleotide-excision repair, DNA gap filling|cellular response to UV|DNA replication proofreading|fatty acid homeostasis|nucleic acid phosphodiester bond hydrolysis|","nucleotide binding|DNA binding|chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|3'-5'-exodeoxyribonuclease activity|3'-5' exonuclease activity|metal ion binding|4 iron, 4 sulfur cluster binding|",2,8,714000000,2.1%
P19639,0.058262161,0.710833333,23.76214883,-3.249666667,0.004205185,-4.493589692,1.225,3.978,1.804,-0.769,-1.174,-0.799,P19639,Gstm3,P19639_Gstm3,P19639,Gstm3,1,2,2,2,G5E8M7|P19639|P15626|Q80W21|O35660|D3YVP5|D3YX76|D3YVP6,MOUSE,25929.4,8.7,490,490.1,20.81,20.81,,218,Glutathione S-transferase Mu 3,cytoplasm|,metabolic process|cellular response to drug|cellular response to organic cyclic compound|,glutathione transferase activity|protein homodimerization activity|,2,2,72800000,8.7%
A0A075B5T5,0.850670217,0.271,1.364254339,0.145833333,0.730423212,0.364402538,0.151,0.216,,0.949,0.112,-0.073,A0A075B5T5,NotFound,A0A075B5T5_NotFound,A0A075B5T5,Ighv1-5,1,3,2,2,A0A075B5T5,MOUSE,10960.1,18.3,491,491.1,20.7,20.7,,98,Immunoglobulin heavy variable V1-5,,,,2,3,548000000,18.3%
F8VQ75,0.452865805,0.0268,6.296636235,0.4105,0.234604521,1.349363083,0.005,-0.444,,0.114,0.425,0.034,F8VQ75,Kif13a,F8VQ75_Kif13a,F8VQ75,Kif13a,1,4,3,3,F8VQ75|Q9EQW7,MOUSE,197294.8,2.1,492,492.1,20.69,20.69,,1749,Kinesin-like protein KIF13A,centrosome|kinesin complex|microtubule|endosome membrane|midbody|,cytokinesis|intracellular protein transport|microtubule-based movement|metabolic process|endosome to lysosome transport|melanosome organization|cargo loading into vesicle|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|,3,4,228000000,2.1%
Q80T14,0.619108766,0.0194,3.773032259,-0.221833333,0.419466009,-0.878636311,0.223,0.082,,-0.103,-0.046,-0.059,Q80T14,Fras1,Q80T14_Fras1,Q80T14,Fras1,1,3,2,2,Q80T14,MOUSE,453771.9,0.7,493,493.1,20.68,20.68,,4010,Extracellular matrix protein FRAS1,basement membrane|plasma membrane|integral component of membrane|sublamina densa|,morphogenesis of an epithelium|metanephros morphogenesis|cell communication|protein transport|embryonic limb morphogenesis|skin development|palate development|,metal ion binding|,2,3,25100000,0.7%
Q63836,0.015300471,0.544833333,33.34315013,-1.785666667,0.000463111,-6.844122799,1.748,1.334,1.231,-0.372,-0.551,-0.121,Q63836,Selenbp2,Q63836_Selenbp2,Q63836,Selenbp2,1,2,2,2,Q63836|P17563|D6RHN2|A0A0R4J135|G3UYY2,MOUSE,53179.6,5.9,494,494.1,20.25,20.25,,472,Selenium-binding protein 2,extracellular space|nucleolus|cytosol|membrane|extracellular exosome|,protein transport|,selenium binding|,2,2,10100000,5.9%
E9Q8Y0,0.193614767,0.719,14.38762968,-3.853333333,0.036411371,-2.844447911,0.741,5.321,,-0.681,-1.036,-0.75,E9Q8Y0,NotFound,E9Q8Y0_NotFound,E9Q8Y0,Myl2,1,4,2,2,E9Q8Y0|P51667,MOUSE,19865,12.5,495,495.1,20.25,20.25,,176,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform",cytoskeleton|myofibril|actin cytoskeleton|,heart morphogenesis|heart development|post-embryonic development|negative regulation of cell growth|muscle cell fate specification|muscle fiber development|cardiac myofibril assembly|ventricular cardiac muscle tissue morphogenesis|heart contraction|cardiac muscle contraction|,actin monomer binding|calcium ion binding|,2,4,8630000,12.5%
A2ARZ3,0.019997503,0.882166667,31.27867425,-3.015,0.000744959,-6.293685564,1.466,2.821,2.882,-0.103,-0.958,-0.815,A2ARZ3,NotFound,A2ARZ3_NotFound,A2ARZ3,Fsip2,1,5,3,3,A2ARZ3,MOUSE,790434.4,0.2,496,496.1,20.15,20.15,,6995,Fibrous sheath-interacting protein 2,mitochondrion|motile cilium|,,protein binding|,3,5,276000000,0.2%
O88569,0.189842544,-0.279166667,14.82017804,0.577666667,0.03295962,2.751679209,-0.686,-0.474,-0.544,-0.007,0.047,-0.011,O88569,Hnrnpa2b1,O88569_Hnrnpa2b1,O88569,Hnrnpa2b1,1,4,2,2,O88569|Q5EBP8|O88569-2|P49312|O88569-3|P49312-2,MOUSE,37459.1,5,497,497.1,20.04,20.04,,353,Heterogeneous nuclear ribonucleoproteins A2/B1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|ribonucleoprotein complex|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|RNA transport|",nucleotide binding|RNA binding|single-stranded telomeric DNA binding|poly(A) RNA binding|pre-mRNA intronic binding|,2,4,35000000,5.0%
E9Q616,0.155174868,-0.2028,16.47354937,1.058666667,0.022523976,3.245025569,-1.111,-0.565,,0.496,0.144,0.022,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,5,4,4,E9Q616,MOUSE,605040.9,1.1,498,498.1,19.91,19.91,,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,4,5,976000000,1.1%
A0A075B5K6,0.565439223,0.5286,4.6811669,0.524333333,0.340316738,1.05325762,0.121,0.307,,0.923,1.372,-0.08,A0A075B5K6,NotFound,A0A075B5K6_NotFound,A0A075B5K6,Igkv2-109,1,10,1,1,A0A075B5K6|P03976,MOUSE,13170.8,10.8,499,499.1,19.88,19.88,,120,Immunoglobulin kappa variable 2-109 (Fragment),,,,1,10,901000000,10.8%
Q0KL02-4,0.946089108,0.5822,0.588169281,-0.108,0.873339437,-0.16784237,0.678,0.616,,1.695,-0.261,0.183,Q0KL02,Trio,Q0KL02-4_Trio,Q0KL02-4,Trio,1,6,3,3,Q0KL02-4|Q0KL02|Q0KL02-3|Q0KL02-2|G5E825|Q9CWR0|A0A0R4J211|Q9CWR0-2|A0A1Y7VNM7|A0A1W2P6R9,MOUSE,351137,1,500,500.1,19.81,19.81,,3102,Isoform 4 of Triple functional domain protein,cytoplasm|,protein phosphorylation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity|ATP binding|enzyme binding|,3,6,61600000000,1.0%
B99906,0.035407766,1.132833333,27.26661593,-2.837,0.001876456,-5.268657824,2.004,2.522,3.128,0.356,-1.312,0.099,B99906,NotFound,B99906_NotFound,B99906,,1,11,3,3,B99906,PromTArt6,4855.8,60.8,501,501.1,19.64,19.64,,46,VATVSLPR-like Promega trypsin artifact 1-5 concatentated (871.1) xATVSLPR [Sus scrofa],,,,3,11,25800000000,60.8%
G3X9D6,0.263987871,0.417666667,11.22948731,-1.092666667,0.07534445,-2.147014207,1.451,1.527,-0.086,-0.089,-0.541,0.244,G3X9D6,Apon,G3X9D6_Apon,G3X9D6,Apon,1,2,2,2,G3X9D6,MOUSE,28249.3,11.1,502,502.1,19.5,19.5,,251,Apolipoprotein N,extracellular space|cytoplasm|,,,2,2,125000000,11.1%
Q8R5K4,0.71523561,0.2526,2.726860055,0.330166667,0.533720636,0.667880848,0.269,-0.16,,1.196,-0.127,0.085,Q8R5K4,Nol6,Q8R5K4_Nol6,Q8R5K4,Nol6,1,13,3,3,Q8R5K4|Q8R5K4-2|Q810B6|Q2NKI2|Q2NKI2-2|Q9DCM2|A0A0N4SVE5,MOUSE,130081.4,1.6,503,503.1,19.48,19.48,,1152,Nucleolar protein 6,condensed nuclear chromosome|nucleus|nucleolus|mitochondrion|small-subunit processome|CURI complex|UTP-C complex|,rRNA processing|tRNA export from nucleus|,poly(A) RNA binding|,5,13,2350000000,1.6%
Q3U492,0.368631529,0.209666667,8.03919601,-0.780666667,0.157065355,-1.61636242,1.281,0.968,-0.449,-0.265,-0.25,-0.027,Q3U492,Kcp,Q3U492_Kcp,Q3U492,Kcp,1,4,2,2,Q3U492|Q3U492-2|E9QNB3,MOUSE,178777.4,1.5,504,504.1,19.29,19.29,,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,2,4,9430000,1.5%
E9PZ36,0.746286063,0.369166667,2.428619391,-0.559,0.571660337,-0.59831418,-0.368,-0.531,2.845,-0.141,-0.033,0.443,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,6,3,3,E9PZ36,MOUSE,450351.1,1.1,505,505.1,19.15,19.15,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,3,6,4320000000,1.1%
A0A075B5L7,0.314778944,0.1594,9.691198692,0.938166667,0.107369302,1.958300787,-0.502,-0.305,,-0.233,0.685,1.152,A0A075B5L7,NotFound,A0A075B5L7_NotFound,A0A075B5L7,Igkv4-80,1,7,2,2,A0A075B5L7,MOUSE,12676,18.9,506,506.1,19.03,19.03,,116,Immunoglobulin kappa variable 4-80 (Fragment),,,,2,7,1000000000,18.9%
P15535,0.561700919,-0.995333333,4.786243173,1.835333333,0.332181684,1.055328831,0.24,0.15,-6.129,-0.088,-0.11,-0.035,P15535,B4galt1,P15535_B4galt1,P15535,B4galt1,1,3,2,2,P15535|P15535-2|B1AXY5,MOUSE,44809.7,7,507,507.1,19.03,19.03,,399,"Beta-1,4-galactosyltransferase 1",Golgi trans cisterna|extracellular space|Golgi apparatus|plasma membrane|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|desmosome|glycocalyx|filopodium|brush border membrane|Golgi cisterna membrane|extracellular exosome|,epithelial cell development|acute inflammatory response|lactose biosynthetic process|galactose metabolic process|protein glycosylation|protein N-linked glycosylation|cell adhesion|binding of sperm to zona pellucida|penetration of zona pellucida|negative regulation of cell proliferation|glycoprotein biosynthetic process|oligosaccharide biosynthetic process|extracellular matrix organization|mammary gland development|wound healing|regulation of cell proliferation|positive regulation of apoptotic process|development of secondary sexual characteristics|branching morphogenesis of an epithelial tube|leukocyte migration|regulation of cellular component movement|regulation of acrosome reaction|positive regulation of epithelial cell proliferation involved in wound healing|angiogenesis involved in wound healing|positive regulation of apoptotic process involved in mammary gland involution|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|protein binding|cytoskeletal protein binding|galactosyltransferase activity|protein kinase binding|manganese ion binding|UDP-galactosyltransferase activity|protein homodimerization activity|alpha-tubulin binding|beta-tubulin binding|",2,3,36300000,7.0%
Q9Z0J4-5,0.145366797,-0.2408,16.95704808,1.2245,0.020150935,3.350742965,-0.554,-1.397,,0.41,0.311,0.026,Q9Z0J4,Nos1,Q9Z0J4-5_Nos1,Q9Z0J4-5,Nos1,1,6,3,3,Q9Z0J4-5|F8WGF2|Q9Z0J4|S4R255|Q9Z0J4-3|Q9Z0J4-4|Q9Z0J4-2,MOUSE,165708.8,2,508,508.1,19.01,19.01,,1429,"Isoform NNOS Mu of Nitric oxide synthase, brain",mitochondrion|mitochondrial outer membrane|cytosol|cytoskeleton|vesicle membrane|postsynaptic density|sarcoplasmic reticulum|Z disc|T-tubule|nuclear membrane|sarcoplasmic reticulum membrane|sarcolemma|azurophil granule|dendritic spine|membrane raft|synapse|caveola|,"response to hypoxia|regulation of sodium ion transport|nitric oxide biosynthetic process|striated muscle contraction|nitric oxide mediated signal transduction|female pregnancy|aging|negative regulation of cell proliferation|response to heat|response to lead ion|response to activity|peptidyl-cysteine S-nitrosylation|positive regulation of guanylate cyclase activity|response to lipopolysaccharide|response to vitamin E|multicellular organismal response to stress|positive regulation of histone acetylation|response to nicotine|exogenous drug catabolic process|negative regulation of apoptotic process|negative regulation of potassium ion transport|response to peptide hormone|response to estrogen|response to ethanol|negative regulation of blood pressure|negative regulation of heart contraction|positive regulation of transcription, DNA-templated|negative regulation of vasoconstriction|positive regulation of vasodilation|positive regulation of transcription from RNA polymerase II promoter|negative regulation of insulin secretion|behavioral response to cocaine|regulation of neurogenesis|negative regulation of hydrolase activity|negative regulation of cytosolic calcium ion concentration|negative regulation of serotonin uptake|negative regulation of calcium ion transport|regulation of sensory perception of pain|oxidation-reduction process|cellular response to mechanical stimulus|cellular response to growth factor stimulus|response to nitric oxide|positive regulation of the force of heart contraction|positive regulation of long-term synaptic potentiation|positive regulation of adrenergic receptor signaling pathway involved in heart process|positive regulation of neuron death|",NADPH-hemoprotein reductase activity|nitric-oxide synthase activity|iron ion binding|protein binding|calmodulin binding|FMN binding|enzyme binding|heme binding|protein homodimerization activity|flavin adenine dinucleotide binding|NADP binding|,3,6,10300000000,2.0%
E9Q5P0,0.579921534,0.303166667,4.438967196,-0.523,0.359834898,-0.991132685,0.228,-0.246,1.712,-0.132,0.2,0.057,E9Q5P0,Hpn,E9Q5P0_Hpn,E9Q5P0,Hpn,1,3,2,2,E9Q5P0|O35453|O35453-2|G3UWE8,MOUSE,48900.6,5.1,509,509.1,18.93,18.93,,445,Serine protease hepsin,endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extracellular exosome|nuclear membrane|,proteolysis|sensory perception of sound|regulation of cell shape|negative regulation of alkaline phosphatase activity|negative regulation of epithelial to mesenchymal transition|positive regulation of plasminogen activation|positive regulation of cell growth|basement membrane disassembly|cholesterol homeostasis|negative regulation of apoptotic process|positive regulation by host of viral transcription|negative regulation of epithelial cell proliferation|positive regulation of hepatocyte proliferation|,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|serine-type exopeptidase activity|,2,3,33100000,5.1%
P56480,0.239764543,0.4642,11.8641175,-2.0455,0.065101089,-2.361126662,0.272,3.111,,-0.132,-0.502,-0.428,P56480,Atp5b,P56480_Atp5b,P56480,Atp5b,1,2,2,2,P56480,MOUSE,56299.5,5.6,510,510.1,18.87,18.87,,529,"ATP synthase subunit beta, mitochondrial","nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|plasma membrane|cell surface|membrane|mitochondrial membrane|mitochondrial nucleoid|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",angiogenesis|osteoblast differentiation|lipid metabolic process|ATP biosynthetic process|negative regulation of cell adhesion involved in substrate-bound cell migration|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|proton transport|regulation of intracellular pH|,"ATP binding|MHC class I protein binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",2,2,3710000,5.6%
Q3U515,0.019718998,0.972833333,31.47746636,-2.991666667,0.000711629,-6.348076502,1.924,2.194,3.288,-0.386,-1.122,-0.061,Q3U515,Vwce,Q3U515_Vwce,Q3U515,Vwce,1,3,2,2,Q3U515,MOUSE,103029.8,2.9,511,511.1,18.81,18.81,,929,von Willebrand factor C and EGF domain-containing protein,extracellular region|,positive regulation of cell proliferation|regulation of signal transduction|,calcium ion binding|,2,3,12000000,2.9%
A0A1Y7VLS3,0.119530648,-0.2238,18.69742155,1.025333333,0.01349764,3.719324197,-0.963,-0.715,,0.329,0.226,0.004,A0A1Y7VLS3,Togaram1,A0A1Y7VLS3_Togaram1,A0A1Y7VLS3,Togaram1,1,6,3,3,A0A1Y7VLS3|Q6A070|Q6A070-2,MOUSE,201882.1,1.7,512,512.1,18.61,18.61,,1826,TOG array regulator of axonemal microtubules protein 1,,,,3,6,1950000000,1.7%
Q9QZ25,0.339304798,0.362666667,8.732034653,-0.854,0.13390492,-1.732004976,0.252,0.26,1.857,0.104,-0.339,0.042,Q9QZ25,Vnn3,Q9QZ25_Vnn3,Q9QZ25,Vnn3,1,2,2,2,Q9QZ25,MOUSE,56931.6,3.6,513,513.1,18.61,18.61,,500,Vascular non-inflammatory molecule 3,extracellular space|plasma membrane|anchored component of membrane|,pantothenate metabolic process|,pantetheine hydrolase activity|,2,2,30300000,3.6%
F6VAN0,0.155174868,-0.2586,16.30524061,0.898166667,0.023414018,3.210421842,-0.986,-0.609,,0.072,0.232,-0.002,F6VAN0,Atf6,F6VAN0_Atf6,F6VAN0,Atf6,1,8,2,2,F6VAN0,MOUSE,73149.6,3,514,514.1,18.58,18.58,,656,Cyclic AMP-dependent transcription factor ATF-6 alpha,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|integral component of endoplasmic reticulum membrane|,"transcription, DNA-templated|endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|cAMP response element binding|protein heterodimerization activity|,2,8,578000000,3.0%
P97821,0.362376595,-0.3196,8.258297613,0.909,0.149337968,1.702217486,-0.05,-1.68,,-0.065,0.112,0.085,P97821,Ctsc,P97821_Ctsc,P97821,Ctsc,1,3,1,1,P97821,MOUSE,53174.2,2.5,515,515.1,18.55,18.55,,462,Dipeptidyl peptidase 1,extracellular space|lysosome|endoplasmic reticulum|Golgi apparatus|membrane|extracellular exosome|,T cell mediated cytotoxicity|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|aging|response to organic substance|proteolysis involved in cellular protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|positive regulation of apoptotic signaling pathway|,cysteine-type endopeptidase activity|serine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|phosphatase binding|chloride ion binding|identical protein binding|protein self-association|chaperone binding|,1,3,20100000,2.5%
P30412,0.098250515,0.599166667,19.97175657,-1.467666667,0.010065245,-3.698585438,0.678,1.785,1.536,-0.112,-0.58,0.288,P30412,Ppic,P30412_Ppic,P30412,Ppic,1,3,2,2,P30412,MOUSE,22907.8,10.3,516,516.1,18.41,18.41,,212,Peptidyl-prolyl cis-trans isomerase C,cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|cyclosporin A binding|,2,3,243000000,10.3%
Q7TQ48,0.850670217,-0.273833333,1.368667967,0.273,0.729681278,0.362231961,0.308,0.631,-2.17,-0.245,-0.042,-0.125,Q7TQ48,Srl,Q7TQ48_Srl,Q7TQ48,Srl,1,6,3,3,Q7TQ48|Q7TQ48-2,MOUSE,99581.6,3,517,517.1,18.37,18.37,,910,Sarcalumenin,sarcoplasmic reticulum lumen|,,GTP binding|,3,6,148000000,3.0%
D3Z623,0.765859545,0.154833333,2.296425749,0.258333333,0.589328474,0.569992021,0.76,0.233,-0.916,0.189,0.3,0.363,D3Z623,9330159F19Rik,D3Z623_9330159F19Rik,D3Z623,9330159F19Rik,1,3,3,3,D3Z623|A0A1L1SS16,MOUSE,74697,5.2,518,518.1,18.33,18.33,,648,"MCG7194, isoform CRA_a",,,,3,3,6620000000,5.2%
A4Q9F4,0.009081837,-0.868,37.45370536,2.44,0.000179734,9.791702492,-2.318,-2.346,,0.095,0.091,0.138,A4Q9F4,Ttll11,A4Q9F4_Ttll11,A4Q9F4,Ttll11,1,4,3,3,A4Q9F4|A4Q9F4-2|A4Q9F4-3,MOUSE,83044.2,4.9,519,519.1,18.19,18.19,,727,Tubulin polyglutamylase TTLL11,cytoplasm|cytoskeleton|cilium|,protein polyglutamylation|microtubule severing|,ligase activity|,3,4,1440000000,4.9%
Q8BMJ2,0.007983705,0.89,39.73788158,-4.19,0.000106221,-8.965795391,3.2,2.273,3.482,-1.113,-1.879,-0.623,Q8BMJ2,Lars,Q8BMJ2_Lars,Q8BMJ2,Lars,1,9,3,3,Q8BMJ2,MOUSE,135445.1,2.4,520,520.1,18.18,18.18,,1178,"Leucine--tRNA ligase, cytoplasmic",nucleus|cytoplasm|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|methionyl-tRNA aminoacylation|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|methionine-tRNA ligase activity|,3,9,25700000000,2.4%
E9PZQ0,0.902789601,0.112,0.928903204,-0.101333333,0.80743892,-0.254703596,0.553,-0.63,0.565,-0.102,-0.053,0.339,E9PZQ0,Ryr1,E9PZQ0_Ryr1,E9PZQ0,Ryr1,1,7,3,3,A0A1L1SQG7|E9PZQ0|K3W4M2|Q5DTZ6|Q5DTZ6-2|Q5DTZ6-3|Q99MV7|Q8CFI7|Q99MV7-3|P18293|Q3UFM5|Q8K4B0|E9PX23|F8WHY8|Q9R190|Q8BKV1|F8WHY9|M0QWK4|H3BLK0|Q3URK1|E0CXM8|Q99N20|E0CZ80,MOUSE,570734.5,0.3,521,521.1,18.14,18.14,,5035,Ryanodine receptor 1,cytoplasm|smooth endoplasmic reticulum|plasma membrane|cell cortex|membrane|integral component of membrane|sarcoplasmic reticulum|junctional membrane complex|T-tubule|I band|sarcoplasmic reticulum membrane|protein complex|extracellular exosome|,response to hypoxia|outflow tract morphogenesis|calcium ion transport|muscle contraction|regulation of muscle contraction|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|skin development|ossification involved in bone maturation|skeletal muscle fiber development|release of sequestered calcium ion into cytosol|calcium ion transmembrane transport|cellular response to caffeine|,protease binding|ryanodine-sensitive calcium-release channel activity|voltage-gated calcium channel activity|calcium channel activity|protein binding|calmodulin binding|enzyme binding|,4,7,9350000000,0.3%
E9Q3P4,0.569326761,0.695,4.617938423,-1.454166667,0.345307616,-1.042546239,3.502,-0.367,,-0.513,1.68,-0.827,E9Q3P4,Cenpf,E9Q3P4_Cenpf,E9Q3P4,Cenpf,1,15,2,2,E9Q3P4,MOUSE,345546.7,0.9,522,522.1,18.07,18.07,,2997,Centromere protein F,"chromosome, centromeric region|spindle pole|condensed chromosome outer kinetochore|nucleus|nuclear envelope|nucleoplasm|cytoplasm|spindle|nuclear matrix|midbody|pronucleus|kinetochore|","mitotic cell cycle|chromosome segregation|regulation of G2/M transition of mitotic cell cycle|protein transport|regulation of striated muscle tissue development|negative regulation of transcription, DNA-templated|metaphase plate congression|",protein C-terminus binding|transcription factor binding|protein homodimerization activity|dynein binding|,2,15,15000000000,0.9%
A0A140T8N8,0.970099283,0.757,0.316014086,-0.080833333,0.929819375,-0.092636518,0.9,0.711,,-0.065,2.388,-0.149,A0A140T8N8,NotFound,A0A140T8N8_NotFound,A0A140T8N8,Igkv9-123,1,6,2,2,A0A140T8N8,MOUSE,12986.4,17.9,523,523.1,18.01,18.01,,117,Immunoglobulin kappa variable 9-123 (Fragment),,,,2,6,461000000,17.9%
Q9R1P4,0.469152357,-0.0862,6.046678642,0.338833333,0.248503286,1.304150227,-0.169,-0.41,,0.07,0.088,-0.01,Q9R1P4,Psma1,Q9R1P4_Psma1,Q9R1P4,Psma1,1,7,2,2,Q9R1P4|A0A1B0GS70,MOUSE,29831.3,5.7,524,524.1,17.88,17.88,,263,Proteasome subunit alpha type-1,"proteasome complex|nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",immune system process|negative regulation of inflammatory response to antigenic stimulus|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,lipopolysaccharide binding|endopeptidase activity|threonine-type endopeptidase activity|protein binding|,2,7,3720000000,5.7%
Q9JHJ8-2,0.612514063,0.1772,3.894810705,-0.244666667,0.407867339,-0.902376461,0.412,0.236,,0.255,0.059,-0.076,Q9JHJ8,Icosl,Q9JHJ8-2_Icosl,Q9JHJ8-2,Icoslg,1,4,3,3,Q9JHJ8-2|A0A1W2P6Q2|Q9JHJ8,MOUSE,39426.3,11.8,525,525.1,17.87,17.87,,322,Isoform 2 of ICOS ligand,integral component of plasma membrane|external side of plasma membrane|integral component of membrane|extracellular exosome|,signal transduction|positive regulation of activated T cell proliferation|T cell activation|isotype switching|positive regulation of interleukin-4 biosynthetic process|,receptor binding|protein binding|,3,4,153000000,11.8%
O89023,0.61589699,0.2288,3.847638687,0.357166667,0.412321643,0.893708377,0.12,-0.091,,0.892,-0.175,0.398,O89023,Tpp1,O89023_Tpp1,O89023,Tpp1,1,6,2,2,O89023,MOUSE,61797.5,3.5,526,526.1,17.8,17.8,,562,Tripeptidyl-peptidase 1,mitochondrion|lysosome|melanosome|extracellular exosome|,proteolysis|lysosome organization|nervous system development|central nervous system development|epithelial cell differentiation|peptide catabolic process|bone resorption|neuromuscular process controlling balance|,endopeptidase activity|serine-type endopeptidase activity|protein binding|peptidase activity|serine-type peptidase activity|tripeptidyl-peptidase activity|metal ion binding|,2,6,138000000,3.5%
Q3UHI0-2,0.232324458,-0.435833333,12.1848516,0.865,0.060466501,2.306465911,-0.407,-0.589,-1.609,-0.185,0.012,0.163,Q3UHI0,Ccser2,Q3UHI0-2_Ccser2,Q3UHI0-2,Ccser2,1,16,2,2,Q3UHI0-2|Q3UHI0,MOUSE,115944.3,1.9,527,527.1,17.71,17.71,,833,Isoform 2 of Serine-rich coiled-coil domain-containing protein 2,microtubule cytoskeleton|,,microtubule binding|,2,16,1.55E+12,1.9%
A0A140LIJ4,0.941165914,0.2595,0.65457317,0.073666667,0.860087593,0.183965275,-0.439,0.602,0.505,0.681,-0.208,0.416,A0A140LIJ4,NotFound,A0A140LIJ4_NotFound,A0A140LIJ4,Dnah14,1,6,3,3,A0A140LIJ4,MOUSE,521611.8,0.9,528,528.1,17.68,17.68,,4489,"Dynein, axonemal, heavy chain 14",,,,3,6,300000000,0.9%
Q9WU60,0.963890373,-0.097,0.420169996,0.078666667,0.907784996,0.120847025,0.612,0.626,-1.647,-0.109,-0.058,-0.006,Q9WU60,Atrn,Q9WU60_Atrn,Q9WU60,Atrn,1,4,2,2,Q9WU60,MOUSE,163133.2,1.4,529,529.1,17.68,17.68,,1428,Attractin,extracellular space|cytoplasm|plasma membrane|integral component of membrane|extracellular exosome|,inflammatory response|response to oxidative stress|cerebellum development|regulation of multicellular organism growth|myelination|pigmentation|,receptor activity|protein binding|carbohydrate binding|,2,4,24700000,1.4%
Q2XU92,0.064716718,-0.4826,23.10063324,1.885666667,0.004897074,4.788975618,-1.964,-1.264,,0.214,-0.096,0.697,Q2XU92,Acsbg2,Q2XU92_Acsbg2,Q2XU92,Acsbg2,1,13,2,2,Q2XU92,MOUSE,75116.7,2.5,530,530.1,17.65,17.65,,667,Long-chain-fatty-acid--CoA ligase ACSBG2,cytoplasm|mitochondrion|cytosol|membrane|,long-chain fatty acid metabolic process|fatty acid metabolic process|fatty acid beta-oxidation|multicellular organismal development|spermatogenesis|cell differentiation|,long-chain fatty acid-CoA ligase activity|ATP binding|acyl-CoA hydrolase activity|,2,13,17400000000,2.5%
P07214,0.848045337,-0.0194,1.421446057,-0.094833333,0.720867414,-0.377919546,0.01,0.065,,-0.093,-0.082,0.003,P07214,Sparc,P07214_Sparc,P07214,Sparc,1,3,2,2,A0A1L1SSH9|P07214|Q5NCU4,MOUSE,35305.2,5.2,531,531.1,17.59,17.59,,302,SPARC,proteinaceous extracellular matrix|basement membrane|extracellular space|cell surface|nuclear matrix|platelet alpha granule|platelet alpha granule membrane|,negative regulation of endothelial cell proliferation|signal transduction|heart development|response to gravity|response to lead ion|positive regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of cell morphogenesis|lung development|response to lipopolysaccharide|response to L-ascorbic acid|response to cytokine|wound healing|regulation of cell proliferation|response to peptide hormone|response to ethanol|response to cadmium ion|inner ear development|response to glucocorticoid|response to cAMP|response to calcium ion|bone development|cellular response to growth factor stimulus|,calcium ion binding|collagen binding|extracellular matrix binding|,2,3,107000000,5.2%
Q99MN9,0.088879092,0.5435,21.04379961,-1.569666667,0.007863575,-3.909388643,2.025,1.359,0.601,-0.077,-0.446,-0.201,Q99MN9,Pccb,Q99MN9_Pccb,Q99MN9,Pccb,1,2,2,2,Q99MN9|E9Q1J7,MOUSE,59035.6,4.6,532,532.1,17.58,17.58,,541,"Propionyl-CoA carboxylase beta chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,propionyl-CoA carboxylase activity|ATP binding|,2,2,6580000,4.6%
P07743,0.269872202,-0.08,11.01697248,0.7875,0.079123001,2.196875252,-0.356,-0.749,,-0.073,0.693,0.085,P07743,Bpifa2,P07743_Bpifa2,P07743,Bpifa2,1,3,1,1,P07743,MOUSE,24923.6,6.8,533,533.1,17.57,17.57,,235,BPI fold-containing family A member 2,extracellular region|secretory granule|extracellular exosome|,defense response to bacterium|,lipopolysaccharide binding|,1,3,25200000,6.8%
Q9CPN9,0.902789601,0.067,0.919158909,-0.088666667,0.809252611,-0.252244351,0.599,0.284,-0.549,0.191,-0.058,-0.065,Q9CPN9,2210010C04Rik,Q9CPN9_2210010C04Rik,Q9CPN9,2210010C04Rik,1,10,1,1,Q9CPN9,MOUSE,27106.2,4.8,534,534.1,17.31,17.31,,247,RIKEN cDNA 2210010C04 gene,extracellular space|,proteolysis|,serine-type endopeptidase activity|,1,10,2050000000,4.8%
P01725,0.955428034,0.1722,0.47460142,0.062833333,0.896478458,0.136845968,0.687,-0.418,,-0.235,0.346,0.481,P01725,NotFound,P01725_NotFound,P01725,,1,6,2,2,P01725,MOUSE,11767.9,26.3,535,535.1,17.29,17.29,,110,Ig lambda-1 chain V region S178,,,antigen binding|,2,6,8780000000,26.3%
E9PUU4,0.189992891,-0.08,14.6325416,1,0.034414847,2.877188396,-0.502,-0.858,,0.753,0.023,0.184,E9PUU4,Gemin5,E9PUU4_Gemin5,E9PUU4,Gemin5,1,10,3,3,E9PUU4|Q8BX17|A2AFQ9,MOUSE,169370,2.2,536,536.1,17.15,17.15,,1503,Gem-associated protein 5,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,3,10,5450000000,2.2%
A0A087WQT1,0.314778944,0.1975,9.699030038,-0.787333333,0.107175865,-2.063978674,,0.788,,-0.043,0.202,-0.157,A0A087WQT1,NotFound,A0A087WQT1_NotFound,A0A087WQT1,BC025446,1,1,1,1,A0A087WQT1|Q8R155,MOUSE,15147.2,18.6,537,537.1,17.03,17.03,,134,cDNA sequence BC025446,,,,1,1,14500000,18.6%
P09411,0.606920005,-0.200166667,4.018988496,0.395666667,0.396370341,0.913001176,0.07,0.067,-1.331,0.106,-0.091,-0.022,P09411,Pgk1,P09411_Pgk1,P09411,Pgk1,1,7,3,3,P09411|S4R2M7,MOUSE,44949.1,7.1,538,538.1,17.01,17.01,,417,Phosphoglycerate kinase 1,cytoplasm|,glycolytic process|phosphorylation|,phosphoglycerate kinase activity|ATP binding|,3,7,1290000000,7.1%
Q7TNB8,0.155174868,0.693666667,16.21480737,-2.085333333,0.02390668,-3.010093353,2.788,0.153,2.268,-0.482,-0.217,-0.348,Q7TNB8,Sbno2,Q7TNB8_Sbno2,Q7TNB8,Sbno2,1,3,3,3,Q7TNB8|Q7TNB8-2,MOUSE,150546.2,3.1,539,539.1,16.97,16.97,,1349,Protein strawberry notch homolog 2,,"macrophage activation involved in immune response|transcription, DNA-templated|bone mineralization|osteoclast differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of inflammatory response|bone trabecula morphogenesis|multinuclear osteoclast differentiation|osteoclast fusion|",protein binding|,3,3,15300000000,3.1%
A0A075B5L3,0.013690476,0.619833333,34.55151921,-1.977,0.000350629,-7.201570522,1.44,1.936,1.449,-0.34,-0.654,-0.112,A0A075B5L3,NotFound,A0A075B5L3_NotFound,A0A075B5L3,Igkv4-90,1,2,1,1,A0A075B5L3,MOUSE,12723.1,13.6,540,540.1,16.85,16.85,,117,Immunoglobulin kappa chain variable 4-90 (Fragment),,,,1,2,4260000,13.6%
Q8BYY9,0.826430946,-0.346833333,1.658179841,0.527666667,0.682624727,0.429549228,0.981,0.752,-3.565,-0.024,-0.074,-0.151,Q8BYY9,Serpina3b,Q8BYY9_Serpina3b,Q8BYY9,Serpina3b,1,2,1,1,Q8BYY9,MOUSE,47642.2,2.6,541,541.1,16.85,16.85,,420,Serine protease inhibitor A3B,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,1,2,11600000,2.6%
P43274,0.021185729,0.777666667,30.89435816,-2.210666667,0.000813887,-6.186699807,1.887,1.4,2.362,0.101,-0.692,-0.392,P43274,Hist1h1e,P43274_Hist1h1e,P43274,Hist1h1e,1,2,2,2,P43274|P43277|P43275|P15864,MOUSE,21976.9,11.8,542,542.1,16.61,16.61,,219,Histone H1.4,nucleosome|nucleus|nuclear heterochromatin|extracellular exosome|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|nucleosome positioning|,DNA binding|protein binding|chromatin DNA binding|poly(A) RNA binding|,2,2,35000000,11.8%
Q9ER39,0.646971682,0.197,3.478616324,0.518333333,0.448888384,0.821812619,-0.96,0.732,,0.926,0.434,-0.147,Q9ER39,Tor1a,Q9ER39_Tor1a,Q9ER39,Tor1a,1,1,1,1,Q9ER39,MOUSE,38228.6,3.3,543,543.1,16.57,16.57,,333,Torsin-1A,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|cytoskeleton|synaptic vesicle|membrane|cell junction|transport vesicle|secretory granule|growth cone|cytoplasmic vesicle membrane|nuclear membrane|extrinsic component of endoplasmic reticulum membrane|intracellular membrane-bounded organelle|extracellular exosome|,"protein deneddylation|response to oxidative stress|organelle organization|nuclear envelope organization|cell adhesion|neuron projection development|protein localization to nucleus|wound healing, spreading of cells|intermediate filament cytoskeleton organization|synaptic vesicle transport|chaperone mediated protein folding requiring cofactor|protein homooligomerization|regulation of dopamine uptake involved in synaptic transmission|chaperone-mediated protein folding|ER-associated misfolded protein catabolic process|nuclear membrane organization|chaperone-mediated protein transport|positive regulation of synaptic vesicle endocytosis|regulation of protein localization to cell surface|",protein binding|ATP binding|cytoskeletal protein binding|ATPase activity|kinesin binding|unfolded protein binding|misfolded protein binding|,1,1,5670000,3.3%
S4R1P5,0.680102626,0.4962,3.147045656,-0.363,0.484501844,-0.754426838,1.021,0.407,,0.982,-0.31,0.381,S4R1P5,Dst,S4R1P5_Dst,S4R1P5,Dst,1,5,3,3,S4R1P5|E9Q9X1|Q91ZU6-4|Q91ZU6-3|Q91ZU6|Q91ZU6-2|A0A087WSP0,MOUSE,876109,0.3,544,544.1,16.5,16.5,,7717,Dystonin,actin cytoskeleton|cytoplasmic membrane-bounded vesicle|hemidesmosome|neuronal postsynaptic density|,cytoskeleton organization|cell cycle arrest|axonogenesis|retrograde axon cargo transport|,actin binding|calcium ion binding|protein binding|,3,5,2000000000,0.3%
P12804,0.112924146,-0.4492,19.08078495,1.041333333,0.012357241,3.804545985,-1.222,-0.926,,-0.101,-0.118,0.121,P12804,Fgl2,P12804_Fgl2,P12804,Fgl2,1,2,1,1,P12804,MOUSE,49634.7,2.3,545,545.1,16.41,16.41,,432,Fibroleukin,extracellular exosome|,cytolysis|,,1,2,41700000,2.3%
Q8BGS1-3,0.432253305,-0.0596,6.7294239,0.384,0.212352613,1.427241048,-0.455,-0.125,,0.131,0.137,0.014,Q8BGS1,Epb41l5,Q8BGS1-3_Epb41l5,Q8BGS1-3,Epb41l5,1,8,2,2,Q8BGS1-3|Q8BGS1|Q8BGS1-2,MOUSE,83272.7,2.8,546,546.1,16.16,16.16,,731,Isoform 3 of Band 4.1-like protein 5,nucleus|cytoplasm|cytoskeleton|plasma membrane|focal adhesion|extrinsic component of membrane|cell leading edge|ruffle membrane|,"cell morphogenesis involved in differentiation|in utero embryonic development|somitogenesis|epithelial to mesenchymal transition|neural plate morphogenesis|positive regulation of cell-matrix adhesion|epithelial cell morphogenesis|apical constriction|substrate-dependent cell migration, cell attachment to substrate|ectoderm development|endoderm development|mesoderm development|mesoderm migration involved in gastrulation|unidimensional cell growth|posttranscriptional regulation of gene expression|positive regulation of epithelial cell migration|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-cell adhesion|actin cytoskeleton organization|actomyosin structure organization|negative regulation of protein binding|positive regulation of protein binding|somite rostral/caudal axis specification|axial mesoderm development|axial mesoderm morphogenesis|paraxial mesoderm development|embryonic foregut morphogenesis|positive regulation of focal adhesion assembly|regulation of establishment of protein localization|left/right axis specification|cellular response to transforming growth factor beta stimulus|",protein binding|cytoskeletal protein binding|protein domain specific binding|,2,8,9070000000,2.8%
Q8K3F2,0.346454144,-0.175,8.560031099,0.7175,0.139314683,1.755833495,-0.091,-1.12,,0.377,-0.048,0.007,Q8K3F2,Mmp21,Q8K3F2_Mmp21,Q8K3F2,Mmp21,1,11,2,2,Q8K3F2,MOUSE,65738.1,3.8,547,547.1,16.07,16.07,,568,Matrix metalloproteinase-21,extracellular region|extracellular matrix|,hematopoietic progenitor cell differentiation|proteolysis|,metalloendopeptidase activity|calcium ion binding|metallopeptidase activity|zinc ion binding|,2,11,15300000000,3.8%
Q91WR8,0.408138607,-0.0542,7.200411138,0.393833333,0.190528034,1.511550758,-0.289,-0.292,,0.144,-0.048,0.214,Q91WR8,Gpx6,Q91WR8_Gpx6,Q91WR8,Gpx6,1,3,1,1,Q91WR8,MOUSE,25188.2,7.6,548,548.1,16.05,16.05,,221,Glutathione peroxidase 6,extracellular region|,response to oxidative stress|oxidation-reduction process|,glutathione peroxidase activity|,1,3,12600000,7.6%
P48356,0.205994858,-0.2204,13.69716781,0.726,0.04268578,2.694109007,-0.682,-0.63,,0.201,-0.134,0.143,P48356,Lepr,P48356_Lepr,P48356,Lepr,1,3,2,2,P48356|P48356-4|P48356-2|P48356-3|P48356-5,MOUSE,132954.3,1.2,549,549.1,15.88,15.88,,1162,Leptin receptor,extracellular region|plasma membrane|integral component of plasma membrane|receptor complex|,signal transduction|cholesterol metabolic process|cytokine-mediated signaling pathway|regulation of metabolic process|negative regulation of gluconeogenesis|negative regulation of hydrolase activity|,transmembrane signaling receptor activity|cytokine receptor activity|protein binding|identical protein binding|,2,3,578000000,1.2%
Q05020,0.159993909,-0.137,16.02784915,0.906666667,0.024958305,3.153757851,-0.58,-0.782,,0.201,0.467,0.009,Q05020,Apoc2,Q05020_Apoc2,Q05020,Apoc2,1,4,2,2,Q05020,MOUSE,10741.1,14.4,550,550.1,15.65,15.65,,97,Apolipoprotein C-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|,positive regulation of phospholipase activity|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle clearance|lipid catabolic process|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|chylomicron remnant clearance|high-density lipoprotein particle clearance|response to drug|lipoprotein transport|negative regulation of catalytic activity|positive regulation of fatty acid biosynthetic process|negative regulation of lipid metabolic process|negative regulation of receptor-mediated endocytosis|positive regulation of lipoprotein lipase activity|positive regulation of phospholipid catabolic process|triglyceride homeostasis|,lipid binding|phospholipase activator activity|protein homodimerization activity|phospholipase binding|lipase inhibitor activity|lipoprotein lipase activator activity|,2,4,282000000,14.4%
F1MB32,0.891021159,0.150333333,1.063736783,-0.226,0.782755849,-0.288476716,-0.945,-0.314,2.049,-0.145,-0.089,0.346,F1MB32,NotFound,F1MB32_NotFound,F1MB32,A2ML1,1,4,2,2,F1MB32,BOVIN,157039.4,1.8,551,551.1,15.52,15.52,,1396,Uncharacterized protein,,,,2,4,1050000000,1.8%
P68433,0.014726443,0.807166667,34.01338731,-2.501,0.000396882,-7.071284329,2.587,1.817,1.769,0.013,-0.786,-0.557,P68433,Hist1h3g,P68433_Hist1h3g,P68433,Hist1h3a,1,3,2,2,A0A1W2P768|P68433|P84228|P84244|P02301|F8WI35,MOUSE,15517.9,10.2,552,552.1,15.4,15.4,,136,Histone H3.1,nuclear nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|DNA replication-dependent nucleosome assembly|protein heterotetramerization|regulation of gene silencing|,DNA binding|protein binding|histone binding|protein heterodimerization activity|,2,3,118000000,10.2%
Q61627,0.112924146,-0.3862,19.10390452,1.194666667,0.012291632,3.809720227,-1.366,-0.84,,0.094,-0.113,0.294,Q61627,Grid1,Q61627_Grid1,Q61627,Grid1,1,4,2,2,Q61627,MOUSE,113178,2.7,553,553.1,15.39,15.39,,1009,"Glutamate receptor ionotropic, delta-1",plasma membrane|ionotropic glutamate receptor complex|cell junction|dendrite|postsynaptic membrane|extracellular exosome|,"ion transmembrane transport|social behavior|ionotropic glutamate receptor signaling pathway|synaptic transmission, glutamatergic|",ionotropic glutamate receptor activity|extracellular-glutamate-gated ion channel activity|,2,4,2010000000,2.7%
Q6ZPY7,0.946089108,0.3385,0.60626576,-0.147,0.869707918,-0.171233798,-1.007,-0.085,2.328,0.4,-0.169,0.564,Q6ZPY7,NotFound,Q6ZPY7_NotFound,Q6ZPY7,Kdm3b,1,21,2,2,B9EKS2|Q6ZPY7,MOUSE,172583.6,1.2,554,554.1,15.33,15.33,,1562,Lysine-specific demethylase 3B,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|oxidation-reduction process|",metal ion binding|dioxygenase activity|,2,21,18300000000,1.2%
P49452,0.311388971,-0.04,9.807281266,0.545,0.104537443,1.976435061,-0.198,-0.536,,0.242,0.253,0.039,P49452,Cenpc1,P49452_Cenpc1,P49452,Cenpc,1,2,2,2,P49452,MOUSE,102722.5,2.4,555,555.1,15.3,15.3,,906,Centromere protein C,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,2,2,2730000000,2.4%
D3YTR0,0.789399258,-0.0694,2.0618152,0.135166667,0.62204024,0.524669263,-0.252,-0.049,,-0.063,0.051,-0.034,D3YTR0,NotFound,D3YTR0_NotFound,D3YTR0,Apc2,1,4,3,3,D3YTR0|Q9Z1K7|G5E832,MOUSE,248334.3,1.1,556,556.1,15.27,15.27,,2303,Adenomatous polyposis coli protein 2,cytoplasm|Golgi apparatus|actin filament|microtubule cytoskeleton|catenin complex|lamellipodium membrane|perinuclear region of cytoplasm|cytoplasmic microtubule|,Wnt signaling pathway|negative regulation of catenin import into nucleus|negative regulation of canonical Wnt signaling pathway|,beta-catenin binding|microtubule binding|,3,4,712000000,1.1%
Q69ZS0,0.337209389,0.0468,8.838744951,0.663,0.130654841,1.805002595,-0.772,0.07,,0.085,0.35,0.501,Q69ZS0,Pdzrn3,Q69ZS0_Pdzrn3,Q69ZS0,Pdzrn3,1,6,2,2,Q69ZS0|Q69ZS0-3|Q69ZS0-2,MOUSE,120996.6,1.6,557,557.1,15.12,15.12,,1063,E3 ubiquitin-protein ligase PDZRN3,neuromuscular junction|,neuromuscular junction development|protein ubiquitination|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,6,2240000000,1.6%
P06869,0.714779565,0.0084,2.73641062,-0.200166667,0.532548221,-0.669567935,-0.159,0.416,,-0.058,-0.104,-0.053,P06869,Plau,P06869_Plau,P06869,Plau,1,2,2,2,P06869,MOUSE,49693.4,5.3,558,558.1,15.11,15.11,,433,Urokinase-type plasminogen activator,extracellular space|focal adhesion|cell surface|membrane|extracellular exosome|,angiogenesis|response to hypoxia|spermatogenesis|embryo implantation|positive regulation of cell proliferation|regulation of receptor activity|response to activity|smooth muscle cell migration|regulation of smooth muscle cell migration|positive regulation of smooth muscle cell migration|plasminogen activation|regulation of cell adhesion mediated by integrin|cellular response to hepatocyte growth factor stimulus|regulation of cell proliferation|fibrinolysis|skeletal muscle tissue regeneration|response to hyperoxia|positive regulation of ovulation|neuron death|cellular response to lipopolysaccharide|cellular response to glucose stimulus|cellular response to hypoxia|cellular response to fluid shear stress|cellular response to staurosporine|regulation of smooth muscle cell-matrix adhesion|regulation of hepatocyte proliferation|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|,2,2,90200000,5.3%
Q91VS8,0.007983705,0.9,44.21203488,-2.908666667,3.79137E-05,-10.67527632,2.734,2.001,2.328,-0.427,-0.668,-0.568,Q91VS8,Farp2,Q91VS8_Farp2,Q91VS8,Farp2,1,3,2,2,Q91VS8,MOUSE,122248.2,1.6,559,559.1,15.11,15.11,,1065,"FERM, ARHGEF and pleckstrin domain-containing protein 2",cytoplasm|cytosol|cytoskeleton|extrinsic component of membrane|,cell adhesion|neuron remodeling|Rac protein signal transduction|osteoclast differentiation|actin cytoskeleton reorganization|regulation of integrin activation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|semaphorin-plexin signaling pathway|podosome assembly|,Rho guanyl-nucleotide exchange factor activity|cytoskeletal protein binding|Rac guanyl-nucleotide exchange factor activity|,2,3,370000000,1.6%
P08228,0.08962435,0.368666667,20.89472544,-1.841333333,0.008138183,-3.880785836,0.667,2.272,0.929,-0.522,-0.865,-0.269,P08228,Sod1,P08228_Sod1,P08228,Sod1,1,3,3,3,P08228,MOUSE,16113.6,22.7,560,560.1,15.09,15.09,,154,Superoxide dismutase [Cu-Zn],extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|cytosol|extracellular matrix|dense core granule|cytoplasmic vesicle|dendrite cytoplasm|neuronal cell body|myelin sheath|protein complex|extracellular exosome|plasma membrane|,activation of MAPK activity|response to reactive oxygen species|response to superoxide|ovarian follicle development|positive regulation of cytokine production|retina homeostasis|response to amphetamine|myeloid cell homeostasis|glutathione metabolic process|superoxide metabolic process|cellular iron ion homeostasis|response to oxidative stress|spermatogenesis|embryo implantation|aging|cell aging|sensory perception of sound|locomotory behavior|anterograde axon cargo transport|retrograde axon cargo transport|regulation of blood pressure|response to heat|response to organic substance|transmission of nerve impulse|removal of superoxide radicals|response to nutrient levels|peripheral nervous system myelin maintenance|positive regulation of superoxide anion generation|response to carbon monoxide|cellular response to potassium ion|regulation of multicellular organism growth|response to drug|response to hydrogen peroxide|superoxide anion generation|negative regulation of apoptotic process|positive regulation of catalytic activity|regulation of GTPase activity|negative regulation of neuron apoptotic process|response to ethanol|negative regulation of cholesterol biosynthetic process|regulation of protein kinase activity|response to antibiotic|response to copper ion|muscle cell cellular homeostasis|response to axon injury|hydrogen peroxide biosynthetic process|regulation of mitochondrial membrane potential|oxidation-reduction process|heart contraction|neurofilament cytoskeleton organization|relaxation of vascular smooth muscle|auditory receptor cell stereocilium organization|cellular response to cadmium ion|cellular response to ATP|reactive oxygen species metabolic process|response to antipsychotic drug|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|protein phosphatase 2B binding|identical protein binding|Rac GTPase binding|chaperone binding|,3,3,197000000,22.7%
P10639,0.433615197,0.130833333,6.684997391,-1.218333333,0.21453604,-1.388980717,1.071,2.318,-1.169,-0.292,-0.904,-0.239,P10639,Txn1,P10639_Txn1,P10639,Txn,1,3,2,2,P10639,MOUSE,12017.6,19,561,561.1,15.06,15.06,,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",2,3,15200000,19.0%
A0A075B5K3,0.529307414,-0.1688,5.209763276,0.430333333,0.301317026,1.151895794,-0.854,0,,-0.261,0.166,0.105,A0A075B5K3,NotFound,A0A075B5K3_NotFound,A0A075B5K3,Igkv17-121,1,4,1,1,A0A075B5K3|A0A075B5J9,MOUSE,12863.4,13.7,562,562.1,15.02,15.02,,116,Immunoglobulin kappa variable 17-121,,,,1,4,274000000,13.7%
A2AFG3,0.090035954,-0.225,20.81950102,1.300833333,0.008280373,4.205280331,-1.174,-0.837,,0.04,0.582,0.264,A2AFG3,Pdzd4,A2AFG3_Pdzd4,A2AFG3,Pdzd4,1,6,2,2,A2AFG3,MOUSE,74414.1,2.4,563,563.1,15.01,15.01,,657,PDZ domain-containing protein 4,,protein ubiquitination|,ubiquitin protein ligase activity|,2,6,2320000000,2.4%
Q3UGX2,0.049087232,0.820166667,24.94836591,-3.411666667,0.003200099,-4.755897427,1.716,1.702,4.16,-0.879,-1.232,-0.546,Q3UGX2,Sptb,Q3UGX2_Sptb,Q3UGX2,Sptb,1,2,2,2,Q3UGX2|E9Q397|P15508,MOUSE,268999.3,0.9,564,564.1,14.95,14.95,,2329,Spectrin beta chain,cytoplasm|plasma membrane|spectrin|cell surface|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|protein complex|,porphyrin-containing compound biosynthetic process|plasma membrane organization|hemopoiesis|,actin binding|structural constituent of cytoskeleton|phospholipid binding|ankyrin binding|protein heterodimerization activity|actin filament binding|,2,2,23100000,0.9%
Q9CSN1,0.049306582,-0.636833333,24.8455822,1.537666667,0.003276738,4.703352359,-2.003,-1.241,-0.973,0.251,0.112,0.033,Q9CSN1,Snw1,Q9CSN1_Snw1,Q9CSN1,Snw1,1,15,2,2,Q9CSN1|A0A0B4J1E2,MOUSE,61531.4,2.6,565,565.1,14.89,14.89,,536,SNW domain-containing protein 1,nucleus|nucleoplasm|spliceosomal complex|nuclear matrix|catalytic step 2 spliceosome|positive transcription elongation factor complex b|SMAD3-SMAD4 protein complex|,"negative regulation of transcription from RNA polymerase II promoter|mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transforming growth factor beta receptor signaling pathway|skeletal muscle cell differentiation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|positive regulation of neurogenesis|positive regulation of histone H3-K4 methylation|regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D receptor signaling pathway|cellular response to retinoic acid|",transcription coactivator activity|transcription corepressor activity|Notch binding|protein binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|poly(A) RNA binding|SMAD binding|,2,15,4.55E+11,2.6%
Q8R1L8,0.819375851,-0.248333333,1.763554263,0.542666667,0.666261278,0.453467374,1.009,0.811,-3.379,0.157,-0.298,0.21,Q8R1L8,Angptl8,Q8R1L8_Angptl8,Q8R1L8,Angptl8,1,2,1,1,Q8R1L8,MOUSE,22119.7,8,566,566.1,14.84,14.84,,198,Angiopoietin-like protein 8,extracellular region|,glucose metabolic process|positive regulation of protein processing|regulation of lipid metabolic process|cellular lipid metabolic process|type B pancreatic cell proliferation|fat cell differentiation|cell maturation|regulation of lipoprotein metabolic process|negative regulation of lipoprotein lipase activity|triglyceride homeostasis|glucose metabolic process|type B pancreatic cell proliferation|,hormone activity|,1,2,31100000,8.0%
P16460,0.124053945,0.579333333,18.40382586,-2.758666667,0.01444167,-3.412075515,0.481,3.679,1.716,-0.425,-1.175,-0.8,P16460,Ass1,P16460_Ass1,P16460,Ass1,1,2,2,2,P16460,MOUSE,46868.9,4.8,567,567.1,14.82,14.82,,412,Argininosuccinate synthase,cytoplasm|mitochondrion|myelin sheath|extracellular exosome|,urea cycle|citrulline metabolic process|argininosuccinate metabolic process|arginine biosynthetic process|aspartate metabolic process|positive regulation of nitric oxide biosynthetic process|cellular response to laminar fluid shear stress|negative regulation of leukocyte cell-cell adhesion|,argininosuccinate synthase activity|ATP binding|amino acid binding|identical protein binding|poly(A) RNA binding|,2,2,6590000,4.8%
Q9JI20,0.326571299,-0.2806,9.149733595,0.7115,0.121626061,1.861211558,-0.205,-1.21,,-0.055,0.051,0.016,Q9JI20,Adarb2,Q9JI20_Adarb2,Q9JI20,Adarb2,1,2,2,2,Q9JI20|Q6PB89,MOUSE,82984.4,1.2,568,568.1,14.79,14.79,,745,Double-stranded RNA-specific editase B2,nucleus|,mRNA processing|,adenosine deaminase activity|poly(A) RNA binding|metal ion binding|,2,2,16400000,1.2%
Q8C2E4,0.987463289,-0.004166667,0.121299643,-0.017,0.972456169,-0.035989834,0.671,0.347,-1.005,0.143,-0.206,0.025,Q8C2E4,Ptcd1,Q8C2E4_Ptcd1,Q8C2E4,Ptcd1,1,3,3,3,Q8C2E4,MOUSE,78334.7,6,569,569.1,14.75,14.75,,695,"Pentatricopeptide repeat-containing protein 1, mitochondrial",mitochondrial matrix|,tRNA 3'-end processing|,,3,3,105000000,6.0%
P62806,0.009081837,0.841833333,37.80797317,-2.613666667,0.000165654,-8.267300549,2.682,1.758,2.006,-0.287,-0.672,-0.436,P62806,Hist1h4h,P62806_Hist1h4h,P62806,Hist1h4a,1,1,1,1,P62806,MOUSE,11367.1,9.7,570,570.1,14.74,14.74,,103,Histone H4,nuclear chromosome|nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|nucleosome assembly|DNA replication-dependent nucleosome assembly|DNA replication-independent nucleosome assembly|negative regulation of megakaryocyte differentiation|protein heterotetramerization|,DNA binding|protein binding|histone binding|poly(A) RNA binding|protein heterodimerization activity|,1,1,79700000,9.7%
Q8K426,0.266899372,0.613666667,11.13193931,-1.357333333,0.077055931,-2.134528469,2.289,0.149,1.439,-0.374,-0.539,0.718,Q8K426,Retnlg,Q8K426_Retnlg,Q8K426,Retnlg,1,4,1,1,Q8K426,MOUSE,13276.1,10.2,571,571.1,14.7,14.7,,117,Resistin-like gamma,extracellular space|,myeloid dendritic cell chemotaxis|,hormone activity|,1,4,62300000,10.2%
Q91X17,0.417911844,-0.19,7.022483206,0.381666667,0.198495963,1.479744402,-0.463,-0.375,,-0.102,-0.101,0.091,Q91X17,Umod,Q91X17_Umod,Q91X17,Umod,1,2,2,2,Q91X17,MOUSE,73582.4,2.8,572,572.1,14.69,14.69,,642,Uromodulin,spindle pole|basolateral plasma membrane|apical plasma membrane|anchored component of membrane|ciliary membrane|extracellular exosome|primary cilium|,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|excretion|chemical homeostasis|metanephric ascending thin limb development|metanephric distal convoluted tubule development|metanephric thick ascending limb development|neutrophil migration|regulation of ion homeostasis|,calcium ion binding|IgG binding|,2,2,162000000,2.8%
E9QA60,0.324543254,-0.099,9.473770391,0.525,0.112881549,1.916716682,-0.458,-0.37,,-0.012,0.336,0.009,E9QA60,NotFound,E9QA60_NotFound,E9QA60,Zfp626,1,10,2,2,A0A0U1RQ84|E9QA60,MOUSE,32071.4,9.1,573,573.1,14.66,14.66,,272,Zinc finger protein 626,,"regulation of transcription, DNA-templated|",nucleic acid binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,2,10,8520000000,9.1%
B2RQ80,0.029946872,0.772,28.89439976,-2.698666667,0.001289912,-5.668500362,1.537,3.009,1.818,-0.048,-0.972,-0.712,B2RQ80,Tnik,B2RQ80_Tnik,B2RQ80,Tnik,1,3,2,2,B2RQ80|B9EKN8|E9PUL9|P83510|E0CY98|E0CXD6|P83510-2|E0CZD7|E0CZF8|Q9JM52-3|G3X9G2|Q5SXG3|Q5SXG1|Q9JM52|E9PVG7|A0A0A6YW53|Q9JM52-2|A0A0A6YWM8|F8VPL5|A0A0A6YWR8|P97820|B2RUE8|B7ZNR9,MOUSE,155455.9,1.4,574,574.1,14.66,14.66,,1360,Tnik protein,nucleus|nucleoplasm|cytoplasm|cytoskeleton|apical plasma membrane|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,MAPK cascade|positive regulation of protein phosphorylation|positive regulation of defense response to virus by host|protein phosphorylation|cytoskeleton organization|activation of JNKK activity|regulation of mitotic cell cycle|microvillus assembly|stress-activated protein kinase signaling cascade|actin cytoskeleton reorganization|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|protein autophosphorylation|neuron projection morphogenesis|regulation of dendrite morphogenesis|protein localization to plasma membrane|,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,3,166000000,1.4%
Q9CR42,0.427513465,-0.426,6.850741186,0.906666667,0.20650277,1.452766346,-1.958,0.018,,-0.126,-0.012,-0.052,Q9CR42,Ankrd1,Q9CR42_Ankrd1,Q9CR42,Ankrd1,1,5,2,2,Q9CR42,MOUSE,36345.4,5.6,575,575.1,14.61,14.61,,319,Ankyrin repeat domain-containing protein 1,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,2,5,1980000000,5.6%
O88427,0.444597864,0.3292,6.396220653,-0.451333333,0.229286209,-1.367324805,0.96,0.24,,0.281,0.08,0.085,O88427,NotFound,O88427_NotFound,O88427,Cacna1h,1,5,2,2,O88427|O88427-2|E9Q6P9|E0CYZ3,MOUSE,265334.1,1.9,576,576.1,14.59,14.59,,2365,Voltage-dependent T-type calcium channel subunit alpha-1H,plasma membrane|voltage-gated calcium channel complex|caveola|integral component of membrane|sarcolemma|,aldosterone biosynthetic process|ion transmembrane transport|cortisol biosynthetic process|regulation of ion transmembrane transport|regulation of membrane potential|positive regulation of calcium ion-dependent exocytosis|calcium ion import|calcium ion transmembrane transport|membrane depolarization during action potential|positive regulation of acrosome reaction|,protein binding|low voltage-gated calcium channel activity|metal ion binding|scaffold protein binding|,2,5,249000000,1.9%
O89051,,0.137666667,,,,,,,,-0.141,0.417,0.137,O89051,Itm2b,O89051_Itm2b,O89051,Itm2b,1,1,1,1,O89051,MOUSE,30772.9,7.1,577,577.1,14.57,14.57,,266,Integral membrane protein 2B,extracellular space|Golgi apparatus|plasma membrane|endosome membrane|membrane|Golgi-associated vesicle membrane|integral component of organelle membrane|intracellular membrane-bounded organelle|extracellular exosome|,negative regulation of amyloid precursor protein biosynthetic process|,beta-amyloid binding|ATP binding|,1,1,24900000,7.1%
Q61884,0.012721282,0.674833333,35.07243005,-2.071,0.000310998,-7.360284239,2.143,1.447,1.541,-0.529,-0.366,-0.187,Q61884,Mns1,Q61884_Mns1,Q61884,Mns1,1,9,2,2,Q61884,MOUSE,60291.8,2.8,578,578.1,14.56,14.56,,491,Meiosis-specific nuclear structural protein 1,nuclear envelope|intermediate filament|axoneme|sperm flagellum|,spermatogenesis|cilium organization|positive regulation of cilium assembly|meiotic cell cycle|left/right axis specification|,identical protein binding|,2,9,698000000,2.8%
Q8CE64,0.131134782,0.760666667,17.9827949,-1.666,0.015911844,-3.322778362,0.88,2.454,1.447,0.034,-0.678,0.427,Q8CE64,Zfp276,Q8CE64_Zfp276,Q8CE64,Znf276,1,2,2,2,Q8CE64,MOUSE,68935.4,2.4,579,579.1,14.56,14.56,,614,Zinc finger protein 276,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|zinc ion binding|,2,2,56600000,2.4%
E9Q7N9,0.007983705,-0.9716,39.52294305,2.707333333,0.000111611,10.80290034,-2.629,-2.563,,0.067,0.112,0.155,E9Q7N9,Dnah11,E9Q7N9_Dnah11,E9Q7N9,Dnah11,1,3,3,3,E9Q7N9,MOUSE,520359.5,0.7,580,580.1,14.55,14.55,,4488,"Dynein, axonemal, heavy chain 11",dynein complex|motile primary cilium|,cilium movement|regulation of cilium beat frequency|determination of left/right symmetry|metabolic process|sperm motility|,microtubule motor activity|ATP binding|ATPase activity|,3,3,1330000000,0.7%
Q8CC86,0.819375851,-0.011,1.747919858,0.113333333,0.668664111,0.454039265,-0.059,-0.099,,0.029,0.004,0.07,Q8CC86,Naprt,Q8CC86_Naprt,Q8CC86,Naprt,1,2,2,2,Q8CC86,MOUSE,58834.8,2.9,581,581.1,14.55,14.55,,538,Nicotinate phosphoribosyltransferase,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|cytosol|extracellular exosome|,response to oxidative stress|NAD biosynthetic process|nicotinate nucleotide salvage|,nicotinate-nucleotide diphosphorylase (carboxylating) activity|nicotinate phosphoribosyltransferase activity|ligase activity|,2,2,9670000,2.9%
Q9ESF1,0.697122426,0.766,2.954693691,-0.508333333,0.506443068,-0.715732073,1.557,0.585,,0.242,-0.281,1.727,Q9ESF1,Otof,Q9ESF1_Otof,Q9ESF1,Otof,1,2,2,2,Q9ESF1|E9PYR6|Q9ESF1-2|A0A0R4J1K2|Q9ESF1-3,MOUSE,228512.6,2,582,582.1,14.54,14.54,,1997,Otoferlin,endoplasmic reticulum membrane|integral component of membrane|basolateral plasma membrane|cell junction|synaptic vesicle membrane|,sensory perception of sound|synaptic vesicle exocytosis|synaptic vesicle priming|,calcium ion binding|protein binding|AP-2 adaptor complex binding|,2,2,50200000,2.0%
Q3UHK6-2,0.432253305,-0.2152,6.732893908,0.492166667,0.212183012,1.427863691,-0.906,-0.115,,-0.148,0.106,-0.013,Q3UHK6,Tenm4,Q3UHK6-2_Tenm4,Q3UHK6-2,Tenm4,1,4,3,3,Q3UHK6-2|Q3UHK6-4|Q3UHK6|Q3UHK6-3,MOUSE,318101.1,1.4,583,583.1,14.53,14.53,,2771,Isoform 2 of Teneurin-4,nucleus|cytoplasm|integral component of plasma membrane|neuron projection|,gastrulation with mouth forming second|signal transduction|positive regulation of myelination|central nervous system myelin formation|neuron development|positive regulation of oligodendrocyte differentiation|cardiac muscle cell proliferation|cardiac cell fate specification|self proteolysis|positive regulation of gastrulation|,protein homodimerization activity|,3,4,79300000,1.4%
Q6P5E4,0.641492083,0.0434,3.536234208,-0.265166667,0.44297231,-0.83203685,0.548,-0.143,,-0.053,-0.098,-0.037,Q6P5E4,Uggt1,Q6P5E4_Uggt1,Q6P5E4,Uggt1,1,1,1,1,Q6P5E4,MOUSE,177115,0.8,584,584.1,14.53,14.53,,1551,UDP-glucose:glycoprotein glucosyltransferase 1,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|protein binding|unfolded protein binding|,1,1,1840000,0.8%
Q9WV54,0.155174868,0.261166667,16.22877669,-1.543666667,0.023829906,-3.004276404,1.349,1.826,-0.076,-0.635,-0.572,-0.325,Q9WV54,Asah1,Q9WV54_Asah1,Q9WV54,Asah1,1,2,1,1,Q9WV54,MOUSE,45068.1,2,585,585.1,14.51,14.51,,394,Acid ceramidase,lysosome|extracellular exosome|,lipid metabolic process|,ceramidase activity|,1,2,43300000,2.0%
Q6DFZ1,0.239722797,-0.1362,11.88795843,0.898833333,0.06474469,2.358383148,-0.354,-0.997,,-0.075,0.66,0.085,Q6DFZ1,Gbf1,Q6DFZ1_Gbf1,Q6DFZ1,Gbf1,1,7,2,2,Q6DFZ1,MOUSE,208832.4,1,586,586.1,14.49,14.49,,1861,Golgi-specific brefeldin A-resistance factor 1,Golgi membrane|mitochondrion|peroxisome|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi stack|cis-Golgi network|trans-Golgi network|plasma membrane|membrane|cell leading edge|trans-Golgi network|,"cell activation involved in immune response|retrograde vesicle-mediated transport, Golgi to ER|Golgi to endosome transport|Golgi organization|regulation of mitotic cell cycle|regulation of cell adhesion|neutrophil chemotaxis|regulation of ARF protein signal transduction|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|COPI coating of Golgi vesicle|establishment of monopolar cell polarity|protein localization to endoplasmic reticulum exit site|Golgi disassembly|endoplasmic reticulum-Golgi intermediate compartment organization|reactive oxygen species biosynthetic process|protein localization to endoplasmic reticulum tubular network|regulation of protein localization to cell surface|vesicle-mediated transport|","ARF guanyl-nucleotide exchange factor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",2,7,1680000000,1.0%
E9PZ26,0.409535436,-0.0628,7.17475625,0.561166667,0.191656863,1.508453582,0.08,-0.879,,0.133,0.216,0.136,E9PZ26,Brd1,E9PZ26_Brd1,E9PZ26,Brd1,1,4,2,2,E9PZ26|G5E8P1|E9Q412,MOUSE,135652.4,1.2,587,587.1,14.48,14.48,,1189,Bromodomain-containing 1,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,2,4,1810000000,1.2%
H3BKH6,0.374847149,0.731,7.864422023,-0.708,0.163515075,-1.586936197,1.798,0.65,0.807,0.572,-0.266,0.825,H3BKH6,Esd,H3BKH6_Esd,H3BKH6,Esd,1,3,2,2,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9,MOUSE,33399.4,8.4,588,588.1,14.48,14.48,,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",2,3,19500000,8.4%
Q99MY8,0.328498076,-0.246333333,9.109553007,0.771333333,0.122756557,1.79461297,-0.876,0.212,-1.232,0.056,0.46,-0.098,Q99MY8,Ash1l,Q99MY8_Ash1l,Q99MY8,Ash1l,1,4,3,3,Q99MY8,MOUSE,334864.7,1,589,589.1,14.41,14.41,,2958,Histone-lysine N-methyltransferase ASH1L,nucleoplasm|chromosome|cytoplasm|Golgi apparatus|bicellular tight junction|extracellular exosome|,"negative regulation of acute inflammatory response|transcription, DNA-templated|interleukin-6 production|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAPK cascade|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|histone H3-K4 methylation|",DNA binding|chromatin binding|zinc ion binding|histone methyltransferase activity (H3-K4 specific)|,3,4,54300000,1.0%
F6ZDS4,0.090242298,-0.3594,20.74000167,1.252666667,0.008433344,4.186424863,-0.866,-1.356,,0.096,0.314,0.015,F6ZDS4,Tpr,F6ZDS4_Tpr,F6ZDS4,Tpr,1,2,2,2,F6ZDS4|Q7M739|Q8BQ30-2|Q8BQ30,MOUSE,274384.7,0.6,590,590.1,14.35,14.35,,2431,Nucleoprotein TPR,kinetochore|nucleus|nuclear envelope|nuclear pore|cytoplasm|cytoplasmic dynein complex|extrinsic component of membrane|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|mitotic spindle|kinetochore|,negative regulation of transcription from RNA polymerase II promoter|MAPK import into nucleus|RNA import into nucleus|RNA export from nucleus|nuclear pore organization|mitotic nuclear division|mitotic spindle assembly checkpoint|regulation of mitotic sister chromatid separation|positive regulation of heterochromatin assembly|mRNA export from nucleus in response to heat stress|cellular response to heat|cellular response to interferon-alpha|positive regulation of protein import into nucleus|negative regulation of translational initiation|positive regulation of protein export from nucleus|negative regulation of RNA export from nucleus|cell division|response to epidermal growth factor|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of intracellular protein transport|regulation of mitotic spindle assembly|protein import into nucleus|protein export from nucleus|nuclear pore organization|regulation of protein stability|regulation of protein import into nucleus|nuclear matrix organization|nuclear pore complex assembly|,chromatin binding|mRNA binding|nucleocytoplasmic transporter activity|protein binding|tubulin binding|heat shock protein binding|protein homodimerization activity|poly(A) RNA binding|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein anchor|,2,2,379000000,0.6%
Q8C341-2,0.61112239,1.3488,3.973565733,-1.342,0.400537725,-0.919134773,3.781,0.527,,2.369,1.336,-1.269,Q8C341,Suco,Q8C341-2_Suco,Q8C341-2,Suco,1,2,2,2,Q8C341-2|Q8C341,MOUSE,140779.6,1.5,591,591.1,14.3,14.3,,1250,Isoform 2 of SUN domain-containing ossification factor,rough endoplasmic reticulum|membrane|integral component of membrane|rough endoplasmic reticulum membrane|,multicellular organismal development|positive regulation of collagen biosynthetic process|positive regulation of osteoblast differentiation|regulation of bone remodeling|,,2,2,89000000,1.5%
A0A075B5J6,0.363472989,-0.1294,8.196379948,0.567666667,0.15148234,1.689021698,-0.785,-0.155,,-0.041,0.37,-0.036,A0A075B5J6,NotFound,A0A075B5J6_NotFound,A0A075B5J6,Gm20730,1,2,1,1,A0A075B5J6|P01629,MOUSE,13242.9,10.9,592,592.1,14.25,14.25,,119,"Predicted gene, 20730",,,,1,2,23700000,10.9%
Q3UR32,0.206287245,1.0996,13.64527632,-2.754,0.043198868,-2.699324849,1.133,4.371,,0.356,-0.628,0.266,Q3UR32,P2rx3,Q3UR32_P2rx3,Q3UR32,P2rx3,1,2,2,2,Q3UR32|A2AW04|A2AW03,MOUSE,45121,3.7,593,593.1,14.25,14.25,,397,P2X purinoceptor 3,integral component of nuclear inner membrane|rough endoplasmic reticulum|Golgi apparatus|integral component of plasma membrane|axon|neuron projection|neuronal cell body|terminal bouton|dendritic spine|receptor complex|membrane raft|,response to hypoxia|ion transport|cation transport|synaptic transmission|neuromuscular synaptic transmission|response to temperature stimulus|response to heat|response to cold|response to mechanical stimulus|response to carbohydrate|response to organic substance|urinary bladder smooth muscle contraction|neuronal action potential|peristalsis|response to ATP|purinergic nucleotide receptor signaling pathway|regulation of synaptic plasticity|behavioral response to pain|sensory perception of taste|protein homooligomerization|cation transmembrane transport|,purinergic nucleotide receptor activity|extracellular ATP-gated cation channel activity|ATP binding|,2,2,79900000,3.7%
A0A1D5RLM8,0.418742462,-0.084,6.995543407,0.39,0.199731084,1.474924387,-0.345,-0.291,,0.25,-0.009,-0.025,A0A1D5RLM8,NotFound,A0A1D5RLM8_NotFound,A0A1D5RLM8,Gm11639,1,3,3,3,A0A1D5RLM8,MOUSE,655392.6,0.5,594,594.1,14.23,14.23,,5808,Predicted gene 11639,,,,3,3,6360000000,0.5%
E9Q328,0.087381505,0.563666667,21.17512382,-2.387333333,0.007629351,-3.951940856,2.994,1.612,0.666,-0.665,-0.895,-0.33,E9Q328,5430401F13Rik,E9Q328_5430401F13Rik,E9Q328,5430401F13Rik,1,2,1,1,E9Q328|F6URP1,MOUSE,18977.3,6.8,595,595.1,14.19,14.19,,175,RIKEN cDNA 5430401F13 gene,,,,1,2,275000000,6.8%
Q60963,0.332209056,0.149166667,9.029789329,-0.569,0.125031968,-1.780747424,0.816,0.649,-0.164,-0.146,-0.164,-0.096,Q60963,Pla2g7,Q60963_Pla2g7,Q60963,Pla2g7,1,4,1,1,Q60963,MOUSE,49599.7,2.7,596,596.1,14.18,14.18,,440,Platelet-activating factor acetylhydrolase,cytoplasm|low-density lipoprotein particle|,inflammatory response|lipid catabolic process|low-density lipoprotein particle remodeling|lipid oxidation|plasma lipoprotein particle oxidation|positive regulation of monocyte chemotaxis|,1-alkyl-2-acetylglycerophosphocholine esterase activity|phospholipid binding|calcium-independent phospholipase A2 activity|,1,4,35400000,2.7%
Q6P9P0,0.362789855,-1.217833333,8.241096762,2.797,0.149930615,1.652226051,-0.342,-0.8,-6.707,0.24,0.293,0.009,Q6P9P0,Slf2,Q6P9P0_Slf2,Q6P9P0,Slf2,1,14,2,2,Q6P9P0|E9Q839|K4JR88|K4JBS4|K4JR71,MOUSE,144937.3,1,597,597.1,14.12,14.12,,1278,SMC5-SMC6 complex localization factor protein 2,chromatin|extracellular space|nucleus|intracellular membrane-bounded organelle|,,,2,14,3.28E+11,1.0%
E9Q3M9,0.819375851,-0.571,1.765156588,0.623333333,0.666015507,0.453828818,0.44,1.084,-4.172,-0.371,-0.352,-0.055,E9Q3M9,2010300C02Rik,E9Q3M9_2010300C02Rik,E9Q3M9,2010300C02Rik,1,5,2,2,E9Q3M9|Q3UHU5|Q3UHU5-3|Q3TYL0,MOUSE,126478.6,1.1,598,598.1,14.11,14.11,,1175,RIKEN cDNA 2010300C02 gene,,,,2,5,657000000,1.1%
P10166,0.970099283,0.050166667,0.328371484,-0.051666667,0.927177431,-0.095296729,-0.818,-0.208,1.254,0.085,-0.073,0.061,P10166,Mycl,P10166_Mycl,P10166,Mycl,1,12,2,2,P10166,MOUSE,41361,2.9,599,599.1,14.1,14.1,,368,Protein L-Myc,nucleus|,"regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|protein dimerization activity|,2,12,9130000000,2.9%
P61027,0.007983705,0.948833333,40.92991884,-2.792333333,8.0725E-05,-9.358875438,2.651,1.873,2.511,-0.452,-0.656,-0.234,P61027,Rab10,P61027_Rab10,P61027,Rab10,1,1,1,1,P61027,MOUSE,22768.7,6,600,600.1,14.06,14.06,,200,Ras-related protein Rab-10,endosome|endoplasmic reticulum membrane|Golgi apparatus|trans-Golgi network|focal adhesion|endosome membrane|phagocytic vesicle membrane|insulin-responsive compartment|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|endoplasmic reticulum tubular network|primary cilium|exocyst|plasma membrane|,intracellular protein transport|Golgi to plasma membrane transport|vesicle docking involved in exocytosis|axonogenesis|protein secretion|vesicle-mediated transport|endosomal transport|regulation of exocytosis|antigen processing and presentation|polarized epithelial cell differentiation|Rab protein signal transduction|cellular response to insulin stimulus|Golgi to plasma membrane protein transport|establishment of neuroblast polarity|basolateral protein localization|cellular response to antibiotic|endoplasmic reticulum tubular network organization|protein localization to plasma membrane|establishment of protein localization to membrane|establishment of protein localization to endoplasmic reticulum membrane|,GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,1,1,33500000,6.0%
F8VQL9,0.075595681,-0.4688,21.92173323,1.842833333,0.006424313,4.4889084,-1.986,-1.163,,-0.184,0.498,0.491,F8VQL9,Ncor2,F8VQL9_Ncor2,F8VQL9,Ncor2,1,5,2,2,F8VQL9|E9Q701|Q9WU42|E9PY55|E9Q9V3|Q9WU42-2,MOUSE,274089,1.1,601,601.1,14,14,,2507,Nuclear receptor corepressor 2,histone deacetylase complex|nucleus|nucleoplasm|membrane|nuclear matrix|nuclear body|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|heart morphogenesis|telencephalon development|cell proliferation in forebrain|forebrain development|glucose homeostasis|negative regulation of fat cell differentiation|negative regulation of transcription, DNA-templated|white fat cell differentiation|Type I pneumocyte differentiation|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter|positive regulation of protein deacetylation|",DNA binding|chromatin binding|transcription corepressor activity|Notch binding|protein binding|histone deacetylase binding|sequence-specific DNA binding|protein N-terminus binding|,2,5,39700000000,1.1%
Q70FJ1,0.132703003,-0.2028,17.73685914,1.502,0.016838914,3.520335126,-1.322,-0.886,,-0.204,0.909,0.489,Q70FJ1,Akap9,Q70FJ1_Akap9,Q70FJ1,Akap9,1,7,2,2,Q70FJ1|Q70FJ1-2|E9QQ10|Q70FJ1-3,MOUSE,439405.6,0.4,602,602.1,13.96,13.96,,3797,A-kinase anchor protein 9,pericentriolar material|cytoplasm|Golgi apparatus|centrosome|ciliary basal body|,signal transduction|spermatogenesis|Sertoli cell development|,protein binding|protein complex scaffold|,2,7,2600000000,0.4%
A2AQB2,0.967231362,0.246666667,0.367726353,0.032666667,0.918813494,0.106261105,0.362,-0.063,0.392,0.745,0.071,-0.027,A2AQB2,NotFound,A2AQB2_NotFound,A2AQB2,Neb,1,9,2,2,A2AQB2,MOUSE,354700.3,0.4,603,603.1,13.88,13.88,,3044,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,9,19300000000,0.4%
P14576,0.821775379,0.474333333,1.710509218,-0.526,0.674448943,-0.441463917,-1.657,0.962,2.907,0.396,-0.826,1.064,P14576,Srp54a,P14576_Srp54a,P14576,Srp54,1,2,2,2,P14576,MOUSE,56005.1,3.5,604,604.1,13.85,13.85,,504,Signal recognition particle 54 kDa protein,"signal recognition particle, endoplasmic reticulum targeting|nuclear speck|",SRP-dependent cotranslational protein targeting to membrane|metabolic process|,GTPase activity|GTP binding|7S RNA binding|,2,2,73400000,3.5%
P29416,0.237207834,-0.21475,12.00929288,0.908333333,0.062960869,2.544863361,,-0.896,,0.09,-0.067,0.014,P29416,Hexa,P29416_Hexa,P29416,Hexa,1,1,1,1,P29416,MOUSE,61182.5,2,605,605.1,13.83,13.83,,528,Beta-hexosaminidase subunit alpha,lysosome|membrane|extracellular exosome|,skeletal system development|carbohydrate metabolic process|ganglioside catabolic process|lysosome organization|sensory perception of sound|locomotory behavior|adult walking behavior|lipid storage|sexual reproduction|glycosaminoglycan metabolic process|myelination|cell morphogenesis involved in neuron differentiation|neuromuscular process controlling posture|neuromuscular process controlling balance|SMAD protein signal transduction|,beta-N-acetylhexosaminidase activity|protein heterodimerization activity|,1,1,5130000,2.0%
Q8BI79,0.472601761,0.2732,6.000802111,-0.424666667,0.251142255,-1.295830253,0.578,0.478,,0.521,-0.174,-0.037,Q8BI79,Ccdc40,Q8BI79_Ccdc40,Q8BI79,Ccdc40,1,3,3,3,Q8BI79|Q8BI79-2|Q8BI79-3,MOUSE,137283.3,2.3,606,606.1,13.83,13.83,,1192,Coiled-coil domain-containing protein 40,cytoplasm|cilium|axoneme|,heart looping|cilium movement|epithelial cilium movement|regulation of cilium beat frequency|sperm motility|lung development|determination of pancreatic left/right asymmetry|inner dynein arm assembly|motile cilium assembly|epithelial cilium movement involved in determination of left/right asymmetry|axonemal dynein complex assembly|determination of digestive tract left/right asymmetry|determination of liver left/right asymmetry|,,3,3,59000000,2.3%
Q8R116,0.294065232,0.284333333,10.27073732,-0.918,0.093956378,-1.987341268,0.526,1.639,0.065,0.169,-0.533,-0.16,Q8R116,Notum,Q8R116_Notum,Q8R116,Notum,1,4,1,1,Q8R116|Q8R116-2,MOUSE,57496.3,1.3,607,607.1,13.83,13.83,,503,Palmitoleoyl-protein carboxylesterase NOTUM,extracellular region|,Wnt signaling pathway|negative regulation of Wnt signaling pathway|protein depalmitoleylation|GPI anchor release|,palmitoleyl hydrolase activity|,1,4,14800000,1.3%
Q6JHY2,0.155174868,0.8206,16.2068901,-1.604833333,0.023950302,-3.198333129,2.147,1.42,,-0.542,0.766,0.312,Q6JHY2,Smgc,Q6JHY2_Smgc,Q6JHY2,Muc19,1,1,1,1,Q6JHY2|Q6JHY2-2|Q6JHY2-5|Q6JHY2-3,MOUSE,74495.3,2.5,608,608.1,13.8,13.8,,733,Submandibular gland protein C,extracellular region|,,,1,1,2090000,2.5%
Q9WVB3,0.364618865,0.323166667,8.13445458,-0.581666667,0.153657776,-1.632153018,0.233,0.561,1.048,-0.418,0.519,-0.004,Q9WVB3,Tle6,Q9WVB3_Tle6,Q9WVB3,Tle6,1,2,2,2,Q9WVB3|D3Z5E1,MOUSE,65970.1,4.4,609,609.1,13.69,13.69,,581,Transducin-like enhancer protein 6,nucleus|cell cortex|protein complex|,positive regulation of neuron differentiation|positive regulation of neurogenesis|,protein binding|,2,2,226000000,4.4%
P26040,0.293538613,0.177666667,10.36575646,-0.696,0.091923035,-2.003111452,0.38,0.03,1.167,-0.162,-0.029,-0.32,P26040,Ezr,P26040_Ezr,P26040,Ezr,1,5,2,2,P26040|P26041|P26043|Q7TSG6,MOUSE,69519.7,4,610,610.1,13.63,13.63,,586,Ezrin,ruffle|uropod|extracellular space|intracellular|nucleolus|cytoplasm|endosome|cytosol|actin filament|plasma membrane|microvillus|brush border|focal adhesion|cell cortex|actin cytoskeleton|membrane|basolateral plasma membrane|apical plasma membrane|extrinsic component of membrane|filopodium|T-tubule|microvillus membrane|vesicle|ruffle membrane|ciliary basal body|myelin sheath|cell body|microspike|membrane raft|apical part of cell|cell tip|extracellular exosome|cell periphery|astrocyte projection|Schwann cell microvillus|cytoplasmic side of apical plasma membrane|focal adhesion|,intestinal D-glucose absorption|sphingosine-1-phosphate signaling pathway|leukocyte cell-cell adhesion|regulation of cell shape|positive regulation of gene expression|membrane to membrane docking|actin cytoskeleton reorganization|receptor internalization|regulation of microvillus length|establishment or maintenance of apical/basal cell polarity|positive regulation of multicellular organism growth|filopodium assembly|phosphatidylinositol-mediated signaling|positive regulation of protein secretion|actin filament bundle assembly|establishment of endothelial barrier|positive regulation of establishment of protein localization to plasma membrane|regulation of organelle assembly|terminal web assembly|positive regulation of protein localization to early endosome|positive regulation of cellular protein catabolic process|positive regulation of early endosome to late endosome transport|microvillus assembly|,protein binding|protein domain specific binding|poly(A) RNA binding|cell adhesion molecule binding|actin filament binding|,3,5,170000000,4.0%
K3W4R5,0.898438274,-0.147166667,0.990805701,0.072333333,0.796011661,0.270175218,-0.107,0.141,-0.584,-0.111,-0.157,-0.065,K3W4R5,Ckap5,K3W4R5_Ckap5,K3W4R5,Ckap5,1,3,2,2,K3W4R5|A2AGT5|A0A0R4J0K2|A2AGT5-3|Z4YL78|A2AGT5-2,MOUSE,227286.2,0.7,611,611.1,13.56,13.56,,2032,Cytoskeleton-associated protein 5,spindle pole|cytoplasm|centrosome|membrane|protein complex|gamma-tubulin complex|microtubule plus-end|,spindle organization|establishment or maintenance of microtubule cytoskeleton polarity|centrosome organization|,microtubule binding|ribonucleoprotein complex binding|,2,3,795000000,0.7%
Q8C257,0.560202106,-0.215833333,4.823570482,0.612333333,0.32933884,1.062095999,-0.523,0.598,-1.641,0.351,-0.083,0.003,Q8C257,Il18r1,Q8C257_Il18r1,Q8C257,Il18r1,1,4,2,2,Q8C257,MOUSE,43230.5,4.5,612,612.1,13.45,13.45,,372,Il18r1 protein,,natural killer cell activation|positive regulation of interferon-gamma production|interleukin-18-mediated signaling pathway|positive regulation of NF-kappaB import into nucleus|T-helper 1 cell differentiation|,interleukin-18 receptor activity|,2,4,622000000,4.5%
E9Q9F7,0.417911844,-1.718166667,7.028391464,4.094333333,0.198226108,1.447608264,-0.526,-0.148,-10.622,-0.267,0.648,0.606,E9Q9F7,Ccdc146,E9Q9F7_Ccdc146,E9Q9F7,Ccdc146,1,2,2,2,E9Q9F7|Q8R422|Q6P1H4|Q9WVL6|G3X8Z3|Q9R0S0|Q9Z111,MOUSE,115632.1,1.2,613,613.1,13.43,13.43,,977,Coiled-coil domain-containing 146,centriole|,,,2,2,197000000,1.2%
Q9ESG6,0.434226419,0.458666667,6.624528131,-0.706,0.217544039,-1.377214482,0.014,0.528,1.893,0.23,-0.171,0.258,Q9ESG6,P2ry14,Q9ESG6_P2ry14,Q9ESG6,P2ry14,1,5,2,2,A0A0G2JEW9|Q9ESG6,MOUSE,39259.9,6.5,614,614.1,13.42,13.42,,338,P2Y purinoceptor 14,integral component of plasma membrane|,G-protein coupled receptor signaling pathway|G-protein coupled purinergic nucleotide receptor signaling pathway|,G-protein coupled purinergic nucleotide receptor activity|,2,5,43000000000,6.5%
Q8CIM1,0.820031235,0.1144,1.732074438,0.124,0.671108217,0.450410802,0.133,-0.053,,-0.022,0.345,0.169,Q8CIM1,Lrrc45,Q8CIM1_Lrrc45,Q8CIM1,Lrrc45,1,2,2,2,Q8CIM1,MOUSE,76781.7,4.1,615,615.1,13.35,13.35,,670,Leucine-rich repeat-containing protein 45,cytoplasm|centrosome|,,,2,2,147000000,4.1%
Q99PT9,0.785095327,0.034,2.104108751,0.208,0.616011933,0.528605707,0.061,0.448,-0.719,-0.274,0.527,0.161,Q99PT9,Kif19a,Q99PT9_Kif19a,Q99PT9,Kif19,1,8,2,2,Q99PT9|A2AC95,MOUSE,112127.5,2,616,616.1,13.33,13.33,,997,Kinesin-like protein KIF19,kinesin complex|microtubule|cilium|axoneme|,microtubule-based movement|metabolic process|axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|,"ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|",2,8,1190000000,2.0%
A9Z1V5,0.035407766,0.824333333,27.22136801,-2.041333333,0.001896109,-5.255811574,2.487,1.387,1.661,-0.67,0.036,0.045,A9Z1V5,Vwa5b1,A9Z1V5_Vwa5b1,A9Z1V5,Vwa5b1,1,9,2,2,A9Z1V5,MOUSE,135567.6,2.2,617,617.1,13.33,13.33,,1215,von Willebrand factor A domain-containing protein 5B1,extracellular region|,,,2,9,10500000000,2.2%
Q5SYL3,0.260682132,-0.027,11.32275625,1.1725,0.073743607,2.254659059,-1.32,-0.141,,0.723,-0.17,0.773,Q5SYL3,2610507B11Rik,Q5SYL3_2610507B11Rik,Q5SYL3,Kiaa0100,1,8,2,2,Q5SYL3,MOUSE,256974.9,1.1,618,618.1,13.3,13.3,,2234,Protein KIAA0100,extracellular region|,,,2,8,1410000000,1.1%
Q3U2I3,0.948474645,-0.0835,0.540666217,-0.082333333,0.882944445,-0.153611737,0.31,0.774,-1.211,-0.296,-0.143,0.065,Q3U2I3,Fam160a2,Q3U2I3_Fam160a2,Q3U2I3,Fam160a2,1,2,2,2,A0A1C7CYU5|Q3U2I3|Q3U2I3-2|F8WHJ1|Q3U2I3-3,MOUSE,107509.4,1.7,619,619.1,13.24,13.24,,975,FTS and Hook-interacting protein,FHF complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,,2,2,242000000,1.7%
P86793,0.352431702,0.1088,8.440927702,-0.4495,0.1431882,-1.732544741,0.375,0.382,,-0.22,0.005,0.002,P86793,Ccl21c,P86793_Ccl21c,P86793,Ccl21c,1,2,1,1,P86793|P84444,MOUSE,14983.2,7.5,620,620.1,13.24,13.24,,133,C-C motif chemokine 21c,extracellular space|,inflammatory response|immune response|cell chemotaxis|,chemokine activity|CCR7 chemokine receptor binding|,1,2,2910000,7.5%
Q499D5,0.324543254,-0.6256,9.470493891,1.620666667,0.112966744,1.923173186,-2.977,-0.219,,-0.125,0.22,-0.027,Q499D5,Zfp235,Q499D5_Zfp235,Q499D5,Zfp235,1,2,2,1,Q499D5|G3UVV3|G3X952|Q3U4L8|B1ARH2|Q8VC29|F6R4Z5|Q9R164|Q99K53|A0A0U1RPC5|Q9R166|E9Q8I5|Q8CCP6|Q571J5|E9Q6Y4|Q61117|Q4VA44|E9QPD3|O88253,MOUSE,81699.4,4.7,621,621.1,13.24,8.16,,702,Zinc finger protein 235,intracellular|,"regulation of transcription, DNA-templated|",nucleic acid binding|metal ion binding|,2,2,890000000,4.7%
Q61116,0.966296393,0.11825,0.380208452,-0.050333333,0.916176515,-0.112011851,,0.156,,-0.292,0.274,0.335,Q61116,Zfp93,Q61116_Zfp93,Q61116,Znf235,1,1,2,1,Q61116,MOUSE,75178.9,6,621,621.2,10.2,5.12,,645,Zinc finger protein 235,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|metal ion binding|,1,1,147000000,4.6%
Q8K2A4,0.326571299,-0.06325,9.211234576,0.887666667,0.119915837,1.968491843,,-0.729,,-0.221,0.232,0.465,Q8K2A4,Zfp87,Q8K2A4_Zfp87,Q8K2A4,Zfp87,1,1,2,1,Q8K2A4,MOUSE,65205.8,5.7,621,621.3,9.31,4.23,,540,"MCG140700, isoform CRA_c",intracellular|,"regulation of transcription, DNA-templated|",nucleic acid binding|metal ion binding|,1,1,354000000,4.0%
P04919,0.145366797,1.237333333,16.88742571,-3.956,0.02047658,-3.131592665,1.216,2.437,5.993,0.043,-1.708,-0.557,P04919,Slc4a1,P04919_Slc4a1,P04919,Slc4a1,1,2,2,2,P04919|P04919-2,MOUSE,103475.9,2.3,622,622.1,13.22,13.22,,929,Band 3 anion transport protein,integral component of plasma membrane|membrane|basolateral plasma membrane|Z disc|cortical cytoskeleton|extracellular exosome|blood microparticle|,anion transport|chloride transport|bicarbonate transport|regulation of intracellular pH|anion transmembrane transport|chloride transmembrane transport|,actin binding|inorganic anion exchanger activity|protein binding|protein C-terminus binding|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|ankyrin binding|protein homodimerization activity|,2,2,9650000,2.3%
Q5FW60,0.592453065,-0.0355,4.272684683,0.717,0.373879395,0.961081354,-1.268,-1.149,1.235,-0.031,0.969,0.031,Q5FW60,Mup20,Q5FW60_Mup20,Q5FW60,Mup20,1,6,2,2,Q5FW60,MOUSE,21157.8,13.2,623,623.1,13.21,13.21,,181,Major urinary protein 20,extracellular region|extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|olfactory learning|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",mating pheromone activity|insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,2,6,647000000,13.2%
Q8VHP9,0.223777099,-0.0868,13.02986898,0.700333333,0.04977521,2.56728571,-0.584,-0.43,,0.296,0.298,-0.014,Q8VHP9,Asb17,Q8VHP9_Asb17,Q8VHP9,Asb17,1,2,2,2,Q8VHP9|A0A0G2JE91,MOUSE,35041.4,8.4,624,624.1,13.14,13.14,,295,Ankyrin repeat and SOCS box protein 17,intracellular|,protein ubiquitination|intracellular signal transduction|,,2,2,41300000,8.4%
P21550,0.314778944,0.104666667,9.715633515,-1.835333333,0.106766904,-1.8983118,1.678,2.585,-1.196,-0.746,-1.159,-0.534,P21550,Eno3,P21550_Eno3,P21550,Eno3,1,5,2,2,P21550,MOUSE,47366.4,2.9,625,625.1,13.12,13.12,,434,Beta-enolase,phosphopyruvate hydratase complex|extracellular space|cytoplasm|plasma membrane|extracellular exosome|,glycolytic process|aging|response to drug|skeletal muscle tissue regeneration|,magnesium ion binding|phosphopyruvate hydratase activity|protein homodimerization activity|protein heterodimerization activity|,2,5,30800000000,2.9%
Q9ESK3,0.941122499,0.2568,0.66030945,0.063833333,0.858952316,0.186993685,0.141,0.296,,0.72,0.19,-0.063,Q9ESK3,Capn10,Q9ESK3_Capn10,Q9ESK3,Capn10,1,5,2,2,Q9ESK3|D6RGR0|Q9CPY2,MOUSE,76078.2,4.9,626,626.1,13.08,13.08,,666,Calpain-10,cell|cytoplasm|mitochondrion|cytosol|,proteolysis|actin cytoskeleton reorganization|positive regulation of insulin secretion|positive regulation of intracellular transport|cellular response to insulin stimulus|positive regulation of glucose import|type B pancreatic cell apoptotic process|positive regulation of type B pancreatic cell apoptotic process|,calcium-dependent cysteine-type endopeptidase activity|,2,5,378000000,4.9%
P10648,0.069588246,1.0824,22.52608184,-3.930166667,0.005589743,-4.672576469,,4.503,2.378,0.51,-1.206,-0.773,P10648,Gsta2,P10648_Gsta2,P10648,Gsta2,1,2,1,1,P13745|Q6P8Q0|P10648|P30115,MOUSE,25655.6,4.9,627,627.1,13.04,13.04,,222,Glutathione S-transferase A2,extracellular exosome|,glutathione metabolic process|response to stilbenoid|,glutathione transferase activity|,1,2,68000000,4.9%
A11112,0.702114845,0.3066,2.878056529,-0.284,0.515459261,-0.699321569,0.883,0.071,,0.438,-0.249,0.39,A11112,NotFound,A11112_NotFound,A11112,,1,2,2,2,A11112,MOUSE,26302.5,9.4,628,628.1,13.02,13.02,,,mKate2,,,,2,2,9990000,9.4%
E9QAP7,0.311388971,-0.05975,9.79792095,0.759,0.104762995,2.083963457,,-0.629,,0.231,0.16,-0.001,E9QAP7,Taf4,E9QAP7_Taf4,E9QAP7,Taf4,1,11,2,2,E9QAP7,MOUSE,105590,2.2,629,629.1,13.01,13.01,,1042,TATA-box-binding protein-associated factor 4,nucleus|nucleoplasm|transcription factor TFIID complex|cytoplasm|transcription factor TFTC complex|MLL1 complex|,"ovarian follicle development|DNA-templated transcription, initiation|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|positive regulation of transcription, DNA-templated|",DNA binding|protein binding|protein heterodimerization activity|sequence-specific DNA binding transcription factor activity|,2,11,57200000000,2.2%
Q9R0P5,0.155174868,0.678,16.46862301,-2.174166667,0.022549541,-3.267125052,1.357,2.608,,0.232,-1.186,0.379,Q9R0P5,Dstn,Q9R0P5_Dstn,Q9R0P5,Dstn,1,1,1,1,Q9R0P5,MOUSE,18863.6,7.8,630,630.1,13.01,13.01,,165,Destrin,cytoplasm|cortical actin cytoskeleton|extracellular exosome|,actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing|,actin binding|,1,1,9280000,7.8%
E9PUR0,0.002112047,0.940166667,53.08259636,-4.339,4.91745E-06,-15.13508216,3.224,2.969,3.136,-1.179,-1.663,-0.846,E9PUR0,Ankhd1,E9PUR0_Ankhd1,E9PUR0,Ankhd1,1,3,2,2,E9PUR0|E9Q1M6|A0A0A6YX17|Q9CWU0|E1BKR4|Q5RJG1|Q9ET22,MOUSE,271726.3,0.5,631,631.1,12.98,12.98,,2548,Ankyrin repeat and KH domain-containing 1,,,poly(A) RNA binding|,2,3,115000000,0.5%
Q8VHI3,0.102636656,0.796166667,19.68448161,-1.619,0.01075355,-3.643069507,1.15,1.202,2.465,0.259,-0.46,0.161,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,2,2,2,Q8VHI3,MOUSE,49770.7,3.9,632,632.1,12.97,12.97,,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,2,2,38100000,3.9%
P00342,0.612514063,0.0034,3.947342892,-0.647666667,0.402963501,-0.914039241,-0.734,1.518,,-0.044,-0.475,-0.248,P00342,Ldhc,P00342_Ldhc,P00342,Ldhc,1,3,2,2,P00342|A0A1B0GRE9|A0A1B0GSR2|A0A1B0GSX0|P06151|A0A1B0GSR9|A0A1B0GQX5,MOUSE,36253.5,6.3,633,633.1,12.95,12.95,,332,L-lactate dehydrogenase C chain,nucleus|cytoplasm|cilium|motile cilium|extracellular exosome|,carbohydrate metabolic process|pyruvate metabolic process|ATP biosynthetic process|lactate biosynthetic process from pyruvate|lactate oxidation|sperm motility|,L-lactate dehydrogenase activity|protein binding|,2,3,132000000,6.3%
O09010,0.326571299,-0.4856,9.22354598,1.613166667,0.11957638,1.878689888,-2.859,-0.048,,0.092,0.381,0.006,O09010,Lfng,O09010_Lfng,O09010,Lfng,1,6,2,2,O09010,MOUSE,42464.9,5.8,634,634.1,12.92,12.92,,378,"Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe",Golgi membrane|integral component of Golgi membrane|extracellular vesicle|,ovarian follicle development|somitogenesis|female meiotic division|compartment pattern specification|metabolic process|regulation of Notch signaling pathway|regulation of somitogenesis|positive regulation of protein binding|positive regulation of Notch signaling pathway|,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity|metal ion binding|,2,6,1.92E+11,5.8%
Q4U4S6,0.016132211,-1.1382,32.63901276,3.398833333,0.000544626,7.811080003,-3.785,-2.57,,0.289,0.301,0.074,Q4U4S6,Xirp2,Q4U4S6_Xirp2,Q4U4S6,Xirp2,1,3,2,2,Q4U4S6|Q4U4S6-2,MOUSE,431560.9,0.7,635,635.1,12.91,12.91,,3784,Xin actin-binding repeat-containing protein 2,Z disc|cell junction|,ventricular septum development|actin cytoskeleton organization|cell-cell junction organization|cardiac muscle tissue morphogenesis|,actin binding|protein binding|zinc ion binding|alpha-actinin binding|,2,3,6850000000,0.7%
Q5S006,0.232324458,-0.113,12.28444059,0.788333333,0.059095708,2.427727638,-0.901,-0.271,,0.303,0.311,-0.007,Q5S006,Lrrk2,Q5S006_Lrrk2,Q5S006,Lrrk2,1,6,2,2,Q5S006|V9GX76|V9GXM4|E9Q174|Q64331|E9PVU0|E9Q3L1|E9Q175,MOUSE,288720.5,0.4,636,636.1,12.8,12.8,,2527,Leucine-rich repeat serine/threonine-protein kinase 2,extracellular space|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial matrix|lysosome|endosome|endoplasmic reticulum|Golgi apparatus|trans-Golgi network|cytosol|plasma membrane|synaptic vesicle|inclusion body|cell junction|axon|dendrite|ribonucleoprotein complex|synaptic vesicle membrane|cytoplasmic vesicle|mitochondrial membrane|cytoplasmic side of mitochondrial outer membrane|dendrite cytoplasm|neuron projection|neuronal cell body|terminal bouton|perikaryon|membrane raft|synapse|extracellular exosome|,"MAPK cascade|activation of MAPKK activity|activation of MAPK activity|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|protein phosphorylation|endocytosis|autophagy|response to oxidative stress|mitochondrion organization|Golgi organization|lysosome organization|small GTPase mediated signal transduction|neuromuscular junction development|determination of adult lifespan|positive regulation of autophagy|regulation of protein kinase A signaling|negative regulation of protein processing|regulation of neuron maturation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|calcium-mediated signaling|olfactory bulb development|tangential migration from the subventricular zone to the olfactory bulb|positive regulation of protein ubiquitination|negative regulation of protein binding|positive regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of GTPase activity|cellular response to oxidative stress|cellular protein localization|intracellular signal transduction|regulation of kidney size|exploration behavior|locomotory exploration behavior|synaptic vesicle recycling|regulation of locomotion|regulation of membrane potential|positive regulation of programmed cell death|positive regulation of GTPase activity|GTP metabolic process|protein autophosphorylation|intracellular distribution of mitochondria|neuron projection morphogenesis|mitochondrion localization|regulation of mitochondrial depolarization|regulation of synaptic transmission, glutamatergic|regulation of excitatory postsynaptic membrane potential|regulation of dopamine receptor signaling pathway|positive regulation of dopamine receptor signaling pathway|regulation of dendritic spine morphogenesis|neuron death|cellular response to manganese ion|reactive oxygen species metabolic process|regulation of neuron death|negative regulation of neuron death|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of protein autoubiquitination|regulation of neuroblast proliferation|regulation of synaptic vesicle transport|negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation|negative regulation of hydrogen peroxide-induced cell death|negative regulation of protein targeting to mitochondrion|cellular response to dopamine|regulation of branching morphogenesis of a nerve|regulation of synaptic vesicle exocytosis|negative regulation of peroxidase activity|",SNARE binding|glycoprotein binding|actin binding|GTPase activity|protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity|GTPase activator activity|protein binding|ATP binding|GTP binding|tubulin binding|kinase activity|Rho GTPase binding|syntaxin-1 binding|clathrin binding|GTP-dependent protein kinase activity|peroxidase inhibitor activity|identical protein binding|protein homodimerization activity|ion channel binding|protein kinase A binding|,2,6,1380000000,0.4%
E9QAX2,0.145366797,-0.5672,17.1463137,1.937166667,0.019291617,3.395340336,-2.604,-0.855,,0.339,0.272,0.012,E9QAX2,Myo18a,E9QAX2_Myo18a,E9QAX2,Myo18a,1,7,2,2,E9QAX2|Q9JMH9-6|Q9JMH9|B2RRE2|K3W4L0|Q9JMH9-1|Q9JMH9-4|A0A1C7ZN10|Q9JMH9-2|Q9JMH9-7|Q9JMH9-5|E9Q405|E9QA74,MOUSE,237125.2,1.5,637,637.1,12.76,12.76,,2083,Unconventional myosin-XVIIIa,Golgi membrane|trans-Golgi network|cytoskeleton|membrane|myosin complex|actomyosin|,Golgi organization|metabolic process|cell migration|actomyosin structure organization|negative regulation of apoptotic process|Golgi vesicle budding|positive regulation of protein secretion|Golgi ribbon formation|asymmetric Golgi ribbon formation|,motor activity|ATP binding|ADP binding|poly(A) RNA binding|actin filament binding|,2,7,14700000000,1.5%
E9PUN6,0.032325932,0.845166667,28.0119282,-2.410333333,0.001580546,-5.44697807,2.155,1.225,2.771,-0.201,-0.712,-0.167,E9PUN6,Adamts9,E9PUN6_Adamts9,E9PUN6,Adamts9,1,3,2,2,E9PUN6|E9PYV8,MOUSE,223166.7,1.7,638,638.1,12.76,12.76,,1931,"A disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9",proteinaceous extracellular matrix|extracellular space|,proteolysis|positive regulation of melanocyte differentiation|regulation of developmental pigmentation|,endopeptidase activity|metalloendopeptidase activity|metallopeptidase activity|zinc ion binding|,2,3,82300000,1.7%
Q9DBN5,0.960539053,0.0065,0.446046021,-0.076333333,0.902392335,-0.127957946,0.926,0.512,-1.304,0.038,-0.048,-0.085,Q9DBN5,Lonp2,Q9DBN5_Lonp2,Q9DBN5,Lonp2,1,5,2,2,Q9DBN5|Q9DBN5-3|Q8BK80,MOUSE,95038.2,3.5,639,639.1,12.74,12.74,,852,"Lon protease homolog 2, peroxisomal",nucleus|cytoplasm|peroxisome|peroxisomal matrix|membrane|,misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|response to organic cyclic compound|protein processing|protein import into peroxisome matrix|regulation of fatty acid beta-oxidation|,protease binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|receptor binding|protein binding|ATP binding|peptidase activity|enzyme binding|,2,5,3570000000,3.5%
Q8BV42,0.434226419,0.3996,6.634705386,0.585166667,0.217034843,1.411522918,0.025,0.072,,1.065,-0.021,0.857,Q8BV42,Zfp786,Q8BV42_Zfp786,Q8BV42,Znf786,1,2,2,2,Q8BV42,MOUSE,92221.3,2.7,640,640.1,12.61,12.61,,777,Zinc finger protein 786,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|metal ion binding|,2,2,25200000,2.7%
E9Q9F1,0.484829007,0.1108,5.818865876,0.548,0.261886681,1.26377859,-0.159,-0.277,,-0.252,0.973,0.269,E9Q9F1,Kcnq5,E9Q9F1_Kcnq5,E9Q9F1,Kcnq5,1,2,2,2,E9Q9F1|Q9JK45|G3UYG5|G3UYP4|G3UZ84,MOUSE,105647.8,1.4,641,641.1,12.55,12.55,,952,Potassium voltage-gated channel subfamily KQT member 5,voltage-gated potassium channel complex|integral component of membrane|,potassium ion transport|potassium ion transmembrane transport|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|,2,2,127000000,1.4%
K7N784,0.155174868,0.329333333,16.24791475,-0.827333333,0.023725126,-3.001999183,0.519,0.513,1.197,-0.025,-0.108,-0.12,K7N784,NotFound,K7N784_NotFound,K7N784,Vmn2r4,1,2,2,2,K7N784|E9Q277|E9PYL5|H3BK29|E9PZ74|L7N478,MOUSE,104813.9,4.3,642,642.1,12.51,12.51,,913,"Vomeronasal 2, receptor 4",plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|,2,2,111000000,4.3%
Q62266,0.011010904,0.7638,35.91140186,-4.053666667,0.000256366,-9.159910097,3.271,3.121,,-1.226,-1.219,-0.128,Q62266,Sprr1a,Q62266_Sprr1a,Q62266,Sprr1a,1,1,1,1,Q62266,MOUSE,16620.8,5.5,643,643.1,12.5,12.5,,144,Cornifin-A,cornified envelope|cytoplasm|cell periphery|,peptide cross-linking|keratinocyte differentiation|keratinization|,"structural molecule activity|protein binding, bridging|",1,1,23300000,5.5%
O54988,0.062809723,-0.4308,23.29786309,1.497833333,0.004679653,4.821151375,-1.621,-1.038,,0.18,0.304,0.021,O54988,Slk,O54988_Slk,O54988,Slk,1,11,2,2,O54988|O54988-2,MOUSE,142138.8,1.3,644,644.1,12.47,12.47,,1233,STE20-like serine/threonine-protein kinase,cytoplasm|extracellular exosome|,apoptotic process|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|regulation of apoptotic process|protein autophosphorylation|,protein serine/threonine kinase activity|ATP binding|identical protein binding|protein homodimerization activity|,2,11,676000000,1.3%
Q80Z25,0.096032951,1.3475,20.37759037,-3.249,0.00916729,-3.792622218,2.738,2.064,4.114,-1.152,-1.037,1.358,Q80Z25,Ofd1,Q80Z25_Ofd1,Q80Z25,Ofd1,1,2,2,2,A2AEG2|Q80Z25,MOUSE,117799.6,1.4,645,645.1,12.44,12.44,,1017,Oral-facial-digital syndrome 1 protein homolog,nucleus|centrosome|centriole|cilium|microtubule cytoskeleton|membrane|centriolar satellite|ciliary basal body|,embryonic body morphogenesis|axoneme assembly|cilium morphogenesis|epithelial cilium movement involved in determination of left/right asymmetry|negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation|mitotic nuclear division|centriole replication|mitotic spindle assembly|,alpha-tubulin binding|gamma-tubulin binding|,2,2,5370000000,1.4%
A0A0A6YW72,0.439181245,-0.1516,6.508679413,0.4665,0.22342515,1.387576887,-0.105,-0.758,,-0.219,0.171,0.153,A0A0A6YW72,NotFound,A0A0A6YW72_NotFound,A0A0A6YW72,Dchs2,1,3,2,2,A0A0A6YW72,MOUSE,367194.3,0.7,646,646.1,12.43,12.43,,3346,Dachsous cadherin-related 2,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,2,3,1980000000,0.7%
B2RQE8,0.389479065,-0.2062,7.546773192,0.701333333,0.175923024,1.574988276,-1.232,-0.022,,0.225,-0.172,0.17,B2RQE8,Arhgap42,B2RQE8_Arhgap42,B2RQE8,Arhgap42,1,4,2,2,B2RQE8,MOUSE,95375.7,3.5,647,647.1,12.43,12.43,,841,Rho GTPase-activating protein 42,,signal transduction|positive regulation of GTPase activity|,GTPase activator activity|,2,4,1960000000,3.5%
P35550,0.098250515,1.0258,20.04775828,-4.352833333,0.009890635,-4.061298629,1.845,5.43,,-0.802,-0.534,-0.81,P35550,Fbl,P35550_Fbl,P35550,Fbl,1,5,2,2,P35550,MOUSE,34420.3,3,648,648.1,12.43,12.43,,327,rRNA 2'-O-methyltransferase fibrillarin,dense fibrillar component|granular component|nucleus|nucleolus|Cajal body|membrane|box C/D snoRNP complex|small-subunit processome|extracellular exosome|,box C/D snoRNA 3'-end processing|osteoblast differentiation|tRNA processing|snoRNA metabolic process|rRNA methylation|histone glutamine methylation|,RNA binding|rRNA methyltransferase activity|poly(A) RNA binding|histone-glutamine methyltransferase activity|,2,5,413000000,3.0%
A2AS03,0.044980087,1.6476,25.55224075,-5.163166667,0.002784684,-5.501778372,3.212,6.279,,-0.459,-0.101,-0.693,A2AS03,Helz2,A2AS03_Helz2,A2AS03,Helz2,1,2,2,2,A2AS03|E9QAM5|A2AS05,MOUSE,338736.3,1.4,649,649.1,12.36,12.36,,2970,Helicase with zinc finger domain 2,membrane|,positive regulation of transcription from RNA polymerase II promoter|,ATP binding|ligand-dependent nuclear receptor transcription coactivator activity|poly(A) RNA binding|,2,2,203000000,1.4%
Q9QYX7,0.075595681,-0.4866,21.95134499,1.813166667,0.006380658,4.496286231,-1.986,-1.163,,-0.184,0.409,0.491,Q9QYX7,Pclo,Q9QYX7_Pclo,Q9QYX7,Pclo,1,5,2,2,Q9QYX7|Q9QYX7-2,MOUSE,552707.3,0.6,650,650.1,12.36,12.36,,5068,Protein piccolo,intracellular|postsynaptic density|cell junction|synapse|presynaptic active zone|extracellular exosome|,cytoskeleton organization|synapse assembly|synaptic vesicle targeting|regulation of exocytosis|cAMP-mediated signaling|insulin secretion|,calcium ion binding|protein binding|profilin binding|calcium-dependent phospholipid binding|,2,5,39600000000,0.6%
Q9Z160,0.558282094,1.087,4.850276851,-0.965833333,0.327319828,-1.086303762,2.647,0.686,,1.009,1.614,-0.521,Q9Z160,Cog1,Q9Z160_Cog1,Q9Z160,Cog1,1,3,2,2,Q9Z160,MOUSE,110360.4,2.6,652,652.1,12.31,12.31,,980,Conserved oligomeric Golgi complex subunit 1,Golgi membrane|Golgi apparatus|Golgi transport complex|,protein transport|,,2,3,1260000000,2.6%
Q9WUF3,0.258645356,0.0505,11.44711522,1.079333333,0.071661926,2.428773779,,-0.759,,0.675,0.279,0.007,Q9WUF3,Casp8ap2,Q9WUF3_Casp8ap2,Q9WUF3,Casp8ap2,1,2,2,2,Q9WUF3|E9Q368|Q3V2J0|Q9R0K4|B1AX75,MOUSE,221996.7,0.7,653,653.1,12.3,12.3,,1962,CASP8-associated protein 2,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,2,2,764000000,0.7%
F8VQD1,0.381886167,0.448666667,7.688604621,-1.498,0.17027055,-1.559392732,3.375,0.692,-0.474,-0.522,-0.081,-0.298,F8VQD1,Pbrm1,F8VQD1_Pbrm1,F8VQD1,Pbrm1,1,2,2,2,F8VQD1|E9Q4Y5|D3Z1N4|Q8BSQ9|E9Q7L2|Q8BSQ9-2|E9Q7L3|D3Z1W6|D6RI94|D6RIL0,MOUSE,195966.4,1.1,654,654.1,12.29,12.29,,1704,Protein polybromo-1,kinetochore|nucleus|BAF-type complex|,placenta development|heart development|negative regulation of cell proliferation|,chromatin binding|,2,2,1870000000,1.1%
Q6R891,0.237373291,-0.1782,11.97022349,0.733833333,0.063529824,2.369506268,-0.928,-0.309,,0.211,0.092,0.043,Q6R891,Ppp1r9b,Q6R891_Ppp1r9b,Q6R891,Ppp1r9b,1,2,2,2,Q6R891|Q6R891-2,MOUSE,89632.8,4,655,655.1,12.28,12.28,,817,Neurabin-2,nucleoplasm|cytoplasm|plasma membrane|adherens junction|lamellipodium|filopodium|cortical actin cytoskeleton|ruffle membrane|dendritic spine|synapse|,regulation of protein phosphorylation|actin filament organization|dendrite development|cell migration|calcium-mediated signaling|actin cytoskeleton organization|negative regulation of cell growth|regulation of cell proliferation|filopodium assembly|regulation of synaptic transmission|cellular response to morphine|regulation of opioid receptor signaling pathway|,actin binding|protein binding|protein phosphatase 1 binding|,2,2,3030000000,4.0%
E9PX59,0.09808131,-0.2804,20.1298798,1.361,0.009705368,4.043456873,-0.772,-1.422,,0.274,0.483,0.035,E9PX59,Samd9l,E9PX59_Samd9l,E9PX59,Samd9l,1,10,2,2,E9PX59|Q69Z37,MOUSE,184076.8,1,656,656.1,12.25,12.25,,1579,Sterile alpha motif domain-containing protein 9-like,early endosome|,hematopoietic progenitor cell differentiation|stem cell division|endosomal vesicle fusion|common myeloid progenitor cell proliferation|regulation of protein catabolic process|spleen development|,,2,10,1400000000,1.0%
P21836,0.044980087,0.6445,25.46149368,-1.571666667,0.002843483,-4.841026701,1.782,0.842,1.667,-0.047,-0.335,-0.042,P21836,Ache,P21836_Ache,P21836,Ache,1,3,2,2,P21836|A0A0G2JDM6,MOUSE,68566.6,2.7,657,657.1,12.23,12.23,,614,Acetylcholinesterase,extracellular region|basal lamina|extracellular space|Golgi apparatus|plasma membrane|cell surface|membrane|cell junction|anchored component of membrane|neuromuscular junction|synapse|perinuclear region of cytoplasm|,regulation of receptor recycling|osteoblast development|acetylcholine catabolic process|cell adhesion|receptor internalization|neurotransmitter receptor biosynthetic process|protein tetramerization|retina development in camera-type eye|,acetylcholinesterase activity|cholinesterase activity|protein binding|collagen binding|hydrolase activity|serine hydrolase activity|acetylcholine binding|protein homodimerization activity|laminin binding|protein self-association|,2,3,13600000,2.7%
Q99LJ1,0.946089108,-0.0988,0.577500453,-0.063,0.87548751,-0.164870659,-0.565,0.443,,-0.161,-0.109,-0.102,Q99LJ1,Fuca1,Q99LJ1_Fuca1,Q99LJ1,Fuca1,1,2,2,2,Q99LJ1,MOUSE,52564.9,3.9,658,658.1,12.1,12.1,,452,Tissue alpha-L-fucosidase,lysosome|extracellular exosome|,fucose metabolic process|glycoside catabolic process|,alpha-L-fucosidase activity|,2,2,9060000,3.9%
Q8K389,0.558282094,-0.0802,4.858969117,0.343833333,0.326665363,1.085878725,-0.606,0.033,,0.042,0.184,-0.054,Q8K389,Cdk5rap2,Q8K389_Cdk5rap2,Q8K389,Cdk5rap2,1,2,2,2,Q8K389,MOUSE,207196.3,0.8,659,659.1,12.03,12.03,,1822,CDK5 regulatory subunit-associated protein 2,pericentriolar material|spindle pole|cytoplasm|Golgi apparatus|centrosome|microtubule|cell junction|perinuclear region of cytoplasm|extracellular exosome|,"establishment of mitotic spindle orientation|microtubule cytoskeleton organization|microtubule bundle formation|chromosome segregation|brain development|neurogenesis|negative regulation of neuron differentiation|positive regulation of transcription, DNA-templated|negative regulation of centriole replication|centrosome organization|regulation of spindle checkpoint|",protein binding|calmodulin binding|microtubule binding|tubulin binding|protein kinase binding|transcription regulatory region DNA binding|,2,2,4540000000,0.8%
Q80TF3,0.418742462,1.2854,6.992623054,-1.610166667,0.199865436,-1.478319202,1.545,2.958,,2.589,-0.259,-0.406,Q80TF3,Pcdh19,Q80TF3_Pcdh19,Q80TF3,Pcdh19,1,4,2,2,Q80TF3|E9Q5E1,MOUSE,127231.1,1.5,660,660.1,12.02,12.02,,1145,Protocadherin-19,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|brain development|,calcium ion binding|,2,4,26500000000,1.5%
E9PVB5,0.595604295,-0.0504,4.139605514,0.622666667,0.385513374,0.95125638,0.553,-1.401,,-0.22,0.311,0.505,E9PVB5,Ttc17,E9PVB5_Ttc17,E9PVB5,Ttc17,1,3,2,2,E9PVB5|E9PVB5-2|A2AFY7,MOUSE,136716.5,2,661,661.1,11.97,11.97,,1198,Tetratricopeptide repeat protein 17,cytoplasm|plasma membrane|actin cytoskeleton|,actin filament polymerization|cilium organization|,,2,3,958000000,2.0%
E9PYL1,0.629762175,0.2938,3.6396458,-0.282,0.432549107,-0.852460825,0.831,0.095,,0.186,0.272,0.085,E9PYL1,Chd5,E9PYL1_Chd5,E9PYL1,Chd5,1,3,2,2,E9PYL1|A2A8L1|E9PYU4|E9QAS5|Q6PDQ2|E9QAS4,MOUSE,224164.2,1.2,662,662.1,11.97,11.97,,1952,Chromodomain-helicase-DNA-binding protein 5,chromatin|nucleus|membrane|,transcription from RNA polymerase II promoter|regulation of transcription involved in cell fate commitment|histone H3-K27 trimethylation|,DNA binding|chromatin binding|ATP binding|ATP-dependent helicase activity|zinc ion binding|H3K27me3 modified histone binding|,2,3,2550000000,1.2%
Q9JL70,0.472601761,-0.1972,5.957969032,0.363,0.253631445,1.288055717,-0.636,-0.194,,-0.129,-0.007,-0.02,Q9JL70,Fanca,Q9JL70_Fanca,Q9JL70,Fanca,1,3,2,2,Q9JL70|D3Z6Y5,MOUSE,163834.7,2.9,663,663.1,11.94,11.94,,1439,Fanconi anemia group A protein homolog,nucleus|nucleolus|cytoplasm|Fanconi anaemia nuclear complex|,DNA repair|male meiosis|male gonad development|female gonad development|regulation of cell proliferation|,,2,3,828000000,2.9%
B2RQC6,0.296957679,1.0076,10.14140572,-2.723166667,0.09679645,-2.044532939,0.443,4.84,,0.372,-0.64,0.023,B2RQC6,Cad,B2RQC6_Cad,B2RQC6,Cad,1,2,2,2,B2RQC6|G3UWN2|E9QAI5|B2RQC6-2,MOUSE,245801.4,0.7,664,664.1,11.93,11.93,,2225,CAD protein,nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|membrane|nuclear matrix|neuronal cell body|terminal bouton|protein complex|extracellular exosome|,urea cycle|liver development|'de novo' pyrimidine nucleobase biosynthetic process|UTP biosynthetic process|arginine biosynthetic process|glutamine metabolic process|heart development|female pregnancy|lactation|response to amine|drug metabolic process|peptidyl-threonine phosphorylation|response to caffeine|organ regeneration|response to testosterone|cellular response to drug|'de novo' UMP biosynthetic process|protein autophosphorylation|response to cortisol|cellular response to epidermal growth factor stimulus|,UTP binding|aspartate carbamoyltransferase activity|carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|dihydroorotase activity|protein kinase activity|ATP binding|zinc ion binding|amino acid binding|enzyme binding|identical protein binding|,2,2,348000000,0.7%
E9Q043,0.031812923,-0.4564,28.19318698,1.776,0.001515938,6.223393344,-1.603,-1.441,,0.495,0.23,0.037,E9Q043,Fndc1,E9Q043_Fndc1,E9Q043,Fndc1,1,5,1,1,E9Q043,MOUSE,189544.2,0.4,665,665.1,11.86,11.86,,1732,Fibronectin type III domain-containing 1,nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|mitochondrial membrane|,positive regulation of protein phosphorylation|positive regulation of cardiac muscle cell apoptotic process|regulation of protein transport|cellular response to hypoxia|,,1,5,59900000,0.4%
P24369,0.987463289,-0.437,0.128714295,-0.058,0.970797324,-0.038172268,0.72,2.055,-3.999,-0.315,-0.497,-0.586,P24369,Ppib,P24369_Ppib,P24369,Ppib,1,1,1,1,P24369,MOUSE,23713,6,666,666.1,11.84,11.84,,216,Peptidyl-prolyl cis-trans isomerase B,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|membrane|macromolecular complex|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|positive regulation of multicellular organism growth|positive regulation by host of viral process|positive regulation by host of viral genome replication|protein stabilization|bone development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein complex binding|peptide binding|poly(A) RNA binding|RNA polymerase binding|collagen binding|,1,1,913000,6.0%
P16015,0.187844192,0.1364,14.92878056,-2.601833333,0.03214563,-2.952006671,0.261,3.134,,-0.703,-0.811,-1.199,P16015,Car3,P16015_Car3,P16015,Ca3,1,1,1,1,P16015,MOUSE,29651,4.6,667,667.1,11.81,11.81,,260,Carbonic anhydrase 3,cytosol|,one-carbon metabolic process|response to oxidative stress|dephosphorylation|response to ethanol|,carbonate dehydratase activity|zinc ion binding|nickel cation binding|phosphatase activity|,1,1,24900000,4.6%
Q9R0M0,0.630078008,0.01475,3.630113614,0.354333333,0.433499538,0.868720327,,-0.251,,0.395,-0.081,-0.004,Q9R0M0,NotFound,Q9R0M0_NotFound,Q9R0M0,Celsr2,1,4,2,2,Q9R0M0|A2AEE7|Q9R0M0-2,MOUSE,322437.2,0.9,668,668.1,11.8,11.8,,2920,Cadherin EGF LAG seven-pass G-type receptor 2,cytoplasm|plasma membrane|integral component of membrane|,"neuron migration|cilium movement|regulation of transcription, DNA-templated|homophilic cell adhesion via plasma membrane adhesion molecules|G-protein coupled receptor signaling pathway|Wnt signaling pathway|ventricular system development|neural plate anterior/posterior regionalization|regulation of protein localization|cerebrospinal fluid secretion|cilium assembly|",G-protein coupled receptor activity|calcium ion binding|protein binding|,2,4,11200000000,0.9%
Q8VCY6,0.578243439,0.9266,4.50071835,-0.9665,0.354754706,-1.020332715,2.933,0.08,,0.756,1.08,-0.216,Q8VCY6,Utp6,Q8VCY6_Utp6,Q8VCY6,Utp6,1,2,2,2,Q8VCY6|Q6I6G8|Q9JLV2|Q9JLV2-2|A0A0R4J0M8|Q8CDV6|Q8CDV6-2|Q9DAQ9|Q9DAQ9-2|A0A1L1SQQ1,MOUSE,70941.6,2.1,669,669.1,11.78,11.78,,597,U3 small nucleolar RNA-associated protein 6 homolog,nucleolus|small-subunit processome|Pwp2p-containing subcomplex of 90S preribosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|",snoRNA binding|,2,2,76400000,2.1%
Q64323,0.108167445,-0.59,19.36108767,1.894166667,0.011584872,3.879782027,-1.007,-2.446,,0.134,0.304,0.065,Q64323,Piga,Q64323_Piga,Q64323,Piga,1,2,1,1,Q64323|A0A140LI97,MOUSE,55095.4,1.4,670,670.1,11.77,11.77,,485,N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex|endoplasmic reticulum membrane|membrane|integral component of membrane|,GPI anchor biosynthetic process|,"transferase activity, transferring glycosyl groups|",1,2,267000000,1.4%
O89001,0.269872202,-0.0856,11.0143447,1.197333333,0.079170891,2.198199614,-1.379,-0.229,,1.101,-0.002,0.081,O89001,Cpd,O89001_Cpd,O89001,Cpd,1,11,2,2,O89001,MOUSE,153429.8,1,671,671.1,11.77,11.77,,1377,Carboxypeptidase D,membrane|integral component of membrane|extracellular exosome|,proteolysis|,metallocarboxypeptidase activity|serine-type carboxypeptidase activity|zinc ion binding|,2,11,13200000000,1.0%
Q80YA7,0.326571299,0.509833333,9.269042604,-1.582333333,0.118330238,-1.82391738,0.559,0.021,3.323,-0.327,-0.467,-0.05,Q80YA7,Dpp8,Q80YA7_Dpp8,Q80YA7,Dpp8,1,2,2,2,Q80YA7|A0A1L1STG9,MOUSE,102868.7,1.4,672,672.1,11.75,11.75,,892,Dipeptidyl peptidase 8,nucleoplasm|cytoplasm|membrane|,proteolysis|,aminopeptidase activity|serine-type peptidase activity|,2,2,5470000,1.4%
Q03717,0.209985542,0.867166667,13.46985947,-1.233,0.044979441,-2.524040679,0.78,1.488,2.183,0.484,-0.465,0.733,Q03717,Kcnb1,Q03717_Kcnb1,Q03717,Kcnb1,1,5,2,2,Q03717,MOUSE,96445.6,2.2,673,673.1,11.71,11.71,,857,Potassium voltage-gated channel subfamily B member 1,intracellular|plasma membrane|voltage-gated potassium channel complex|integral component of membrane|lateral plasma membrane|cell junction|axon|dendrite|dendrite membrane|neuronal cell body membrane|sarcolemma|perikaryon|postsynaptic membrane|,action potential|potassium ion transport|vesicle docking involved in exocytosis|glutamate receptor signaling pathway|positive regulation of norepinephrine secretion|cellular response to nutrient levels|positive regulation of catecholamine secretion|regulation of ion transmembrane transport|glucose homeostasis|positive regulation of calcium ion-dependent exocytosis|negative regulation of insulin secretion|protein homooligomerization|cellular response to glucose stimulus|potassium ion transmembrane transport|protein targeting to plasma membrane|positive regulation of protein targeting to membrane|regulation of action potential|positive regulation of long term synaptic depression|regulation of motor neuron apoptotic process|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|protein binding|outward rectifier potassium channel activity|ubiquitin-like protein binding|ion channel binding|protein heterodimerization activity|protein N-terminus binding|,2,5,63800000,2.2%
A2AFQ0,0.538807288,-0.0242,5.053303597,-0.716166667,0.312370232,-1.124270403,-0.608,1.419,,-0.284,-0.338,-0.31,A2AFQ0,Huwe1,A2AFQ0_Huwe1,A2AFQ0,Huwe1,1,2,2,2,A2AFQ0|Q7TMY8|Q7TMY8-3|Q7TMY8-4|Q7TMY8-2|Q8K482|Q8BLW8,MOUSE,486619.9,0.2,674,674.1,11.67,11.67,,4378,E3 ubiquitin-protein ligase HUWE1,nucleoplasm|cytoplasm|membrane|extracellular exosome|,protein polyubiquitination|base-excision repair|protein monoubiquitination|histone ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein targeting to mitochondrion|,ubiquitin-protein transferase activity|ligase activity|poly(A) RNA binding|,2,2,49700000,0.2%
P50544,0.628183779,-0.090833333,3.665291201,0.989,0.4300024,0.846416286,-0.036,1.249,-2.969,1.68,-0.393,-0.076,P50544,Acadvl,P50544_Acadvl,P50544,Acadvl,1,6,2,2,P50544|B1AR28,MOUSE,71273.6,4.2,675,675.1,11.65,11.65,,656,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|,temperature homeostasis|epithelial cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid oxidation|regulation of cholesterol metabolic process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,2,6,209000000,4.2%
P35951,0.031812923,0.4795,28.32991198,-1.513666667,0.001468956,-5.506301505,1.318,1.535,0.856,-0.111,-0.481,-0.24,P35951,Ldlr,P35951_Ldlr,P35951,Ldlr,1,1,1,1,P35951|A0A1L1SRE8,MOUSE,98425.9,1.2,676,676.1,11.64,11.64,,862,Low-density lipoprotein receptor,lysosome|endosome|early endosome|late endosome|Golgi apparatus|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|low-density lipoprotein particle|receptor complex|apical part of cell|,lipid metabolic process|receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of triglyceride biosynthetic process|regulation of phosphatidylcholine catabolic process|phospholipid transport|intestinal cholesterol absorption|cholesterol transport|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein catabolic process|cholesterol homeostasis|cholesterol import|regulation of cholesterol homeostasis|,glycoprotein binding|low-density lipoprotein receptor activity|calcium ion binding|protein binding|low-density lipoprotein particle binding|very-low-density lipoprotein particle receptor activity|,1,1,4240000,1.2%
Q7TQA1,0.337209389,-0.2098,8.862852077,0.720333333,0.129931602,1.809911318,-0.139,-1.145,,-0.072,0.004,0.303,Q7TQA1,Igsf1,Q7TQA1_Igsf1,Q7TQA1,Igsf1,1,6,2,2,Q7TQA1|Q7TQA1-5|Q7TQA1-2|Q7TQA1-3,MOUSE,148946.8,0.9,677,677.1,11.61,11.61,,1317,Immunoglobulin superfamily member 1,extracellular region|membrane|integral component of membrane|,"regulation of transcription, DNA-templated|signal transduction|",receptor activity|coreceptor activity|inhibin binding|,2,6,551000000,0.9%
Q9WVB4,0.583023561,0.2222,4.391422687,-0.321333333,0.363795842,-0.997793282,0.463,0.367,,0.473,-0.225,0.033,Q9WVB4,Slit3,Q9WVB4_Slit3,Q9WVB4,Slit3,1,2,2,2,Q9WVB4,MOUSE,173771.9,1.9,678,678.1,11.58,11.58,,1523,Slit homolog 3 protein,extracellular space|,axon guidance|negative regulation of cell proliferation|organ morphogenesis|negative regulation of gene expression|negative regulation of cell growth|cellular response to hormone stimulus|Roundabout signaling pathway|axon extension involved in axon guidance|negative chemotaxis|response to cortisol|apoptotic process involved in luteolysis|negative regulation of chemokine-mediated signaling pathway|,receptor binding|calcium ion binding|Roundabout binding|,2,2,29800000,1.9%
Q6DFV5-3,0.774476598,-0.183166667,2.169976784,0.251,0.606739573,0.542869502,-0.536,0.617,-1.007,-0.354,-0.036,0.217,Q6DFV5,Helz,Q6DFV5-3_Helz,Q6DFV5-3,Helz,1,3,2,2,Q6DFV5-3|A0A0R4J0Y3|Q6DFV5|A2AAU3|Q6DFV5-2,MOUSE,221802.9,0.6,679,679.1,11.57,11.57,,1964,Isoform 3 of Probable helicase with zinc finger domain,nucleus|membrane|,metabolic process|,helicase activity|protein binding|ATP binding|poly(A) RNA binding|metal ion binding|,2,3,111000000,0.6%
E9Q555,0.411690299,0.468,7.141174837,-0.9375,0.193144576,-1.505040993,2.017,0.044,,0.136,0.049,0.094,E9Q555,NotFound,E9Q555_NotFound,E9Q555,Rnf213,1,2,2,2,E9Q555|A0A171EBL2,MOUSE,592076.1,0.5,680,680.1,11.54,11.54,,5152,E3 ubiquitin-protein ligase RNF213,nucleolus|cytoplasm|membrane|,protein ubiquitination|protein autoubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ATPase activity|,2,2,717000000,0.5%
Q8BLR5,0.966296393,0.8696,0.377251965,-0.1265,0.91680042,-0.109897886,0.305,1.586,,2.909,-0.501,0.049,Q8BLR5,Psd4,Q8BLR5_Psd4,Q8BLR5,Psd4,1,4,1,1,Q8BLR5,MOUSE,113986.3,0.7,681,681.1,11.54,11.54,,1005,PH and SEC7 domain-containing protein 4,plasma membrane|membrane|cell junction|trans-Golgi network|,neuron differentiation|regulation of ARF protein signal transduction|positive regulation of GTPase activity|vesicle-mediated transport|,ARF guanyl-nucleotide exchange factor activity|lipid binding|,1,4,299000000,0.7%
D3YUJ1,0.366039448,0.095,8.105586471,1.126666667,0.154682561,1.750906636,,-0.75,,0.13,-0.127,1.127,D3YUJ1,Rnf181,D3YUJ1_Rnf181,D3YUJ1,Rnf181,1,2,2,2,D3YUJ1,MOUSE,23533.5,9.2,682,682.1,11.51,11.51,,206,E3 ubiquitin-protein ligase RNF181,,protein autoubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|,2,2,1720000000,9.2%
E9Q9C6,0.198868004,0.331333333,14.03640792,-2.587333333,0.03947837,-2.627025026,3.002,2.584,-0.711,-0.964,-1.098,-0.825,E9Q9C6,Fcgbp,E9Q9C6_Fcgbp,E9Q9C6,Fcgbp,1,14,1,1,E9PVG8|E9Q9C6|E9Q0B5,MOUSE,287674,0.3,683,683.1,11.49,11.49,,2583,Fc fragment of IgG-binding protein,proteinaceous extracellular matrix|extracellular exosome|,,,1,14,42600000000,0.3%
P27106,0.20003038,-0.1322,13.97368757,0.909666667,0.040052649,2.747233063,-0.555,-0.801,,0.221,-0.123,0.597,P27106,NotFound,P27106_NotFound,P27106,Amh,1,8,1,1,P27106|Q5EC55,MOUSE,60405,1,684,684.1,11.49,11.49,,555,Muellerian-inhibiting factor,extracellular region|,gonadal mesoderm development|cell differentiation|,growth factor activity|,1,8,709000000,1.0%
G3X9L9,0.106154353,0.883,19.49013964,-3.373333333,0.011245688,-3.619197591,1.455,4.669,1.585,-0.859,-1.401,-0.151,G3X9L9,Pde4dip,G3X9L9_Pde4dip,G3X9L9,Pde4dip,1,2,2,2,G3X9L9|E9Q1A0|Q80YT7|Q80YT7-2,MOUSE,279214.5,0.5,685,685.1,11.48,11.48,,2463,Myomegalin,nucleus|cytoplasm|centrosome|,,protein binding|,2,2,45200000,0.5%
Q8BYH8,0.402796108,-0.3124,7.290248259,0.759333333,0.1866273,1.529127146,-0.046,-1.49,,-0.22,0.044,0.15,Q8BYH8,Chd9,Q8BYH8_Chd9,Q8BYH8,Chd9,1,3,2,2,Q8BYH8|Q8BYH8-2|A0A1B0GR76,MOUSE,326022.2,0.8,686,686.1,11.48,11.48,,2885,Chromodomain-helicase-DNA-binding protein 9,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,2,3,80300000,0.8%
Q8R418,0.070949964,0.651833333,22.37942943,-1.693666667,0.00578172,-4.180551569,0.927,1.241,2.328,-0.108,-0.139,-0.338,Q8R418,NotFound,Q8R418_NotFound,Q8R418,Dicer1,1,2,2,2,Q8R418|F8VQ54,MOUSE,219555.4,0.9,687,687.1,11.47,11.47,,1916,Endoribonuclease Dicer,nucleus|cytoplasm|RISC complex|micro-ribonucleoprotein complex|RISC-loading complex|,"negative regulation of transcription from RNA polymerase II promoter|meiotic spindle organization|angiogenesis|regulation of protein phosphorylation|hair follicle development|apoptotic DNA fragmentation|RNA processing|cell proliferation|regulation of Notch signaling pathway|post-embryonic development|zygote asymmetric cell division|regulation of gene expression|negative regulation of Schwann cell proliferation|positive regulation of gene expression|regulation of muscle cell apoptotic process|positive regulation of Schwann cell differentiation|myoblast differentiation involved in skeletal muscle regeneration|rRNA catabolic process|stem cell maintenance|spinal cord motor neuron differentiation|nerve development|olfactory bulb interneuron differentiation|cerebral cortex development|lung development|embryonic limb morphogenesis|production of siRNA involved in RNA interference|targeting of mRNA for destruction involved in RNA interference|pre-miRNA processing|hair follicle morphogenesis|regulation of myelination|positive regulation of myelination|peripheral nervous system myelin formation|conversion of ds siRNA to ss siRNA involved in RNA interference|siRNA loading onto RISC involved in RNA interference|embryonic hindlimb morphogenesis|production of miRNAs involved in gene silencing by miRNA|multicellular organism growth|miRNA loading onto RISC involved in gene silencing by miRNA|conversion of ds siRNA to ss siRNA|regulation of odontogenesis of dentin-containing tooth|regulation of viral genome replication|regulation of cell differentiation|regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|mRNA stabilization|spleen development|digestive tract development|reproductive structure development|regulation of oligodendrocyte differentiation|epidermis morphogenesis|branching morphogenesis of an epithelial tube|neuron projection morphogenesis|anatomical structure development|regulation of neurogenesis|cartilage development|spindle assembly|regulation of RNA metabolic process|defense response to virus|regulation of cell cycle|cardiac muscle cell development|inner ear receptor cell development|negative regulation of glial cell proliferation|intestinal epithelial cell development|cardiac neural crest cell development involved in outflow tract morphogenesis|ganglion development|regulation of enamel mineralization|hair follicle cell proliferation|RNA phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|regulation of miRNA metabolic process|positive regulation of miRNA metabolic process|",double-stranded RNA binding|helicase activity|endoribonuclease activity|ribonuclease III activity|deoxyribonuclease I activity|protein binding|ATP binding|protein domain specific binding|siRNA binding|miRNA binding|metal ion binding|pre-miRNA binding|pre-miRNA binding|,2,2,376000000,0.9%
Q8BWS5,0.326571299,-0.0668,9.253767285,0.586166667,0.118747171,1.877405551,-0.675,-0.162,,0.403,0.076,0.024,Q8BWS5,Gprin3,Q8BWS5_Gprin3,Q8BWS5,Gprin3,1,4,2,2,Q8BWS5,MOUSE,81396,2.8,688,688.1,11.43,11.43,,763,G protein-regulated inducer of neurite outgrowth 3,,,,2,4,2850000000,2.8%
E9Q048,0.007983705,0.7025,39.78488072,-2.650333333,0.000105078,-8.934966924,2.546,1.836,1.701,-0.633,-0.693,-0.542,E9Q048,Ermard,E9Q048_Ermard,E9Q048,Ermard,1,3,2,2,E9Q048|Q3TVE4,MOUSE,71714.1,1.9,689,689.1,11.41,11.41,,622,ER membrane-associated RNA degradation,,,,2,3,88600000,1.9%
Q3TQQ9-2,0.380217511,0.203,7.718976868,-0.731333333,0.169083922,-1.562523543,1.484,0.504,-0.282,-0.327,-0.053,-0.108,Q3TQQ9,BC055324,Q3TQQ9-2_BC055324,Q3TQQ9-2,,1,8,1,1,Q3TQQ9-2|Q3TQQ9|Q3TQQ9-3,MOUSE,105599.9,1.5,690,690.1,11.33,11.33,,903,Isoform 2 of Uncharacterized protein C1orf112 homolog,,,,1,8,285000000,1.5%
Q8CB77,0.384298925,-0.1288,7.649927695,0.542833333,0.171793699,1.591733772,-0.801,-0.108,,-0.141,0.129,0.277,Q8CB77,Eloa,Q8CB77_Eloa,Q8CB77,Eloa,1,3,2,2,Q8CB77,MOUSE,87502.1,3.6,691,691.1,11.33,11.33,,773,Elongin-A,extracellular space|nucleus|cytoplasm|integral component of membrane|elongin complex|,regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,DNA binding|ubiquitin-protein transferase activity|,2,3,349000000,3.6%
P97366,0.919118991,0.0878,0.807597028,-0.083666667,0.830310055,-0.225750592,0.543,-0.267,,0.34,-0.15,-0.027,P97366,NotFound,P97366_NotFound,P97366,Evi5,1,3,2,2,P97366|F8VPT6,MOUSE,93682.9,3.4,692,692.1,11.32,11.32,,809,Ecotropic viral integration site 5 protein,nucleus|Golgi apparatus|microtubule organizing center|spindle|cytosol|intracellular membrane-bounded organelle|,"cell cycle|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|cell division|",GTPase activator activity|Rab GTPase binding|,2,3,369000000,3.4%
A7DTG3,0.826430946,-0.0458,1.665929228,0.121166667,0.681407763,0.435194346,0.03,-0.267,,-0.152,0.167,-0.007,A7DTG3,Sertad4,A7DTG3_Sertad4,A7DTG3,Sertad4,1,7,1,1,A7DTG3,MOUSE,41836.9,1.8,693,693.1,11.31,11.31,,377,SERTA domain-containing protein 4,nucleus|,,,1,7,400000000,1.8%
Q9D0I9,0.177690852,-0.0775,15.25965602,1.491333333,0.029787524,3.294865976,,-1.196,,0.557,-0.105,0.434,Q9D0I9,Rars,Q9D0I9_Rars,Q9D0I9,Rars,1,2,2,2,Q9D0I9,MOUSE,76470.9,4.5,694,694.1,11.3,11.3,,660,"Arginine--tRNA ligase, cytoplasmic",nucleoplasm|cytoplasm|mitochondrion|membrane|aminoacyl-tRNA synthetase multienzyme complex|extracellular exosome|,arginyl-tRNA aminoacylation|,tRNA binding|arginine-tRNA ligase activity|ATP binding|arginine binding|,2,2,585000000,4.5%
P11369,0.014726443,-0.8452,33.8568405,2.438,0.000411449,8.236734195,-2.522,-2.094,,-0.064,0.291,0.163,P11369,NotFound,P11369_NotFound,P11369,Pol,1,2,2,2,P11369,MOUSE,150604.7,2.6,695,695.1,11.29,11.29,,1281,LINE-1 retrotransposable element ORF2 protein,,RNA-dependent DNA replication|DNA recombination|nucleic acid phosphodiester bond hydrolysis|,RNA-directed DNA polymerase activity|endonuclease activity|metal ion binding|,2,2,3390000000,2.6%
A0A0J9YUA8,0.489116217,0.0098,5.716726247,0.333,0.268118867,1.244143072,-0.153,-0.227,,0.227,0.253,-0.051,A0A0J9YUA8,Med13l,A0A0J9YUA8_Med13l,A0A0J9YUA8,Med13l,1,2,2,2,A0A0J9YUA8|E9QLJ3|Q6JPI3,MOUSE,245751.8,0.9,696,696.1,11.23,11.23,,2216,Mediator of RNA polymerase II transcription subunit 13,,,,2,2,5600000000,0.9%
Q6P549,0.374847149,-0.2374,7.844616768,0.781,0.16426246,1.628171832,-1.363,-0.049,,-0.126,-0.039,0.39,Q6P549,Inppl1,Q6P549_Inppl1,Q6P549,Inppl1,1,2,2,2,Q6P549,MOUSE,139769.5,3.1,697,697.1,11.23,11.23,,1257,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",cytoplasm|Golgi apparatus|cytosol|cytoskeleton|plasma membrane|lamellipodium|filopodium|,endochondral ossification|immune system process|glucose metabolic process|phosphatidylinositol biosynthetic process|endocytosis|actin filament organization|cell adhesion|negative regulation of cell proliferation|post-embryonic development|negative regulation of gene expression|response to insulin|cellular lipid metabolic process|phosphatidylinositol dephosphorylation|ruffle assembly|,actin binding|protein binding|hydrolase activity|SH3 domain binding|SH2 domain binding|,2,2,301000000,3.1%
A0A075B5W7,0.877114071,0.2562,1.194343238,0.121166667,0.759566279,0.323232787,0.151,0.216,,0.041,0.867,0.006,A0A075B5W7,NotFound,A0A075B5W7_NotFound,A0A075B5W7,Ighv1-56,1,2,2,2,A0A075B5W7,MOUSE,10961.1,25.5,698,698.1,11.2,11.2,,98,Immunoglobulin heavy variable 1-56,,,,2,2,545000000,25.5%
Q6A037,0.61589699,-0.0396,3.825572436,0.2565,0.414421956,0.888896708,-0.397,0.01,,0.239,-0.043,-0.007,Q6A037,N4bp1,Q6A037_N4bp1,Q6A037,N4bp1,1,10,2,2,Q6A037,MOUSE,99886.7,3.1,699,699.1,11.18,11.18,,893,NEDD4-binding protein 1,nucleus|nucleolus|PML body|,negative regulation of protein ubiquitination|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|cellular response to UV|,protein binding|,2,10,3120000000,3.1%
Q8C3Y4,0.649693137,0.202,3.453105534,-0.240833333,0.451532949,-0.815532084,0.448,0.245,,0.403,-0.06,-0.026,Q8C3Y4,Kntc1,Q8C3Y4_Kntc1,Q8C3Y4,Kntc1,1,3,2,2,Q8C3Y4,MOUSE,253263.4,2.1,700,700.1,11.16,11.16,,2207,Kinetochore-associated protein 1,condensed chromosome kinetochore|spindle pole|nucleus|cytoplasm|kinetochore microtubule|plasma membrane|actin cytoskeleton|RZZ complex|,mitotic nuclear division|mitotic cell cycle checkpoint|cell division|,,2,3,243000000,2.1%
Q02357-6,0.226044132,1.259833333,12.83134736,-3.519,0.052103304,-2.420735994,2.268,0.481,6.309,-0.106,-1.178,-0.215,Q02357,Ank1,Q02357-6_Ank1,Q02357-6,Ank1,1,2,2,2,Q02357-6|A0A0R4J1N7|Q02357-4|Q0VGY9|D3Z5M4|D3YTV8|Q02357-3|G8JL84|Q02357|E9QNT8|B7ZW98|Q02357-2|G5E8J2|Q02357-5,MOUSE,210742.6,1.6,701,701.1,11.12,11.12,,1862,Isoform 6 of Ankyrin-1,plasma membrane|spectrin-associated cytoskeleton|membrane|sarcoplasmic reticulum|cortical cytoskeleton|,porphyrin-containing compound biosynthetic process|ER to Golgi vesicle-mediated transport|signal transduction|monovalent inorganic cation transport|erythrocyte development|iron ion homeostasis|protein targeting to plasma membrane|,cytoskeletal adaptor activity|enzyme binding|spectrin binding|ATPase binding|,2,2,6660000,1.6%
A0A0B4J1K5,0.535239042,0.026,5.118624572,0.482666667,0.307707118,1.166030823,,-0.336,,0.003,0.458,-0.021,A0A0B4J1K5,NotFound,A0A0B4J1K5_NotFound,A0A0B4J1K5,Iglv3,1,3,1,1,A0A0B4J1K5,MOUSE,13587,8.1,702,702.1,11.1,11.1,,122,Immunoglobulin lambda variable 3 (Fragment),,,,1,3,19100000,8.1%
Q80W93,0.518220351,0.0276,5.364316613,0.319333333,0.290782549,1.179564477,-0.08,-0.248,,0.297,0.197,-0.028,Q80W93,Hydin,Q80W93_Hydin,Q80W93,Hydin,1,3,2,2,Q80W93|Q80W93-2,MOUSE,587046.8,0.3,703,703.1,11.05,11.05,,5154,Hydrocephalus-inducing protein,axonemal central pair projection|,epithelial cell development|cilium movement|multicellular organismal development|ventricular system development|axoneme assembly|trachea development|,,2,3,5280000000,0.3%
P63154,0.195202915,-0.4802,14.20790394,1.278833333,0.03794981,2.798493651,-1.913,-0.582,,0.069,0.018,0.007,P63154,Crnkl1,P63154_Crnkl1,P63154,Crnkl1,1,2,2,2,P63154,MOUSE,83699.4,1.5,704,704.1,11.03,11.03,,690,Crooked neck-like protein 1,spliceosomal complex|nuclear speck|catalytic step 2 spliceosome|,"spliceosomal complex assembly|mRNA splicing, via spliceosome|positive regulation of defense response to virus by host|activation of mitophagy in response to mitochondrial depolarization|",RNA binding|poly(A) RNA binding|,2,2,40600000,1.5%
Q9JK39-2,0.966296393,0.0066,0.383663436,0.034333333,0.91544795,0.111595178,-0.303,0.275,,-0.021,0.162,-0.08,Q9JK39,Btnl10,Q9JK39-2_Btnl10,Q9JK39-2,Btnl10,1,3,1,1,Q9JK39-2|Q9JK39|A0A0R4J1C6,MOUSE,54778.1,1.4,705,705.1,11.03,11.03,,275,Isoform 2 of Butyrophilin-like protein 10,integral component of membrane|,,,1,3,14600000,1.4%
P54822,0.701970982,-0.392666667,2.91099671,0.954,0.511564417,0.697867698,0.813,0.726,-4.148,0.217,-0.29,0.326,P54822,Adsl,P54822_Adsl,P54822,Adsl,1,2,1,1,P54822|E9Q242,MOUSE,55607,2.2,706,706.1,11.02,11.02,,484,Adenylosuccinate lyase,mitochondrion|cytosol|,response to hypoxia|AMP biosynthetic process|'de novo' IMP biosynthetic process|response to nutrient|aerobic respiration|response to muscle activity|response to starvation|'de novo' AMP biosynthetic process|protein tetramerization|,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity|(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity|",1,2,31900000,2.2%
Q8K0R6,0.169195181,0.5025,15.75271406,-2.593666667,0.026590628,-2.927566684,0.549,3.639,1.21,-0.715,-1.656,-0.012,Q8K0R6,Gltpd2,Q8K0R6_Gltpd2,Q8K0R6,Gltpd2,1,1,1,1,Q8K0R6|J3KMU5,MOUSE,34794.7,2.1,707,707.1,11.01,11.01,,321,Glycolipid transfer protein domain-containing protein 2,cytoplasm|,glycolipid transport|,glycolipid transporter activity|glycolipid binding|,1,1,2780000,2.1%
Q9Z0X4,0.62503481,0.170333333,3.70973319,-0.272666667,0.425624561,-0.85423398,0.066,0.001,0.853,-0.136,0.288,-0.05,Q9Z0X4,Pde3a,Q9Z0X4_Pde3a,Q9Z0X4,Pde3a,1,3,2,2,Q9Z0X4,MOUSE,125994,2,708,708.1,10.99,10.99,,1141,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",cytosol|membrane|integral component of membrane|,oocyte maturation|cAMP catabolic process|diterpenoid metabolic process|cAMP-mediated signaling|cGMP-mediated signaling|regulation of meiotic nuclear division|response to drug|negative regulation of apoptotic process|negative regulation of vascular permeability|positive regulation of vascular permeability|response to cAMP|positive regulation of oocyte development|cellular response to cGMP|cellular response to transforming growth factor beta stimulus|,"3',5'-cyclic-AMP phosphodiesterase activity|cGMP-inhibited cyclic-nucleotide phosphodiesterase activity|cAMP binding|metal ion binding|",2,3,71800000,2.0%
Q059U7,0.326571299,-0.206,9.405229067,0.5525,0.114677203,1.904463033,-0.634,-0.441,,-0.209,-0.017,0.271,Q059U7,Intu,Q059U7_Intu,Q059U7,Intu,1,3,2,2,Q059U7|Q059U7-2,MOUSE,105789,2.6,709,709.1,10.98,10.98,,942,Protein inturned,cytoplasm|cell surface|,nervous system development|regulation of smoothened signaling pathway|negative regulation of keratinocyte proliferation|spinal cord dorsal/ventral patterning|keratinocyte differentiation|hair follicle morphogenesis|cilium assembly|positive regulation of smoothened signaling pathway|negative regulation of cell division|limb development|cilium morphogenesis|,,2,3,221000000,2.6%
Q62056,0.329490318,-0.375,9.082946343,0.668333333,0.123510923,1.848324403,-1.215,-0.337,,-0.247,-0.079,0.003,Q62056,Psg17,Q62056_Psg17,Q62056,Psg17,1,1,1,1,Q62056,MOUSE,53425.2,4,710,710.1,10.95,10.95,,475,MCG130054,,immune response|female pregnancy|,protein binding|heparan sulfate proteoglycan binding|,1,1,227000000,4.0%
Q6P9Q6-2,0.774476598,1.259,2.191044455,-0.7275,0.6038034,-0.55373988,1.608,1.783,,3.517,-0.579,-0.034,Q6P9Q6,Fkbp15,Q6P9Q6-2_Fkbp15,Q6P9Q6-2,Fkbp15,1,3,2,2,Q6P9Q6-2|Q6P9Q6|Q80YW9|Q80YW6|Q80YW7,MOUSE,137952.3,1.9,711,711.1,10.93,10.93,,1216,Isoform B of FK506-binding protein 15,early endosome|membrane|axon|growth cone|actin filament|,protein folding|endocytosis|negative regulation of phosphatase activity|,actin binding|peptidyl-prolyl cis-trans isomerase activity|,2,3,3120000000,1.9%
Q8BXX9,0.711671958,-0.017666667,2.762124518,-0.147333333,0.529404402,-0.666979493,0.229,0.028,-0.089,-0.194,-0.059,-0.021,Q8BXX9,Ccdc169,Q8BXX9_Ccdc169,Q8BXX9,Ccdc169,1,6,1,1,Q8BXX9|D3YWT6|Q8BXX9-2|E9Q3J3,MOUSE,24753.8,4.6,712,712.1,10.92,10.92,,214,Coiled-coil domain-containing protein 169,,,,1,6,122000000,4.6%
Q8VCQ6,0.064953611,-0.28275,23.01845926,2.065666667,0.004990615,5.548834955,,-1.832,,0.365,0.269,0.067,Q8VCQ6,Sgms1,Q8VCQ6_Sgms1,Q8VCQ6,Sgms1,1,2,1,1,Q8VCQ6|E3W996|Q8VCQ6-3|Q8VCQ6-2,MOUSE,49829.3,2.1,713,713.1,10.92,10.92,,419,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Golgi trans cisterna|nucleus|endoplasmic reticulum|plasma membrane|membrane|integral component of Golgi membrane|,sphingomyelin biosynthetic process|apoptotic process|cell growth|phosphorylation|negative regulation of extrinsic apoptotic signaling pathway|,kinase activity|sphingomyelin synthase activity|ceramide cholinephosphotransferase activity|,1,2,62900000,2.1%
Q8CIK8,0.212252355,-0.1262,13.39968919,0.8105,0.04571209,2.637337944,-0.363,-0.862,,0.394,0.188,0.012,Q8CIK8,Rfwd3,Q8CIK8_Rfwd3,Q8CIK8,Rfwd3,1,2,2,2,Q8CIK8,MOUSE,85736.9,6,714,714.1,10.92,10.92,,774,E3 ubiquitin-protein ligase RFWD3,nucleus|cytoplasm|PML body|site of double-strand break|,positive regulation of defense response to virus by host|DNA repair|response to ionizing radiation|protein ubiquitination|mitotic G1 DNA damage checkpoint|activation of mitophagy in response to mitochondrial depolarization|regulation of DNA damage checkpoint|,p53 binding|ubiquitin-protein transferase activity|zinc ion binding|ligase activity|MDM2/MDM4 family protein binding|,2,2,38400000,6.0%
A2CI98,0.880399509,0.0732,1.15581646,0.081166667,0.766334458,0.313656976,0.021,0.028,,0.236,0.094,-0.013,A2CI98,Dytn,A2CI98_Dytn,A2CI98,Dytn,1,4,2,2,A2CI98,MOUSE,75027.4,3.3,715,715.1,10.91,10.91,,653,Dystrotelin,plasma membrane|,,zinc ion binding|,2,4,1780000000,3.3%
Q920R0-2,0.239764543,0.226333333,11.84992347,-0.576,0.065314206,-2.247720961,0.655,0.667,0.221,-0.177,-0.194,0.186,Q920R0,Als2,Q920R0-2_Als2,Q920R0-2,Als2,1,5,1,1,Q920R0-2|Q8C025-2,MOUSE,101241.8,0.8,716,716.1,10.87,10.87,,1651,Isoform 2 of Alsin,ruffle|nucleus|cytoplasm|early endosome|centrosome|cytosol|postsynaptic density|membrane|lamellipodium|axon|dendrite|growth cone|vesicle|neuronal cell body|dendritic spine|protein complex|centrosome|,"behavioral fear response|in utero embryonic development|receptor recycling|response to oxidative stress|endosome organization|lysosomal transport|axonogenesis|neuromuscular junction development|locomotory behavior|protein localization|cell death|vesicle organization|endosomal transport|Rac protein signal transduction|regulation of Rho protein signal transduction|synaptic transmission, glutamatergic|regulation of GTPase activity|positive regulation of GTPase activity|positive regulation of protein kinase activity|neuron projection morphogenesis|regulation of endosome size|protein homooligomerization|positive regulation of protein serine/threonine kinase activity|",GTPase activator activity|protein binding|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|Rac guanyl-nucleotide exchange factor activity|identical protein binding|protein homodimerization activity|protein serine/threonine kinase activator activity|Rac GTPase binding|guanyl-nucleotide exchange factor activity|,1,5,41100000,0.8%
Q8R294,0.946089108,-0.081,0.60883659,0.155,0.869193242,0.173401981,1.298,-1.646,,-0.091,-0.147,0.181,Q8R294,Vmn1r233,Q8R294_Vmn1r233,Q8R294,Vmn1r233,1,2,2,2,Q8R294|Q05A06,MOUSE,36219.2,11.5,717,717.1,10.86,10.86,,319,Vomeronasal type-1 receptor,integral component of plasma membrane|,G-protein coupled receptor signaling pathway|response to pheromone|,pheromone binding|pheromone receptor activity|,2,2,2330000000,11.5%
Q8VGD7,0.310558297,0.202,9.885316874,-2.457333333,0.102675851,-1.926572406,3.136,2.771,-1.615,-1.031,-1.34,-0.709,Q8VGD7,Olfr1395,Q8VGD7_Olfr1395,Q8VGD7,Olfr1395,1,5,1,1,Q8VGD7|Q8VFM4|Q9EPF5|Q8VFM5|Q9EPF6|Q7TRN3|K7N641,MOUSE,36080.7,2.2,718,718.1,10.85,10.85,,317,Olfactory receptor 1395,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|sensory perception of smell|detection of chemical stimulus involved in sensory perception of smell|,G-protein coupled receptor activity|olfactory receptor activity|,1,5,1760000000,2.2%
O88737,0.679569317,-0.184,3.164295666,0.44,0.482581238,0.757971698,-1.324,0.428,,-0.194,0.274,-0.104,O88737,Bsn,O88737_Bsn,O88737,Bsn,1,2,2,2,O88737|O88737-2,MOUSE,420832.3,0.6,719,719.1,10.85,10.85,,3942,Protein bassoon,trans-Golgi network|cytoskeleton|cell surface|postsynaptic density|extrinsic component of membrane|cell junction|axon|dendrite|neuronal cell body|neuron projection terminus|synapse|presynaptic active zone|excitatory synapse|neuronal postsynaptic density|integral component of membrane|,synapse assembly|,protein binding|metal ion binding|,2,2,3180000000,0.6%
S4R1G0,0.275554082,-0.0936,10.86052845,0.578166667,0.082025173,2.166370357,-0.356,-0.525,,-0.022,0.265,0.17,S4R1G0,NotFound,S4R1G0_NotFound,S4R1G0,Dnase2a,1,2,2,2,S4R1G0,MOUSE,16303.3,13.4,720,720.1,10.83,10.83,,149,Deoxyribonuclease II alpha,lysosome|extracellular exosome|,"DNA catabolic process, endonucleolytic|DNA catabolic process|apoptotic DNA fragmentation|erythrocyte differentiation|",deoxyribonuclease II activity|,2,2,81600000,13.4%
Q01853,0.987463289,-0.099666667,0.107583908,-0.017333333,0.975532201,-0.031968875,0.509,0.538,-1.32,-0.212,-0.048,-0.065,Q01853,Vcp,Q01853_Vcp,Q01853,Vcp,1,8,2,2,Q01853,MOUSE,90004.9,3.7,721,721.1,10.82,10.82,,806,Transitional endoplasmic reticulum ATPase,proteasome complex|Hrd1p ubiquitin ligase complex|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|site of double-strand break|myelin sheath|protein complex|perinuclear region of cytoplasm|extracellular exosome|VCP-NSFL1C complex|,"double-strand break repair|ubiquitin-dependent protein catabolic process|ER to Golgi vesicle-mediated transport|activation of cysteine-type endopeptidase activity involved in apoptotic process|cellular response to DNA damage stimulus|protein ubiquitination|protein N-linked glycosylation via asparagine|viral genome replication|translesion synthesis|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|positive regulation of protein complex assembly|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|protein hexamerization|positive regulation of protein catabolic process|ATP metabolic process|protein homooligomerization|aggresome assembly|ER-associated misfolded protein catabolic process|positive regulation of protein K63-linked deubiquitination|positive regulation of Lys63-specific deubiquitinase activity|",protein binding|ATP binding|lipid binding|ATPase activity|protein phosphatase binding|protein domain specific binding|polyubiquitin binding|protein complex binding|deubiquitinase activator activity|K48-linked polyubiquitin binding|MHC class I protein binding|identical protein binding|ADP binding|ubiquitin-like protein ligase binding|poly(A) RNA binding|ubiquitin-specific protease binding|,2,8,944000000,3.7%